Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.6703021413514186,-2.2369547679531676,0.0,0.0,0.0,15/55,8.22%,TAGLN;ACTA2;SLIT3;LMOD1;SYNPO2;COL14A1;MYH11;MYL9;COL15A1;PAMR1;LAMB2;CXCL12;MYLK;COL1A2;EDNRA
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.5583440000013666,-2.004383697744003,0.0,0.004821889667175486,0.01,14/65,8.27%,TWIST2;PRRX1;TRABD2B;SLIT2;LAMC1;LMOD1;COL14A1;SERPINH1;COL5A2;LAMB2;FKBP9;PTPN21;EDNRA;NOTCH3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.7390784614151759,-1.9948589128070453,0.0,0.012858372445801295,0.04,19/57,8.22%,TAGLN;TWIST2;TPM2;ITGA8;JPH2;DKK3;ACTA2;LMOD1;SERPINH1;FOXL1;MYL9;MSRB3;COL5A2;IGFBP7;COL13A1;ADGRA2;CXCL12;COL1A2;EDNRA
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.6478350096117912,-1.9335556713274937,0.0,0.03134228283664066,0.12,20/64,9.52%,TAGLN;PRRX1;ACTA2;LMOD1;COL14A1;CPED1;MYL9;MSRB3;COL5A2;FBLN2;IGFBP7;COL15A1;PAMR1;ADGRA2;CXCL12;MYLK;COL1A2;PRKG1;SPARC;ABCA8
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.634110724568233,-1.8942855105213143,0.0,0.05400516427236544,0.23,21/76,8.22%,TAGLN;TPM2;KCNMB1;PRRX1;ACTA2;LMOD1;SYNPO2;COL14A1;MYH11;MYL9;COL5A2;FBLN2;COL15A1;PAMR1;LAMB2;FKBP9;PTPN21;CXCL12;MYLK;COL1A2;EDNRA
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.8644597365835814,-1.8352371240396896,0.0,0.11572535201221165,0.42,3/9,5.30%,SPRY3;SPRY1;DSTYK
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.5710310989934178,-1.790600169154174,0.0,0.20527473154547063,0.67,29/95,8.27%,TAGLN;TPM2;ITGA8;KCNMB1;JPH2;PRRX1;DKK3;ACTA2;SLIT3;LMOD1;SYNPO2;COL14A1;MYH11;MYL9;MSRB3;COL5A2;FBLN2;NOX4;IRAG1;COL15A1;PAMR1;LAMB2;NEXN;CXCL12;MYLK;COL1A2;PRKG1;EDNRA;NOTCH3
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.8544001531600559,-1.7819179970125167,0.0,0.19649200393740104,0.68,1/10,1.10%,CD4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.8857675748052087,-1.754578745548675,0.0,0.24859520061882504,0.77,1/6,0.14%,SPRY3
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.8411066324932415,-1.7162880024480884,0.0,0.37900052783999316,0.92,3/8,8.62%,PLA2G4C;AKR1C3;MGLL
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.6741705476471965,-1.7088785002509432,0.0,0.3787375156763291,0.94,5/17,7.04%,WDFY4;CD4;NRP1;DOCK8;ETV6
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.9339143059139619,-1.7075924250168115,0.0,0.35039064914808526,0.94,2/6,1.16%,SPRY3;SPRY1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.8887206602622161,-1.6734459562328914,0.0,0.48367262507667946,0.98,1/5,8.31%,RBL1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.8686496489434958,-1.6515341177298526,0.0,0.5889593807764342,1.0,4/12,3.97%,SPRY3;SPRY1;SLIT2;MAPKAP1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.8140042071430852,-1.6488099633171245,0.1111111111111111,0.5696258993489973,1.0,1/6,4.28%,ARSB
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.7348315604130421,-1.6395652755915364,0.0,0.5967088463129664,1.0,5/14,9.74%,OSBPL6;CYP27A1;PER2;AKR1C3;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.7829037945752748,-1.6202318453861482,0.05263157894736842,0.684708332738919,1.0,2/6,2.85%,CACNA1D;MAPK14
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5098442752710309,-1.6152180131631575,0.0,0.6782791465160183,1.0,23/94,8.47%,TAGLN;MCAM;PRRX1;ACTA2;SLIT3;LMOD1;SYNPO2;COL14A1;KCNJ8;COL5A2;INPP4B;FBLN2;COL15A1;PAMR1;ADGRA2;VIM;CXCL12;HEYL;GNB4;COL1A2;EDNRA;NOTCH3;SPARC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.7916923094841062,-1.610783820106764,0.0,0.6740494187377942,1.0,1/11,0.73%,CDK6
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.45554233756430684,-1.6083718234260298,0.0,0.6552948057691484,1.0,18/100,8.47%,TAGLN;TPM2;ITGA8;FGF1;PRRX1;DKK3;ACTA2;LMOD1;COL14A1;MYL9;COL5A2;COL15A1;PAMR1;CXCL12;MYLK;COL1A2;EDNRA;SPARC
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.82506388263373,-1.6073193377281647,0.047619047619047616,0.6314379326063135,1.0,1/5,1.43%,DDI2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.8004139846526966,-1.6041635694813206,0.04,0.6246538887022788,1.0,2/9,3.75%,OSBPL6;CYP27A1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.6079160030447799,-1.6039635313074512,0.0,0.5979143187297602,1.0,3/22,6.28%,PKN1;NRP1;ADGRA2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.5446309063705842,-1.598471303234449,0.0,0.6011289118412105,1.0,18/67,8.47%,TAGLN;TPM2;PRRX1;DKK3;ACTA2;SLIT3;LMOD1;COL14A1;MYL9;COL5A2;PAMR1;LAMB2;CXCL12;MYLK;COL1A2;PRKG1;EDNRA;SPARC
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5628654670267741,-1.5975937922083552,0.0,0.5820985206214245,1.0,17/62,8.47%,TAGLN;PRRX1;DKK3;ACTA2;LMOD1;COL14A1;MYL9;COL5A2;FBLN2;IGFBP7;COL15A1;PAMR1;ADGRA2;CXCL12;COL1A2;EDNRA;SPARC
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.9020899544151869,-1.5961692344048015,0.0,0.570837553675621,1.0,1/8,0.33%,CAV2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.9834067290913021,1.5948279072770752,0.0,0.7060795887347263,0.44,1/5,0.85%,TBC1D20
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.8399516718702436,1.5896422480948698,0.0,0.41860432760701627,0.5,7/23,6.42%,STC1;NKAIN3;SYT1;NEDD4L;SPTBN4;ANK3;SNX6
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.4953628382297824,-1.583450194259978,0.0,0.6218451785594459,1.0,20/76,8.47%,TAGLN;TPM2;PRRX1;DKK3;ACTA2;SLIT3;LMOD1;COL14A1;KCNJ8;PDZRN3;MYL9;COL5A2;IGFBP7;PAMR1;LAMB2;PTPN21;CXCL12;COL1A2;EDNRA;SPARC
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.6920393550304775,-1.5607079498227812,0.0625,0.7163000236617928,1.0,4/11,15.80%,PHLDB2;CORO1C;PTEN;THBS1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.6920393550304775,-1.5607079498227812,0.0625,0.7163000236617928,1.0,4/11,15.80%,PHLDB2;CORO1C;PTEN;THBS1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.9143768104547341,1.560377686351156,0.0,0.6354716298612536,0.79,1/12,0.20%,WWC1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.8001607589067092,1.5508781164977492,0.0,0.6152979273259758,0.88,2/30,0.60%,SRSF12;HNRNPL
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.9412786817760266,-1.5454048618904692,0.0,0.7978620102619703,1.0,2/6,5.47%,BCL2L11;NCK1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.907621976722271,-1.5443079377168814,0.0,0.7786574088348542,1.0,2/7,3.15%,NFU1;NUBPL
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.8818665446265819,-1.5339802978634236,0.06451612903225806,0.8215294520450234,1.0,1/5,2.20%,RPL30
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.9544406014825023,1.5332568103213677,0.0,0.78475702862231,0.95,3/7,3.35%,ADAMTS9;KLF2;EPN1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.8095749956332898,-1.5330640303728669,0.03333333333333333,0.8036482778625809,1.0,1/7,4.13%,PIP4K2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.7937878421632747,-1.531415019540863,0.07692307692307693,0.7890880620048353,1.0,1/5,2.78%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.49704401334732257,-1.5261137590023934,0.0,0.8067710254565612,1.0,5/38,1.66%,SPRY3;IL34;EDN3;SPRY1;FGF1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.8634027151120655,1.5252050641901198,0.024096385542168676,0.8338463714581529,0.98,1/15,0.16%,SRSF12
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.8914673220215398,-1.5238597723375025,0.038461538461538464,0.7793216272894432,1.0,2/5,6.54%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.8914673220215398,-1.5238597723375025,0.038461538461538464,0.7793216272894432,1.0,2/5,6.54%,PHLDB2;DAG1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.80966074302246,1.5218241374601074,0.0,0.7910973351333973,0.99,9/38,3.86%,NELL1;NKAIN3;ELAVL3;DPP10;NXPH1;CRMP1;DNER;ADGRB3;CACNA1B
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.46339326011605964,-1.515142457086513,0.0,0.814899353752657,1.0,18/80,10.45%,NTN4;SPRY1;JPH2;LAMC1;LMOD1;COL5A2;LAMB2;FKBP9;PTPN21;DAG1;HEYL;EDNRA;NOTCH3;ARHGEF17;ITGA7;ZNF423;ADCY6;TNS2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.8257354456813493,-1.5140776876392315,0.08,0.800680961144319,1.0,2/8,4.16%,PLA2G4C;INPP5F
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.8914119257292334,-1.5113947160260717,0.09375,0.8004336847511306,1.0,1/5,1.81%,SLIT2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5264473894392201,-1.509100001578936,0.0,0.7959646162791143,1.0,21/70,8.47%,ITGA8;PRRX1;SLIT2;ACTA2;SLIT3;LMOD1;SYNPO2;COL14A1;MYH11;KCNJ8;MSRB3;COL5A2;COL15A1;PAMR1;ADGRA2;CXCL12;MYLK;COL1A2;PRKG1;EDNRA;SPARC
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.8302816088210773,-1.5032414372167526,0.029411764705882353,0.8197212434198325,1.0,2/9,1.81%,NRP1;SLIT2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.9100811179714254,1.5025220650496431,0.0,1.0,1.0,1/9,0.16%,SRSF12
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.8388261338856744,1.4992445126939127,0.0,1.0,1.0,3/15,1.44%,STC1;ADAMTS9;MCC
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.9100581863568189,1.4969805187753091,0.0,1.0,1.0,1/10,0.16%,SRSF12
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.8043293768789086,-1.4961303074991865,0.038461538461538464,0.8241047794809011,1.0,3/7,7.23%,ZDHHC15;ZDHHC21;ZDHHC3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.8043293768789086,-1.4961303074991865,0.038461538461538464,0.8241047794809011,1.0,3/7,7.23%,ZDHHC15;ZDHHC21;ZDHHC3
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.7372289069869462,-1.4960906863421137,0.09523809523809523,0.805791339936881,1.0,2/12,3.75%,OSBPL6;CYP27A1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.8212632185449371,-1.4936332450845677,0.06060606060606061,0.8042073375341375,1.0,3/6,13.77%,ATP2B4;DAB2IP;ADAMTS12
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.7215697705729542,-1.492093858777868,0.08333333333333333,0.7957143884811291,1.0,4/12,12.03%,JPH2;RYR2;AFG3L2;MCU
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.9526430324814171,1.4848078568138914,0.0,1.0,1.0,1/5,0.42%,SOD1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.857401625822662,1.4838174550505172,0.0,1.0,1.0,4/19,3.26%,ADAMTS9;GJA1;NRG1;SGCZ
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.9210238295500767,-1.4832153237863537,0.030303030303030304,0.8339860003518933,1.0,3/5,5.91%,NSUN3;TFB1M;DIMT1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.7831907381863046,1.4831519331997836,0.0125,1.0,1.0,9/22,9.54%,SLC2A3;BTD;MMUT;MTHFD2L;SLC23A2;PANK2;ALDH1L1;SLC2A1;MCCC2
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.7706444546521435,1.482635364971128,0.011111111111111112,1.0,1.0,12/39,14.07%,SOD1;SLC23A2;GNPAT;CADM1;DHRS3;CACNA1B;ESR2;SOD2;ACSL4;SLC25A4;SIAH1;PABPC1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.7960304782203244,1.4824144417488403,0.0,0.948164019158061,1.0,4/24,1.97%,NELL1;SRGN;ANKH;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.9690835463554948,1.4797314510391877,0.0,0.9500553037707434,1.0,1/5,0.19%,NELL1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6978633283598307,-1.4789914680305873,0.05555555555555555,0.8407801084968847,1.0,2/15,6.17%,WDFY4;DOCK8
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.8404284527270947,-1.4789014242808074,0.0,0.824736008673695,1.0,1/7,1.04%,PRPSAP1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.8787724995653463,-1.4747854603796013,0.04,0.8342814592775782,1.0,1/5,0.48%,FGF13
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.9864118672802099,1.4693398528866666,0.0,1.0,1.0,2/5,1.07%,TAF7;TAF1B
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5995926514088048,-1.4677363877972707,0.1,0.8636746223090859,1.0,1/13,0.48%,FGF13
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.8114779497821353,-1.4669510584562777,0.09375,0.8513819529326074,1.0,3/5,8.59%,PGF;CXCL12;NTF3
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.9376462312906149,1.4654024178064669,0.0,1.0,1.0,4/8,3.97%,SYT1;PLAA;NEDD4L;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.9376462312906149,1.4654024178064669,0.0,1.0,1.0,4/8,3.97%,SYT1;PLAA;NEDD4L;RIMS2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.9469016453811465,1.4600667439585215,0.0,1.0,1.0,2/6,4.64%,DDX3X;AGO2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.8168276420126905,-1.4595453707411195,0.10714285714285714,0.8800841585126219,1.0,1/6,4.13%,PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.753352694368525,-1.4594325333957636,0.16666666666666666,0.864783994127618,1.0,4/7,10.75%,NRP1;BAIAP2L2;NTF3;CDC42
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.921907806914247,1.4578316097805464,0.014084507042253521,1.0,1.0,3/7,5.04%,KCNE4;KCNQ1;NOS1AP
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.8404244087105024,-1.4570042771567961,0.0,0.8603628849003115,1.0,1/5,4.42%,SNAPC3
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.7264824104967094,-1.4567369960467966,0.04,0.8476374467561116,1.0,4/10,9.72%,FOXQ1;GPRC5C;AKR1C3;SPP1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.9593879612426199,1.4561051188682408,0.0136986301369863,1.0,1.0,1/5,0.84%,SYT1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.7729399818153547,1.4558639563042521,0.010869565217391304,1.0,1.0,3/26,6.79%,CD44;MID1;NCAM1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.9009990842387078,1.4557259003873033,0.02631578947368421,1.0,1.0,1/7,0.95%,AKAP8
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.8136323295516376,1.4529568596545042,0.047058823529411764,1.0,1.0,2/16,1.40%,STC1;GJA1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.9338631207342738,1.4523443628043822,0.014084507042253521,1.0,1.0,2/6,3.50%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.8251966937493052,1.450984853850757,0.02666666666666667,1.0,1.0,4/12,14.76%,SRSF12;PTBP2;TMBIM6;SRSF10
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.5563436920182961,-1.4509359696063793,0.0,0.8667762356891657,1.0,2/27,0.73%,SPRY3;CDK6
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.8993568205299406,1.4490502784154289,0.0136986301369863,1.0,1.0,1/10,3.26%,SGCZ
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.8294136397981878,1.4434770388373745,0.03571428571428571,1.0,1.0,4/15,5.07%,STC1;PRKACA;KCNQ1;PDE4B
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.8582255560512811,1.4433021903597296,0.0,1.0,1.0,1/11,0.19%,NELL1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.7016791551760759,-1.4419340933780296,0.043478260869565216,0.8986694708518922,1.0,4/8,8.20%,GLB1;GPC6;HGSNAT;GPC3
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.8996644124637915,-1.4407717599320524,0.029411764705882353,0.8764772562236358,1.0,3/5,8.22%,EDN3;ACTA2;EDNRA
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.8996644124637915,-1.4407717599320524,0.029411764705882353,0.8764772562236358,1.0,3/5,8.22%,EDN3;ACTA2;EDNRA
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.8276046519260495,-1.4377517353267006,0.1724137931034483,0.8775839194259384,1.0,1/6,0.16%,ATP10A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.9300749063131573,1.437677482540806,0.0,1.0,1.0,2/5,2.62%,CD44;KDM1A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.9300749063131573,1.437677482540806,0.0,1.0,1.0,2/5,2.62%,CD44;KDM1A
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8774381028640137,-1.4375967905009204,0.0,0.865031698705037,1.0,2/5,2.71%,PARP9;ZNF618
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.7665609080964741,1.4369616690293945,0.012048192771084338,1.0,1.0,2/20,0.48%,STC1;ADAMTS9
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6111199621066854,-1.4355544640498963,0.0,0.857994992653038,1.0,4/16,10.48%,OSBPL6;CYP27A1;PER2;ACACA
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5391999370461946,-1.4343332807963096,0.07692307692307693,0.8523617273207127,1.0,3/19,3.97%,SPRY3;SPRY1;MAPKAP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.8139384596277468,1.433833308240802,0.025,1.0,1.0,2/15,1.75%,STC1;GRIN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6555982070631595,-1.433126949046968,0.0,0.8442690453618168,1.0,3/15,4.31%,CTNNA3;FGF13;RYR2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.7164301424047484,1.4314628747794773,0.03333333333333333,1.0,1.0,5/29,2.93%,WWC1;SLC22A6;CRMP1;SPTBN4;GLIS3
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.9097466522566005,1.429396760733751,0.05405405405405406,1.0,1.0,1/7,1.40%,GJA1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.8295510411563782,1.4286647636117795,0.0,1.0,1.0,6/19,3.52%,ADAMTS9;KLF2;RHOJ;CEMIP2;EPN1;ITGA5
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.8750685590025943,1.4227433663722504,0.02564102564102564,1.0,1.0,1/8,1.77%,UBA5
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.8529463586408389,1.4211239615114721,0.037037037037037035,1.0,1.0,3/11,8.45%,MTMR9;SYMPK;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.8991642120587631,1.4202997019867145,0.013157894736842105,1.0,1.0,3/9,2.62%,CD44;TPT1;KDM1A
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7891897892591173,-1.418897572076637,0.0967741935483871,0.9095379345337877,1.0,1/5,1.29%,JADE3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.7734115018206473,1.4177113265312182,0.023255813953488372,1.0,1.0,8/28,10.30%,EPM2A;TSC2;DDIT4;RHEB;SLC38A9;SEC13;UBR1;TNFAIP8L1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.698511692652984,1.4174533342494433,0.043478260869565216,1.0,1.0,10/39,14.42%,IPO9;TSC2;NUP153;IPO5;SEC13;CSE1L;NUP88;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.8803319506621132,1.4171300802563247,0.012658227848101266,1.0,1.0,3/9,7.43%,RIMS2;RNF10;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.654244383755786,-1.4165267768579277,0.1111111111111111,0.9103444051058659,1.0,1/11,0.48%,FGF13
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.8031408717321087,-1.4158402587363403,0.13793103448275862,0.9010644256313146,1.0,3/6,5.91%,NSUN3;TFB1M;DIMT1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.621393736906496,-1.413748994486339,0.0625,0.8993513070663305,1.0,3/11,5.72%,JPH2;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.6671530683763418,-1.4133932794949213,0.1111111111111111,0.8896726005633643,1.0,2/10,2.05%,NRP1;PGF
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.8861647943219702,1.4133649824136565,0.03614457831325301,1.0,1.0,3/8,7.07%,GJA1;KDM1A;EIF2AK2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.8259238300039291,-1.413242084467837,0.0967741935483871,0.8777178608055821,1.0,1/6,0.93%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.885347051703572,1.4131680160462148,0.029850746268656716,1.0,1.0,2/6,5.07%,NOS1AP;PDE4B
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.7931969321392193,1.4118901243247464,0.0,1.0,1.0,4/19,5.16%,VAPB;MYDGF;WIPI1;ACADVL
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.8019199356646307,-1.4112911021360892,0.15789473684210525,0.8741491487041148,1.0,2/7,8.62%,PLA2G4C;MGLL
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.8711081921041939,1.4107315672410787,0.024390243902439025,1.0,1.0,5/8,8.45%,TAF7;HDAC2;AP2A1;SELENOS;TGFB1
prerank,MSigDB_Hallmark_2020__Glycolysis,0.6792856285783307,1.4102663624005887,0.0,1.0,1.0,26/76,23.62%,STC1;SOD1;CD44;COG2;DDIT4;ENO1;RARS1;STMN1;EGFR;GLRX;PDK3;HDLBP;AK3;HSPA5;PGK1;ADORA2B;ANGPTL4;GPC4;ME2;MXI1;IRS2;ECD;TPI1;UGP2;FUT8;GCLC
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.9279685336486756,1.4093402256905272,0.0,1.0,1.0,2/8,3.97%,SYT1;RIMS2
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.9505203821109439,1.409136267718909,0.014705882352941176,1.0,1.0,1/6,4.16%,RPS21
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.858295196387316,1.4088778853148574,0.012987012987012988,1.0,1.0,2/8,11.65%,KDM1A;KDM3A
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.8069428976940182,-1.4088712827758454,0.16666666666666666,0.8732833151281871,1.0,4/5,16.78%,MCAM;SULF2;ITGA3;XPNPEP3
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.7948306861899143,-1.407241831107079,0.20588235294117646,0.8707689820296637,1.0,3/5,17.35%,COL13A1;FOXC1;BMPR1B
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.9618696656149477,1.406777600280244,0.013888888888888888,1.0,1.0,1/5,0.33%,TAF7
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.6955299076568494,1.4059150752873153,0.021505376344086023,1.0,1.0,19/55,18.10%,CSF1;NFKBIA;ITGA5;RAF1;PDE4B;SEMA4D;IL18;SLC7A2;EIF2AK2;TNFRSF1B;SELENOS;F3;HIF1A;PTPRE;SLC1A2;ACVR1B;ACVR2A;ADORA2B;ABCA1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.47705089943279183,-1.4056925699759175,0.0,0.8662905462580799,1.0,15/59,8.47%,TAGLN;PRRX1;DKK3;ACTA2;LMOD1;COL14A1;MYL9;COL5A2;FBLN2;COL15A1;PAMR1;CXCL12;COL1A2;EDNRA;SPARC
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.8107085624303777,-1.404941575353547,0.06896551724137931,0.8581711168697772,1.0,2/6,6.50%,DERL1;VCP
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.7866882087250643,1.4011766193686275,0.024691358024691357,1.0,1.0,5/21,9.80%,CD44;DDX3X;RAF1;NAIP;RNF34
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.7109353416894785,1.40111514454766,0.03260869565217391,1.0,1.0,9/34,9.54%,BTD;MTHFD2L;PANK2;CPD;ACOT11;ALDH1L1;SGPL1;CPM;MCCC2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8301130586627421,1.4003165876440913,0.024096385542168676,1.0,1.0,6/10,14.53%,NR4A3;ACADVL;PPARA;PPARGC1A;ACADL;PDK4
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.899955044841662,1.3991689576113706,0.028169014084507043,1.0,1.0,2/7,6.02%,CSF1;IL18
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.7862518992320519,1.3987972203306578,0.04878048780487805,1.0,1.0,5/18,14.04%,NELL1;FMN2;EGFR;CST3;MDM4
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.78365368195534,1.3973293991250046,0.08571428571428572,1.0,1.0,4/10,11.68%,DDX3X;HABP4;CDC123;UHMK1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.7205065803220901,1.39680427385491,0.03409090909090909,1.0,1.0,4/26,2.37%,RHOB;RIPOR1;CDC42EP4;RHOJ
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.7816373347339712,-1.3965069431707449,0.1111111111111111,0.8883404425296374,1.0,5/8,20.87%,CACNA1D;HCN2;CACNB2;SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5619034727007368,-1.395291065930579,0.07142857142857142,0.8834434309202275,1.0,4/18,12.31%,SDAD1;MRPL1;RPL6;RPL23A
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.8867919876021684,1.3952242722840686,0.02702702702702703,1.0,1.0,1/7,9.31%,TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.7445740831225665,1.3950654868981154,0.010752688172043012,1.0,1.0,10/39,12.56%,LPIN1;GJA1;KDM1A;SCD;IL18;PPARGC1A;CEBPB;PRLR;KDM3A;ACADL
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.7478338938445556,1.394665976551928,0.0,1.0,1.0,12/31,12.45%,CADM1;CDH18;CDH2;CSF1R;NECTIN2;PRKCI;CDH12;TGFB1;CTNND2;CADM2;CDH10;CDH20
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.9228727627218094,1.3938137679642837,0.0,1.0,1.0,2/7,4.09%,KLF15;BASP1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.67895466733636,1.3933888982558607,0.0,1.0,1.0,16/76,12.81%,STC1;WWC1;SRGN;HS3ST5;GJA1;MCC;RHEB;WWC2;ACOT11;ADAM17;TGFB1;EGFR;ROBO1;CHSY1;ROCK2;MAP2K6
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.6677694354396471,-1.393182400945085,0.13333333333333333,0.8815619784013581,1.0,2/12,0.62%,CAV2;EDN3
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.894834784212781,1.392460576721861,0.01282051282051282,1.0,1.0,1/6,1.57%,KCNC2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.663337352355751,1.3922725907951368,0.010309278350515464,1.0,1.0,24/91,16.10%,STC1;SLC2A3;MTHFD2L;PDK1;DDIT4;ACTR3;ENO1;ETF1;SEC11A;SCD;GBE1;SLC2A1;TBK1;PPA1;GLRX;FADS2;GSR;GMPS;PSMA4;HSPA5;CD9;PGK1;PSMD14;CANX
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.8376867503141789,1.392057733327314,0.05405405405405406,1.0,1.0,1/10,2.47%,RAD21
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.8409533903437622,-1.3919257008441517,0.07407407407407407,0.8763933293846605,1.0,3/5,7.40%,HECW2;CDC27;TPR
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8465633638103627,-1.391618285599531,0.15,0.8668816765061098,1.0,2/7,6.54%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.8264891959791748,1.3909089523080334,0.0273972602739726,1.0,1.0,4/9,12.95%,PSMB1;PSMB2;PSMA7;PSMA4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.7352407320131953,1.3906384591479728,0.024691358024691357,1.0,1.0,6/31,10.19%,CD44;DDX3X;RAF1;DELE1;NAIP;EPHA7
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.7297729551587806,1.3895371543130317,0.04597701149425287,1.0,1.0,10/31,14.42%,IPO9;TSC2;NUP153;IPO5;SEC13;CSE1L;NUP88;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8883541764021762,1.3894562597979159,0.05194805194805195,1.0,1.0,1/6,0.73%,COL4A6
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.762302820482694,1.3889613197452444,0.023529411764705882,1.0,1.0,6/16,13.52%,HDAC2;GRIN1;RAB27A;PPARA;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.8929883643031287,1.3871812764115805,0.05,1.0,1.0,3/8,7.80%,GRIN1;RAB27A;PPARA
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.8413708248381397,1.387025345629086,0.038461538461538464,1.0,1.0,4/10,11.23%,KCNC2;GRIN1;FARSB;GRIN2B
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.7967914851721489,1.38669363847865,0.11688311688311688,1.0,1.0,3/13,3.50%,SOD1;SGCZ;KCNQ1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.7197999616163228,1.3861908664383558,0.06741573033707865,1.0,1.0,6/28,11.99%,SOD1;SEC11A;CPD;ENPEP;CPM;GSR
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.8903474888675427,1.3855604053419484,0.0273972602739726,1.0,1.0,3/7,7.80%,SNX6;ERRFI1;PPARA
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.8905001362209622,1.3847521825657674,0.07894736842105263,1.0,1.0,1/8,0.67%,KLF2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.7814204800281982,-1.3845657820050938,0.06896551724137931,0.8953610066326334,1.0,2/8,3.15%,NFU1;NUBPL
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.6931541063070444,1.3841627645647523,0.03225806451612903,1.0,1.0,6/55,4.30%,STC1;GPR161;MID1;COL4A6;GJA1;TENM3
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7122433058615748,1.3835316101742554,0.046511627906976744,1.0,1.0,6/27,5.37%,SOD1;ADGRV1;SPTBN4;KCNQ1;HOMER2;NDUFB9
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.8548696700093846,1.3832007027574458,0.024390243902439025,1.0,1.0,3/7,8.45%,CD44;CEMIP2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5629306733563137,-1.3830489904607137,0.125,0.8921643953243024,1.0,4/23,2.68%,SPRY3;SPRY1;TNIP1;WNK2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.7327666198135295,1.382955526253394,0.08860759493670886,1.0,1.0,10/22,13.86%,SOD1;PDLIM1;MGST1;SOD2;SELENOS;OXSR1;MBP;GLRX;GSR;NDUFS2
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.8665164422580218,1.3824852046702967,0.05128205128205128,1.0,1.0,3/10,9.23%,ZC3H7B;AGO2;ZC3H7A
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.7573124871912725,1.3824234338943906,0.05333333333333334,1.0,1.0,4/17,8.45%,SOD1;GRIN1;RAB27A;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.7993128874067896,1.382359872440156,0.011363636363636364,1.0,1.0,5/22,5.78%,SYT1;PLAA;NEDD4L;RIMS2;SEMA4D
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5030668712803407,-1.3806770080488344,0.0,0.8942619848629924,1.0,9/41,7.60%,NTN4;CAV2;JPH2;ACTA2;MYH11;MYL9;LAMB2;FKBP9;MYLK
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7122630084707923,1.3799285887195947,0.03488372093023256,1.0,1.0,6/26,5.37%,SOD1;ADGRV1;SPTBN4;KCNQ1;HOMER2;NDUFB9
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.9275819622929082,1.378770996970643,0.0,1.0,1.0,2/5,3.50%,KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.8824228329933093,1.378565279051941,0.028169014084507043,1.0,1.0,3/5,7.85%,SOD1;KLF2;SOD2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.9071641620659753,1.378047848348009,0.0,1.0,1.0,3/7,4.70%,WWC1;SOD1;WWC2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5815973339837143,-1.3762491357945255,0.12,0.9040482441109013,1.0,3/17,2.11%,CDK6;BTBD2;ERCC6
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.767422879282557,-1.3762016082348962,0.15,0.8937677330215159,1.0,3/8,12.24%,DDB2;CUL4B;XPC
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.6736190040721891,1.3760801534045601,0.0,1.0,1.0,15/62,15.97%,STC1;CD44;ADAMTS4;ANKH;GJA1;SUFU;PAPSS1;MMP16;ZBTB16;DEAF1;PAPSS2;TBX3;FGFR2;PPIB;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.8598812677295429,1.3758837046700974,0.013157894736842105,1.0,1.0,2/9,3.19%,CD44;NR4A3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.7969590535436626,-1.3757726107346897,0.20689655172413793,0.8852551075328084,1.0,1/5,2.33%,ATM
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.7867250581717666,1.3756909502129275,0.04,1.0,1.0,5/13,16.11%,ANKH;TGFB1;CEBPB;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.8947232608321974,1.3750403263288677,0.057971014492753624,1.0,1.0,1/5,2.62%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.74742075924428,1.3748669402678155,0.021052631578947368,1.0,1.0,10/39,11.09%,SYT1;PLAA;DDX3X;NEDD4L;RIMS2;SEMA4D;ADAM17;EGFR;SDCBP;ADNP2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.7988762106018243,1.3740432906124278,0.025,1.0,1.0,4/17,10.05%,OS9;AMFR;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8774208255270035,1.3729703901414507,0.038461538461538464,1.0,1.0,1/7,0.67%,KLF2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.7480091266868416,1.3728761438532902,0.06172839506172839,1.0,1.0,1/12,1.85%,DDX3X
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.8634454214229081,1.3725900365010675,0.043478260869565216,1.0,1.0,2/8,5.07%,NOS1AP;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.8921360819230058,1.3722961580163995,0.03896103896103896,1.0,1.0,2/7,2.62%,GJA1;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.7726979585186298,-1.3717461031194271,0.15789473684210525,0.8951377649558806,1.0,1/8,1.81%,SLIT2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.8207522994339456,1.3717434341433687,0.037037037037037035,1.0,1.0,1/9,0.56%,CD44
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.788939495892664,1.3716812786663892,0.07692307692307693,1.0,1.0,4/13,7.80%,CSF1;NFKBIA;IL18;PPARA
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.7109555593810208,1.3715281074145724,0.08433734939759036,1.0,1.0,3/20,10.19%,DDX3X;ERRFI1;EPHA7
prerank,PanglaoDB_Augmented_2021__Monocytes,0.7391895074772747,1.3714207519308517,0.047058823529411764,1.0,1.0,6/19,11.37%,CD44;CSF1R;ZFP36L2;TNFRSF1B;NFKBIZ;CEBPB
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.9003812019608429,1.3710384367855144,0.04054054054054054,1.0,1.0,1/5,6.72%,ERRFI1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.90809743881149,1.3708072921548808,0.03896103896103896,1.0,1.0,3/6,5.54%,OS9;UBAC2;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.90809743881149,1.3708072921548808,0.03896103896103896,1.0,1.0,3/6,5.54%,OS9;UBAC2;UBE2J1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.90809743881149,1.3708072921548808,0.03896103896103896,1.0,1.0,3/6,5.54%,OS9;UBAC2;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.978083137279532,1.3704874769948276,0.0,1.0,1.0,2/5,0.99%,TAF7;KLF15
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.8006426949453618,1.3704300488840726,0.05263157894736842,1.0,1.0,7/16,14.53%,PANK2;PDK1;ACADVL;PPARA;PDK3;ACADL;PDK4
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.6069709251349023,-1.369652831752163,0.10526315789473684,0.895478487746345,1.0,2/19,4.13%,TTC7A;PIP4K2B
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.8144326567473427,1.3691777999775228,0.075,1.0,1.0,3/11,7.54%,TBC1D20;SEC24A;SEC13
prerank,PanglaoDB_Augmented_2021__Interneurons,0.6483599957650621,1.3690395755779339,0.02,1.0,1.0,20/96,11.40%,SYT1;PHYHIPL;ELAVL3;KCNC2;PCBP3;NXPH1;DHRS3;DNAJC6;ADGRB3;CACNA1B;PRKCB;HIVEP2;CTNNA2;SNAP25;ACSL4;KCNQ5;CTNND2;CADM2;TRIM9;CCN2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.8959991349934291,1.3686640699102992,0.05555555555555555,1.0,1.0,1/6,4.64%,AGO2
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.8103233960479782,1.367708538427233,0.025974025974025976,1.0,1.0,4/10,11.69%,SLC2A3;SLC23A2;SLC2A1;GLUD1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.8711429900354302,1.367465872169084,0.014285714285714285,1.0,1.0,3/6,7.58%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7803905720675759,1.3667612214146583,0.0125,1.0,1.0,4/22,7.63%,CD44;DDX3X;RAF1;NAIP
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.8505708622193833,1.3665199887977033,0.037037037037037035,0.9957532661643576,1.0,3/8,8.45%,CD44;CEMIP2;TGFB1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.7025332764934726,1.3656064872936364,0.060240963855421686,0.9991966480290818,1.0,7/25,8.45%,PLAA;PDE4B;IL18;CTR9;TNFRSF1B;SELENOS;TGFB1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.773086261907656,1.3653831206194056,0.04938271604938271,0.993681995046482,1.0,4/14,4.30%,CADM1;PTPRD;TENM2;TENM3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.7980706436301628,1.3641403887417964,0.03571428571428571,1.0,1.0,3/13,7.75%,CD44;ITGA5;ADAM17
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.816332135338625,1.363350702642371,0.10526315789473684,1.0,1.0,4/10,15.07%,ADAMTS9;ROBO2;ROBO1;HECTD1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.9315774601992028,1.3622514676816435,0.0,1.0,1.0,1/5,2.99%,CCP110
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.7758191290272759,-1.3622149762788835,0.12903225806451613,0.9218817190057045,1.0,2/7,7.17%,PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.8576945068143069,1.361243984089663,0.0410958904109589,1.0,1.0,1/8,0.11%,STC1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.7577001739828535,-1.3597365193651374,0.21621621621621623,0.9249642265903584,1.0,2/5,6.48%,ERCC6;APLF
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.8309678773189214,-1.359535098006003,0.16666666666666666,0.9061048838402955,1.0,3/5,2.43%,NRP1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.8309678773189214,-1.359535098006003,0.16666666666666666,0.9061048838402955,1.0,3/5,2.43%,NRP1;SLIT2;SLIT3
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.840538484228628,1.358665610527557,0.0375,1.0,1.0,1/8,0.16%,SRSF12
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.7067584429528834,1.3555703557914154,0.056179775280898875,1.0,1.0,7/31,10.13%,LPIN1;GNPAT;ACOT11;PPARA;SGPL1;ACSL4;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.6858689607096902,-1.355434156449299,0.18181818181818182,0.9137227135630852,1.0,1/8,1.10%,CD4
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8300230807786804,1.3554089013741897,0.09876543209876543,1.0,1.0,1/8,3.80%,ADGRB3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.9031801064176497,1.3551471866018154,0.04411764705882353,1.0,1.0,1/5,0.11%,STC1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.6601738471251993,1.3550472868838688,0.043478260869565216,1.0,1.0,10/53,11.04%,SRGN;CSF1;DARS1;IL18;RARS1;PRKCB;TGFB1;APBB1;EGFR;HIF1A
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.8966239879154372,1.354534072999713,0.05714285714285714,1.0,1.0,2/5,6.17%,LPIN1;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.883788139854922,1.3544382498355978,0.04285714285714286,1.0,1.0,1/6,0.95%,AKAP8
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.828521447026596,1.3542886508223788,0.05128205128205128,1.0,1.0,1/9,2.19%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.7052300798887995,1.3531262912058888,0.010869565217391304,1.0,1.0,12/35,16.24%,SOD1;CSF1;SNX6;TNFRSF1B;NAIP;PRKCI;SOD2;PPARGC1A;PTPRZ1;LRRK2;UNC5B;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.8198563770685146,1.3523550542160656,0.1267605633802817,1.0,1.0,3/9,12.44%,SRGN;TGFB1;ROCK2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7516066485121911,-1.352147867519375,0.17391304347826086,0.910094392027307,1.0,2/6,10.56%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7516066485121911,-1.352147867519375,0.17391304347826086,0.910094392027307,1.0,2/6,10.56%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.8904686357595546,1.3521206285334093,0.058823529411764705,1.0,1.0,1/6,0.42%,SOD1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.890416643020678,1.3494162687329085,0.01282051282051282,1.0,1.0,3/7,7.58%,NR4A3;PRKCB;SLC2A1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.7898136442398858,1.3486324498023672,0.07894736842105263,1.0,1.0,3/8,13.17%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.7881928667835156,1.3465783882092461,0.04878048780487805,1.0,1.0,7/15,11.04%,DDX3X;CSF1R;IL18;EIF2AK2;ADAM17;MBP;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.7711274932177985,1.3462627714400657,0.0641025641025641,1.0,1.0,3/13,6.76%,GPR161;SUFU;BTRC
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.8152326439686318,1.346231027223737,0.013513513513513514,1.0,1.0,4/14,2.79%,ELAVL3;GRIN1;NXPH1;DNER
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.7731182233352026,1.3458845889921602,0.12658227848101267,1.0,1.0,4/16,10.84%,ZC3H7B;AGO2;ZC3H7A;TUT7
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5976713658980608,-1.3449448913972069,0.047619047619047616,0.933970506758419,1.0,2/10,2.12%,ERCC6;PARP9
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.7842980510528433,1.3447091945892162,0.10256410256410256,1.0,1.0,4/11,11.23%,GRIN1;DELE1;EPHA7;GRIN2B
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.7066582735009164,1.344292275078717,0.010869565217391304,1.0,1.0,3/32,6.79%,CD44;MID1;NCAM1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.6654790285115006,1.342909014652587,0.05319148936170213,1.0,1.0,13/55,8.86%,ELAVL3;FAT3;CRMP1;FMN2;PTPRD;LSAMP;ADGRB3;CACNA1B;DCLK1;PCDH17;ROBO2;CTNNA2;SNAP25
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9292186915280747,1.3427140852745032,0.028169014084507043,1.0,1.0,1/5,0.67%,KLF2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8431960789268518,1.3422379978612005,0.11428571428571428,1.0,1.0,1/7,0.42%,SOD1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.8174174842490246,1.3401031312847937,0.02631578947368421,1.0,1.0,4/13,10.05%,OS9;AMFR;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.7056327786887084,1.3398971096608068,0.05319148936170213,1.0,1.0,11/43,14.87%,LPIN1;GJA1;KDM1A;SCD;IL18;PPARGC1A;CEBPB;PRLR;KDM3A;ACADL;INSR
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.823167418989713,1.338247741798262,0.0375,1.0,1.0,1/11,0.39%,HS3ST5
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.7856831635265102,1.338092339582752,0.09090909090909091,1.0,1.0,2/11,10.84%,AGO2;TUT7
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7851876786527702,1.3378171512353105,0.06097560975609756,1.0,1.0,1/10,1.99%,PDLIM1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7851876786527702,1.3378171512353105,0.06097560975609756,1.0,1.0,1/10,1.99%,PDLIM1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.8910159670727829,1.3371062854259637,0.06493506493506493,1.0,1.0,1/5,0.73%,COL4A6
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.7652370350636835,1.3367450596923238,0.09333333333333334,1.0,1.0,4/18,7.57%,GJA1;NR4A3;IL18;DNMT1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.687183377522249,1.3365142533076295,0.07692307692307693,1.0,1.0,12/37,20.50%,TBC1D20;SEC24A;VAPB;CSNK1D;SEC13;VAPA;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.887734324832073,1.3362164162482026,0.014492753623188406,1.0,1.0,2/6,6.72%,SNX6;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.7122825423225003,1.3361640261300043,0.0449438202247191,1.0,1.0,3/28,3.72%,PLAA;NEDD4L;RAB27A
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.8427415861026107,1.3353801529499543,0.06756756756756757,1.0,1.0,2/9,10.84%,AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.8833285160816067,1.3336924441203228,0.11267605633802817,1.0,1.0,1/6,0.84%,SYT1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.7295944671782103,1.333169544619657,0.09523809523809523,1.0,1.0,4/22,8.45%,NFKBIA;KDM1A;HABP4;TGFB1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.4173135025378695,-1.332456063469996,0.0,0.9861007899155038,1.0,16/78,9.24%,TAGLN;PRRX1;DKK3;SLIT3;LMOD1;COL14A1;PDZRN3;COL5A2;IGFBP7;COL15A1;PAMR1;CXCL12;COL1A2;EDNRA;SPARC;COL10A1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.8170149036574553,1.3324090419442727,0.08536585365853659,1.0,1.0,2/11,3.06%,SRSF12;STRAP
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.8183498944314606,1.332203910993194,0.036585365853658534,1.0,1.0,1/12,0.23%,RNMT
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.8183498944314606,1.332203910993194,0.036585365853658534,1.0,1.0,1/12,0.23%,RNMT
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.7921565358559749,1.3304083122956007,0.07407407407407407,1.0,1.0,4/10,15.18%,PDK1;CD38;CD9;PPIB
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.767788826326731,1.3302593589936287,0.13924050632911392,1.0,1.0,4/15,12.17%,PLAA;CTNNA2;NEXMIF;ULK4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8095353750651133,-1.3302421573987468,0.21739130434782608,0.9860764369373867,1.0,1/5,0.48%,FGF13
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.6788800032353045,1.3302163657116604,0.07526881720430108,1.0,1.0,9/44,14.24%,NELL1;DDX3X;GIGYF2;IGF2BP2;EIF2AK2;CNOT8;EIF4ENIF1;CST3;CAMK2N1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.7283917061197277,1.3300721977901475,0.03571428571428571,1.0,1.0,7/23,8.98%,CADM1;TENM3;CDH2;ROBO2;NECTIN2;KIRREL3;ROBO1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.757893687523044,-1.3298078410044394,0.25,0.9784139290999445,1.0,1/5,0.33%,CAV2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.8751642114673879,1.3290170754641168,0.1038961038961039,1.0,1.0,2/6,11.04%,NR4A3;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.8030412134972884,1.3283414219148577,0.10810810810810811,1.0,1.0,3/7,13.17%,EAPP;RNF168;TCERG1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.457482285542904,-1.3279337046232766,0.0,0.9763853841749263,1.0,13/68,8.22%,TPM2;LMCD1;JPH2;PRRX1;LMOD1;PDZRN3;COL5A2;LAMB2;FKBP9;PTPN21;COL1A2;PRKG1;EDNRA
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.6881044707443247,1.3279233090284448,0.04395604395604396,1.0,1.0,14/52,16.39%,IPO9;TSC2;TOR1AIP2;NUP153;IPO5;SEC13;CSE1L;NUP88;NUP133;EIF4ENIF1;TBRG1;MDM2;STAT3;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.7780650008595972,1.3278747829555146,0.09523809523809523,1.0,1.0,1/14,0.20%,WWC1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.7238562795612342,1.3275815817959598,0.058823529411764705,1.0,1.0,5/22,14.38%,DARS1;RARS1;FARSB;PPA1;YARS1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.8107885611981632,1.3269973098928491,0.09210526315789473,1.0,1.0,3/11,7.57%,KDM1A;CTR9;DNMT1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8088347285021869,1.3269545311926942,0.1282051282051282,1.0,1.0,3/10,7.75%,SNX6;ERRFI1;ADAM17
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.6618344072552547,1.3257844748042462,0.02127659574468085,1.0,1.0,18/74,20.58%,NFKBIA;CD38;PTPN1;PDE4B;PSMB2;PELI1;EIF2AK2;SOD2;ZNFX1;C1R;HIF1A;CFH;STAT3;LATS2;PTPN2;IFIT3;IFITM3;MARCHF1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6659341359238024,-1.3256140651878767,0.08333333333333333,0.9774859830157684,1.0,2/10,2.31%,SCN1A;CACNA1D
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.6514044737767464,1.3253339940305855,0.053763440860215055,1.0,1.0,2/55,0.60%,SRSF12;HNRNPL
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.782840591195937,-1.3248530697836964,0.09375,0.9709616674037405,1.0,2/7,8.17%,SLIT2;PRKG1
prerank,MSigDB_Hallmark_2020__Hypoxia,0.62924200834569,1.3245613001650989,0.010526315789473684,1.0,1.0,33/90,21.91%,STC1;SLC2A3;NEDD4L;PDK1;DDIT4;ENO1;ERRFI1;GBE1;SLC2A1;BNIP3L;EGFR;DUSP1;GLRX;F3;PPARGC1A;PDK3;CCN2;KDM3A;CP;HDLBP;HSPA5;PGK1;SCARB1;TIPARP;ADORA2B;ANGPTL4;RBPJ;CDKN1B;GPC4;HK1;MXI1;IRS2;KLF6
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.7768014884499573,1.324321374424507,0.07407407407407407,1.0,1.0,1/12,0.11%,STC1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.6721288731632183,1.3241075904780408,0.09090909090909091,1.0,1.0,10/35,11.27%,SRGN;PITRM1;SEC11A;CPD;ADAM17;MMP16;CPM;F3;C1R;CTSL
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.9089218701251073,1.324079246873373,0.05405405405405406,1.0,1.0,1/5,1.07%,TAF1B
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.873084653890755,1.3239746306580376,0.043478260869565216,1.0,1.0,1/6,0.48%,ADAMTS9
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.8809626575453632,1.323620149790279,0.05555555555555555,1.0,1.0,1/6,1.85%,DDX3X
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.895118372070556,1.3230981273814368,0.07142857142857142,1.0,1.0,2/5,7.91%,NOS1AP;SELENOS
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.7824339418711429,-1.3230332223098018,0.09523809523809523,0.9692457458610075,1.0,4/9,18.10%,ATM;UBE2V2;MRE11;BRCA1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.7255827422515531,1.3227617543687518,0.08333333333333333,1.0,1.0,7/23,18.53%,SOD1;HNRNPF;SOD2;RAP1B;CFL1;PDCD4;ARF1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.6540162069587289,1.3227349776229034,0.05263157894736842,1.0,1.0,17/61,15.56%,EPM2A;ATP6V1G1;PRKACA;TSC2;ATP6V1H;RHEB;SNX6;SLC38A9;BNIP3L;TBK1;ATP6V1E1;LZTS1;SESN1;EXOC1;WAC;LRRK2;C9ORF72
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.7301096715547317,1.322501001908246,0.05405405405405406,1.0,1.0,7/22,16.80%,AZI2;NFKBIA;TBK1;RPS27A;TANK;ROCK2;MAP3K14
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.687700540852397,1.322394499959944,0.05263157894736842,1.0,1.0,5/51,4.61%,TAF7;SOD1;CSF1;TSC2;CAMKK2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.6468930563842737,-1.3212284990995276,0.05263157894736842,0.9668343677938469,1.0,3/12,15.80%,MAPK14;HMGB1;THBS1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.7593649654323191,1.3203342400147164,0.07142857142857142,1.0,1.0,3/18,6.02%,NR4A3;OGN;IL18
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8247785140796159,1.320147290427973,0.10144927536231885,1.0,1.0,1/10,0.48%,ADAMTS9
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.7243162024219337,-1.3196809324243224,0.07692307692307693,0.9646483197715741,1.0,1/7,1.57%,PHLDB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.7241454884838195,1.318471412029934,0.10843373493975904,1.0,1.0,7/24,18.53%,SOD1;HNRNPF;SOD2;RAP1B;CFL1;PDCD4;ARF1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.8210510534102655,1.3182749473776834,0.07692307692307693,1.0,1.0,3/7,8.45%,CSF1R;FLT1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.8287939392609237,1.3179767308842119,0.06172839506172839,1.0,1.0,1/6,7.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5660176405995261,-1.3177479186541448,0.07142857142857142,0.9647351104474804,1.0,1/14,0.48%,FGF13
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.6944175006054869,-1.3172410332180418,0.12,0.9580077305720396,1.0,3/10,7.17%,PPIP5K2;CYP27A1;IPPK
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.921495422590927,1.3166852178475417,0.0,1.0,1.0,2/5,3.50%,NRG1;KCNQ1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.7018261041155274,1.3163622670311865,0.010869565217391304,1.0,1.0,13/45,11.60%,ETV5;PHYHIPL;ELAVL3;NXPH1;CRMP1;GFAP;ADGRB3;DCLK1;SYNDIG1;SNAP25;CORO2B;CTNND2;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.7502852493880053,1.31603925457813,0.0963855421686747,1.0,1.0,5/15,14.04%,FMN2;PPARA;EGFR;CST3;MDM4
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.7327453009999595,1.3160142304340967,0.09411764705882353,1.0,1.0,5/15,9.40%,SYT1;RIMS2;LIN7A;SNAP25;SYN3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.7999097238211494,1.315997600705482,0.056338028169014086,1.0,1.0,5/12,10.79%,GLRB;GRIN1;IPO5;SLC38A9;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.7793647963084479,1.3159892478272908,0.08974358974358974,1.0,1.0,2/15,3.71%,CD44;ANK3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7597699712709142,1.315570382722644,0.08536585365853659,1.0,1.0,5/18,11.91%,NRG3;CACNA1B;BTBD9;GRIK2;NLGN1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.866976526142472,1.3153476899512047,0.09859154929577464,1.0,1.0,1/7,0.84%,SYT1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.642742801273566,1.314556743254374,0.0,1.0,1.0,27/121,16.11%,SOD1;LPIN1;GJA1;CADM1;KDM1A;ENO1;AGO2;NIBAN2;SCD;IL18;EIF2AK2;TGFB1;PPARGC1A;SDCBP;ZBTB16;CEBPB;PRLR;KDM3A;NLGN1;SMURF2;ACADL;TAPT1;CFL1;TP53BP1;PPIB;ACVR1B;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.8468799809749948,1.3138791590606205,0.09333333333333334,1.0,1.0,1/8,1.29%,PLAA
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.7172792558590464,-1.3133688257338678,0.3055555555555556,0.9672710672354023,1.0,1/5,1.94%,NT5C3A
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.8962417056858036,1.3133369628066496,0.07352941176470588,1.0,1.0,1/5,4.64%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.7475799047657481,1.3132104622713177,0.10714285714285714,1.0,1.0,3/16,8.45%,NELL1;ADGRV1;TGFB1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.7599933323282273,-1.3129095291153787,0.23076923076923078,0.9611633403236468,1.0,4/5,17.04%,ST6GALNAC3;LARGE1;ST3GAL5;ST8SIA1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5211035434954536,-1.3118324522224682,0.12,0.9574034144522181,1.0,5/21,6.81%,NSUN3;TARBP1;TFB1M;DIMT1;TRMT44
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8329433593959144,1.3117349430048553,0.0821917808219178,1.0,1.0,2/6,6.58%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.7739782502658439,1.311611170950153,0.10126582278481013,1.0,1.0,2/9,12.66%,ADGRV1;TTC8
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.8368095721231958,1.3115699127842304,0.05194805194805195,1.0,1.0,3/7,10.39%,NFKBIA;SUFU;TMSB4X
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6395368765215499,1.311469851578161,0.03296703296703297,1.0,1.0,17/77,11.41%,SLC2A3;CSF1;CD44;KLF2;RHOB;NFKBIA;NR4A3;PDE4B;IL18;SOD2;KLF9;DUSP1;SLC16A6;F3;PTPRE;CEBPB;TANK
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.8606046060854985,1.3112298155605249,0.09090909090909091,1.0,1.0,1/5,5.52%,CDH2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.5071889074010469,-1.310866711621776,0.18181818181818182,0.9528566041418459,1.0,2/21,3.99%,BCL2L11;RPS3
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.8649407878359486,1.310450858816908,0.075,1.0,1.0,1/7,1.26%,ATP6V1G1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.8126983441346185,1.3101063183300994,0.125,1.0,1.0,2/9,2.62%,CD44;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.7670265095762093,1.3098747511813649,0.16,1.0,1.0,5/11,16.11%,CD44;KDM1A;RNF34;MDM2;TWIST1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.8308779193263138,1.3095604793260065,0.06756756756756757,1.0,1.0,5/10,11.04%,CSF1R;IL18;EIF2AK2;ADAM17;HIF1A
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.8745534033644486,1.309466104162796,0.07936507936507936,1.0,1.0,2/6,6.25%,TET3;CTR9
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.8346477026624967,1.309461467784828,0.09090909090909091,1.0,1.0,2/7,4.11%,WASF3;WASF1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7019239146291987,1.3088473338193387,0.05813953488372093,1.0,1.0,6/26,10.33%,PHYHIPL;ELAVL3;NXPH1;CACNA1B;SNAP25;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.6990076911892598,1.3087999508134185,0.10344827586206896,1.0,1.0,10/27,16.24%,SOD1;SNX6;NAIP;PRKCI;SOD2;PPARGC1A;HIF1A;PTPRZ1;UNC5B;CPEB4
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.8135897466109605,1.3073362976710652,0.06578947368421052,1.0,1.0,4/10,14.53%,PDK1;SCARB2;PDK3;PDK4
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.7555743259951133,1.307282582163832,0.08536585365853659,1.0,1.0,1/14,2.48%,CYTH1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.8156414681669111,1.3061436460434404,0.1111111111111111,1.0,1.0,2/6,5.07%,KCNQ1;PDE4B
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4640278272883667,-1.3056131197496863,0.0,0.9684384721021922,1.0,9/41,9.18%,TPM2;JPH2;PRRX1;LMOD1;SYNPO2;PRKG1;EDNRA;NOTCH3;ITGA7
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.8177840504976617,1.3051455192546197,0.12162162162162163,1.0,1.0,2/10,8.37%,DDX3X;TBK1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.7489405334933491,1.3042098368568753,0.09411764705882353,1.0,1.0,4/20,9.57%,ZC3H7B;AGO2;ZC3H7A;CNOT8
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6367888245490316,1.3040233303241302,0.08421052631578947,1.0,1.0,17/76,13.59%,SYT1;ELAVL3;FAT3;NRG1;CRMP1;KCNH7;ADGRB3;CACNA1B;DCLK1;LZTFL1;HOMER2;SNAP25;EPHA7;CADM2;ZNF536;NLGN1;CNTNAP2
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.8809344340003614,1.303507661294641,0.11764705882352941,1.0,1.0,2/5,8.45%,IL18;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.8042659220516502,1.3034479474223384,0.0945945945945946,1.0,1.0,2/10,4.70%,WWC1;WWC2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.8957659899238383,1.3032373362522844,0.06944444444444445,1.0,1.0,1/5,4.64%,AGO2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.8957659899238383,1.3032373362522844,0.06944444444444445,1.0,1.0,1/5,4.64%,AGO2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.8177140537598422,1.302712634401228,0.08,1.0,1.0,3/8,11.23%,GRIN1;FARSB;GRIN2B
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.8232645615791361,1.3026552499140691,0.0958904109589041,1.0,1.0,1/7,0.42%,SOD1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8037656072583688,-1.3025083318693624,0.1,0.9739378538187144,1.0,2/8,4.31%,CTNNA3;RYR2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.8275366721192865,1.3024678904187477,0.09333333333333334,1.0,1.0,1/8,0.95%,AKAP8
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.8620474995897284,1.3015688077230163,0.07142857142857142,1.0,1.0,3/6,13.35%,TNFRSF1B;TGFB1;CST3
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.796518224447,1.3013062801579582,0.07692307692307693,1.0,1.0,3/10,15.25%,SNX6;ERRFI1;SH3BP5
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.888185402388427,1.3006267509964526,0.08450704225352113,1.0,1.0,2/5,3.26%,SOD1;SGCZ
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6830050576624698,-1.3000385052565435,0.24,0.9755181612868474,1.0,2/6,19.76%,ZNHIT6;RPL35
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6961006111495693,1.2998012720598422,0.05319148936170213,1.0,1.0,12/38,21.37%,TAF7;TSC2;PTPRQ;PTPN1;CAMK2N1;SH3BP5;UBASH3B;PPM1E;CDKN1B;ABL1;NF1;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.8202926709357141,1.2998004649505572,0.10666666666666667,1.0,1.0,2/9,4.11%,WASF3;WASF1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.8171762939598648,1.2997434534465093,0.0958904109589041,1.0,1.0,3/7,5.32%,KCNE4;KCNQ1;ATP1B3
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.8711540518816301,1.299163406239161,0.14285714285714285,1.0,1.0,1/5,1.36%,RIPOR1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.7029041640246549,-1.2981601607682745,0.15625,0.9756702220573714,1.0,2/5,3.88%,CDK6;EIF2B3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.8588213943338391,1.2973464266456252,0.04,1.0,1.0,1/8,0.11%,STC1
prerank,MSigDB_Hallmark_2020__Apoptosis,0.6215608267309009,1.2963415568083154,0.08333333333333333,1.0,1.0,12/71,11.99%,SOD1;CD44;ANKH;RHOB;CD38;ETF1;EMP1;IL18;SOD2;BNIP3L;MADD;GSR
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.8412360417774476,1.296196259099814,0.11538461538461539,1.0,1.0,1/5,7.91%,SELENOS
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.7801368645713675,1.2958581861478122,0.0821917808219178,1.0,1.0,3/10,11.06%,CD44;NCAM1;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.7603360808578894,1.295816652064151,0.09722222222222222,1.0,1.0,3/12,13.42%,USP15;RIOK3;ANKRD17
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.7981006587139545,1.295398587062993,0.08333333333333333,1.0,1.0,2/9,7.85%,SOD1;SOD2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.796878657599376,1.2947509132244341,0.11428571428571428,1.0,1.0,2/7,11.99%,SOD1;GSR
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7148933896028115,1.294531467724005,0.0963855421686747,1.0,1.0,4/19,11.06%,NELL1;ADGRV1;TGFB1;ZBTB16
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8197608251219881,1.2943807342880744,0.10810810810810811,1.0,1.0,3/7,8.06%,KLF2;DHRS3;CTBP2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.7145454920604506,1.2943422295673561,0.14285714285714285,1.0,1.0,9/23,15.65%,SLC23A2;SLC7A2;SLC16A7;SLC16A12;SLC3A2;SLC13A3;SLC25A4;SLC36A4;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.8082206126810529,1.2942239115151346,0.08450704225352113,1.0,1.0,5/10,14.42%,GRIN1;MBP;GRIN2B;ROCK2;STAT3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.8124693332880762,1.293463635523472,0.05333333333333334,1.0,1.0,1/10,0.39%,HS3ST5
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.8538268298337092,1.293351887060795,0.1232876712328767,1.0,1.0,2/5,11.37%,SOD1;CEBPB
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.8709960793720603,1.2932786739830888,0.12857142857142856,1.0,1.0,2/5,7.80%,CRY1;PPARA
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.8529373909141035,1.292517560643489,0.11764705882352941,1.0,1.0,1/5,4.87%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.8529373909141035,1.292517560643489,0.11764705882352941,1.0,1.0,1/5,4.87%,MGST1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.8428441141312627,1.2920748935420399,0.07042253521126761,1.0,1.0,1/7,2.47%,RAD21
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.708510159689323,1.2916365186103462,0.12048192771084337,1.0,1.0,2/21,5.13%,STC1;HOMER2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.6631057616328755,1.2916253682968692,0.031914893617021274,1.0,1.0,11/45,12.84%,NRCAM;DNER;CDH18;CDH2;KIRREL3;CDH12;CTNND2;NLGN1;CDH10;CDH20;FARP1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8290924114312499,1.290601456826955,0.1388888888888889,1.0,1.0,3/5,13.76%,NR4A3;NLGN1;SGIP1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.7733060467480818,1.2901923821416217,0.14942528735632185,1.0,1.0,3/11,13.99%,LPIN1;GK5;PLAAT3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6918575164686855,-1.2900226291141643,0.275,0.9776082422739588,1.0,2/5,7.40%,ATM;TPR
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6918575164686855,-1.2900226291141643,0.275,0.9776082422739588,1.0,2/5,7.40%,ATM;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6918575164686855,-1.2900226291141643,0.275,0.9776082422739588,1.0,2/5,7.40%,ATM;TPR
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6918575164686855,-1.2900226291141643,0.275,0.9776082422739588,1.0,2/5,7.40%,ATM;TPR
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.7674851631409593,1.2895548590171646,0.12643678160919541,1.0,1.0,3/11,9.65%,TMEM232;GFAP;MYO16
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6828473240583264,1.2895535921231578,0.06593406593406594,1.0,1.0,13/38,12.45%,ELAVL3;KCNC2;NXPH1;KCND2;GFAP;ADGRB3;CACNA1B;KCNQ3;CTNNA2;SNAP25;CADM2;GRIN2B;CDH20
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.8341248179120713,1.2891510755582423,0.057971014492753624,1.0,1.0,3/7,12.56%,PANK2;ACADVL;ACADL
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.662948859996257,1.2879787772326485,0.03225806451612903,1.0,1.0,17/58,11.60%,PHYHIPL;ELAVL3;FAT3;NXPH1;LSAMP;ADGRB3;CACNA1B;DCLK1;ROBO2;HIVEP2;CTNNA2;SNAP25;ROBO1;EPHA7;CTNND2;CADM2;ZNF536
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.7517119930663428,1.287908317776642,0.1388888888888889,1.0,1.0,3/12,8.45%,RHBDD1;ADAM17;TGFB1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.5873792632507089,-1.2874974307142577,0.05,0.9816893078139729,1.0,3/17,2.43%,NRP1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8820488882384074,1.28626859462997,0.06349206349206349,1.0,1.0,2/5,7.43%,RNF10;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.7306576132467761,1.2855007323527745,0.1375,1.0,1.0,3/16,12.38%,DDX3X;TBK1;RIOK3
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7708667461711023,1.2854824097912076,0.14634146341463414,1.0,1.0,3/11,14.53%,NOS1AP;TNFRSF1B;PDK4
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8368805335366101,1.2852601112919844,0.08108108108108109,1.0,1.0,3/5,13.80%,TGFB1;SRA1;TBX3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.6818320078300918,1.2850548135053874,0.08235294117647059,1.0,1.0,8/32,11.23%,CSF1;RRAS2;DDIT4;TNFRSF1B;TBK1;EFNB2;PPARGC1A;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6660593887784843,1.2844495896569217,0.09411764705882353,1.0,1.0,12/37,24.53%,NFKBIA;KDM1A;HABP4;PSME3IP1;SYMPK;TMBIM6;LRRK2;GOLGA2;ZFPM1;MITD1;LEF1;JUN
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6415996050983432,-1.2842913299596557,0.19047619047619047,0.9874289181854968,1.0,2/16,3.04%,SERPINI1;SERPINH1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8197513098573759,1.284120430803034,0.08045977011494253,1.0,1.0,3/9,8.82%,TSC2;GIGYF2;IRS1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.8148251457781451,1.2839530050141286,0.11764705882352941,1.0,1.0,2/6,9.54%,BTD;MCCC2
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.8023783001403259,1.2839527116602734,0.012195121951219513,1.0,1.0,5/11,15.96%,SYT1;RAB27A;RIMS2;LRRK2;PREPL
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.8409806915518248,1.2837836177105664,0.1791044776119403,1.0,1.0,2/5,13.66%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.8409806915518248,1.2837836177105664,0.1791044776119403,1.0,1.0,2/5,13.66%,PELI1;SLC25A4
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.6821951634405425,1.2833693637004884,0.08139534883720931,1.0,1.0,11/35,11.60%,PHYHIPL;ELAVL3;KCNC2;NXPH1;SPTBN4;GFAP;ADGRB3;SNAP25;CTNND2;CADM2;ZNF536
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.7613502452317993,1.2827510459115694,0.16666666666666666,1.0,1.0,2/11,2.37%,PARVB;RHOJ
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.8729121880697961,1.282583872756848,0.07894736842105263,1.0,1.0,2/6,9.60%,CD44;MBP
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.8614042351124644,1.2824893142069345,0.10810810810810811,1.0,1.0,2/5,5.30%,PTPN1;NIBAN2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.6977989688864334,1.2818632107436811,0.09523809523809523,1.0,1.0,6/17,15.82%,HDAC2;RHBDD1;BTRC;TNFRSF1B;TANK;WDR48
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.8485741794405051,1.2814184978746657,0.14473684210526316,1.0,1.0,3/5,15.00%,NR4A3;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7858550644399436,1.281408216743972,0.05333333333333334,1.0,1.0,3/11,7.27%,KLF2;IPO5;SLC38A9
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7808473289553828,1.2809724294981002,0.13513513513513514,1.0,1.0,3/10,7.57%,GJA1;NR4A3;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.8189206449810391,1.280671764212363,0.18571428571428572,1.0,1.0,2/9,8.37%,DDX3X;TBK1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.7102098648478525,-1.280291791802778,0.20833333333333334,0.9957979886857244,1.0,1/5,11.14%,TRIM25
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.8481541993252877,-1.2799546256961911,0.20588235294117646,0.9886802573576614,1.0,2/5,2.22%,WNT5B;ACTA2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.7590749941952778,1.2791822736445155,0.11842105263157894,1.0,1.0,2/15,3.68%,WWC1;PTPN1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.731539105104955,1.2791713530051996,0.12643678160919541,1.0,1.0,4/17,6.42%,GJA1;GRIN1;CACNA1B;SNX6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7477543175200041,-1.2790933307430372,0.24,0.9844308714160491,1.0,2/6,3.66%,NRP1;PLXNC1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6630159675320669,1.2788638312479155,0.07692307692307693,1.0,1.0,13/48,15.00%,SYT1;NRG3;CACNA1B;RIMS2;DGKI;CDH2;BTBD9;GRIK2;SYN3;MCTP2;NLGN1;GRM7;LRRK2
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7902822738953788,1.2788474963927876,0.10810810810810811,1.0,1.0,4/8,13.52%,IL18;TGFB1;CST3;RUNX1
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.711166197546417,1.2785516112800919,0.2125,1.0,1.0,1/15,0.11%,STC1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.6699970787939201,1.2774060899319177,0.058823529411764705,1.0,1.0,8/38,10.86%,HNRNPL;PCBP3;RC3H2;HNRNPF;IGF2BP2;TNFRSF1B;PTBP2;GRSF1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.7469295440535662,1.277333368081119,0.10843373493975904,1.0,1.0,2/15,8.45%,SYMPK;TGFB1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.8519766531685822,1.277260070903501,0.1111111111111111,1.0,1.0,1/6,1.21%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.8011827212106557,1.2770836811420219,0.22972972972972974,1.0,1.0,1/7,5.77%,ZFP36L2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.7206374761786953,1.2769237225875099,0.13580246913580246,1.0,1.0,6/18,14.62%,PLEKHG4B;CRMP1;CACNA1B;EPHA7;CNTNAP2;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.6254894381808862,-1.2766933659516744,0.14285714285714285,0.9873863203509109,1.0,3/9,9.38%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.8821041469868203,1.2766507634273878,0.1044776119402985,1.0,1.0,1/5,1.85%,DDX3X
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.7443344166183129,-1.2763610428864798,0.17391304347826086,0.981706599426509,1.0,1/5,4.31%,RYR2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.8030205491770217,1.276167979647925,0.09523809523809523,1.0,1.0,2/12,5.86%,TAF7;TBPL1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.8220245634168065,1.2759628249605752,0.11764705882352941,1.0,1.0,1/5,13.85%,BRD1
prerank,MSigDB_Hallmark_2020__E2F Targets,0.6304763398499921,1.2757007556744535,0.04395604395604396,1.0,1.0,18/55,24.30%,RAD21;CCP110;DUT;NUP153;STMN1;DNMT1;CSE1L;MELK;NAA38;EED;DONSON;RPA1;CDKN1B;NAP1L1;CTCF;NUP205;TRA2B;RBBP7
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6888956808577538,1.2750297028484345,0.15,1.0,1.0,7/20,23.77%,SYT1;DNAJC6;NLGN1;CANX;GAK;PIP5K1C;DNM2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.6628972627512418,1.274989262190149,0.16666666666666666,1.0,1.0,10/32,20.50%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.6628972627512418,1.274989262190149,0.16666666666666666,1.0,1.0,10/32,20.50%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.6628972627512418,1.274989262190149,0.16666666666666666,1.0,1.0,10/32,20.50%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.711875435322321,1.274193762486399,0.15476190476190477,1.0,1.0,6/16,14.87%,ENO1;PPARA;PPARGC1A;TMSB4X;HIF1A;INSR
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.6320867815485343,1.2738287219783746,0.07368421052631578,1.0,1.0,15/52,16.89%,WASF3;DARS1;WASF1;WIPF1;SLC2A1;LIN7A;PPARGC1A;NUP133;ST13;RANBP9;MDM2;MDM4;NAPG;TEAD1;SPG7
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.7565811017474855,1.2736972940468587,0.1527777777777778,1.0,1.0,1/9,2.47%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.7236965674011723,1.273247410594934,0.1375,1.0,1.0,6/19,17.23%,AGO2;TGFB1;EGFR;EIF4ENIF1;STAT3;MAP2K1
prerank,PanglaoDB_Augmented_2021__Platelets,0.6874370249373443,1.2729200605701783,0.03296703296703297,1.0,1.0,7/37,9.96%,SLC2A3;SRGN;PDLIM1;WIPF1;FHL1;TNFRSF1B;RAP1B
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.7613046068549209,-1.272879881648525,0.3333333333333333,0.9874033910706016,1.0,1/5,1.16%,SPRY1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7887886622006364,1.2728408868728356,0.11428571428571428,1.0,1.0,3/7,14.50%,ENO1;RPS27A;PGK1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6482392791362496,1.2727202499117312,0.06382978723404255,1.0,1.0,14/53,12.45%,CADM1;PTPRD;TENM2;TENM3;CDH18;CDH2;ROBO2;NECTIN2;KIRREL3;CDH12;ROBO1;NLGN1;CDH10;CDH20
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.7922928739218467,1.272608062213153,0.16216216216216217,1.0,1.0,2/7,16.98%,WIPI1;WDR45B
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.72365990101849,1.2720599050745387,0.1111111111111111,1.0,1.0,4/16,14.24%,HDAC2;BTRC;CST3;CAMK2N1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.7602499072969691,1.271177444700782,0.1348314606741573,1.0,1.0,7/14,17.34%,HDAC2;EMP1;UGCG;CCN2;FGFR2;COL7A1;SVEP1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.7225509063277938,1.2704080628648473,0.12790697674418605,1.0,1.0,4/18,15.12%,AKAP8;KDM1A;PPARGC1A;GLYR1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.7383191537697362,1.27027509505692,0.20270270270270271,1.0,1.0,3/11,16.10%,SYT1;NLGN1;CANX
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.8444970523844402,1.2697256027434394,0.15942028985507245,1.0,1.0,2/5,7.07%,NELL1;EIF2AK2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.8364463150180264,1.2696430029553125,0.1388888888888889,1.0,1.0,1/7,0.16%,SRSF12
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.6129336829668551,1.269613509495209,0.04081632653061224,1.0,1.0,19/85,18.80%,TBC1D20;SEC24A;VAPB;COG2;SPTBN4;ANK3;COG7;SEC13;ATL2;VAPA;NRBP1;ARFGAP3;NSF;CAPZB;SEC24D;COL7A1;ARF4;CNIH3;GOLGA2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.7825903490239593,1.2695014538902887,0.16666666666666666,1.0,1.0,3/5,18.04%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.7825903490239593,1.2695014538902887,0.16666666666666666,1.0,1.0,3/5,18.04%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.7281733245001538,1.2693411158946217,0.14457831325301204,1.0,1.0,4/17,11.37%,NELL1;ADGRV1;TGFB1;CEBPB
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.8287415906413165,1.2691180553923858,0.08571428571428572,1.0,1.0,1/9,4.09%,BASP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.6492708974567206,1.2683831096760494,0.16483516483516483,1.0,1.0,8/42,8.76%,CD44;SPTBN4;DDIT4;RAF1;STK4;TBK1;TGFB1;EGFR
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.7005933128760995,-1.2683623952765801,0.16666666666666666,0.997686063597586,1.0,2/6,14.39%,PGS1;ABCA3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.7437180172129574,1.267878888397175,0.11904761904761904,1.0,1.0,7/15,19.14%,PTPRQ;PTPN1;DUSP1;PTPN9;PTPRZ1;PTPN2;UBASH3B
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.6578601188696986,1.2676456207658877,0.10588235294117647,1.0,1.0,7/25,18.13%,MID1;EIF2AK2;EGFR;ULK4;MAPK1;MAP2K1;PER1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.747061256954575,1.2673579216968474,0.14285714285714285,1.0,1.0,5/15,14.53%,PDK1;SELENOS;IRS1;PDK3;PDK4
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.6868561188695869,1.266835482089658,0.10714285714285714,1.0,1.0,5/25,14.38%,DARS1;RARS1;FARSB;PPA1;YARS1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.6600625194757143,1.2662045037680287,0.13043478260869565,1.0,1.0,10/30,23.23%,NELL1;MTMR9;RUBCN;WDR6;CST3;STAT3;GOLGA2;MTMR2;MT3;TAB2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6801348713412502,1.2660449244346506,0.21333333333333335,1.0,1.0,3/14,11.41%,TBK1;RPS27A;TANK
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6801348713412502,1.2660449244346506,0.21333333333333335,1.0,1.0,3/14,11.41%,TBK1;RPS27A;TANK
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7384609764317052,1.2659067935279145,0.1125,1.0,1.0,2/14,4.82%,ACTR3;AKIRIN1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.769114569819483,1.265832831889459,0.16901408450704225,1.0,1.0,2/8,10.84%,RPS27A;TUT7
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.7134809937627662,1.2658151013647811,0.15476190476190477,1.0,1.0,3/14,2.62%,CD44;TPT1;KDM1A
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.46506164675566636,-1.265705666840152,0.0,1.0,1.0,9/44,8.22%,TPM2;ACTA2;LMOD1;MYH11;MYOM1;MYL9;VIM;MYLK;EDNRA
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.8183719126937156,1.2656855840467163,0.11842105263157894,1.0,1.0,1/9,4.64%,AGO2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.8232386674661532,1.264967654317855,0.11864406779661017,1.0,1.0,1/5,3.71%,ANK3
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.7248152899170175,1.2644966833535949,0.13414634146341464,1.0,1.0,5/18,13.96%,KLF2;NEDD4L;SSH1;ROCK2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7981508255769861,1.264277082910587,0.18309859154929578,1.0,1.0,4/6,10.39%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7981508255769861,1.264277082910587,0.18309859154929578,1.0,1.0,4/6,10.39%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7486674360679287,1.2640899836933823,0.1625,1.0,1.0,5/12,11.04%,ITGA5;PTPN1;NIBAN2;PRKCB;HIF1A
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.783983312851154,1.2640215580932972,0.09090909090909091,1.0,1.0,4/14,11.77%,MDGA2;ZC4H2;AGTPBP1;SIN3A
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.7096814685408223,-1.2634906332563383,0.19230769230769232,1.0,1.0,3/8,7.44%,DAPK2;SLIT2;RIPOR2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.7810375143578946,1.2629510283550556,0.1038961038961039,1.0,1.0,1/10,0.42%,SOD1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.7384317103865825,1.26275099794714,0.1686746987951807,1.0,1.0,2/11,12.89%,CAMKK2;SREBF1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.7399942956203747,1.262526004645758,0.15789473684210525,1.0,1.0,2/12,5.26%,WIPI1;AP2A1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.6733680061350186,1.2624493688497795,0.10465116279069768,1.0,1.0,6/22,15.01%,RC3H2;ZFP36L2;GIGYF2;TUT7;ROCK2;METTL14
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6982588165823729,1.262103043658009,0.13793103448275862,1.0,1.0,8/26,15.00%,TPT1;DDX3X;ENO1;SOD2;SELENOS;TMBIM6;MDM2;LRRK2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.78946240798601,1.2617180088867688,0.16901408450704225,1.0,1.0,3/7,18.01%,ADAMTS9;CTSL;MANBA
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6069041090010596,1.2611046725089035,0.13402061855670103,1.0,1.0,7/52,10.28%,CSF1;HDAC2;DDX3X;NFKBIA;BTRC;TGFB1;ELAVL1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.8004320527612865,1.2605030061898812,0.17647058823529413,1.0,1.0,2/6,16.11%,FGFR2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.8068648262718653,1.2604688621854492,0.1282051282051282,1.0,1.0,2/9,6.58%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.6491414624513634,1.2604249233604006,0.17045454545454544,1.0,1.0,5/29,10.39%,DDX3X;NFKBIA;EIF2AK2;EGFR;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.6423656302651853,1.2602731889487995,0.10752688172043011,1.0,1.0,19/52,19.91%,CSF1;KLF2;NFKBIA;NEDD4L;IL18;TGFB1;SMURF2;ROCK2;RAB7A;NSF;RANBP9;WWP1;TIPARP;HECW1;CSNK2A1;AREL1;ABCB10;SLC25A37;CDKN1B
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.6175614268344859,1.2602688944089548,0.07291666666666667,1.0,1.0,23/78,16.98%,ATP6V1G1;RIPOR1;ATP6V1H;WIPI1;SIK2;RHEB;EIF2AK2;SLC38A9;SEC13;PPARA;ATP6V1E1;SZT2;RNF152;EIF2AK4;CEBPB;SREBF1;SESN1;HSPA5;PDK4;LRRK2;CPEB4;MAPK1;WDR45B
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.7429559320177117,-1.2594854698653177,0.20689655172413793,1.0,1.0,3/6,12.03%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.7429559320177117,-1.2594854698653177,0.20689655172413793,1.0,1.0,3/6,12.03%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.7066596272121977,-1.2593018397994213,0.28,0.9964524291471237,1.0,3/5,14.25%,ST6GALNAC3;ST3GAL1;ST3GAL5
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.7320031730071886,1.2590094619538441,0.16279069767441862,1.0,1.0,4/13,12.00%,MMUT;GLUL;GLUD1;ASPA
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.7022690553246124,1.2584186857470392,0.15384615384615385,1.0,1.0,8/18,12.92%,EPM2A;TSC2;DDIT4;UBR1;SZT2;RNF152;TNFAIP8L1;SESN1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.6439307358975538,1.2583002433755521,0.12790697674418605,1.0,1.0,4/28,12.39%,SOD1;ATP6V1G1;CP;NDFIP1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6711849747924096,1.2581542171214326,0.16483516483516483,1.0,1.0,10/31,12.47%,KCNC2;KCNH7;KCND2;KCNE4;KCNQ1;KCNQ3;ATP1B3;KCNQ5;ABCC9;NALCN
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.7975571968920969,-1.2577391449669773,0.22580645161290322,0.9959329466982307,1.0,2/5,13.83%,MYL9;PPP1R12B
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.835600121647232,1.2577006630929413,0.15789473684210525,1.0,1.0,2/5,11.91%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.6166584078744368,1.257611810874003,0.11827956989247312,1.0,1.0,8/53,8.56%,TP53TG5;GJA1;DDX3X;ENO1;FHL1;ESR2;TGFB1;APBB1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.7994478456631531,1.2575750321841888,0.1643835616438356,1.0,1.0,4/6,15.90%,GJA1;AGO2;SMURF2;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.7351080015501125,1.2572875347133508,0.17721518987341772,1.0,1.0,3/12,12.38%,DDX3X;TBK1;RIOK3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6521158595829616,1.256993752221047,0.13793103448275862,1.0,1.0,4/44,2.37%,STC1;ADAMTS9;RHOB;RHOJ
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.8440612944539775,1.2567255428528519,0.11688311688311688,1.0,1.0,1/6,2.54%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.7876568903086223,1.256709888514266,0.20833333333333334,1.0,1.0,1/7,7.91%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.7876568903086223,1.256709888514266,0.20833333333333334,1.0,1.0,1/7,7.91%,SELENOS
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.6746583571052331,1.2564277965643933,0.19753086419753085,1.0,1.0,6/16,22.49%,EAPP;RNF168;WDR43;TCERG1;SUPT16H;ELL
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.7940265351866993,1.2560923116330993,0.17142857142857143,1.0,1.0,1/8,5.99%,MTMR9
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.6986074964214708,1.2559208527597536,0.0989010989010989,1.0,1.0,9/28,21.68%,TAF7;TSC2;CAMK2N1;UBASH3B;PPM1E;CDKN1B;NF1;YWHAG;IRS2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6624835234949099,1.255880633174703,0.13414634146341464,1.0,1.0,9/22,22.29%,RHEB;ACOT11;ADAM17;MAP2K6;PLCL1;LGR4;NOVA1;RBPJ;LNPEP
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7822821870066247,1.2552578172570947,0.13157894736842105,1.0,1.0,1/6,0.42%,SOD1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.684847991615184,1.254961162320518,0.13043478260869565,1.0,1.0,9/30,18.30%,GPR161;S1PR3;ADGRB3;GNB1;ADGRG2;ADGRE2;LGR4;ABCA1;PTH1R
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7593643409600852,1.2546049729141067,0.15853658536585366,1.0,1.0,4/11,15.51%,DDX3X;DELE1;CASP8AP2;TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.6734294008421287,1.2544296106790611,0.16279069767441862,1.0,1.0,6/24,17.82%,WWC1;KDM1A;REEP5;LRRK2;ADGRE2;STXBP4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.765880746427746,1.2542906272802095,0.11842105263157894,1.0,1.0,3/9,15.51%,DDX3X;RNF34;TNFRSF10B
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.743258221037304,1.2542887536200542,0.1794871794871795,1.0,1.0,2/9,13.45%,TRIOBP;CAPZB
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.743258221037304,1.2542887536200542,0.1794871794871795,1.0,1.0,2/9,13.45%,TRIOBP;CAPZB
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6718007152000777,1.2541535686363439,0.14814814814814814,1.0,1.0,9/20,22.29%,RHEB;ACOT11;ADAM17;MAP2K6;PLCL1;LGR4;NOVA1;RBPJ;LNPEP
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.6896856910844941,1.2541532019689219,0.16049382716049382,1.0,1.0,5/25,6.61%,DPM1;TMEM165;UBE2J1;MGAT4A;MGAT1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.7524890520246892,-1.25401685670895,0.25925925925925924,1.0,1.0,4/7,17.25%,CORO1C;TMCC1;CHMP4B;SLC25A46
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6614148338407627,1.2539310946774245,0.11827956989247312,1.0,1.0,7/37,7.34%,STC1;TPT1;VAPB;NEDD4L;ATP1B3;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8182156598199638,1.2534202698971038,0.17391304347826086,1.0,1.0,3/5,18.13%,CRY1;CLOCK;PER1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.8405807600628266,1.2530248004521016,0.12307692307692308,1.0,1.0,3/6,15.04%,ENO1;RHBDD1;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8370743593469887,1.252736919524848,0.12857142857142856,1.0,1.0,2/5,6.58%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.8370743593469887,1.252736919524848,0.12857142857142856,1.0,1.0,2/5,6.58%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.8179948601856051,1.2524517508874946,0.16883116883116883,1.0,1.0,2/8,13.15%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.620623240592373,1.2523449471442076,0.16666666666666666,1.0,1.0,14/35,23.23%,PLAA;PDE4B;PELI1;CTR9;TNFRSF1B;ADAM17;SELENOS;MAPKAPK2;ERBIN;SCARB1;PDCD4;SMAD6;AXL;TAB2
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7100103528191061,1.2523119298229282,0.1625,1.0,1.0,2/13,13.46%,DNAJC15;HSPA5
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6775238345972799,1.2520715653005583,0.19047619047619047,1.0,1.0,7/23,21.34%,SYT1;RIMS2;MCTP2;NSF;RAB12;RAB8B;SNCAIP
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.8520119808465334,1.2514151686249666,0.08641975308641975,1.0,1.0,4/5,14.42%,NR4A3;EIF2AK4;SGIP1;STAT3
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.42471222867151864,-1.2509525869959082,0.0,1.0,1.0,10/69,8.22%,NTN4;CAV2;FGF1;COL5A2;LAMB2;FKBP9;PTPN21;CXCL12;COL1A2;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.8663046302808853,1.2504552009807903,0.1038961038961039,1.0,1.0,1/6,0.33%,TAF7
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.8128572373331159,1.250031120243963,0.16417910447761194,1.0,1.0,1/5,6.25%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7849009159015581,1.2498874212615159,0.12658227848101267,1.0,1.0,2/11,5.04%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7849009159015581,1.2498874212615159,0.12658227848101267,1.0,1.0,2/11,5.04%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.6401341765433879,1.249355270712133,0.1,1.0,1.0,12/38,12.92%,ATP6V1G1;ATP6V1H;RHEB;EIF2AK2;SLC38A9;SEC13;ATP6V1E1;SZT2;RNF152;EIF2AK4;CEBPB;SESN1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6440924614517147,-1.2492654538556862,0.2857142857142857,1.0,1.0,3/8,10.07%,NTN4;LAMB2;FLRT2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.7856849938735679,1.2492217886027803,0.20253164556962025,1.0,1.0,3/7,16.11%,CSF1R;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.7024739776607734,1.2490568964048132,0.20930232558139536,1.0,1.0,8/18,23.84%,SOD1;NRCAM;SIN3A;INSR;LATS2;ABL1;DNM2;OLFM1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5926858746014674,-1.2487432127042375,0.15789473684210525,1.0,1.0,2/12,3.47%,SMARCAL1;THOC1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.7082463425360028,1.2486583105178686,0.15,1.0,1.0,3/16,12.79%,TAF1B;PWP1;FUBP3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.7257779964984307,1.2485144088706046,0.14285714285714285,1.0,1.0,4/16,9.69%,RHEB;SLC38A9;SEC13;GPR137C
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.8306401121882868,1.2481044844886038,0.056338028169014086,1.0,1.0,1/7,1.55%,HDAC2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.634099194274257,1.2477373782128423,0.2127659574468085,1.0,1.0,6/31,10.19%,CD44;ITGA5;SEMA4D;TGFB1;EGFR;EPHA7
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7975549100667518,1.2477204878264538,0.18571428571428572,1.0,1.0,2/5,14.62%,TGFB1;FGFR2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.8187272269256003,1.247137371684322,0.20833333333333334,1.0,1.0,3/7,14.13%,NEDD4L;KCNQ1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.7028715932796008,-1.2464042317693966,0.14285714285714285,0.9978595053494282,1.0,2/6,5.72%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.7028715932796008,-1.2464042317693966,0.14285714285714285,0.9978595053494282,1.0,2/6,5.72%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.61769229534858,-1.246175730402298,0.13043478260869565,0.9915558570137225,1.0,2/9,5.38%,ZDHHC21;PER2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.7115424323427016,-1.2459621560897929,0.3448275862068966,0.9854737007289898,1.0,2/5,22.64%,SLC8B1;JAM2
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.826636869265986,1.2456174092935361,0.1794871794871795,1.0,1.0,1/6,8.65%,DSE
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.826636869265986,1.2456174092935361,0.1794871794871795,1.0,1.0,1/6,8.65%,DSE
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.7410888769601146,1.2455220701909044,0.16666666666666666,1.0,1.0,8/14,19.40%,ETV5;CSF1R;SCD;DDX3Y;SOAT1;CEBPD;STEAP4;ADGRF5
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.7947995250150343,1.245318063786501,0.2054794520547945,1.0,1.0,1/8,2.19%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.5925760291003692,1.2451966443230968,0.04040404040404041,1.0,1.0,45/185,18.98%,SOD1;CD44;TPT1;HDAC2;DDX3X;NFKBIA;FMN2;MYDGF;CD38;ITGA5;RHBDD1;RAF1;NIBAN2;SEMA4D;SNX6;APIP;NAIP;PRKCI;SOD2;BNIP3L;EGFR;WDR73;RPS27A;PPARGC1A;TMBIM6;PRLR;PTRH2;NAA38;FZD3;HSPA5;TBX3;PTPRZ1;PDK4;CFL1;UNC5B;CPEB4;MAPK1;NAA15;ARF4;IFIT3;DNAJA1;CSNK2A1;GLO1;AREL1;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.7348465412401788,1.2449583480636603,0.15853658536585366,1.0,1.0,4/17,14.07%,VAPB;DDX3X;PPARA;PABPC1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7529924787779335,1.2445018069464888,0.16666666666666666,1.0,1.0,2/11,1.54%,GJA1;PRKACA
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.7098699504164655,1.2437694647937139,0.1686746987951807,1.0,1.0,6/13,22.72%,ERRFI1;CTSL;ROCK2;RUNX1;CBFB;SGPP1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6952681119844318,1.2433296820881994,0.12345679012345678,1.0,1.0,5/18,21.05%,RAD21;XRCC4;TNKS;RPA1;CTCF
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.6839430255233855,1.24332835857131,0.12941176470588237,1.0,1.0,7/22,20.38%,HDAC2;KDM1A;FUBP1;GMPS;ATAD5;SUPT16H;NAP1L1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.8534496194868509,1.2432266541413306,0.2054794520547945,1.0,1.0,4/5,14.13%,KCNE4;ANK3;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.676074270105494,1.2431934808986735,0.17777777777777778,1.0,1.0,2/18,7.48%,DDX3X;DHX29
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.6858978255632958,1.2431556759250615,0.17857142857142858,1.0,1.0,7/26,15.90%,DDX3X;DELE1;TNFRSF1B;CASP8AP2;TGFB1;TNFRSF10B;ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7861562673543314,1.242702674339423,0.17073170731707318,1.0,1.0,2/9,11.04%,SOD2;HIF1A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7701017409327514,1.242513218806059,0.18309859154929578,1.0,1.0,3/9,5.04%,KCNE4;KCNQ1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.6769591047387868,1.2423006376366703,0.13953488372093023,1.0,1.0,6/30,14.07%,TBC1D20;VAPB;DDX3X;PPARA;RAB7A;PABPC1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.8240811569618636,1.2421245536874104,0.18840579710144928,1.0,1.0,2/6,6.47%,PCBP3;IGF2BP2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.8319635501990048,1.2421158579543692,0.19444444444444445,1.0,1.0,2/5,12.56%,ACADVL;ACADL
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7517169788691003,1.2419105461115674,0.18666666666666668,1.0,1.0,5/12,12.30%,SYT1;PHYHIPL;EBF4;SHC2;PTOV1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.6391154054865539,1.241784838997932,0.14942528735632185,1.0,1.0,8/39,11.68%,DDX3X;HABP4;AGO2;CDC123;CSDE1;EIF2AK4;CEBPB;UHMK1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.6092517401120974,1.2413524016919937,0.04081632653061224,1.0,1.0,22/92,20.10%,RNMT;TAF7;TAF1B;TEFM;GLIS3;TBPL1;CTR9;PKNOX1;PWP1;DDX21;CCNH;DEAF1;FUBP3;CEBPD;POLR1C;NFIX;CBFB;AFF4;RTF1;MLLT1;CCNK;SUPT16H
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.628932059029216,1.2412781554762566,0.1111111111111111,1.0,1.0,18/44,21.09%,ELAVL3;PCBP3;GRIN1;NXPH1;ADGRB3;CACNA1B;HIVEP2;CTNNA2;SNAP25;CTNND2;CADM2;CNTNAP2;NRXN1;TSHZ1;PPM1E;DLGAP1;GRIA2;PLP1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.7588707543215225,1.2409501991232055,0.17721518987341772,1.0,1.0,3/9,12.62%,NAA11;AGTPBP1;VKORC1L1
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.7844824075211705,1.2409486152052578,0.12345679012345678,1.0,1.0,5/7,18.98%,IL18;CEBPB;CEBPD;LGALS3;ANGPTL4
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.6369202036515449,1.2404993755708627,0.16091954022988506,1.0,1.0,8/34,14.42%,NUP153;AGO2;SEC13;NUP88;TGFB1;ELAVL1;NUP133;STAT3
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.8247630568692936,1.240130794729056,0.2028985507246377,1.0,1.0,3/5,15.18%,TBC1D20;VAPA;PPIB
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6844759294834274,1.2400863171287713,0.20987654320987653,1.0,1.0,5/13,22.02%,EPOR;ERBIN;ITGAV;IRS2;GRB2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.7447215568582735,1.2398677383941965,0.1951219512195122,1.0,1.0,1/11,0.42%,SOD1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.7251717242902271,1.2396824052630808,0.1891891891891892,1.0,1.0,3/12,16.10%,SYT1;NLGN1;CANX
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.8060852824174602,1.2395312092324342,0.19230769230769232,1.0,1.0,1/6,12.02%,SYTL4
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.659481073103971,-1.2394551897385906,0.21052631578947367,1.0,1.0,2/10,6.50%,DERL1;VCP
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.8136042784107315,1.2394496806636541,0.2222222222222222,1.0,1.0,1/5,14.62%,FGFR2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6652581333139446,1.2394358048934273,0.12087912087912088,1.0,1.0,5/34,7.34%,STC1;TPT1;VAPB;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7254156334123767,1.2392379481052949,0.18666666666666668,1.0,1.0,3/10,15.85%,LRRC7;PRKCI;ERBIN
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.5901013758809364,-1.2381265034314413,0.23333333333333334,1.0,1.0,1/11,2.12%,PARP9
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.8380268806645738,1.237997237672106,0.13513513513513514,1.0,1.0,1/7,0.33%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.619168851546803,1.237914269675966,0.1702127659574468,1.0,1.0,7/40,13.31%,CDC42EP4;TENM2;CCP110;ACTR3;AKIRIN1;NLGN1;TAPT1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7935821017084199,1.2377752479713005,0.2125,1.0,1.0,2/8,10.41%,KLF15;DIP2B
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.7323358958836212,1.2373457911038677,0.18666666666666668,1.0,1.0,3/8,4.90%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6421438109912312,1.236532025892992,0.11956521739130435,1.0,1.0,4/34,5.30%,ADAMTS9;KLF2;EPN1;NIBAN2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5935200089635462,-1.236514901565342,0.3333333333333333,1.0,1.0,4/14,13.26%,MTERF1;ANXA1;HMGB1;MRE11
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6717339366670602,1.2357837164006809,0.16049382716049382,1.0,1.0,6/20,22.75%,TGFB1;SDCBP;SNX25;ACVR2A;SMAD7;SMAD6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.6552638266732581,1.2357119660507543,0.12222222222222222,1.0,1.0,14/36,26.94%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1;DNM2;SEC23A;AP2M1;CLTC
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.6646458522252152,1.2349512927754813,0.10344827586206896,1.0,1.0,8/27,21.74%,KDM1A;PSME3IP1;SYMPK;TMBIM6;LRRK2;GOLGA2;ZFPM1;MITD1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.8479278883066701,1.234932373114242,0.14473684210526316,1.0,1.0,3/5,14.42%,CDH2;PTPRZ1;STAT3
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6800392118503578,1.2348524563281833,0.19480519480519481,1.0,1.0,6/19,22.75%,ANKH;CHSY1;ZBTB16;TWIST1;RBPJ;SMAD6
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4848167372349328,-1.2348479875478406,0.11764705882352941,1.0,1.0,4/16,6.98%,PGR;DKK3;MECOM;ST6GAL1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.6083340798747955,1.2346980588268297,0.08602150537634409,1.0,1.0,8/69,9.93%,HNRNPL;PCBP3;RBMS2;DDX3X;AGO2;HNRNPF;ADARB2;HNRNPC
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.653803582224575,1.2343374433191159,0.15217391304347827,1.0,1.0,11/35,21.37%,PRKACA;TUBA1A;CCP110;CSNK1D;CEP57;CEP70;ATAD5;PAFAH1B1;CNTRL;CEP290;YWHAG
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.8130380694745587,1.2343077511379286,0.10810810810810811,1.0,1.0,1/6,0.95%,AKAP8
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.7789604100181136,1.2342344498602338,0.11594202898550725,1.0,1.0,4/8,10.39%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.814493483095949,1.2335472473415097,0.13157894736842105,1.0,1.0,4/6,16.07%,OS9;TAPT1;HSPA5;ANKRD13C
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.49329959295942966,-1.2332963131284926,0.23529411764705882,0.999652159859401,1.0,3/20,6.51%,NRP1;ADGRA2;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6855402396170487,1.2330166344117293,0.12359550561797752,1.0,1.0,7/27,12.07%,HDAC2;CRMP1;CBFA2T2;EFNB2;OMG;NLGN1;PTPN9
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.6096769286419169,1.232963922823403,0.10638297872340426,1.0,1.0,23/83,24.36%,SLC2A3;CSF1;CD44;RHOB;DHRS3;EMP1;TNFRSF1B;NFKBIZ;PTRH2;MAPKAPK2;PRNP;PTH1R;CA2;PHTF2;IFITM3;ITGAV;KLF6;MAP3K8;RABGAP1L;CD81;CCND3;CYFIP1;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.586095887991682,-1.2328840499318805,0.22727272727272727,0.9944022330960431,1.0,2/12,4.11%,EDN3;CDC27
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.693084186017474,-1.2323390666786456,0.3333333333333333,0.9896050383163464,1.0,3/7,7.44%,DOCK8;CXCL12;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.665854049587444,1.232334545324326,0.21176470588235294,1.0,1.0,6/31,8.76%,CD44;RAF1;STK4;TBK1;TGFB1;EGFR
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7889645106983642,1.2322902470958803,0.16666666666666666,1.0,1.0,1/6,0.95%,AKAP8
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7439873716479098,1.2311679558964348,0.12,1.0,1.0,2/10,7.07%,MID1;EIF2AK2
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.649900558220846,1.231117683041915,0.21978021978021978,1.0,1.0,9/31,20.52%,RARRES1;ACADVL;EMP1;TP63;GYPC;CD9;LGALS3;SLC25A37;BNIP3
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6152297128762738,1.2311122050289076,0.17073170731707318,1.0,1.0,9/26,22.75%,USP15;TGFB1;HIVEP1;ACVR2A;PDCD4;USP9Y;SMAD2;SMAD7;SMAD6
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.7741521980355099,1.2310804595410585,0.171875,1.0,1.0,4/8,16.11%,CD44;KDM1A;MDM2;TWIST1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.785636319866731,1.2308454819558174,0.18309859154929578,1.0,1.0,2/6,20.78%,DGKI;DGKH
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.6262400702689055,1.230671444712886,0.10989010989010989,1.0,1.0,10/44,14.42%,IPO9;TSC2;NUP153;IPO5;SEC13;CSE1L;NUP88;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5926884329710542,-1.230284503661621,0.1875,0.9902004215211552,1.0,4/9,14.02%,SPRY1;DAB2IP;USF3;PTEN
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.7355669678454195,1.2298900932167809,0.1951219512195122,1.0,1.0,4/14,13.15%,RAB27A;SDCBP;SYTL4;RAB7A
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7478085026889663,1.229737665273142,0.24358974358974358,1.0,1.0,7/11,24.67%,TGFB1;FGFR2;MYL3;TTN;ZFPM1;SMAD7;PKP2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6664494878165241,-1.229612582541408,0.17391304347826086,0.9861237103654964,1.0,1/6,2.12%,PARP9
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.6474258052465512,1.2293651123223182,0.14893617021276595,1.0,1.0,8/35,14.62%,NRCAM;SPTBN4;ANK3;ATL1;APBB1;CTNNA2;GRM7;FGFR2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6500435559538819,1.2290105663229443,0.24719101123595505,1.0,1.0,12/30,22.72%,CSNK1G2;VAPB;SGPL1;VAPA;SAMD8;SCCPDH;ACER3;ELOVL5;CERS6;SPTLC1;SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7553486946437908,1.2289046982639926,0.21333333333333335,1.0,1.0,4/10,17.35%,CRY1;SELENOS;PPARGC1A;PTPN2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6683622109760662,1.2288134325169529,0.16853932584269662,1.0,1.0,6/31,7.34%,STC1;TPT1;VAPB;GRIN1;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.6143616171586036,1.228659947915335,0.08421052631578947,1.0,1.0,20/70,18.27%,RIPOR1;DDX3X;FSIP2;UBAC2;MTCH2;COG7;IFT140;CSNK1D;TMEM30A;VAPA;WASHC2C;MDM2;LRRK2;PACSIN2;ZBTB7A;DCP1A;CNTLN;RPA1;PRNP;DNAJA1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7849912699835451,1.2281562746628112,0.17105263157894737,1.0,1.0,1/5,10.11%,F3
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6259015193285881,-1.227517565395008,0.2,0.9870470770651949,1.0,3/8,9.38%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.6478036127253151,1.2274160534771,0.20930232558139536,1.0,1.0,4/25,12.39%,SOD1;ATP6V1G1;CP;NDFIP1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.7447993509337368,1.2273942541719816,0.19736842105263158,1.0,1.0,3/9,10.75%,BASP1;WNT2B;CSDE1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.6958811445292493,1.2272444422648854,0.189873417721519,1.0,1.0,5/16,16.42%,NFKBIA;KDM1A;HABP4;SIN3A;TNKS
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.6845229719347254,-1.2268660108940486,0.2222222222222222,0.9829188769295267,1.0,1/5,1.66%,FGF1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6260550658090925,1.2264218284776767,0.15853658536585366,1.0,1.0,16/31,30.38%,FMN2;KCND2;BNIP3L;HIF1A;MDM2;MDM4;PGK1;TWIST1;CPEB4;BNIP3;MT3;P4HB;RGCC;UBQLN1;CPEB2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.8118358964986392,1.2263507064537638,0.14705882352941177,1.0,1.0,2/6,12.44%,TGFB1;ROCK2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.6609713984925601,1.2260294340587625,0.13793103448275862,1.0,1.0,7/40,8.37%,SRGN;SOD1;CADM1;IGF2BP2;EIF2AK2;TNFRSF1B;TBK1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.7620062686334965,1.225195986232453,0.15384615384615385,1.0,1.0,4/8,17.82%,KLF9;CASK;FGFR2;STXBP4
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.6578703956197863,1.2250798667456135,0.17647058823529413,1.0,1.0,5/22,7.91%,PLAA;PDE4B;CTR9;TNFRSF1B;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7010912750445216,1.225076629767404,0.14444444444444443,1.0,1.0,2/21,8.51%,NELL1;TP63
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7057052888904304,1.2250541766667853,0.2602739726027397,1.0,1.0,5/12,16.53%,PTPRD;SEMA4D;SYNDIG1;NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.7394182858295822,1.225045876251548,0.125,1.0,1.0,5/12,15.96%,RIMS2;RAP1B;NLGN1;LRRK2;PREPL
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7695496951890441,1.2250285884562082,0.16216216216216217,1.0,1.0,3/6,16.52%,USP15;ANKRD17;ZDHHC5
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.7865345118461256,1.2241171067988934,0.15714285714285714,1.0,1.0,2/5,13.42%,USP15;ANKRD17
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.443168852158384,-1.2241102391486909,0.125,0.9871891807067349,1.0,1/16,0.48%,FGF13
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7633892762076822,1.2240075121448133,0.15384615384615385,1.0,1.0,3/11,17.11%,CHST11;CHSY1;CHST15
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.7291509677891457,1.223830624048719,0.11538461538461539,1.0,1.0,1/11,2.96%,DDIT4
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7862059589919348,1.2235212046919772,0.2631578947368421,1.0,1.0,1/8,1.36%,RIPOR1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.8032998620510048,1.2233981917988574,0.2,1.0,1.0,2/5,13.90%,CTR9;WAC
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7653862872485367,1.2233962074685094,0.16049382716049382,1.0,1.0,4/9,15.83%,ZNFX1;SMCHD1;MBD2;EZH1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.7272394537001727,1.2232025069784729,0.13924050632911392,1.0,1.0,5/14,17.56%,DDX3X;RNF34;MADD;TNFRSF10B;LGALS3
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.747174630666189,1.223202451284334,0.23076923076923078,1.0,1.0,6/10,22.72%,ERRFI1;CTSL;ROCK2;RUNX1;CBFB;SGPP1
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6963288795463254,1.2225353136915833,0.125,1.0,1.0,1/19,0.11%,STC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.6378040835941422,1.2225273364473481,0.1702127659574468,1.0,1.0,10/39,18.53%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.7568822301816813,1.2221503039928128,0.20253164556962025,1.0,1.0,1/9,1.29%,PLAA
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7697934291116819,1.2218348208677028,0.18666666666666668,1.0,1.0,3/8,14.42%,PTPN1;PRLR;STAT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.8178526256127245,1.221714198531799,0.17105263157894737,1.0,1.0,2/6,9.18%,TGFB1;EFNB2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.7450885814691857,-1.2214224168298933,0.35714285714285715,0.9907908322489246,1.0,1/5,2.34%,OAZ2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.819183173673082,1.2213029611360804,0.16216216216216217,1.0,1.0,2/6,13.15%,SDCBP;RAB7A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7222172169510407,1.2212638212665323,0.1875,1.0,1.0,5/10,24.41%,CNOT8;DCP2;DCP1A;DIS3;PATL1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6931582252720146,1.2209198245828385,0.1625,1.0,1.0,5/16,18.41%,PRKACA;RAP1B;ROCK2;RUNX1;CBFB
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.5740629587320717,1.2207195956341232,0.01,1.0,1.0,67/285,19.65%,WWC1;TAF7;KLF2;ETV5;PRDM6;HDAC2;NEDD4L;KDM1A;TENM2;GLIS3;NR4A3;SUFU;ENO1;ZNF608;HCFC2;WWC2;CRY1;SEMA4D;CTR9;SAP130;ESR2;PPARA;CTBP2;APBB1;CXXC5;RPS27A;SDCBP;RARB;ZBTB16;MTF2;CEBPB;ZNF536;SIN3A;ZFPM2;SMURF2;DEAF1;CREM;MYT1L;TCERG1;MXD4;BCL6;RUNX1;TBX3;PHF21A;MDM2;MDM4;EED;STAT3;FGFR2;MBD2;HIVEP1;EZH1;LCOR;TWIST1;ZBTB7A;MZF1;ZBTB1;PER1;NFIX;CBFB;ZMYM5;SMAD2;SMARCA4;ZFPM1;RTF1;RBPJ;FOXP2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.8029280842074313,1.2195274771611124,0.2236842105263158,1.0,1.0,3/5,18.19%,PTPN2;LGALS3;PRNP
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.8029280842074313,1.2195274771611124,0.2236842105263158,1.0,1.0,3/5,18.19%,PTPN2;LGALS3;PRNP
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5940328528560505,1.2192312866341442,0.2391304347826087,1.0,1.0,12/42,13.52%,PTPRD;TENM2;DDIT4;TENM3;SMARCA1;UGCG;ACSL4;WNT2B;ADNP2;FZD3;MYT1L;RUNX1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6234128112061971,1.2189320335955158,0.17391304347826086,1.0,1.0,11/46,10.64%,PHYHIPL;ELAVL3;LSAMP;DPP6;ADGRB3;CACNA1B;PCDH17;ROBO2;SNAP25;CTNND2;CADM2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6825093095043204,1.2186642433103676,0.275,1.0,1.0,3/15,6.61%,DPM1;UBE2J1;MGAT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6825093095043204,1.2186642433103676,0.275,1.0,1.0,3/15,6.61%,DPM1;UBE2J1;MGAT1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.6147473058954922,1.2181932360536822,0.16279069767441862,1.0,1.0,7/36,13.42%,NFKBIA;USP15;IL18;TGFB1;NFKBIZ;RIOK3;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6695477575501831,-1.2176693250579977,0.28125,0.9988025634640462,1.0,1/6,1.38%,BCL2L11
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.6976320247569925,1.217326171947282,0.17073170731707318,1.0,1.0,4/14,9.40%,SYT1;LIN7A;SNAP25;SYN3
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.6244300713315162,1.2173046324257502,0.16483516483516483,1.0,1.0,12/39,12.92%,ATP6V1G1;ATP6V1H;RHEB;EIF2AK2;SLC38A9;SEC13;ATP6V1E1;SZT2;RNF152;EIF2AK4;CEBPB;SESN1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.6427024611721546,1.2172344690379693,0.17204301075268819,1.0,1.0,5/41,10.48%,HS3ST5;CHST11;OGN;DSE;CHSY1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.7621445913167469,1.2165650524611402,0.20512820512820512,1.0,1.0,5/8,20.05%,ADAMTS9;TGFB1;FGFR2;MYL3;SMAD7
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.6651003016463806,1.2163895344230171,0.25925925925925924,1.0,1.0,6/16,20.64%,SYMPK;CPSF2;GRSF1;CSTF3;PABPC1;AHCYL1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.6651003016463806,1.2163895344230171,0.25925925925925924,1.0,1.0,6/16,20.64%,SYMPK;CPSF2;GRSF1;CSTF3;PABPC1;AHCYL1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.7952163370661058,1.2159020470477628,0.14285714285714285,1.0,1.0,1/7,2.73%,SPTBN4
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7822559006347566,1.2158231853516472,0.17567567567567569,1.0,1.0,2/9,6.58%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7677387096355923,1.2155706135442426,0.2077922077922078,1.0,1.0,4/8,16.53%,GRIN1;RIMS2;NLGN1;NRXN1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6694786154445163,1.2155654936715263,0.20238095238095238,1.0,1.0,3/21,16.11%,HDAC2;TBX3;TWIST1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.7677934742815484,1.2155401171741953,0.13924050632911392,1.0,1.0,3/8,3.50%,NEDD4L;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.7516458802639139,1.2154596922269862,0.2,1.0,1.0,3/8,16.11%,NIBAN2;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6246722940510093,1.2144948615479632,0.27472527472527475,1.0,1.0,12/34,22.72%,CSNK1G2;VAPB;SGPL1;AGK;VAPA;SAMD8;ACER3;ELOVL5;CERS6;SPTLC1;SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.8057833589674799,1.214033365883783,0.11688311688311688,1.0,1.0,1/6,1.57%,KCNC2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.6276678747092878,1.2140201573121792,0.13978494623655913,1.0,1.0,17/44,22.61%,BTD;GNPAT;PANK2;PDHX;ACOT11;PPARA;SGPL1;ACSL4;MCCC2;CYP3A5;CKB;CKMT2;GLO1;PTGR1;ME2;ALDH1A2;MTHFD1L
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.7278310724551311,1.2139804606529416,0.24193548387096775,1.0,1.0,1/6,11.00%,DNAJC15
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7501002650338116,1.213382240524697,0.14814814814814814,1.0,1.0,3/11,14.07%,AGO2;ZFP36L2;PABPC1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7501002650338116,1.213382240524697,0.14814814814814814,1.0,1.0,3/11,14.07%,AGO2;ZFP36L2;PABPC1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6705883428781858,1.212878391501064,0.13953488372093023,1.0,1.0,6/20,25.84%,MICALL2;SREBF1;LRRK2;UBE2D3;ARIH2;UBE2L3
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7267345195495458,1.2128215449832571,0.24675324675324675,1.0,1.0,3/9,11.91%,RAB27A;SYNDIG1;NLGN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6616580896259936,1.2125614978846997,0.21686746987951808,1.0,1.0,1/18,2.96%,DDIT4
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.683496159801911,1.2124848701566981,0.1951219512195122,1.0,1.0,4/21,12.44%,RHOB;ANK3;STMN1;ROCK2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.8154721086671346,1.212419484652872,0.22666666666666666,1.0,1.0,2/7,11.20%,NECTIN2;CEP57
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7240606932234344,1.2119856716091213,0.25,1.0,1.0,2/9,16.58%,NAA11;NAA15
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.7485334608565851,1.2118157056362693,0.1794871794871795,1.0,1.0,3/11,12.10%,SLC22A6;SLCO1A2;SLC13A3
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6179696616198896,1.2116974596767247,0.15730337078651685,1.0,1.0,10/33,17.35%,CSF1;CD44;CD38;PTPN1;TNFRSF1B;TGFB1;CD9;STAT3;ACVR1B;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6934263208819036,1.2116962486656686,0.21686746987951808,1.0,1.0,3/14,16.28%,TGFB1;SDCBP;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.7934159802481278,1.211488351189713,0.2753623188405797,1.0,1.0,2/7,10.39%,DDX3X;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6085038142666481,1.2110839364287629,0.15555555555555556,1.0,1.0,9/37,21.68%,MYDGF;SEMA4D;IL18;FLT1;EPOR;INSR;UNC5B;KDR;IRS2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.7382203520658508,1.2109036852066135,0.2465753424657534,1.0,1.0,4/8,23.59%,METTL14;VIRMA;METTL16;WTAP
prerank,MSigDB_Hallmark_2020__UV Response Up,0.6069237480046462,1.210472390286508,0.16483516483516483,1.0,1.0,22/54,21.51%,GRINA;RHOB;PRKACA;NFKBIA;PTPRD;RAB27A;AGO2;CDC5L;MGAT1;SOD2;DDX21;TMBIM6;SLC25A4;PLCL1;IGFBP2;CHKA;DNAJA1;CA2;SLC6A12;JUNB;GPX3;CCK
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5943119262127212,-1.2096822752987073,0.30434782608695654,1.0,1.0,2/10,7.07%,TPM2;VIM
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5943119262127212,-1.2096822752987073,0.30434782608695654,1.0,1.0,2/10,7.07%,TPM2;VIM
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5936572687997175,1.2096404443792932,0.14130434782608695,1.0,1.0,10/42,11.23%,PHYHIPL;ELAVL3;KCNC2;GRIN1;NXPH1;LSAMP;CACNA1B;CTNNA2;SNAP25;GRIN2B
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6034686699460776,1.2093970520720425,0.10526315789473684,1.0,1.0,28/72,21.17%,SYT1;GLRB;PRKACA;GRIN1;PDE7B;KCND2;CACNA1B;KCNQ3;CAMKK2;GABRE;SNAP25;GRIK2;MBP;SDCBP;GRIN2B;NLGN1;GRM7;SLC1A2;MAPK1;NRXN1;PRKAR2A;GABRB1;NOVA1;PAFAH1B1;DLGAP1;GRIA2;PLP1;RPS6KA2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.761596456796379,1.2093414784259615,0.2375,1.0,1.0,6/8,22.69%,PURB;PRKCB;RUNX1;LGALS3;CBFB;MYSM1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.6518346340211048,1.209293329676935,0.16304347826086957,1.0,1.0,7/40,3.88%,PHYHIPL;ELAVL3;NXPH1;CRMP1;DNER;GFAP;DCLK1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.6619763657755011,1.2091362262120493,0.1927710843373494,1.0,1.0,8/20,18.53%,PANK2;SSH1;PPARA;RNF34;PDK3;PDK4;ARF4;ARF1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.789170857055072,1.2089571016022673,0.22077922077922077,1.0,1.0,2/7,13.35%,TGFB1;CST3
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.6236330062433445,1.2086603996235321,0.25842696629213485,1.0,1.0,10/34,23.08%,SOD1;ATP6V1G1;CP;NDFIP1;PRNP;ARF1;GLRX3;SKP1;TF;MT3
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.605388212880836,1.208606346476516,0.15217391304347827,1.0,1.0,9/47,13.52%,TAF7;CD44;MGST1;ARID3A;CDH2;CSF1R;PTPRE;ELF1;RUNX1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.7135610468824047,1.208562676281761,0.189873417721519,1.0,1.0,5/14,15.54%,FLT1;RUBCN;TGFB1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.7167181263546497,1.208461414453203,0.21176470588235294,1.0,1.0,5/16,13.34%,MUCL1;C1GALT1;GALNT15;GALNT11;GALNT7
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5904070195414716,1.2078075941750868,0.09375,1.0,1.0,16/79,13.96%,SRGN;ADAMTS9;ADGRV1;PITRM1;SUFU;CPD;ENPEP;ADAM17;DESI2;MMP16;CPM;UFSP2;F3;CTSL;SENP1;MDM2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.767340665710627,1.2077832189619946,0.11594202898550725,1.0,1.0,3/6,17.23%,TGFB1;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.7641806128817853,1.2077560362432227,0.18181818181818182,1.0,1.0,1/8,1.40%,GJA1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.7702553357695033,-1.2077478265334263,0.2857142857142857,1.0,1.0,2/5,13.18%,MAPK14;HMGB1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.689391387249858,1.207395298348743,0.23170731707317074,1.0,1.0,6/15,20.11%,OLFM2;ARFGAP3;RAB12;CANX;ABCA1;RAB8B
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6001357836958674,1.2073417082800697,0.18292682926829268,1.0,1.0,9/27,22.75%,USP15;TGFB1;HIVEP1;ACVR2A;PDCD4;USP9Y;SMAD2;SMAD7;SMAD6
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.7536813121688491,1.2065860091609428,0.2638888888888889,1.0,1.0,2/10,6.58%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.6720394085509688,-1.2054283231431435,0.17857142857142858,1.0,1.0,3/7,20.24%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8300279520428676,1.2052062263796481,0.16,1.0,1.0,3/6,13.31%,NRG1;CDH2;TAPT1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7913747790415552,1.2050931026562663,0.23076923076923078,1.0,1.0,2/5,13.10%,AK3;AK9
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.8000167541648467,1.2047777802073738,0.19230769230769232,1.0,1.0,1/9,1.85%,DDX3X
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.7362921479607241,1.2045601774714603,0.24096385542168675,1.0,1.0,3/8,16.89%,MIGA1;CHCHD3;SPG7
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.6196035211072837,1.2044467380966561,0.18478260869565216,1.0,1.0,15/48,24.53%,SYT1;ADGRV1;ANK3;EGFR;NLGN1;LRRK2;MAPK1;PRNP;RYR3;CDKN1B;BNIP3;CAMK2D;TF;MT3;JUN
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6687423858273244,-1.204078447658084,0.38095238095238093,1.0,1.0,2/5,3.02%,NRP1;RALBP1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.7499855419928421,1.2037216128603072,0.16455696202531644,1.0,1.0,3/8,16.98%,WIPI1;UGCG;WDR45B
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.6681998593265984,1.2035975467179532,0.25301204819277107,1.0,1.0,1/16,2.36%,MICALL2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.7903825951025213,1.2034537653845931,0.23943661971830985,1.0,1.0,1/5,8.45%,TGFB1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.6520877038732475,-1.2027597371473915,0.28125,1.0,1.0,1/6,1.10%,CD4
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.7523992795214287,1.2026265031917565,0.2,1.0,1.0,1/9,2.19%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7665284928799605,1.202603010707954,0.2361111111111111,1.0,1.0,3/6,11.04%,ITGA5;PRKCB;HIF1A
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5984189230879079,-1.20257290280753,0.23333333333333334,1.0,1.0,3/8,20.24%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.6377274988944288,1.2025418866080144,0.2235294117647059,1.0,1.0,12/39,19.18%,KCNC2;ATL1;APIP;ATL2;SOD2;ELAVL1;TP53BP1;SLC1A2;ZBTB1;RYR3;GOLGA2;STEAP4
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.7786157140983968,1.2020012460955023,0.2535211267605634,1.0,1.0,2/5,6.81%,MTHFD2L;ALDH1L1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.7786157140983968,1.2020012460955023,0.2535211267605634,1.0,1.0,2/5,6.81%,MTHFD2L;ALDH1L1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6689634606632497,1.2019186285368697,0.21794871794871795,1.0,1.0,4/19,7.85%,GJA1;NR4A3;DNMT1;SOD2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.7255748097972194,1.2014925042189495,0.189873417721519,1.0,1.0,4/17,16.33%,WWC1;STK4;TEAD1;LATS2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7081870693626633,1.200702925928898,0.21839080459770116,1.0,1.0,5/16,13.31%,NRG1;CDH2;SEMA4D;SEMA3B;TAPT1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5830098127370184,1.2006909808537594,0.020202020202020204,1.0,1.0,39/163,16.89%,NELL1;GLRB;BTD;NRCAM;ADGRV1;NRG1;CRMP1;DNER;LSAMP;DCLK1;DPYSL2;CDH2;ZC4H2;ROBO2;IGF2BP2;KIRREL3;SLC2A1;NAIP;TGFB1;ROBO1;MBP;SZT2;MOBP;ZBTB16;NLGN1;SH3GL3;FARP1;MYT1L;TBX3;NDUFS2;SIAH1;APAF1;PTPRZ1;STAT3;TEAD1;ACVR1B;WWP1;NRXN1;SPG7
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6737992091581243,1.2004559381502145,0.19318181818181818,1.0,1.0,4/15,3.50%,GJA1;NEDD4L;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.8099513007444858,1.2003651006219953,0.19736842105263158,1.0,1.0,2/5,10.56%,MGST1;SLC16A12
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5968520420512797,1.2003568119383057,0.1935483870967742,1.0,1.0,7/53,10.78%,HDAC2;NFKBIA;KDM1A;SUFU;BTRC;TMSB4X;EIF2AK4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.644786794417465,1.2003057903387628,0.16279069767441862,1.0,1.0,16/38,28.33%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1;MARCHF1;DNM2;SEC23A;AP2M1;CLTC;MARCHF8
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.577338113296159,1.2001791516044642,0.11224489795918367,1.0,1.0,22/103,14.42%,BTD;NRCAM;GRIN1;DNER;DDIT4;DCLK1;SLC6A17;CDH2;SMARCA1;ROBO2;SLC2A1;MBP;SZT2;EPHA7;ZBTB16;GRIN2B;RAB18;SH3GL3;CNTNAP2;TBX3;PTPRZ1;STAT3
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5790665254398235,-1.200088578252225,0.2,1.0,1.0,2/12,2.50%,CSRP2;LMOD1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.779015911084638,1.2000140419076717,0.19480519480519481,1.0,1.0,3/7,18.63%,SSH1;ABCC9;RYR3
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.744553710706619,-1.199474173295687,0.3333333333333333,1.0,1.0,4/5,25.34%,ANXA1;THBS1;COL3A1;F13A1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7952361427884379,1.199423808310717,0.2535211267605634,1.0,1.0,1/6,1.12%,GLRB
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8186011229038219,1.1992675330280869,0.18461538461538463,1.0,1.0,1/5,6.05%,RNF10
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.6352750021542619,1.1990971638115417,0.21978021978021978,1.0,1.0,9/31,18.83%,AGO2;ZFP36L2;GIGYF2;CNOT8;EIF4ENIF1;ROCK2;PABPC1;METTL14;PRR5L
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5979883367651836,1.198870652469069,0.20930232558139536,1.0,1.0,8/47,13.55%,PRKACA;PCBP3;ZFP36L2;ALKBH5;PPARGC1A;DCP2;TCERG1;CSTF3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.746262239579983,1.1987856548032187,0.2875,1.0,1.0,5/7,20.27%,SOD1;RUNX1;ZBTB1;CBFB;ABL1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5820268583779413,1.198668845723374,0.1875,1.0,1.0,11/62,13.59%,GRIN1;DDIT4;SLC6A17;CDH2;SMARCA1;ROBO2;CTNNA2;EPHA7;GRIN2B;RAB18;CNTNAP2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7456765687798883,1.1981802018130845,0.2638888888888889,1.0,1.0,5/10,12.45%,CDH18;CDH12;NLGN1;CDH10;CDH20
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6453569296729127,1.1981505412873144,0.1348314606741573,1.0,1.0,15/33,25.00%,ELAVL3;CRMP1;CACNA1B;NCAM1;EGFR;EPHA7;TSHZ1;PURG;PPM1E;DAB1;ERC2;PROS1;MAPK4;GRM5;MAP1B
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.7545036515673245,-1.1980804732626515,0.3103448275862069,1.0,1.0,2/5,4.92%,NFU1;YAE1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.8151288746669917,1.1979676671575075,0.1527777777777778,1.0,1.0,1/6,0.56%,CD44
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8078178559598723,1.1976111599700936,0.10294117647058823,1.0,1.0,1/5,1.57%,KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8078178559598723,1.1976111599700936,0.10294117647058823,1.0,1.0,1/5,1.57%,KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8078178559598723,1.1976111599700936,0.10294117647058823,1.0,1.0,1/5,1.57%,KCNC2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.7467006683957943,1.1975811971026653,0.19230769230769232,1.0,1.0,3/10,8.70%,WASF3;WASF1;CTNNA2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.7122666999553229,1.1975239103297384,0.19230769230769232,1.0,1.0,1/9,7.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.7252018111905373,1.1973070158273613,0.21686746987951808,1.0,1.0,3/14,15.12%,TAF7;PPARGC1A;GLYR1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.7504311291592711,1.1971603686369292,0.3055555555555556,1.0,1.0,4/6,21.45%,MTCH2;LRRK2;DNAJA1;HK1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6740152854246416,1.1966465612866146,0.2261904761904762,1.0,1.0,4/17,15.00%,TSC2;RUBCN;LZTS1;LRRK2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7478258192619727,1.1966312975228943,0.22857142857142856,1.0,1.0,2/7,11.91%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7478258192619727,1.1966312975228943,0.22857142857142856,1.0,1.0,2/7,11.91%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7122050524559905,1.196223559775685,0.22077922077922077,1.0,1.0,3/11,14.42%,PTPN1;PRLR;STAT3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5895071377669,1.1960819760711354,0.19318181818181818,1.0,1.0,8/36,19.43%,ADAM17;TGFB1;SDCBP;ACVR1B;RNF111;ACVR2A;SMAD2;RBPJ
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.7641995329868769,1.1959657611558963,0.1625,1.0,1.0,5/8,19.14%,CSF1;PRXL2A;CEBPB;FBN1;UBASH3B
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.7644149703593723,1.1956156445980304,0.22784810126582278,1.0,1.0,2/7,12.75%,GMPS;AK3
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.7791196540420867,1.1956062684053743,0.2916666666666667,1.0,1.0,1/5,2.47%,RAD21
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.7217322730348584,1.1954093190305952,0.2727272727272727,1.0,1.0,5/13,14.39%,PDE7B;RIMS2;PDE7A;AKAP6;PDE4D
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.7596727577318427,1.1949233460012365,0.2191780821917808,1.0,1.0,3/10,17.06%,TET3;CTR9;KDM6A
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7277420062787631,1.1949136024203129,0.20270270270270271,1.0,1.0,3/8,20.05%,USP15;TGFB1;SMAD7
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.6687160731223597,1.194826080822964,0.22727272727272727,1.0,1.0,9/19,14.44%,SLC23A2;SLC6A17;SLC16A6;SLC16A7;SLC16A12;SLC16A4;SLC3A2;SLC13A3;SLC36A4
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.6915352417886222,1.194543691137805,0.25882352941176473,1.0,1.0,3/16,6.42%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.8061189983607198,1.194072576664396,0.1891891891891892,1.0,1.0,3/5,19.14%,PTPN1;BRAP;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.7293238546747303,1.1940122493405063,0.15294117647058825,1.0,1.0,7/12,23.08%,KLF2;HIF1A;CEBPB;HSPA5;ATF6;RBPJ;MT3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.778072101161109,1.1939964121389364,0.18181818181818182,1.0,1.0,6/8,21.68%,NR4A3;PPARA;IRS1;PPARGC1A;TWIST1;IRS2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.7427670437752816,1.1939933224575556,0.2289156626506024,1.0,1.0,4/10,15.65%,GJA1;SLC22A6;SLC13A3;SLC1A2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.5663219617829452,1.1939720420800957,0.0707070707070707,1.0,1.0,23/140,15.01%,SRSF12;RNMT;HNRNPL;PRKACA;RBM17;RAVER2;CDC5L;HNRNPF;CCAR1;SYMPK;CPSF2;ALKBH5;CWC27;HNRNPC;PPARGC1A;ELAVL1;RBM4B;CCNH;TCERG1;CSTF3;PABPC1;SRSF10;METTL14
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.7290598148626743,1.1938352816233542,0.19753086419753085,1.0,1.0,5/9,24.41%,CNOT8;DCP2;DCP1A;DIS3;PATL1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8458602295167618,1.1937455170056543,0.2602739726027397,1.0,1.0,1/5,5.63%,CSF1R
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6622922019022284,1.1936835976130242,0.2375,1.0,1.0,6/22,14.89%,SYT1;RAB27A;RIMS2;SYTL4;NSF;RAB12
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.7588351787026053,1.1932726648110095,0.18055555555555555,1.0,1.0,4/8,19.20%,PDE4B;IL18;PDE4D;ZFPM1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.8224272499839104,1.1931386726625164,0.15151515151515152,1.0,1.0,1/6,0.99%,KLF15
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.8012244711740638,1.1929095651400399,0.13513513513513514,1.0,1.0,2/7,7.57%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7908370454735898,1.1928979268037179,0.2597402597402597,1.0,1.0,1/6,0.85%,TBC1D20
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.7519405721697215,1.1928922573550496,0.19736842105263158,1.0,1.0,4/8,18.50%,SPTBN4;SZT2;C12ORF57;PAFAH1B1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7345032056817336,1.1923652763611567,0.3048780487804878,1.0,1.0,2/7,17.97%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.5751146114467093,1.1921892287928666,0.08,1.0,1.0,32/126,20.50%,TBC1D20;SEC24A;WASF3;DARS1;WASF1;WIPF1;CSNK1D;CSNK1A1;SEC13;SLC2A1;LIN7A;PPARGC1A;CDC123;PDE4DIP;NSF;ST13;RANBP9;MDM2;MDM4;SEC24D;NAPG;LRRK2;TEAD1;RBX1;COL7A1;SPG7;CNIH3;GOLGA2;SMARCA4;WDR19;SKP1;ANKRD28
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.6272197267801691,1.192184957996821,0.25609756097560976,1.0,1.0,5/27,10.62%,NUP153;AGO2;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.6272197267801691,1.192184957996821,0.25609756097560976,1.0,1.0,5/27,10.62%,NUP153;AGO2;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.7120583403907994,1.1914907071884973,0.25301204819277107,1.0,1.0,4/9,20.44%,MIGA1;CHCHD3;SPG7;EEA1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6580125016620499,1.1913146353201265,0.2558139534883721,1.0,1.0,5/26,12.56%,LPIN1;MMUT;ACADVL;ECHDC1;ACADL
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8194191367250755,1.1913090620903262,0.2328767123287671,1.0,1.0,4/6,15.04%,VAPB;ATL1;ATL2;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.7459529335357774,1.191083448396211,0.19736842105263158,1.0,1.0,3/9,11.17%,KDM1A;DNMT1;MTF2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.7683019939123253,1.1907766739134662,0.25,1.0,1.0,1/7,1.29%,PLAA
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.8244849793575981,1.190654872733915,0.17567567567567569,1.0,1.0,2/5,12.17%,ADGRV1;ULK4
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.785217494659334,1.1905132524120512,0.25,1.0,1.0,2/5,11.37%,APOLD1;CEBPB
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7391033935526661,1.1898334794537015,0.16901408450704225,1.0,1.0,4/10,18.41%,PRKACA;ROCK2;RUNX1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.8020758223393573,1.1897659372646803,0.2753623188405797,1.0,1.0,3/6,14.42%,AGO2;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.8020758223393573,1.1897659372646803,0.2753623188405797,1.0,1.0,3/6,14.42%,AGO2;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.746975144317075,1.189279142108463,0.25675675675675674,1.0,1.0,2/6,18.91%,NR4A3;DOCK4
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6625927052766499,1.189124978497326,0.2608695652173913,1.0,1.0,6/16,23.23%,PELI1;ADAM17;MAPKAPK2;ERBIN;SMAD6;TAB2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.586431725500876,1.189083686607365,0.25274725274725274,1.0,1.0,8/41,10.11%,SRGN;NAA11;PITRM1;CPD;ADAM17;MMP16;CPM;F3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.6740685592202231,1.1887438064480291,0.25,1.0,1.0,3/14,15.97%,CD44;ZBTB16;CREB3L2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.7126238545749841,1.1887291428336284,0.24050632911392406,1.0,1.0,3/12,14.36%,AGO2;TUT7;MOV10L1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6838702438016943,1.188570223494678,0.23529411764705882,1.0,1.0,5/14,5.61%,KCND2;KCNE4;KCNQ1;ANK3;SCN3A
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.6670435750451781,1.1881658347589623,0.27380952380952384,1.0,1.0,3/14,4.90%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.7404180804892206,1.188018327492382,0.24096385542168675,1.0,1.0,4/11,17.94%,LPIN1;SELENOI;PLAAT3;CHKA
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6497813617503161,1.1876120612111856,0.27586206896551724,1.0,1.0,6/22,11.12%,TSC2;PTPN1;SIK2;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7070535906588981,1.1874856446553088,0.16279069767441862,1.0,1.0,1/15,0.39%,HS3ST5
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6434986619222849,1.1871564717750642,0.23809523809523808,1.0,1.0,6/17,15.97%,CD44;TGFB1;WNT2B;ZBTB16;RUNX1;CREB3L2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.7278724276555181,1.18678523161782,0.2638888888888889,1.0,1.0,4/9,23.59%,METTL14;VIRMA;METTL16;WTAP
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7937078715336374,1.1867024799684278,0.2753623188405797,1.0,1.0,1/5,1.16%,LPIN1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.65360199526379,1.186564523245381,0.2891566265060241,1.0,1.0,1/18,0.42%,SOD1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.7003319670514278,-1.186297095799433,0.21739130434782608,1.0,1.0,1/7,6.54%,DAG1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7217100815093268,1.1861368975725983,0.24096385542168675,1.0,1.0,4/9,14.53%,SCD;IRS1;PDK3;PDK4
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.7932642199785209,1.186075634123686,0.2537313432835821,1.0,1.0,2/5,7.65%,SLC22A6;PRKCI
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.7659899243578207,1.185982125350446,0.3188405797101449,1.0,1.0,1/6,0.56%,CD44
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.790584623925539,1.1857041021253438,0.23076923076923078,1.0,1.0,2/8,5.75%,LPIN1;SELENOI
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.5752226806908578,1.1854880635655776,0.20212765957446807,1.0,1.0,22/66,24.84%,SOD1;ETV5;PYROXD1;CAMKK2;SOD2;SELENOS;EGFR;PPARGC1A;HIF1A;ADNP2;GSR;VKORC1L1;LRRK2;MAPK1;PRR5L;ABL1;GPX3;STX2;MT3;ERCC6L2;JUN;FOXO3
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.6542794397121425,1.1850947438142723,0.25882352941176473,1.0,1.0,5/24,11.10%,CSF1;NFKBIA;SSH1;TGFB1;RBM4B
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.7045147954556193,1.185042475452232,0.25,1.0,1.0,4/13,18.58%,LPIN1;LPCAT3;CHKA;CSNK2A1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.6319561226965564,1.1848030290007476,0.22093023255813954,1.0,1.0,11/36,21.84%,NEDD4L;AMFR;ZNRF1;PELI1;MARCHF6;RNF34;RNF152;RBX1;UBR5;UBE2B;UBE2K
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6485247885959987,1.1847494088279205,0.3058823529411765,1.0,1.0,8/20,22.80%,NR4A3;PDHX;ENO1;PGK1;GLO1;HK1;ME2;TPI1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.769530973733169,1.1843964462206116,0.2857142857142857,1.0,1.0,1/5,3.50%,KCNQ1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.6308056001254135,1.18414264425914,0.21686746987951808,1.0,1.0,7/26,13.73%,BCKDHB;BLMH;MCCC2;GLUL;GLUD1;ASPA;BCAT2
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6811332233045578,1.1838933538720298,0.15,1.0,1.0,6/15,20.52%,MICOS10;SLC25A4;CHCHD3;SPG7;DNAJC11;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6762483685400941,1.1837453007148473,0.25316455696202533,1.0,1.0,9/14,26.40%,TGFB1;HIF1A;STAT3;TEAD1;SMARCA4;JUN;FOXO3;ETS1;FOS
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.42522294310614395,-1.1836042302997238,0.14285714285714285,1.0,1.0,6/38,4.98%,ZBTB7C;EDN3;TNFRSF19;WNK2;PDZRN3;TMEM132C
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.6367086957075511,1.1828842442491225,0.21978021978021978,1.0,1.0,6/30,11.80%,RHOB;MCC;SCD;KIF13B;GLUL;CP
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.6017122872341045,-1.1828206541979107,0.2,1.0,1.0,1/12,1.35%,NRP1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.7485219654870974,1.182766093130559,0.2125,1.0,1.0,5/8,22.64%,KDM1A;PTPRZ1;LRRK2;NAP1L1;TAFA1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.6620263755486087,1.1826658227134594,0.24390243902439024,1.0,1.0,4/22,13.65%,IFT52;IFT140;TRAF3IP1;IFT57
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.6023703386728015,-1.1824675959691366,0.25,1.0,1.0,3/10,12.31%,FASTKD2;RPL6;RPL23A
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5981318673141223,-1.1824168356045976,0.2692307692307692,1.0,1.0,4/9,7.27%,SCN1A;CACNA1D;SCN7A;HCN2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.6348863793178011,1.1823175254161147,0.3170731707317073,1.0,1.0,5/19,20.84%,FMN2;EGFR;MDM4;PRNP;ITGAV
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7084527367390085,1.182059956931422,0.2692307692307692,1.0,1.0,4/13,15.11%,WWC1;WWC2;IQCJ-SCHIP1;NF2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7686589434877957,1.1819903617245242,0.2564102564102564,1.0,1.0,4/6,21.68%,PPARA;IRS1;TWIST1;IRS2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.560338243221852,1.1819437230053864,0.09,1.0,1.0,57/205,22.39%,SOD1;CSF1;CD44;MID1;PRKACA;NFKBIA;PSMB1;PSMB2;CSF1R;PELI1;IL18;CTR9;HNRNPF;BTRC;NCAM1;TNFRSF1B;PSMA7;ADAM17;SOD2;UGCG;TGFB1;IRS1;RAP1B;RPS27A;F3;TMSB4X;HIF1A;PRLR;PSMA4;BCL6;PTPRZ1;STAT3;CFL1;TRIM5;CEBPD;PSMD14;RBX1;CANX;TWIST1;MAP3K14;PDCD4;IFIT3;ARF1;LIFR;ST18;SMARCA4;JUNB;SKP1;CDKN1B;ABL2;IFITM3;CAMK2D;GAB2;IRS2;GRB2;PITPNA;MAP3K8
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6520969820908653,1.1819289522893084,0.2619047619047619,1.0,1.0,4/22,11.38%,PRKACA;PPARGC1A;HIF1A;PDK3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6998321217490964,1.1812241757432926,0.18421052631578946,1.0,1.0,8/18,16.53%,SYT1;DGKI;CDH2;NLGN1;GRM7;TSHZ3;LRRK2;NRXN1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7335151646182925,1.1811361683967403,0.26666666666666666,1.0,1.0,6/9,23.42%,PRKCB;ELF1;RUNX1;CBFB;ELF2;CD81
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.7077875254314567,1.1808322046694344,0.25316455696202533,1.0,1.0,2/7,14.78%,EGFR;ATAD5
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.5961380044178639,1.1808046929710974,0.1978021978021978,1.0,1.0,10/53,12.62%,SOD1;ETV5;DDX3X;PYROXD1;SOD2;SELENOS;PPARGC1A;ADNP2;GSR;VKORC1L1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.5841344083759742,1.1807651210722154,0.21739130434782608,1.0,1.0,10/68,14.00%,SRGN;SOD1;SYT1;HABP4;RIMS2;TGFB1;SNAP25;TMSB4X;SYTL4;CD9
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7781126961780087,1.1805605258712233,0.225,1.0,1.0,2/6,15.62%,EHD2;PACSIN2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.8124807960659229,1.1805263149177825,0.3150684931506849,1.0,1.0,1/5,7.75%,ADAM17
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.5813003927383714,1.1803708330224185,0.14736842105263157,1.0,1.0,33/93,21.98%,SYT1;GLRB;PRKACA;GRIN1;PDE7B;KCND2;CACNA1B;KCNQ3;CAMKK2;GABRE;LIN7A;SNAP25;GRIK2;SYN3;MBP;SDCBP;GRIN2B;NLGN1;GRM7;SLC1A2;MAPK1;NRXN1;PRKAR2A;GABRB1;NOVA1;PAFAH1B1;DLGAP1;GRIA2;NAPB;PLP1;RPS6KA2;ERC2;GABRB3
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7779827421420447,1.1803022070925822,0.25,1.0,1.0,3/7,13.31%,NRG1;CDH2;TAPT1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.6570737603055256,1.1799690048768519,0.26744186046511625,1.0,1.0,3/20,12.44%,RHOB;NLGN1;ROCK2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.6096639194415443,1.1797608917614837,0.23595505617977527,1.0,1.0,8/40,14.62%,NRCAM;SPTBN4;ANK3;ATL1;APBB1;CTNNA2;FARP1;FGFR2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.7528726661794486,1.179410090249002,0.2361111111111111,1.0,1.0,1/5,5.63%,CSF1R
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.6083346448014898,1.1793871446729727,0.23655913978494625,1.0,1.0,13/37,21.08%,SOD1;SNX6;NAIP;PRKCI;SOD2;PPARGC1A;EPHA7;PTPRZ1;UNC5B;CPEB4;PRNP;LANCL1;NF1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.7675403801184446,1.179215811975276,0.2916666666666667,1.0,1.0,3/6,20.55%,ANK3;PDE4D;CAMK2D
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.5622432245291861,1.1791507417454605,0.1111111111111111,1.0,1.0,31/155,15.60%,STX6;IPO9;ARL5A;TSC2;NUP153;GGA3;RAB28;AP2A1;COG7;XPO4;SNX6;IPO5;SEC13;CSE1L;NUP88;SYNDIG1;TGFB1;KIF13B;TRIM23;NUP133;EIF4ENIF1;RAB18;NLGN1;ARFGAP3;RAB7A;NSF;NAPG;AKAP6;STAT3;AP3D1;TBC1D15
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.7742175598056165,1.1790432320511253,0.21052631578947367,1.0,1.0,2/8,10.41%,DDX3X;DIP2B
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.733337110156286,1.178641457324511,0.1917808219178082,1.0,1.0,3/11,16.11%,HDAC2;TBX3;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7745721789998007,1.1786040507432463,0.23684210526315788,1.0,1.0,5/6,21.68%,PPARA;IRS1;TWIST1;ABHD5;IRS2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6949152123298796,1.1785582319992,0.29333333333333333,1.0,1.0,3/11,16.13%,ADAM17;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6949152123298796,1.1785582319992,0.29333333333333333,1.0,1.0,3/11,16.13%,ADAM17;SDCBP;RNF111
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.7785223154353201,1.178222263246828,0.2753623188405797,1.0,1.0,2/5,12.13%,ADAM17;GALNT11
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5917884135649761,1.1779039300342262,0.1595744680851064,1.0,1.0,6/49,7.34%,STC1;TPT1;PRKACA;VAPB;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.6471667984347522,1.1778695398231689,0.25,1.0,1.0,5/18,20.52%,PITRM1;SLC25A4;SPG7;ABCB10;BNIP3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.756502381340366,1.1777547459909867,0.2465753424657534,1.0,1.0,1/6,1.35%,RHOB
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.7407215058988823,1.177505335683213,0.21621621621621623,1.0,1.0,2/10,7.57%,CTR9;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.6576991818488325,1.1774054459050947,0.32978723404255317,1.0,1.0,8/24,18.58%,DDX3X;ADAM17;EGFR;SDCBP;ADNP2;AKAP6;INSR;CSNK2A1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.7678092007386801,1.1773626822299255,0.21518987341772153,1.0,1.0,3/6,16.24%,ATP6V1G1;NDUFS2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.683262765240468,1.1772312147047086,0.2716049382716049,1.0,1.0,5/13,20.15%,PLAA;FLT1;FGFR2;ARF4;ABL2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.6087376726147106,-1.1772013318488206,0.38461538461538464,1.0,1.0,3/7,15.35%,LTBP3;SOX5;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7323052357976274,1.1770691750279973,0.2375,1.0,1.0,3/8,20.55%,NEDD4L;STK39;CAMK2D
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.6665725719646737,1.1769633510953779,0.24050632911392406,1.0,1.0,3/15,12.05%,ARRDC2;CEBPB;OSTF1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.40532490912055696,-1.1769083291199933,0.1,1.0,1.0,4/37,5.72%,NRP1;PHLDB2;EPHA3;SLC9A1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.5592464060726334,-1.1769073855767223,0.3333333333333333,1.0,1.0,1/19,0.73%,CDK6
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.501940549074561,-1.1767777698255881,0.2,1.0,1.0,5/24,6.51%,NRP1;SLIT2;PGF;ADGRA2;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.6039921235913119,1.1766370985894565,0.22105263157894736,1.0,1.0,13/50,15.56%,EPM2A;TSC2;CAMKK2;BNIP3L;TBK1;RNF152;EIF2AK4;SESN1;WAC;TRIM5;LRRK2;ATF6;C9ORF72
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6537337688070551,1.1765529524389422,0.2857142857142857,1.0,1.0,4/23,18.01%,ADAMTS9;RAB12;DENND3;MANBA
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7379706428362445,1.176109988457371,0.26436781609195403,1.0,1.0,3/10,15.00%,SOD2;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.7995874476867921,1.1759138731251415,0.2835820895522388,1.0,1.0,4/5,18.50%,UBA5;AGTPBP1;NRXN1;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7173703487364189,1.1755494888560012,0.22077922077922077,1.0,1.0,4/13,16.07%,ITGA5;PTRH2;PDK4;ANKRD13C
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.7547392303378031,1.1755358612671447,0.28,1.0,1.0,6/8,23.08%,ZFP36L2;MAPK1;MAP2K1;KDR;ITGAV;MT3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6468868322076344,1.1749299867347265,0.20238095238095238,1.0,1.0,4/21,10.78%,KDM1A;RHBDD1;GNB1;EIF2AK4
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6206545610792529,1.1743183225510985,0.23863636363636365,1.0,1.0,5/33,12.44%,RHOB;ANK3;STMN1;SPIRE1;ROCK2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7796613306887585,1.1738997903826158,0.22666666666666666,1.0,1.0,3/6,19.43%,EGFR;MVB12B;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.7334319494395001,1.1734375449957406,0.2631578947368421,1.0,1.0,3/8,16.39%,NIBAN2;EGFR;ZBTB7A
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7922074574923219,1.1734078711464813,0.29333333333333333,1.0,1.0,1/5,7.24%,SLC39A11
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7508705274851196,1.1733737034129716,0.2222222222222222,1.0,1.0,1/6,2.75%,PDK1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.6117301405545683,-1.1728139815483938,0.25806451612903225,1.0,1.0,5/8,24.41%,HSPA1A;CLU;HSPA4;PTGES3;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.6422013441019065,1.1725392052183456,0.2727272727272727,1.0,1.0,5/22,16.11%,SELENOS;MBP;MAPKAPK2;STAT3;TWIST1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7124866021855556,-1.1724026443173416,0.2222222222222222,1.0,1.0,2/6,12.33%,ANXA1;CALCRL
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7006565621627187,1.172295743626682,0.2804878048780488,1.0,1.0,3/12,17.11%,CHST11;CHSY1;CHST15
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6419885450629792,1.172191676420675,0.28735632183908044,1.0,1.0,9/25,12.47%,KCNC2;KCNH7;KCND2;KCNQ1;KCNQ3;ATP1B3;KCNQ5;ABCC9;NALCN
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7290219537289091,1.1721307220452108,0.2727272727272727,1.0,1.0,5/10,17.90%,ATL1;ATL2;RAB18;RTN3;REEP3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.5611951381240882,1.1720119417942108,0.2268041237113402,1.0,1.0,19/74,19.06%,NELL1;PRDM6;PCBP3;FUBP1;MTMR9;IGF2BP2;PRDM10;SCARB2;MTMR1;NFKBIZ;HIF1A;ADNP2;ROCK2;FUBP3;TRIM5;KDM6A;NOVA1;ARF1;AFF4
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.6021171567852726,1.1718479609581012,0.24705882352941178,1.0,1.0,13/39,18.75%,CD38;CHL1;CSF1R;ALDH1L1;PPARA;SOD2;CPM;OMG;CP;LRRK2;CPEB4;ABCA1;ANKUB1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.6042712436222466,1.1715467079002002,0.23333333333333334,1.0,1.0,5/29,11.04%,SOD1;CAMKK2;SOD2;EGFR;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.6853895345361649,-1.1714702494337577,0.4166666666666667,1.0,1.0,2/5,17.63%,RIPOR2;LRCH1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5486994936673193,-1.1713829397208055,0.19047619047619047,1.0,1.0,5/9,15.73%,MYLK;ANXA1;ITGB1;ACTG1;PTK2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.6650894832639502,1.1710727146993403,0.2857142857142857,1.0,1.0,4/13,14.50%,ENO1;CRY1;PPARGC1A;PGK1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6917357410707603,-1.1710596560892366,0.34782608695652173,1.0,1.0,1/5,11.21%,SETDB1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.5893461159876683,1.1703007954022935,0.27472527472527475,1.0,1.0,6/49,6.61%,DPM1;TET3;TMEM165;COG7;MGAT4A;MGAT1
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4903259320767037,-1.170203126985033,0.38461538461538464,1.0,1.0,2/20,1.10%,WDFY4;CD4
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6760065811056788,1.169950114624297,0.3103448275862069,1.0,1.0,7/14,27.70%,UBA5;UFSP2;RUNX1;CBFB;CNOT1;STRN3;PAK1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.5739934404285936,1.1695358274048218,0.2127659574468085,1.0,1.0,17/58,19.91%,TSC2;PDK1;ACTR3;RAF1;PRKCB;PPP2R1B;SLC2A1;TBK1;EGFR;MAP2K6;CFL1;MAPK1;PRKAR2A;ARF1;SMAD2;VAV3;CDKN1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7138479320852991,1.1694388150879882,0.21052631578947367,1.0,1.0,1/9,1.54%,PRKACA
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6643124387419225,1.1691021494346385,0.2625,1.0,1.0,2/13,11.38%,PRKACA;PDK3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6875344227791595,-1.1687664961853452,0.25,1.0,1.0,3/7,12.03%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.6507053745517405,1.1687649171435972,0.2962962962962963,1.0,1.0,3/17,3.71%,NKAIN3;SPTBN4;ANK3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.8065528420996405,1.1686812276182161,0.23943661971830985,1.0,1.0,1/6,2.65%,DHRS3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6942612284735082,1.1685755449886788,0.2839506172839506,1.0,1.0,5/12,16.53%,GRIN1;RIMS2;NLGN1;LRRK2;NRXN1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.5989651558761021,-1.1685154735216168,0.3448275862068966,1.0,1.0,2/6,20.19%,LIN7C;PHACTR4
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.6809900295063366,1.1679023236798114,0.26506024096385544,1.0,1.0,2/25,1.97%,SYT1;ADGRV1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.6611047745871951,1.167207743368098,0.3246753246753247,1.0,1.0,4/17,22.35%,KDM1A;KDM3A;KDM6A;KDM2A
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5780065190976177,1.167165471542345,0.2247191011235955,1.0,1.0,12/38,19.70%,CSF1R;ZFP36L2;FLT1;KIRREL3;TGFB1;WNT2B;ZBTB16;MELK;RUNX1;FGFR2;ZFPM1;KDR
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.618579420759616,-1.1668280281479682,0.3333333333333333,1.0,1.0,4/7,7.12%,SLIT2;ANO6;NBL1;CXCL12
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7260376036700581,1.1668216840470558,0.2894736842105263,1.0,1.0,3/8,20.84%,NFKBIA;PTPN2;ITGAV
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.735111909225195,-1.16681342128918,0.3548387096774194,1.0,1.0,2/5,5.83%,TSEN2;C2ORF49
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.735111909225195,-1.16681342128918,0.3548387096774194,1.0,1.0,2/5,5.83%,TSEN2;C2ORF49
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.7715492418680578,1.1667697027897797,0.2835820895522388,1.0,1.0,3/5,22.75%,SNX25;SMAD7;SMAD6
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.46151015082140734,-1.1662631104729626,0.2222222222222222,1.0,1.0,4/17,9.74%,OSBPL6;CYP27A1;AKR1C3;FAXDC2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.6571805331255945,1.1657971916362928,0.21839080459770116,1.0,1.0,5/19,9.34%,NEDD4L;PTPRD;ADGRB3;SEMA4D;LZTS1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.6278198333813588,-1.1655103831111673,0.27586206896551724,1.0,1.0,1/6,0.33%,CAV2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.6736204171532074,1.165233312896745,0.25609756097560976,1.0,1.0,9/17,26.91%,ZFP36L2;TGFB1;FZD3;BCL6;HECA;CDKN1B;TOM1L1;RGCC;ANGEL2
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6692261628304286,1.1651386800992316,0.2875,1.0,1.0,5/13,29.76%,CTR9;STAT3;ST18;PTPN11;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.703903527238997,-1.164177923769018,0.32142857142857145,1.0,1.0,1/5,0.62%,EDN3
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.6324413925973609,1.1640871722906363,0.25882352941176473,1.0,1.0,7/23,16.39%,NUP153;SEC13;SCARB2;NUP88;NUP133;HIF1A;ZBTB7A
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.6309474341115824,1.163887805876118,0.26436781609195403,1.0,1.0,8/24,21.88%,GRIN1;FARSB;APIP;SOD2;GRIN2B;RYR3;GOLGA2;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7593319580662463,1.1637969513191533,0.2916666666666667,1.0,1.0,2/7,9.18%,TGFB1;EFNB2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.4554725648147838,-1.1634222369962863,0.15384615384615385,0.9995877736089513,1.0,4/27,2.36%,NTN4;ITGA8;NRP1;LAMC1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6449487007786199,1.1631233100790195,0.23529411764705882,1.0,1.0,3/16,16.58%,NAA11;CLOCK;NAA15
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.7594686537102753,1.1629610348616006,0.14285714285714285,1.0,1.0,4/7,18.27%,NDFIP2;CORO2B;NDFIP1;DNAJA1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.5745326015164646,1.1627540188691985,0.19148936170212766,1.0,1.0,18/101,15.20%,SRGN;TBC1D20;VAPB;TOR1AIP2;COG2;FAM174B;ANK3;ATL1;COG7;CSNK1D;CSNK1A1;ATL2;VAPA;ARHGEF7;REEP5;LRRK2;WASHC5;AP3D1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.7183110850276047,1.1620812944277181,0.34210526315789475,1.0,1.0,1/9,9.31%,TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6379966446730798,1.1619832635234284,0.20987654320987653,1.0,1.0,5/21,13.46%,DDX3X;RAF1;TRAF3IP1;RIOK3;HSPA5
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.5802893277091128,-1.1614956071847276,0.35294117647058826,1.0,1.0,2/14,4.99%,ZDHHC15;VPS35
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5101735415380231,-1.1614520654858895,0.2608695652173913,0.9952479693455709,1.0,3/13,4.20%,WNT5B;ATM;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7468507366470837,1.1612218048329266,0.3,1.0,1.0,6/9,14.13%,NRG1;NIBAN2;ATP11A;TGFB1;EFNB2;AKAP6
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.6778584547806314,-1.1611037626503478,0.36666666666666664,0.9912816050140044,1.0,1/5,1.02%,ITGA8
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.6693769663700148,1.1610118258026976,0.35,1.0,1.0,2/10,7.85%,SOD1;SOD2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.6484259546129691,1.1609798609368494,0.24705882352941178,1.0,1.0,2/19,7.65%,MICALL2;PRKCI
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7248611439871533,1.160446374445854,0.24324324324324326,1.0,1.0,3/9,7.58%,NEDD4L;PRKCB;SLC2A1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6868356193048502,1.1603711582221148,0.27906976744186046,1.0,1.0,4/14,17.11%,CHST11;DSE;CHSY1;CHST15
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5888216650788253,1.160322527085189,0.25,1.0,1.0,13/46,16.53%,NRCAM;DNER;PTPRD;ANK3;CDH2;ZC4H2;KIRREL3;CTNND2;NLGN1;FARP1;LRRK2;LRFN5;NRXN1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.634410011875024,1.1601825546530453,0.23809523809523808,1.0,1.0,2/29,2.62%,STX6;KDM1A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.794782755399859,1.160178501238114,0.2714285714285714,1.0,1.0,2/5,18.63%,SSH1;RYR3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6361908542981839,1.160132004739644,0.3076923076923077,1.0,1.0,4/19,15.85%,LRRC7;PRKCI;LIN7A;ERBIN
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.6886921583769523,1.1596391318334451,0.21052631578947367,1.0,1.0,6/13,23.09%,PDE4B;IL18;PDE4D;PRNP;ZFPM1;AXL
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.7178349559930343,1.1595896213446077,0.34615384615384615,1.0,1.0,3/7,5.07%,PRKACA;KCNQ1;PDE4B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.7178349559930343,1.1595896213446077,0.34615384615384615,1.0,1.0,3/7,5.07%,PRKACA;KCNQ1;PDE4B
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.5314390942520041,-1.1592522722546528,0.3333333333333333,0.992423618233975,1.0,1/13,2.12%,PARP9
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7655332408862738,1.1591902153582232,0.25675675675675674,1.0,1.0,2/5,7.91%,PRKCB;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.7322149921492065,1.1591109105580506,0.2987012987012987,1.0,1.0,2/9,4.33%,NUP153;SUFU
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.5492959648926491,1.1585575102709476,0.14,1.0,1.0,38/155,26.36%,WWC1;SUFU;HCFC2;WWC2;CTR9;ESR2;YAF2;CCAR1;APBB1;CLOCK;PPARGC1A;HIF1A;MTF2;CEBPB;ZNF536;CREM;STAT3;SRSF10;INSR;ACVR1B;MZF1;PLAG1;SP1;NLK;ABL1;RALY;NCOA2;SP3;NSD2;ZNF138;DNM2;YBX1;RFX3;SFPQ;UBE2L3;ESRRG;ZMIZ1;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.595838967294447,1.15802045815276,0.23655913978494625,1.0,1.0,16/43,20.84%,SYT1;TSC2;PTPN1;RIMS2;NSF;RAB12;LRRK2;PACSIN2;MAPK1;SCARB1;MAP2K1;RAB8B;ABL2;ABL1;RUFY1;ITGAV
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.6039517858397325,1.158011832968463,0.2619047619047619,1.0,1.0,12/34,20.55%,TBK1;OXSR1;ROCK2;LRRK2;ACVR1B;TNKS;MAPK1;MAP2K1;STK39;CSNK2A1;NLK;CAMK2D
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.6722000257251015,1.1579612577114582,0.2716049382716049,1.0,1.0,4/12,5.85%,DPP10;DPP6;ANK3;FHL1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6130185945512809,-1.157752781624346,0.3333333333333333,0.9916938160166598,1.0,1/8,0.36%,PGR
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.6745939694625869,1.1576369686808774,0.2876712328767123,1.0,1.0,3/11,21.45%,PITRM1;DNAJC15;HK1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.6374049917098583,1.1574530371633829,0.30864197530864196,1.0,1.0,2/19,1.35%,SOD1;RHOB
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6087783245066012,-1.1571916947792866,0.25,0.9886334996396767,1.0,1/10,1.38%,BCL2L11
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7670594723018876,1.1565484167874684,0.28169014084507044,1.0,1.0,3/5,22.75%,TBX3;SMAD2;SMAD6
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6862356726063262,1.156394229626838,0.3026315789473684,1.0,1.0,5/13,22.72%,DGKI;CYP3A5;LPCAT3;DGKH;SGPP1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5851189112653178,1.1562304149537308,0.23333333333333334,1.0,1.0,7/42,7.61%,MUCL1;PRKACA;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.5851189112653178,1.1562304149537308,0.23333333333333334,1.0,1.0,7/42,7.61%,MUCL1;PRKACA;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5851189112653178,1.1562304149537308,0.23333333333333334,1.0,1.0,7/42,7.61%,MUCL1;PRKACA;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.5441276417846431,1.1561803590161008,0.04,1.0,1.0,88/391,20.05%,WWC1;SCML1;TAF7;KLF2;ETV5;PRDM6;HDAC2;NRG1;NEDD4L;KDM1A;CBFA2T2;TENM2;GLIS3;CD38;NR4A3;BASP1;SUFU;ENO1;ZNF608;HCFC2;WWC2;CRY1;NIBAN2;SEMA4D;CTR9;SNX6;SAP130;BTRC;ESR2;YAF2;PPARA;CTBP2;TGFB1;TP63;APBB1;CXXC5;CLOCK;RPS27A;SDCBP;RARB;RCOR1;ZBTB16;MTF2;CEBPB;ZNF536;SIN3A;ZFPM2;SMURF2;DEAF1;TSHZ3;CREM;MYT1L;TCERG1;MXD4;BCL6;RUNX1;TBX3;PHF21A;MDM2;MDM4;EED;STAT3;FGFR2;MBD2;HIVEP1;EZH1;LCOR;TWIST1;WWP1;ZBTB7A;MZF1;PDCD4;ZBTB1;LOXL3;PER1;NFIX;CBFB;ZHX3;ZMYM5;SMAD2;SMARCA4;ZFPM1;MBTD1;RTF1;RBPJ;FOXP2;CDKN1B;SMAD7
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.57449003177226,1.1561538454589164,0.20833333333333334,1.0,1.0,8/70,7.71%,STX6;TBC1D20;COG2;FAM174B;COG7;CSNK1D;CSNK1A1;ATL2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.58473542831052,1.1559597265716102,0.21505376344086022,1.0,1.0,6/53,5.71%,GPR161;MID1;GLRB;TENM3;CDH2;SMARCA1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.742580000465758,1.155752442675951,0.28378378378378377,1.0,1.0,3/7,17.23%,LRRK2;MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.701765000389907,1.1557249063952284,0.26506024096385544,1.0,1.0,4/11,15.54%,FLT1;TGFB1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7796140777023628,1.155592194887727,0.2876712328767123,1.0,1.0,3/5,20.27%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7796140777023628,1.155592194887727,0.2876712328767123,1.0,1.0,3/5,20.27%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6202215839081962,1.1555767977037859,0.2441860465116279,1.0,1.0,9/28,20.27%,CSF1R;FLT1;EGFR;PRLR;FGFR2;INSR;KDR;ABL2;ABL1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.7325563159258331,1.1551372390688506,0.2,1.0,1.0,3/9,13.80%,NRG1;PRLR;TBX3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7132856691513849,1.1551101274230406,0.32432432432432434,1.0,1.0,3/6,18.04%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5745257849607095,1.1550402724294444,0.25773195876288657,1.0,1.0,18/55,26.71%,SRGN;HOMER2;PPARA;SELENOS;TBK1;TRAF3IP1;TMSB4X;LGR4;PDCD4;PRNP;ZFPM1;NAV3;SARS1;AXL;LEF1;NPLOC4;RPS6KA5;RGCC
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.7256868868826152,1.154811100828818,0.2676056338028169,1.0,1.0,3/8,16.67%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.7256868868826152,1.154811100828818,0.2676056338028169,1.0,1.0,3/8,16.67%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.6536703738371941,1.1547370812766093,0.21428571428571427,1.0,1.0,9/24,21.82%,NRG1;NDFIP2;RUBCN;NDFIP1;RAB7A;PIP4P2;LGALS3;ITGAV;MTMR2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7788389885545527,1.1545014667351936,0.25,1.0,1.0,2/5,16.53%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7788389885545527,1.1545014667351936,0.25,1.0,1.0,2/5,16.53%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.578132085638694,1.1544757831740713,0.26595744680851063,1.0,1.0,11/53,16.24%,DDX3X;AGO2;GIGYF2;IGF2BP2;EIF2AK2;CNOT8;EIF2AK4;EIF4ENIF1;ROCK2;METTL14;CPEB4
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.725475515033954,1.154378938205025,0.2571428571428571,1.0,1.0,5/10,21.28%,ACADVL;ACADL;SREBF1;LPCAT3;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7951264938693156,1.1541339190767612,0.2564102564102564,1.0,1.0,5/5,20.55%,NEDD4L;FHL1;LRRK2;SMAD7;CAMK2D
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.6538680633182727,1.1537954253488731,0.3176470588235294,1.0,1.0,5/14,17.11%,ENO1;CRY1;PPARGC1A;PGK1;CHST15
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7233666287387515,1.1537459407937143,0.2962962962962963,1.0,1.0,5/10,15.00%,UBAC2;VAPA;TAPT1;HSPA5;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5584885201745633,-1.1535328368474804,0.2631578947368421,0.9954415643562979,1.0,2/15,3.04%,SERPINI1;SERPINH1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.5973815212217817,1.1535248395830402,0.2777777777777778,1.0,1.0,8/34,16.39%,NUP153;SEC13;PPARA;NUP88;NUP133;HIF1A;INSR;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6717336999871872,1.1535149358714871,0.29577464788732394,1.0,1.0,4/10,8.93%,SYT1;ANK3;RIMS2;GRIK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.7916986868381748,1.152368636289519,0.3582089552238806,1.0,1.0,2/5,19.70%,LRRK2;KDR
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6828197930796258,1.1523505441564672,0.22784810126582278,1.0,1.0,2/14,7.65%,MICALL2;PRKCI
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.6793521590154388,1.15200242604548,0.2631578947368421,1.0,1.0,3/13,12.10%,SLC22A6;ENPEP;SLC13A3
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.7322466102069513,1.1518550802240808,0.37333333333333335,1.0,1.0,2/8,6.44%,BASP1;ROBO2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7942832563724814,1.1511834907520155,0.20270270270270271,1.0,1.0,3/6,12.73%,AGO2;SOAT1;NECAB1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.609886622498079,-1.150927470560154,0.391304347826087,0.9990955390387606,1.0,1/9,0.62%,EDN3
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6249590743435576,1.1508885399237245,0.28735632183908044,1.0,1.0,2/20,2.19%,SOD1;NRG1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7860149122179496,1.1504516620736394,0.28,1.0,1.0,3/5,20.89%,PDE4D;MGRN1;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.7159079234163448,1.1503376770190825,0.3372093023255814,1.0,1.0,4/14,8.70%,NRG1;OLFM2;CDH2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5780228358559274,1.150098386262737,0.2608695652173913,1.0,1.0,13/45,20.04%,RHOB;MYDGF;ITGA5;AGO2;FLT1;PRKCB;F3;HIF1A;RUNX1;TWIST1;ANGPTL4;KDR;SP1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.5436806964770005,1.149893774823864,0.13,1.0,1.0,47/176,26.64%,WWC1;SUFU;HCFC2;WWC2;CTR9;ESR2;YAF2;CCAR1;APBB1;CLOCK;PPARGC1A;HIF1A;RBM4B;MTF2;CEBPB;ZNF536;CREM;ANKRD17;STAT3;SRSF10;INSR;ACVR1B;MZF1;RBBP6;PLAG1;SP1;NLK;ABL1;METAP1;MAPKAPK5;NCOA2;SP3;NSD2;ZNF138;DNM2;CYFIP1;YBX1;FOXO3;GRM5;RFX3;SFPQ;UBE2L3;PUM3;ESRRG;RPS6KA5;CCDC88A;TOM1L1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.7288185147187917,1.1493863849804815,0.28378378378378377,1.0,1.0,3/7,16.67%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5591136482208511,1.1490578035327936,0.22448979591836735,1.0,1.0,22/81,20.69%,TP53TG5;GJA1;DDX3X;NRG3;ENO1;FHL1;ESR2;ADAM17;TGFB1;APBB1;EGFR;SDCBP;ADNP2;BCL6;AKAP6;ACVR1B;CRLF3;CSNK2A1;SMARCA4;CDKN1B;CAMK2D;DCBLD2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.7124932604010825,1.1485487545312505,0.24390243902439024,1.0,1.0,3/11,14.07%,AGO2;EIF4ENIF1;PABPC1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.6696569699924603,1.1480437621040578,0.30864197530864196,1.0,1.0,3/10,11.06%,TGFB1;CHSY1;ZBTB16
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.5838635823405303,1.1477823720482319,0.32222222222222224,1.0,1.0,7/36,18.56%,PTPN1;MADD;ELF1;RUNX1;PTPN2;CBFB;LIFR
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6591949958059287,1.1475425157223282,0.28735632183908044,1.0,1.0,5/18,19.20%,ZFP36L2;TGFB1;ANKRD26;ZFPM2;ZFPM1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.6929483125147475,1.1473143824672056,0.2948717948717949,1.0,1.0,5/10,20.02%,TBC1D20;VAPA;EIF2AK4;PPIB;CCNK
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.5074784763513785,-1.1471639613078053,0.2857142857142857,1.0,1.0,9/30,8.10%,CTNNA3;FGF13;GALNT16;HFM1;ATP1B2;RYR2;FILIP1;LRP1B;PREX2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5658587429046585,1.1470263998165648,0.24242424242424243,1.0,1.0,22/107,16.89%,WASF3;PARVB;RHOJ;RAD21;ANK3;DARS1;WASF1;WIPF1;SLC2A1;LIN7A;TGFB1;PPARGC1A;NLGN1;ST13;RANBP9;MDM2;MDM4;NAPG;PAWR;RTN3;TEAD1;SPG7
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.6168069832788147,1.1467982092903162,0.32142857142857145,1.0,1.0,3/19,8.76%,DDX3X;EIF2AK2;EGFR
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.7157470919142765,1.146433737155721,0.2948717948717949,1.0,1.0,3/11,14.53%,ITGA5;PTRH2;PDK4
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.649376871917695,1.1461473438738112,0.3108108108108108,1.0,1.0,2/15,2.62%,CD44;KDM1A
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7145851369280246,1.1459540846191854,0.2727272727272727,1.0,1.0,4/9,16.53%,NRXN3;NCAM2;NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6637220451867113,1.1458744412347395,0.3411764705882353,1.0,1.0,5/16,20.05%,TENM3;TGFB1;EPHA7;NF2;SMAD7
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5704945077771533,1.1457330299923152,0.23958333333333334,1.0,1.0,15/74,15.00%,NRCAM;SPTBN4;ANK3;DCLK1;ATL1;APBB1;CTNNA2;MYO16;CTNND2;EIF2AK4;NLGN1;FARP1;CNTNAP2;FGFR2;LRRK2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.7450456626809232,1.1455475212090664,0.2948717948717949,1.0,1.0,4/7,20.87%,PARP11;TNKS;TIPARP;PARP6
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7332391288074299,1.1454043552211928,0.3116883116883117,1.0,1.0,1/7,1.21%,NRCAM
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7667517486042434,1.1449459023210837,0.30434782608695654,1.0,1.0,1/5,3.09%,HABP4
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.49541459639700214,-1.1442940956403709,0.25,1.0,1.0,1/14,1.35%,NRP1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.5911317965549548,1.1442407301003814,0.21428571428571427,1.0,1.0,5/33,11.01%,SOD1;SLC23A2;GNPAT;FADS2;SLCO1A2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.6552304821150965,1.1441339664844044,0.29069767441860467,1.0,1.0,1/15,1.40%,GJA1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6613937863527793,1.1439097217400023,0.32558139534883723,1.0,1.0,5/13,19.28%,CRMP1;CACNA1B;STMN1;PURG;PPM1E
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7116442002116408,1.1439086699809056,0.3150684931506849,1.0,1.0,3/7,18.97%,TGFB1;GRAMD1A;SMAD2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7901529616157115,1.1438602735288022,0.28169014084507044,1.0,1.0,1/5,4.82%,AKIRIN1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.7894248556899075,1.1438305992909301,0.3333333333333333,1.0,1.0,3/5,15.49%,DENND4C;MADD;DENND3
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.7116752164880328,1.1436308835145679,0.28205128205128205,1.0,1.0,1/8,3.09%,HABP4
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.6984897423869916,-1.143587722087231,0.38461538461538464,1.0,1.0,1/6,1.35%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.6690616267071556,1.143529855557296,0.3023255813953488,1.0,1.0,5/17,15.11%,PPARA;TGFB1;MBP;NEXMIF;NF2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6636776543807104,1.1434407611975739,0.2696629213483146,1.0,1.0,2/18,1.36%,TBC1D20;RIPOR1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.7305829579799364,1.1433553548178166,0.2465753424657534,1.0,1.0,3/8,20.52%,ETF1;INSR;BNIP3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6833691227561582,1.143334271349355,0.2564102564102564,1.0,1.0,2/11,12.02%,NR4A3;SYTL4
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.7050754423030416,1.1431932806268972,0.2839506172839506,1.0,1.0,3/13,14.07%,AGO2;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7219220734741806,-1.1427389752392436,0.35135135135135137,1.0,1.0,1/5,6.59%,AKR1C3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5774554438140119,1.14269431847377,0.26595744680851063,1.0,1.0,12/61,15.62%,RANBP10;RHOB;WASF3;DPYSL2;NECTIN2;DIAPH1;PRKCI;CAPZB;RANBP9;MICAL3;CFL1;PACSIN2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.6150186659168635,1.142550445859086,0.313953488372093,1.0,1.0,13/28,30.44%,AP2A1;BNIP3L;CTSL;RAB7A;MDM2;RAB12;DENND3;AP2B1;BNIP3;AP2M1;CLTC;MALT1;PISD
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7648171921496129,1.1419474075650733,0.3194444444444444,1.0,1.0,3/6,14.42%,NR4A3;UGCG;STAT3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.7629157249439231,1.1418788737296428,0.3283582089552239,1.0,1.0,2/8,10.48%,SRGN;CHSY1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.6469332317151195,1.1417030775864179,0.29545454545454547,1.0,1.0,4/13,13.15%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.6831699504351043,1.141317583135194,0.3103448275862069,1.0,1.0,4/17,16.10%,SEC24A;SEC13;SEC24D;CANX
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.602284879826243,1.141212565957064,0.2345679012345679,1.0,1.0,7/23,22.30%,PTPRD;ANK3;UGCG;NLGN1;NRXN1;STX2;GAK
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6184487980880606,1.141012579666198,0.2808988764044944,1.0,1.0,10/31,21.82%,TSC2;NEDD4L;PTPN1;RUBCN;PACSIN2;LGALS3;ABL2;ABL1;RUFY1;MTMR2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7746656912115757,1.1407837115163855,0.3387096774193548,1.0,1.0,2/6,8.73%,MINPP1;PPA1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.7483823294002337,1.1407084077568803,0.29411764705882354,1.0,1.0,2/5,15.04%,SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7483823294002337,1.1407084077568803,0.29411764705882354,1.0,1.0,2/5,15.04%,SREBF1;LPCAT3
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.5824233968122113,1.1406534790655682,0.29545454545454547,1.0,1.0,7/28,19.77%,NFKBIA;MGAT1;SUSD6;CEBPD;LGALS3;TULP4;JUNB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7101904282858382,1.140572140474949,0.2987012987012987,1.0,1.0,2/10,14.13%,GRIN1;AKAP6
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7265331955707386,1.1404375948398582,0.2682926829268293,1.0,1.0,1/8,2.17%,ATP6V1H
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.6764556521579834,1.1402201163707513,0.20270270270270271,1.0,1.0,4/16,15.35%,PITRM1;AGK;DNAJC15;IMMP1L
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.7732381050808081,1.1398078666550515,0.2876712328767123,1.0,1.0,2/6,12.87%,KDM1A;FZD3
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.5806808609675325,-1.139209934401002,0.35714285714285715,1.0,1.0,1/7,1.35%,NRP1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.7019293613821965,1.139138793996562,0.3,1.0,1.0,2/13,8.14%,HDAC2;UGCG
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.6546585953865994,1.1391288832736022,0.2857142857142857,1.0,1.0,6/15,15.06%,WASF3;MICALL2;WASF1;DIAPH1;SPIRE1;WASHC5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.764433417943085,1.1391259232181934,0.2876712328767123,1.0,1.0,2/5,18.04%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7521280606389148,1.1388103893350965,0.32894736842105265,1.0,1.0,1/5,1.54%,PRKACA
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.7455410602191488,1.138606399622223,0.3088235294117647,1.0,1.0,3/5,20.52%,SLC25A4;SPG7;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.4935828567592812,-1.138369908636485,0.23529411764705882,1.0,1.0,2/21,1.16%,SPRY3;SPRY1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.6414442153666579,1.1381264782583316,0.34615384615384615,1.0,1.0,3/12,18.04%,DDX3X;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.7101498326216807,1.1379016848675225,0.29333333333333333,1.0,1.0,1/10,2.33%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.6258367421193936,1.1373712490604724,0.2988505747126437,1.0,1.0,3/16,8.45%,SUFU;IPO5;TGFB1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.6141803854954735,1.1370017383251985,0.3373493975903614,1.0,1.0,5/22,19.20%,UBA5;ZBTB16;RUNX1;PTPN2;ZFPM1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.6076482599283775,1.1369253413409781,0.3333333333333333,1.0,1.0,8/35,14.69%,PTPRQ;ZFP36L2;TGFB1;ANKRD26;ZBTB16;CEBPB;ZFPM2;TMEM64
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5780910762350182,1.1366732394347752,0.3404255319148936,1.0,1.0,10/34,19.20%,PURB;NR4A3;PRKCB;CTR9;ZBTB16;SIN3A;RUNX1;LGALS3;CBFB;ZFPM1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6740144860350475,1.1364213711304034,0.3333333333333333,1.0,1.0,3/11,16.53%,LRRC7;NLGN1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.7047059679930945,1.1361728091027605,0.3108108108108108,1.0,1.0,3/13,12.90%,NIBAN2;HNRNPC;DCP2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5860237682671696,-1.1359602869124223,0.2962962962962963,1.0,1.0,1/7,2.33%,ATM
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7803987884664292,1.1352177968138921,0.35064935064935066,1.0,1.0,1/6,6.58%,NECTIN2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.739021620161578,1.1352032830743768,0.3055555555555556,1.0,1.0,3/6,23.08%,UGCG;STAT3;MT3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7254385655303277,1.135195663606775,0.32432432432432434,1.0,1.0,4/7,27.37%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.5471977329111486,1.1349910213952004,0.24444444444444444,1.0,1.0,15/55,19.88%,NFKBIA;PSMB1;PSMB2;PELI1;BTRC;PSMA7;RPS27A;HIF1A;TANK;PSMA4;PSMD14;RBX1;USP10;ST18;SKP1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7257319172229237,1.134971147395286,0.39473684210526316,1.0,1.0,3/6,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7257319172229237,1.134971147395286,0.39473684210526316,1.0,1.0,3/6,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7148076562998751,1.1344889799112778,0.32098765432098764,1.0,1.0,1/8,8.65%,DSE
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.6890688029614982,1.1344383608632038,0.32894736842105265,1.0,1.0,4/10,18.19%,CST3;CAMK2N1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.5527676807877439,1.1342640729179783,0.20408163265306123,1.0,1.0,30/105,25.84%,OS9;NEDD4L;AMFR;RC3H2;NDFIP2;BTRC;RNF168;RNF34;RPS27A;NDFIP1;SMURF2;SIAH1;MDM2;RNF19A;PSMD14;RBX1;RNF111;ANAPC4;RBBP6;FBXO11;AREL1;UBE2B;UBE4B;UBE2K;RCHY1;UBE3B;TRIP12;NPLOC4;ARIH2;UBE2L3
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6652070029519731,1.1333062226872508,0.36470588235294116,1.0,1.0,2/15,4.81%,PRKACA;CRY1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.711234979432549,1.133176584798647,0.37333333333333335,1.0,1.0,2/10,6.25%,TET3;CTR9
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6219382167714691,1.1331517057811882,0.35802469135802467,1.0,1.0,3/19,11.23%,GRIN1;DDX3X;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5574113658203232,1.132979640940166,0.29591836734693877,1.0,1.0,20/75,21.37%,TAF7;TSC2;DDIT4;SEMA4D;ERRFI1;TGFB1;TRAF3IP1;SNX25;CAMK2N1;PDE4D;LRRK2;C9ORF72;TWIST1;PRNP;PRR5L;UBASH3B;PPM1E;SMAD7;NF1;YWHAG
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6511307877235721,1.1329572705733115,0.3132530120481928,1.0,1.0,1/12,4.11%,WASF1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.5777505079374854,1.1328925111911616,0.17708333333333334,1.0,1.0,16/102,11.77%,NELL1;CSF1;NRCAM;GJA1;AKIRIN1;CDH2;ZC4H2;IL18;TGFB1;TP63;CTNNA2;SDCBP;ZBTB16;CEBPB;CCN2;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.5004883313568558,-1.132856060413002,0.2727272727272727,1.0,1.0,2/26,0.82%,TNFRSF19;SH3RF3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.7349379766376908,1.1324930691986967,0.34615384615384615,1.0,1.0,4/7,25.67%,DCUN1D4;HIF1A;DCUN1D1;DCUN1D2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.63771810225018,1.1324796043174412,0.27710843373493976,1.0,1.0,6/19,16.67%,TAF1B;SYMPK;CPSF2;CCNH;CSTF3;POLR1C
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.6066455336771471,1.132475442159056,0.30337078651685395,1.0,1.0,6/26,15.62%,ANK3;UGCG;SYTL4;EHD2;NSF;PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6864655762802778,1.1323567187484105,0.25,1.0,1.0,4/9,22.49%,EAPP;TCERG1;SUPT16H;ELL
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6746014341701076,1.1321987693896294,0.37037037037037035,1.0,1.0,2/11,3.71%,GRIN1;ANK3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.7549038107661047,1.1320179006083562,0.3,1.0,1.0,3/7,18.19%,ROCK2;RANBP9;PRNP
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.7075303718872359,1.131918415532778,0.30337078651685395,1.0,1.0,2/11,7.88%,UBA5;DESI2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.71836776950788,1.1312543381490552,0.3,1.0,1.0,1/7,6.44%,ROBO2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6807242924673058,-1.131061651028283,0.30303030303030304,1.0,1.0,1/5,0.33%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7658973430281941,1.1310426209458337,0.34615384615384615,1.0,1.0,3/5,21.68%,IRS1;PTH1R;IRS2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.6602935387660622,1.1309436538256614,0.29411764705882354,1.0,1.0,1/14,1.40%,GJA1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5388043571501818,1.1308454128722634,0.28865979381443296,1.0,1.0,24/75,20.67%,SIK2;CAMKK2;CSF1R;FLT1;STK33;STK4;EIF2AK2;EGFR;OXSR1;EIF2AK4;MELK;UHMK1;MAPKAPK2;MAK;FGFR2;SLK;INSR;LRRK2;ACVR1B;STK39;KDR;ABL1;CAMK2D;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7733640601121079,1.1307869027204698,0.2987012987012987,1.0,1.0,4/5,21.68%,PPARA;IRS1;TWIST1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.7150531583496855,1.1307791237670397,0.38571428571428573,1.0,1.0,2/6,12.56%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.7173890359507507,1.130688179111405,0.3235294117647059,1.0,1.0,2/8,5.63%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.645887748006642,-1.1306220170759027,0.42857142857142855,1.0,1.0,3/7,16.81%,ATM;FEM1B;SMG6
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5735558423547668,-1.1305552980249511,0.35714285714285715,1.0,1.0,5/14,12.90%,NRP1;SLIT2;GLI2;PKD2;PKD1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6971642256244979,1.130447441586937,0.30864197530864196,1.0,1.0,4/11,19.43%,ZFPM2;AKAP6;FGFR2;RBPJ
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7189937303438978,1.1303978363141862,0.40540540540540543,1.0,1.0,2/8,16.61%,TMEM165;TRPC4
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7677472374677934,1.1302210830611874,0.28378378378378377,1.0,1.0,2/5,12.31%,CRACD;WASHC2C
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.5693827694793737,1.13016100102033,0.26881720430107525,1.0,1.0,26/60,25.57%,ARRDC2;ADAMTS4;PHYHIPL;GFAP;SEMA4D;KLHL2;KIF13B;MBP;MOBP;OMG;ASPA;PDE8A;FGFR2;SLC1A2;NRXN1;ST18;GRIA2;PLP1;ARSG;TF;PEX5L;MT3;MAPK4;GPM6B;GRM5;KIF1B
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6860239086226553,1.1298903769623707,0.2823529411764706,1.0,1.0,3/12,7.91%,OS9;RHBDD1;SELENOS
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.6489544676911487,1.129840837266447,0.3170731707317073,1.0,1.0,4/15,20.84%,RAB27A;PIP4P2;SCARB1;ITGAV
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.768504618466618,1.1296474189045824,0.32432432432432434,1.0,1.0,1/5,7.58%,SLC2A1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.5559930008041256,1.1296379062262416,0.3368421052631579,1.0,1.0,29/87,24.84%,RANBP10;ELL2;USP15;MINPP1;BTRC;ALDH1L1;SLC2A1;BNIP3L;SDCBP;AGPAT4;GYPC;GMPS;RIOK3;EPOR;RNF19A;EZH1;DCUN1D1;CA2;SLC25A37;KLF3;MXI1;MARK3;LAMP2;GCLC;CCND3;TSPAN5;GAPVD1;ARHGEF12;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6885775674369873,1.1290294803229497,0.35802469135802467,1.0,1.0,4/12,19.91%,IPO5;CAMK2N1;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.655658145815115,-1.1284183882333119,0.38461538461538464,1.0,1.0,1/6,0.62%,EDN3
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.6918258835088817,1.1283930735017373,0.34615384615384615,1.0,1.0,5/10,25.82%,SLC7A2;SLC3A2;SLC1A2;SLC22A2;SLC1A1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.6816727710647081,1.128364517208648,0.32926829268292684,1.0,1.0,4/11,22.80%,ENO1;PGK1;HK1;TPI1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.6816727710647081,1.128364517208648,0.32926829268292684,1.0,1.0,4/11,22.80%,ENO1;PGK1;HK1;TPI1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7120415039965341,1.12805566310775,0.43209876543209874,1.0,1.0,4/8,21.68%,IRS1;PPARGC1A;PTPN2;IRS2
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5776674940327696,-1.1279568188602218,0.32,1.0,1.0,1/8,2.78%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.6914010334156335,1.1279232152137755,0.32894736842105265,1.0,1.0,5/10,16.39%,NIBAN2;TGFB1;SIN3A;TWIST1;ZBTB7A
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.6430447598350256,1.1277389594811469,0.3780487804878049,1.0,1.0,6/18,19.37%,SOD1;HIF1A;AP3D1;SYBU;PAFAH1B1;DST
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.676799847146088,1.1277315879200724,0.3373493975903614,1.0,1.0,6/13,23.08%,NR4A3;ACADVL;PPARGC1A;NDUFS1;COX10;MT3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7192971373082626,1.12757957497088,0.37662337662337664,1.0,1.0,2/7,10.98%,HDAC2;RCOR1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.5506221137088372,1.1275642592668098,0.2619047619047619,1.0,1.0,16/60,16.11%,FMN2;KCND2;PSMB1;HIF3A;PSMB2;PSMA7;BNIP3L;RPS27A;HIF1A;PSMA4;MDM2;MDM4;PGK1;PSMD14;RBX1;TWIST1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.5510576576707488,1.1268786120509584,0.25806451612903225,1.0,1.0,14/51,18.92%,NFKBIA;IL18;SNX6;TNFRSF1B;PPARA;SELENOS;NFKBIZ;TMSB4X;BCL6;LPCAT3;LRFN5;PTPN2;PDCD4;AREL1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6866640906986704,1.126867509605184,0.3670886075949367,1.0,1.0,4/10,15.00%,GRIN1;GABRE;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.46754688450423443,-1.1268583196678073,0.25,1.0,1.0,4/39,2.68%,SPRY3;SPRY1;TNIP1;WNK2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7024117354096712,1.1268241087164448,0.2972972972972973,1.0,1.0,5/10,20.55%,NOS1AP;DIAPH1;PRNP;UBASH3B;CAMK2D
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6970127328241905,1.1264986411719327,0.33783783783783783,1.0,1.0,1/7,3.72%,RAB27A
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.540580831344269,1.1264422051048406,0.2268041237113402,1.0,1.0,33/147,18.98%,CD44;TPT1;HDAC2;DDX3X;NFKBIA;FMN2;MYDGF;CD38;RHBDD1;RAF1;NIBAN2;SEMA4D;APIP;NAIP;PRKCI;BNIP3L;EGFR;WDR73;RPS27A;TMBIM6;PRLR;NAA38;RAB7A;HSPA5;TBX3;CFL1;NAA15;ARF4;IFIT3;DNAJA1;GLO1;AREL1;ANGPTL4
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5970197407189882,-1.126291063870855,0.3181818181818182,1.0,1.0,4/11,5.96%,NTN4;MYH11;TNXB;LAMB2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.7152251109840474,1.126265950404111,0.34285714285714286,1.0,1.0,3/6,13.52%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.7152251109840474,1.126265950404111,0.34285714285714286,1.0,1.0,3/6,13.52%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.7152251109840474,1.126265950404111,0.34285714285714286,1.0,1.0,3/6,13.52%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7355925805948131,1.1258521909042383,0.3142857142857143,1.0,1.0,1/6,8.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6759507285175789,1.1257421767943787,0.3037974683544304,1.0,1.0,4/17,14.87%,KLF2;NOS1AP;ROCK2;INSR
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6543855002632367,1.1257108473400028,0.3614457831325301,1.0,1.0,4/16,14.87%,NR4A3;PRKCI;IRS1;INSR
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.6718559813637938,1.125648322148491,0.2727272727272727,1.0,1.0,4/15,13.42%,DDX3X;ADAM17;EGFR;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.7285268102596648,1.1256058827134445,0.3380281690140845,1.0,1.0,3/7,16.63%,NOS1AP;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.706106849723109,1.1255967753599962,0.3488372093023256,1.0,1.0,4/10,16.73%,ADGRV1;AKAP6;LRRK2;PRKAR2A
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.6078240483395363,1.125589428184799,0.3670886075949367,1.0,1.0,5/18,22.39%,BTRC;RPS27A;MAPK1;SKP1;MAP3K8
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6321581110329098,1.1255128974538233,0.4074074074074074,1.0,1.0,6/17,26.02%,DDIT4;TGFB1;MAPK1;SMAD7;UBE2K;SPRED1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.7101939404694919,1.1253374225394672,0.36,1.0,1.0,1/8,5.60%,SMAP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.5371927593852139,1.1253282804172746,0.2,1.0,1.0,22/125,18.73%,SRSF12;HNRNPL;RBM17;STRAP;RAVER2;CDC5L;HNRNPF;CCAR1;SYMPK;CPSF2;CWC27;HNRNPC;ELAVL1;RBM4B;CSTF3;PABPC1;SRSF10;METTL14;NOVA1;DHX15;HNRNPUL1;SF3B1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6440016943568109,1.1248774532176053,0.3291139240506329,1.0,1.0,4/13,19.43%,ZFPM2;RUNX1;FGFR2;RBPJ
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7493785502856423,1.1247396988476899,0.3382352941176471,1.0,1.0,2/5,13.06%,PAPSS1;PAPSS2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7460170874909555,1.124720640143087,0.3472222222222222,1.0,1.0,1/8,0.67%,KLF2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7267743151415121,1.1245928219296093,0.3116883116883117,1.0,1.0,4/8,21.68%,SELENOS;IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7244971273977061,1.1245339230854465,0.3333333333333333,1.0,1.0,4/6,26.94%,AP2A1;AP2B1;AP2M1;CLTC
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7244971273977061,1.1245339230854465,0.3333333333333333,1.0,1.0,4/6,26.94%,AP2A1;AP2B1;AP2M1;CLTC
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.5723402171165751,1.1244935349868421,0.34523809523809523,1.0,1.0,6/29,10.33%,PHYHIPL;ELAVL3;CACNA1B;SCN3A;SNAP25;CTNND2
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.7246216422932876,1.1241909720719252,0.36486486486486486,1.0,1.0,2/7,13.96%,NEDD4L;MDM2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6894680401306169,1.1240522882602781,0.32051282051282054,1.0,1.0,5/9,27.47%,INSR;TDG;MYSM1;TRIP12;RAB14
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.5830140760939768,-1.123624520831961,0.2903225806451613,1.0,1.0,2/7,13.37%,ST6GAL1;ST3GAL1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6576292465911519,1.123578250229508,0.3037974683544304,1.0,1.0,2/15,7.65%,MICALL2;PRKCI
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3592300851748909,-1.123161111675321,0.0,1.0,1.0,13/71,8.22%,DKK3;LMOD1;ARHGEF10L;CDH6;SORBS2;MYL9;IGFBP7;PAMR1;LAMB2;CXCL12;SHROOM4;COL1A2;EDNRA
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5740620887872495,1.1231330122229237,0.27956989247311825,1.0,1.0,2/46,0.56%,ADAMTS9;CD44
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7505748265531538,1.1227827319898345,0.3,1.0,1.0,2/5,20.53%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.7505748265531538,1.1227827319898345,0.3,1.0,1.0,2/5,20.53%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7639242600228375,1.1227431935145595,0.3382352941176471,1.0,1.0,1/5,12.44%,ROCK2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.6022162661374892,1.122472243333727,0.3218390804597701,1.0,1.0,2/18,4.30%,MID1;TENM3
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5985731752606848,1.122327742654053,0.3218390804597701,1.0,1.0,3/27,15.85%,NFKBIA;TMSB4X;ERBIN
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.7028555368790871,1.1220671042314585,0.41333333333333333,1.0,1.0,2/8,18.58%,TTN;CSNK2A1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.7453347762585874,1.1220528137571184,0.42105263157894735,1.0,1.0,2/5,7.91%,TMCO1;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.5280014998476624,1.1220297496822027,0.08,1.0,1.0,82/383,20.36%,WWC1;TAF7;KLF2;KLF15;ETV5;LPIN1;HDAC2;GRIN1;DDX3X;NFKBIA;KDM1A;MYDGF;GLIS3;NR4A3;EAPP;ACTR3;TET3;AGO2;AKIRIN1;KANSL3;SMARCA1;IL18;RNF10;CDC5L;PRDM10;PPARA;CTBP2;TBK1;TGFB1;TP63;APBB1;EGFR;MED14;CLOCK;RPS27A;PPARGC1A;RARB;HIF1A;MTF2;CEBPB;SIN3A;ZFPM2;PTOV1;ELF1;FUBP3;SREBF1;TCERG1;RUNX1;TBX3;SENP1;STAT3;FGFR2;PPP3CA;GLYR1;TP53BP1;BCLAF3;ATF6;HIVEP1;TEAD1;TWIST1;RNF111;ACVR2A;TNKS;MZF1;ARF4;CRLF3;SETD3;PLAG1;PER1;NFIX;ST18;SMAD2;SMARCA4;ZFPM1;RBPJ;JUNB;CCNK;SP1;SMAD7;SUPT16H;ABL1;PAXBP1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5380242250221122,1.1215809466348239,0.3258426966292135,1.0,1.0,14/46,23.23%,NFKBIA;PSMB1;PSMB2;PELI1;BTRC;PSMA7;RPS27A;PSMA4;PSMD14;RBX1;ST18;SKP1;MAP3K8;TAB2
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6542694541599777,1.1214997210346036,0.34831460674157305,1.0,1.0,6/17,24.30%,DNMT1;MTF2;EED;CREBZF;JARID2;RBBP7
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.6956712571807055,1.1214904244588058,0.3974358974358974,1.0,1.0,5/10,22.64%,KDM1A;FZD3;LRRK2;NF1;TAFA1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.633437090289031,-1.1214607309729265,0.375,1.0,1.0,1/5,0.29%,ZDHHC15
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5575880984156811,1.1214553352981773,0.24210526315789474,1.0,1.0,19/78,16.78%,WWC1;CD44;GJA1;DHRS3;AMFR;FKBP5;TMEM164;SLC7A2;SLC2A1;UGCG;KAZN;SEMA3B;ELF1;FARP1;PAPSS2;PLAAT3;SH3BP5;SCARB1;TIPARP
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7034413371439668,1.1211792562151552,0.37037037037037035,1.0,1.0,3/11,14.31%,RNF10;TNFRSF1B;PTPRZ1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.684501629289703,1.1209204161349502,0.3,1.0,1.0,2/9,8.45%,TSC2;TGFB1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.6867910453558725,1.1208535151677461,0.37662337662337664,1.0,1.0,6/8,28.41%,SYNDIG1;SNAP25;NLGN1;PIP5K1C;DNAJC5;PCLO
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.324287182267551,-1.1202691638050462,0.0,1.0,1.0,21/156,8.14%,COL24A1;FAT1;FGF13;TPM2;LMOD1;COL14A1;MYH11;SERPINH1;EVL;TNXB;COL5A2;CKAP5;MTM1;COL15A1;COL13A1;VIM;SHROOM4;BMP1;CEP126;ELMO1;COL1A2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5583187813108497,1.1201535542844652,0.31868131868131866,1.0,1.0,11/39,18.87%,NFKBIA;PSMB1;PSMB2;TNFRSF1B;PSMA7;ADAM17;TMSB4X;PSMA4;PSMD14;MAP3K14;ST18
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.6829979682961109,1.1201426209620728,0.30864197530864196,1.0,1.0,3/13,11.77%,NRCAM;ZC4H2;SIN3A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.5340009635772561,1.1201394098932664,0.21,1.0,1.0,21/115,18.73%,SRSF12;HNRNPL;RBM17;RAVER2;CDC5L;HNRNPF;CCAR1;SYMPK;CPSF2;CWC27;HNRNPC;ELAVL1;RBM4B;CSTF3;PABPC1;SRSF10;METTL14;NOVA1;DHX15;HNRNPUL1;SF3B1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5834652577999911,-1.1199809496143145,0.2777777777777778,1.0,1.0,2/8,4.02%,MYH11;SORBS2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5697497676305067,1.11984858095474,0.2558139534883721,1.0,1.0,10/40,15.79%,KLF2;PSMB1;HIF3A;PSMB2;PSMA7;RPS27A;HIF1A;PSMA4;PSMD14;RBX1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7113576579314727,1.119716809631586,0.31645569620253167,1.0,1.0,2/8,5.63%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7548026608630048,1.1194261760312174,0.4057971014492754,1.0,1.0,1/7,2.19%,NRG1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5967364758243214,1.1193351538682879,0.36363636363636365,1.0,1.0,8/35,18.47%,RIPOR1;WIPI1;PPARA;SREBF1;PDK4;LRRK2;WDR45B;MAP1LC3B
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.6634388159952911,1.1191649750779666,0.3,1.0,1.0,7/14,27.85%,CD38;TP53BP1;VAV3;IRS2;CD81;SH3KBP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6041044028773834,1.1187273592645433,0.32941176470588235,1.0,1.0,6/22,16.39%,NUP153;SEC13;NUP88;NUP133;HIF1A;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.6233368229402714,1.1184210409727326,0.3146067415730337,1.0,1.0,1/17,0.20%,WWC1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.720937932178427,1.11832386054535,0.34177215189873417,1.0,1.0,1/6,7.85%,SOD2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.7179940721303258,1.118292559206428,0.4266666666666667,1.0,1.0,4/7,23.42%,CD38;VAV3;IRS2;CD81
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4077890889434685,-1.118223032147114,0.2,1.0,1.0,8/49,8.14%,COL24A1;COL14A1;SERPINH1;COL5A2;COL15A1;COL13A1;BMP1;COL1A2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5662545102261598,1.1180909986036751,0.30851063829787234,1.0,1.0,10/46,15.79%,CSNK1G2;DDX3X;BTRC;CSNK1A1;NXN;WNT2B;RPS27A;FZD3;LRRK2;RBX1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5551345400003707,1.1177799441907377,0.3229166666666667,1.0,1.0,9/55,10.41%,TP53TG5;GJA1;DDX3X;ENO1;FHL1;ESR2;TGFB1;APBB1;DIP2B
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.597361251996815,1.1176792043693575,0.3076923076923077,1.0,1.0,10/26,29.62%,ADAM17;TGFB1;EGFR;ERBIN;GRB2;RPS6KA5;PLCG1;PTK2B;PTPN11;NCK2
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5980326147036239,1.1175742405828326,0.32608695652173914,1.0,1.0,8/34,14.00%,GJA1;CDH18;CDH2;CDH12;CTNND2;CDH10;CDH20;CD9
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.5263265570869237,1.1173990409562664,0.2,1.0,1.0,38/204,15.51%,WWC1;GJA1;DDX3X;ADGRV1;NRG1;MYDGF;RHEB;USP15;NOS1AP;SEMA4D;PELI1;IL18;FLT1;PRKCB;NDFIP2;EIF2AK2;SLC38A9;SEC13;TBK1;TGFB1;EGFR;IRS1;DDX21;VAPA;CXXC5;F3;IQCJ-SCHIP1;NLGN1;NDFIP1;ROCK2;ANKRD17;EPOR;SIAH1;FGFR2;TRIM5;INSR;UNC5B;TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.7310351032817121,1.1167315671338236,0.34146341463414637,1.0,1.0,1/7,1.67%,CAMKMT
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.6990847721794406,1.1166546077880475,0.3333333333333333,1.0,1.0,5/8,23.84%,NRCAM;SIN3A;ABL1;DNM2;OLFM1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.591289078595832,1.1161317349797344,0.31521739130434784,1.0,1.0,9/43,18.30%,GPR161;S1PR3;ADGRB3;ADGRG2;GNAI1;ADGRE2;LGR4;ABCA1;PTH1R
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.591124203973797,1.116130637461859,0.3181818181818182,1.0,1.0,7/39,13.06%,CHST11;OGN;MGST1;PAPSS1;DSE;CHSY1;PAPSS2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6928368597502509,1.1158810137268735,0.42028985507246375,1.0,1.0,3/6,18.97%,ACVR1B;ACVR2A;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5997704738856996,1.1153539265249712,0.27906976744186046,1.0,1.0,8/27,16.53%,SYT1;RIMS2;GRIK2;EIF2AK4;GRIN2B;NLGN1;TSHZ3;NRXN1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.692886203944785,1.1153418141405675,0.3142857142857143,1.0,1.0,3/7,29.76%,STAT3;CANX;IL6ST
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.4850599654939236,-1.1152630826837187,0.34782608695652173,1.0,1.0,4/19,4.87%,ATP10A;ANO6;ABCA4;ATP8A1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.7161461658141808,1.1150460477100406,0.2777777777777778,1.0,1.0,1/8,2.64%,RBM17
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.6212581182266372,1.1149692075104516,0.3684210526315789,1.0,1.0,7/18,30.38%,UBA5;PTPN2;ZFPM1;ABCB10;RPS14;SH2B3;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.6086992645309931,1.1146497656457217,0.3488372093023256,1.0,1.0,9/29,23.23%,MTMR9;RUBCN;LZTS1;WDR6;STAT3;LRRK2;GOLGA2;MT3;TAB2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5682951297085335,-1.1143708408508917,0.35294117647058826,1.0,1.0,3/11,7.23%,ZDHHC15;ZDHHC21;ZDHHC3
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.4403571988888301,-1.1143137446132632,0.2,1.0,1.0,3/23,6.16%,PRPF6;SNRNP200;GCFC2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.6247565705193528,1.1142898532562726,0.33707865168539325,1.0,1.0,4/23,8.45%,CD44;CEMIP2;OGN;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.6874874042578921,1.1140177718052762,0.3780487804878049,1.0,1.0,1/8,1.19%,TEFM
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6682264257526367,1.113809096044039,0.32432432432432434,1.0,1.0,2/9,9.35%,SCD;ACSL4
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.5797635440634163,1.113404039422112,0.27906976744186046,1.0,1.0,4/32,15.01%,HNRNPL;HNRNPF;HNRNPC;METTL14
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.6849408390415086,1.1131207360442192,0.35,1.0,1.0,1/8,2.96%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7699995131839801,1.1126991088883518,0.3880597014925373,1.0,1.0,2/5,11.31%,PPARA;PAG1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6323172696927214,1.1124513894851058,0.367816091954023,1.0,1.0,5/15,21.34%,RIMS2;MCTP2;LRRK2;PREPL;SNCAIP
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7032433613330035,1.112242320071495,0.379746835443038,1.0,1.0,3/6,19.88%,BTRC;GOLGA2;SKP1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.6850602486543639,1.11207303754445,0.2987012987012987,1.0,1.0,7/11,23.81%,SYT1;RIMS2;SNAP25;SNAP23;STX2;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.7022360170860047,-1.112002482207592,0.36,0.9987712349549506,1.0,4/5,26.81%,PODXL;IQGAP1;MYO1E;JAG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.7022360170860047,-1.112002482207592,0.36,0.9987712349549506,1.0,4/5,26.81%,PODXL;IQGAP1;MYO1E;JAG1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6086550529081617,1.1118965543731036,0.30952380952380953,1.0,1.0,5/25,14.42%,CRY1;IRS1;ROCK2;GNAI1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6745001253021102,1.111801889517855,0.34146341463414637,1.0,1.0,3/12,16.11%,NIBAN2;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.562126262006268,1.1110120314569043,0.3103448275862069,1.0,1.0,11/52,16.47%,TSC2;MYDGF;SEMA4D;IL18;FLT1;EGFR;EPOR;INSR;UNC5B;TWIST1;MAPK1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6364164684150273,1.110941077654345,0.37209302325581395,1.0,1.0,8/25,12.45%,CADM1;CDH18;CDH2;NECTIN2;CDH12;CADM2;CDH10;CDH20
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.3755725146673611,-1.1106810483397298,0.25,0.997982468472417,1.0,19/73,8.22%,FAM13C;PRRX1;SLIT2;DKK3;SLIT3;LMOD1;COL14A1;KCNJ8;PDZRN3;COL5A2;PAMR1;EML1;LAMB2;PTPN21;CXCL12;SEMA6D;COL1A2;PRKG1;EDNRA
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.6090816090436367,1.1103372739403108,0.34210526315789475,1.0,1.0,6/16,29.71%,CP;TF;MT3;IREB2;SLC40A1;CYBRD1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5310193810337029,-1.110197501755553,0.38095238095238093,0.9948742707160929,1.0,3/13,9.38%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6450824608321357,1.1101441805813828,0.35714285714285715,1.0,1.0,2/15,3.26%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.46056701530290256,-1.110112516164478,0.24,0.9908246296009153,1.0,2/15,0.73%,TWIST2;CDK6
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.6670365014415285,1.1098060668872152,0.32142857142857145,1.0,1.0,1/12,1.40%,GJA1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.5661219867886048,1.1097923031891828,0.2967032967032967,1.0,1.0,13/52,21.60%,XIST;ACADVL;BCKDHB;PPARA;ACSL4;GLUL;ACADL;SUCLG1;CA2;HSPH1;ELOVL5;METAP1;SERINC1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.6907068457182148,1.1097556845030812,0.379746835443038,1.0,1.0,2/7,13.21%,TGFB1;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.6650753108104123,1.1097415044387515,0.32,1.0,1.0,2/9,13.42%,USP15;ANKRD17
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5333428719888622,-1.1091122945493104,0.35294117647058826,0.9892001828522091,1.0,2/15,4.26%,ZDHHC15;CAPRIN2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.6333134540106946,1.1089652020830478,0.3448275862068966,1.0,1.0,3/16,12.70%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6934767845608644,-1.1088521096687334,0.41379310344827586,0.98537715856574,1.0,2/5,7.12%,DOCK8;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.544741433050612,-1.1086761891350903,0.391304347826087,0.9820859075576555,1.0,2/12,3.04%,SERPINI1;SERPINH1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7412975122556884,1.1086399477857714,0.38095238095238093,1.0,1.0,1/6,6.92%,CSNK1A1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.7013118698704909,1.1084091157027742,0.38461538461538464,1.0,1.0,2/8,14.72%,NIBAN2;CFL1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6209991434853441,1.107927064212154,0.3855421686746988,1.0,1.0,4/16,23.19%,PRKACA;PDK3;SELENOT;TRA2B
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6458193482332789,1.107874482470365,0.4074074074074074,1.0,1.0,1/13,2.17%,ATP6V1H
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.6832542557812191,-1.1077220517560347,0.3333333333333333,0.9801473751792504,1.0,4/5,21.94%,KIFC3;ITGB5;PLEKHA7;VCL
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.5391844391046502,1.1074480095526364,0.31313131313131315,1.0,1.0,22/89,21.37%,SOD1;MTCH2;ATP1B3;GBE1;ATL2;DNAJC15;TANK;RIOK3;ACADL;BCL6;REEP5;RTN3;LPCAT3;SCARB1;SUCLG1;CMPK1;PDCD4;ABCA1;LIFR;ANGPTL4;GPX3;YWHAG
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6928961589073508,1.1073242341878369,0.410958904109589,1.0,1.0,3/5,25.29%,LRRK2;RBX1;MARCHF7
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6524730375345681,-1.107301316593351,0.36363636363636365,0.9767417530945215,1.0,3/8,11.88%,MPP7;ACTB;ACTG1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.67586707180607,1.1069453188914473,0.3835616438356164,1.0,1.0,2/9,8.92%,DPM1;PIGL
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.7375474396582486,1.1068355844619147,0.38028169014084506,1.0,1.0,3/6,16.63%,NOS1AP;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.592411232942234,1.1067888692863608,0.3411764705882353,1.0,1.0,6/24,16.39%,NUP153;SEC13;NUP88;NUP133;HIF1A;ZBTB7A
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.5866996083954302,1.1067221173204118,0.36363636363636365,1.0,1.0,9/25,30.80%,PELI1;RNF168;RNF152;TRIM5;HECTD1;UBE2B;ARIH2;RNF115;NEDD4
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.7539265005329305,1.1062264624385125,0.3380281690140845,1.0,1.0,3/5,23.42%,ADGRB3;CD9;CD81
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7541609873752991,1.1061378986416495,0.40789473684210525,1.0,1.0,1/5,7.80%,PPARA
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.614719759961259,1.1059446001851079,0.38461538461538464,1.0,1.0,2/14,12.38%,DDX52;RIOK3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6333081192240698,1.10585153881747,0.3380281690140845,1.0,1.0,3/15,8.45%,XPO4;CSE1L;TGFB1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6854895700079608,1.1057967117162246,0.345679012345679,1.0,1.0,2/7,5.38%,CRMP1;DPYSL2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5490161200862873,1.1057917005192879,0.25773195876288657,1.0,1.0,20/70,16.53%,PHYHIPL;ELAVL3;GJA1;NRXN3;CDC42EP4;LSAMP;GFAP;DPP6;ADGRB3;CHL1;ALDH1L1;CTNNA2;EGFR;CADM2;GRIN2B;CDH20;AKAP6;PTPRZ1;SLC1A2;NRXN1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.717873103098758,1.1057753800369345,0.44871794871794873,1.0,1.0,3/5,18.41%,BCL6;RUNX1;CBFB
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6387663086500296,1.1057687052897225,0.41025641025641024,1.0,1.0,4/11,23.28%,GIGYF2;ROCK2;METTL14;METTL16
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6452429029416142,1.1051742707648984,0.2911392405063291,1.0,1.0,5/16,17.82%,DDX3X;ADAM17;EGFR;ANKRD17;STXBP4
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.7142642800667378,1.1050769101146656,0.38571428571428573,1.0,1.0,2/8,9.13%,ESR2;ARID1A
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6495932151726483,1.1047456782715737,0.3176470588235294,1.0,1.0,3/15,7.91%,OS9;SEC13;SELENOS
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.63955672133551,1.1044273930378636,0.3764705882352941,1.0,1.0,4/18,13.91%,ENPEP;SGPL1;CYP3A5;SIAH1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.7201878060138259,1.10428016692925,0.3611111111111111,1.0,1.0,1/6,5.46%,SEC11A
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.744579389709066,1.104253377822873,0.37333333333333335,1.0,1.0,1/5,4.87%,MGST1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6548860362385014,1.1036433190786628,0.4050632911392405,1.0,1.0,3/14,9.46%,GLRB;RHBDD1;MARCHF6
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6747815046388413,1.1035491751784194,0.3888888888888889,1.0,1.0,1/8,8.45%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.697074510612905,1.1035152291734835,0.3815789473684211,1.0,1.0,2/5,20.19%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.6076353623273607,1.103494078238269,0.35714285714285715,1.0,1.0,4/19,10.62%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.5632264517814035,-1.1033960489818389,0.38461538461538464,0.9840348283336252,1.0,3/14,3.21%,IQGAP2;NRP1;BAIAP2L2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.6156125988189562,1.103338585585734,0.36585365853658536,1.0,1.0,8/19,25.81%,CTR9;WAC;RBX1;MGRN1;UBE2B;MARCHF7;UBE2D3;RAD18
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.7264815319845935,1.103233680871924,0.36619718309859156,1.0,1.0,2/5,19.60%,SGPL1;ACER3
prerank,MSigDB_Hallmark_2020__DNA Repair,0.5853067896385136,1.1031822937574143,0.32608695652173914,1.0,1.0,10/42,16.67%,RNMT;DUT;PDE4B;DGUOK;GUK1;SDCBP;AK3;CSTF3;RBX1;POLR1C
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5704842028877697,1.1031285604921905,0.3125,1.0,1.0,4/66,1.44%,STC1;RHOB;GJA1;MCC
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7504897118786236,1.1028770885954535,0.36231884057971014,1.0,1.0,2/5,7.99%,MTMR9;MTMR1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6497022105204285,1.1026853874598415,0.3974358974358974,1.0,1.0,7/14,30.99%,COG2;NSF;NAPG;COG6;GOSR1;RAB6A;COG3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.6702038476309526,1.1026297102871325,0.3924050632911392,1.0,1.0,4/10,22.80%,ENO1;PGK1;HK1;TPI1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6818637426475708,1.102426480760681,0.41025641025641024,1.0,1.0,2/9,10.83%,ELAVL1;WDR43
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.6097562756003854,1.1020155709510209,0.4117647058823529,1.0,1.0,3/23,6.42%,GJA1;GRIN1;SNX6
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6621188189049123,1.1019307815244375,0.2898550724637681,1.0,1.0,1/9,4.16%,RPS21
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.659771365999069,1.1017970994385966,0.31645569620253167,1.0,1.0,1/11,1.24%,CHST11
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5896620371633562,-1.1016804887474314,0.3125,0.984850532784715,1.0,2/13,6.50%,DERL1;VCP
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5885008033775713,1.1016175277736258,0.37209302325581395,1.0,1.0,8/25,23.84%,TGFB1;HIF1A;ROCK2;TBX3;LOXL3;RBPJ;LEF1;OLFM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6798349223251691,1.1013281136254263,0.2972972972972973,1.0,1.0,3/10,19.88%,BTRC;GOLGA2;SKP1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.5736654515016995,1.1012087230686824,0.3157894736842105,1.0,1.0,10/48,21.37%,PRKACA;TUBA1A;CCP110;CSNK1D;CEP57;CEP70;PAFAH1B1;CNTRL;CEP290;YWHAG
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6188325111255324,1.1008023404020282,0.35,1.0,1.0,1/18,0.48%,ADAMTS9
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5580643399684586,1.1007977819699524,0.30851063829787234,1.0,1.0,10/54,16.73%,LPIN1;PRKACA;NR4A3;PRKCI;SELENOS;IRS1;DENND4C;INSR;RAB12;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5382834807579981,1.1005864872389133,0.35051546391752575,1.0,1.0,19/77,20.04%,KLF2;DDX3X;NOS1AP;EGFR;IRS1;PPARGC1A;ELAVL1;HIF1A;SREBF1;ATAD5;INSR;METTL14;SCARB1;PTPN2;PTH1R;ABCB10;ELOVL5;SLC25A37;SP1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.5214789675680132,1.1003095643660576,0.27,1.0,1.0,49/159,23.98%,STX6;ARRDC2;ATP6V1G1;ARL5A;ATP6V1H;ANK3;OLFM2;GGA3;RAB28;AP2A1;COG7;PRKCB;SNX6;SEC13;SYNDIG1;ATP6V1E1;TRIM23;RAB18;ARFGAP3;RAB7A;NSF;NAPG;RAB12;AP3D1;TBC1D15;PREPL;CANX;ARF4;ABCA1;ARF1;SNX4;CMTM6;RAB8B;RUFY1;TBC1D8;NAPB;STX2;TBC1D5;CEP290;STX12;TF;SLC10A7;LAMP2;RABGAP1L;USP6NL;BLZF1;DNM2;TBC1D4;USO1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.6963936080581294,1.1002709598566787,0.373134328358209,1.0,1.0,5/6,29.26%,INTS2;INTS8;INTS6L;INTS6;INTS7
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.7256420173245481,1.1002693453838512,0.3333333333333333,1.0,1.0,4/6,27.37%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.7256420173245481,1.1002693453838512,0.3333333333333333,1.0,1.0,4/6,27.37%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5640874451086718,1.100246414219321,0.36666666666666664,1.0,1.0,12/40,20.04%,RHOB;MYDGF;AGO2;FLT1;PRKCB;F3;HIF1A;RUNX1;TWIST1;ANGPTL4;KDR;SP1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5751191344913105,1.100162601048085,0.30851063829787234,1.0,1.0,15/53,25.48%,STC1;RHOB;FRMD5;ROBO1;TCAF1;NF2;NAV3;SCAI;SMAD7;NF1;TP53INP1;KANK1;TMEFF2;FOXO3;STK24
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.613590634684037,1.1000262544696744,0.36470588235294116,1.0,1.0,3/19,13.21%,ACTR3;AKIRIN1;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.7036353984404916,1.099897345355237,0.4782608695652174,1.0,1.0,1/8,2.96%,DDIT4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.639782215877938,1.0996850146936017,0.375,1.0,1.0,1/12,1.54%,PRKACA
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6991640833001648,1.0995301413376863,0.3684210526315789,1.0,1.0,3/8,15.00%,SELENOS;TMBIM6;LRRK2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6647396033201404,1.0994176509859643,0.3974358974358974,1.0,1.0,2/9,5.32%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6647396033201404,1.0994176509859643,0.3974358974358974,1.0,1.0,2/9,5.32%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.647380527879149,1.0993334821580978,0.38461538461538464,1.0,1.0,2/10,10.62%,NUP153;NUP133
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.6583971570633301,1.0992826813007,0.3815789473684211,0.9996194848891589,1.0,2/10,8.92%,DPM1;PIGL
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.6439688252733919,1.0992618860352643,0.38666666666666666,0.9988100223740116,1.0,4/12,19.91%,OGN;SOD2;PDCD4;CDKN1B
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5985382871197232,1.0991478002044064,0.3258426966292135,0.9984059618400567,1.0,6/29,17.74%,KCNC2;ATL1;ATL2;ELAVL1;TP53BP1;ZBTB1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5717674383270509,1.0988692275121896,0.34408602150537637,0.9986559146463565,1.0,17/42,21.51%,PHYHIPL;ELAVL3;KCNC2;NXPH1;LSAMP;GFAP;ADGRB3;SNAP25;CADM2;ZNF536;NRXN1;PDE10A;GABRB1;NEGR1;GRIA2;PLP1;CCK
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6303921716687749,1.0984557224824076,0.3522727272727273,0.999759559038962,1.0,5/16,11.12%,TSC2;PTPN1;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.7292787512870358,1.0984438711506883,0.3698630136986301,0.9988763350844321,1.0,4/6,18.19%,RHBDD1;RUNX1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6892737919198784,1.0979612601490396,0.4657534246575342,0.9999680948042067,1.0,3/8,26.94%,SGIP1;EPS15;CLTC
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.5425932819995326,-1.0979562227707977,0.3333333333333333,0.9924140682931891,1.0,1/11,1.35%,NRP1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.619339257148176,1.0975512650478185,0.36470588235294116,1.0,1.0,8/17,19.85%,CD44;RAB27A;GRSF1;ELF1;EPOR;ADGRE2;SNAP23;SLC25A37
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.5306024827534559,1.0972666519239183,0.29,1.0,1.0,21/83,23.12%,ATP1B3;COG7;CCT4;MTMR9;STK4;PPARGC1A;CCNH;TBRG1;MDM4;NAPG;PPIB;NAA15;ZSWIM7;STXBP4;CCT3;SMAD7;NLK;UBE2B;STX12;MT3;LAMP2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6497594535188037,1.0972161489063044,0.43902439024390244,1.0,1.0,4/12,15.54%,FLT1;TGFB1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.6935960022627805,1.0967765593888839,0.3684210526315789,1.0,1.0,1/7,5.77%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5436482465082781,1.096720643970043,0.3473684210526316,1.0,1.0,17/67,15.31%,CSF1;PURB;PRKACA;PTPRQ;RAF1;SMOC1;PRKCB;EIF2AK2;TGFB1;CEBPB;CCN2;NLGN1;BCL6;RUNX1;FGFR2;ST7;CEBPD
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6648161863955111,1.0964714113337528,0.41975308641975306,1.0,1.0,8/12,29.89%,GNAI1;PDE4D;MGRN1;PRKAR2A;UBE2B;PEX5L;PRKAR1A;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.592994532936159,-1.0961510298587096,0.41935483870967744,0.9944033136315427,1.0,1/6,1.35%,NRP1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.6738132326407064,1.0958133976352002,0.37333333333333335,1.0,1.0,1/9,8.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.557626953154763,-1.0954620896034366,0.3076923076923077,0.9920180541214169,1.0,3/8,5.91%,WDR75;SHQ1;DIMT1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.640375425152843,1.0951841914794878,0.3950617283950617,1.0,1.0,1/13,2.33%,NFKBIA
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6882387223055443,1.0951425004297648,0.4050632911392405,1.0,1.0,2/7,18.50%,CTNNA2;PAFAH1B1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6372366373404738,1.0946039015900015,0.39285714285714285,1.0,1.0,5/15,11.12%,TSC2;PTPN1;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6156798038369984,-1.0944803071728024,0.3333333333333333,0.990175043154486,1.0,1/5,4.16%,INPP5F
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5315959609743929,-1.0944539190583165,0.2857142857142857,0.9860664330169155,1.0,2/11,1.58%,NET1;ARHGEF3
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7202686079590827,1.09444913167943,0.40298507462686567,1.0,1.0,2/5,19.70%,SELENOS;KDR
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.624109505320339,1.094443604828269,0.375,1.0,1.0,3/19,14.72%,CD44;CAPZB;CFL1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.6883490393557481,1.0942586204895868,0.358974358974359,1.0,1.0,3/13,13.66%,PELI1;SDCBP;SLC25A4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.6871506653096872,1.094006646454731,0.36764705882352944,1.0,1.0,2/6,16.11%,FGFR2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4923541915182848,-1.0939096489324067,0.4090909090909091,0.9835857914481432,1.0,8/15,15.85%,MYLK;ANXA1;ITGB1;ACTG1;ST3GAL4;PTK2;THBS1;SMOC2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.6104035071408875,1.0931270553904175,0.38636363636363635,1.0,1.0,4/16,13.15%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.6245925785840778,1.093003425900715,0.4186046511627907,1.0,1.0,9/21,27.56%,NRCAM;DIP2B;SIN3A;ABL1;MT3;DNM2;OLFM1;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6539668626191746,1.0929062141243238,0.4225352112676056,1.0,1.0,6/10,20.84%,NFKBIA;PPARA;PTPN2;ABCA1;ABHD5;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7502224424904937,1.0928511582177625,0.390625,1.0,1.0,3/5,24.83%,NEDD4L;GOPC;GPM6B
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.6052028912415546,1.0928118935965636,0.41975308641975306,1.0,1.0,10/21,27.39%,DNAJC6;AP2A1;SGIP1;CANX;AP2B1;GAK;PIP5K1C;AP2M1;CLTC;GPR107
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6001656225429536,1.092655396802484,0.4125,1.0,1.0,7/16,35.96%,CTR9;STAT3;ST18;PTPN11;IL6ST;PID1;NFKB1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.5924193606458776,1.0926166607204622,0.35294117647058826,1.0,1.0,6/23,16.39%,NUP153;SEC13;NUP88;NUP133;HIF1A;ZBTB7A
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.603045418973218,1.0922119258993075,0.39285714285714285,1.0,1.0,8/23,22.13%,ADGRV1;DHRS3;OPA3;SLC4A10;ATF6;COL18A1;COL11A1;PITPNA
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5480273605827889,1.0921246520147907,0.32978723404255317,1.0,1.0,18/63,21.37%,PRKACA;TUBA1A;CCP110;PSMB1;PSMB2;FHL1;CSNK1D;PSMA7;CEP57;PSMA4;CEP70;PSMD14;RBX1;PAFAH1B1;CNTRL;SKP1;CEP290;YWHAG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.7257271373480539,1.0920403728652488,0.38961038961038963,1.0,1.0,3/5,19.45%,HOMER2;PRNP;NAV3
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.45818036985491223,-1.091994652216456,0.36363636363636365,0.9847767094756583,1.0,7/19,13.24%,NRP1;PGF;MAPK14;NR4A1;ANXA1;NUS1;DAB2IP
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.6590944344511068,1.0918813957320874,0.3684210526315789,1.0,1.0,5/6,31.23%,ZFPM1;KDR;SH2B3;KITLG;KMT2A
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7496259904648079,1.0917437541023658,0.34210526315789475,1.0,1.0,2/5,10.78%,NFKBIA;EIF2AK4
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6556849354408619,1.0917378036187004,0.36046511627906974,1.0,1.0,5/17,14.39%,PDE7B;RIMS2;PDE7A;AKAP6;PDE4D
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5279688975318282,-1.0916875693184913,0.43478260869565216,0.9816893078139729,1.0,1/13,0.19%,WDFY4
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.6320048937181436,1.091479713653933,0.41025641025641024,1.0,1.0,4/11,27.25%,CTR9;WAC;UBE2B;USP22
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6398300913126572,1.091124200787457,0.35365853658536583,1.0,1.0,7/17,20.05%,NRG1;TGFB1;ZFPM2;FGFR2;MYL3;RBPJ;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.743638623830471,1.091122370698812,0.36764705882352944,1.0,1.0,3/6,21.68%,IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.743638623830471,1.091122370698812,0.36764705882352944,1.0,1.0,3/6,21.68%,IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.5464448941592313,1.0910072276672258,0.3695652173913043,1.0,1.0,8/52,16.02%,SRGN;SOD1;HABP4;TGFB1;TMSB4X;SYTL4;CD9;TTN
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.6874950749547873,1.0908734033403857,0.38028169014084506,1.0,1.0,2/5,18.97%,TGFB1;SMAD2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.5783759823318038,1.0908594729834553,0.40229885057471265,0.99963758307857,1.0,13/29,26.69%,PELI1;SCD;ADAM17;PPARA;TGFB1;MAPKAPK2;STAT3;ERBIN;GPX3;SMAD6;TAB2;FOXO3;STRN3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.6176589687991834,1.0906891971386812,0.3707865168539326,0.9994975627875801,1.0,2/14,8.45%,LZTFL1;TGFB1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5400303845118956,-1.0906740940869584,0.29411764705882354,0.9812250254967387,1.0,2/7,8.92%,PGS1;TAMM41
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.6347721221582644,1.0906136154083614,0.45454545454545453,0.9988761501868243,1.0,1/15,0.42%,SOD1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.599269602568672,1.0905516048813628,0.3258426966292135,0.9982651317846639,1.0,5/21,19.87%,MICOS10;AGK;CHCHD3;SPG7;DNAJC11
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5965578497044396,1.0902493702932365,0.313953488372093,0.9986075210061253,1.0,3/30,12.13%,WWC1;ADAM17;GALNT11
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.592922503897666,1.090232636630884,0.3780487804878049,0.9978223638602834,1.0,3/21,8.45%,RHBDD1;ADAM17;TGFB1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.6590097045061135,1.0898709589105455,0.3924050632911392,0.9985429039430939,1.0,4/11,20.55%,PRKACA;AKAP6;PDE4D;CAMK2D
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6767473820540544,1.0894061760622558,0.38666666666666666,0.9996678136562612,1.0,2/9,11.91%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7096409861711134,1.0892219007218618,0.4264705882352941,0.9995194491280035,1.0,4/6,20.95%,ELF1;RUNX1;CBFB;ELF2
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7127932681371819,-1.0892018549378615,0.4411764705882353,0.9819405884830207,1.0,2/5,25.02%,PARN;DIS3L2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6541649150005224,1.0891836536845914,0.40963855421686746,0.9987363254679844,1.0,2/11,14.62%,HDAC2;FGFR2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.706635934369318,1.0891303230918734,0.44285714285714284,0.9980925536915883,1.0,2/7,14.42%,IL18;STAT3
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.6341649058211473,1.0890209959568367,0.36470588235294116,0.9966341388526935,1.0,3/15,12.70%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.6341649058211473,1.0890209959568367,0.36470588235294116,0.9966341388526935,1.0,3/15,12.70%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.70372463524839,1.0889205454297655,0.36363636363636365,0.9962782997046987,1.0,1/6,2.61%,NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.7230183418087665,1.0888184466519122,0.39436619718309857,0.9957673608353107,1.0,2/6,20.27%,SMAD7;ABL1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.4225632327507151,-1.0888067485557427,0.3076923076923077,0.9790583424622872,1.0,6/38,7.10%,NTN4;ITGA8;NRP1;LAMC1;LAMB2;TBCD
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.57351655800755,-1.0887962863789493,0.4166666666666667,0.9751494127722552,1.0,1/10,4.31%,RYR2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7154016180389247,1.0885384636066942,0.40540540540540543,0.9958614619490469,1.0,3/5,18.19%,IL18;TGFB1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7293251837453375,1.088537608477624,0.4305555555555556,0.9949585957097459,1.0,3/5,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6925568280038487,1.088126952654721,0.36363636363636365,0.9957933268194757,1.0,2/7,16.53%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.6197441054947032,1.087938597462981,0.45454545454545453,0.9956771963961251,1.0,4/17,11.68%,RIPOR1;PTPN1;TGFB1;UHMK1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5287945114851264,1.0878898511116886,0.4148936170212766,0.994886387190714,1.0,13/62,16.95%,PHYHIPL;SLC23A2;CDC42EP4;SMARCA1;SCARB2;EGFR;SLC2A12;SHC2;PRLR;SLC4A10;FARP1;TEAD1;LGR4
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.6676709282548394,1.0878212489254098,0.379746835443038,0.9942427968097773,1.0,4/10,14.72%,STMN1;NCKAP5;MICAL3;CFL1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5303593621378787,1.0875458055270906,0.24489795918367346,0.994592666689612,1.0,34/145,21.05%,CSF1;KLF2;GJA1;DDX3X;PTPN1;ANK3;RAB27A;RIMS2;AGO2;NOS1AP;FUBP1;DNMT1;TGFB1;ROBO1;F3;PPARGC1A;HIF1A;ROCK2;FUBP3;NSF;CAMK2N1;STAT3;INSR;TTN;TWIST1;MAPK1;MAP2K1;SLC22A2;RBPJ;C1QTNF1;SP1;UBR5;TBC1D5;CTCF
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.6791437369418355,1.0871130277186878,0.4166666666666667,0.9955422051392434,1.0,1/6,14.72%,CFL1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6669668409294428,1.0870098158352923,0.3787878787878788,0.995099682939462,1.0,6/10,29.26%,INTS2;INTS8;INTS6L;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.6930599633707732,1.0869655238312619,0.3717948717948718,0.994358347915709,1.0,1/6,12.87%,FZD3
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5639733319726123,1.0868827531914989,0.3448275862068966,0.9937906935071832,1.0,5/26,17.60%,NFKBIA;IL18;NFKBIZ;RIOK3;PDCD4
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6076660895636058,1.086800480630577,0.37037037037037035,0.9924230218476653,1.0,4/18,10.62%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.6076660895636058,1.086800480630577,0.37037037037037035,0.9924230218476653,1.0,4/18,10.62%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.5200190115322526,1.0867303879703754,0.23232323232323232,0.9918495839754856,1.0,36/180,18.92%,OS9;PLAA;NEDD4L;PSMB1;AMFR;ZNRF1;PSMB2;RC3H2;PELI1;NDFIP2;BTRC;PSMA7;RNF168;MARCHF6;RNF34;CLOCK;TRIM9;OTUD7A;NDFIP1;SMURF2;PSMA4;SIAH1;MDM2;MVB12B;RNF19A;PSMD14;RBX1;RNF111;WWP1;ZSWIM8;HECW1;APPBP2;ANAPC4;RBBP6;FBXO11;AREL1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.6117577784100852,1.086642426194438,0.3780487804878049,0.9914037113304487,1.0,3/15,12.86%,ZFP36L2;EGFR;PDE8A
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.6365960084927685,1.0862328972641109,0.4457831325301205,0.9923493040753011,1.0,9/14,30.97%,MTHFD2L;ALDH1L1;ME2;MTHFD1L;GCLC;ASS1;SLC19A1;MTHFR;DLST
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6721165434862915,1.0861590516496575,0.3974358974358974,0.9918586709372875,1.0,2/8,13.52%,TGFB1;RUNX1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6721199676573759,1.0858053254549518,0.44,0.9924956854085064,1.0,2/8,8.51%,MUCL1;TP63
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.6011523144922778,1.0857603712254584,0.3614457831325301,0.9917806447733961,1.0,8/25,15.06%,WASF3;MICALL2;WASF1;DIAPH1;SPIRE1;MICAL3;CFL1;WASHC5
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5356287026092138,1.0857041801036003,0.34375,0.991183854939133,1.0,12/75,11.60%,PHYHIPL;ELAVL3;CRMP1;LSAMP;ADGRB3;CACNA1B;DCLK1;PCDH17;SCN3A;SNAP25;CADM2;ZNF536
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.6167709385815271,1.0855826404114621,0.38271604938271603,0.9908038904258073,1.0,7/25,12.10%,SLC22A6;SLC23A2;SLC38A4;SLC7A2;SLCO1A2;SLC3A2;SLC13A3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.6566393600267153,1.0852622908941998,0.3924050632911392,0.9911611313737223,1.0,3/10,15.04%,SOD1;SREBF1;LPCAT3
prerank,PanglaoDB_Augmented_2021__Neurons,0.5095687074067411,1.085225349844256,0.3163265306122449,0.9904229004919683,1.0,28/104,22.50%,PHYHIPL;ELAVL3;ATP6V1H;NXPH1;DNER;ADGRB3;CACNA1B;SLC6A17;CTNNA2;SNAP25;ACSL4;CADM2;GNAI1;CNTNAP2;SGIP1;NAPG;CAMK2N1;SLC36A4;NRXN1;UNC79;IFIT3;DLGAP1;GRIA2;ERC2;CCK;VSNL1;MATN2;NBEA
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.6398636980319132,1.0849518556464466,0.38461538461538464,0.9906184553823013,1.0,3/17,11.17%,CTR9;DNMT1;MTF2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.663681100722947,1.084775611569845,0.39473684210526316,0.9904015890753946,1.0,1/9,13.52%,RUNX1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.5166716365564454,1.084669162428546,0.2755102040816326,0.9899703033383107,1.0,35/123,24.86%,SYT1;VAPB;TOR1AIP2;DNAJC6;SGCZ;EPN1;ANK3;ACTR3;AP2A1;PRKCI;SCARB2;EGFR;VAPA;RPS27A;SGIP1;NAPG;LPCAT3;AP3D1;PACSIN2;AP2B1;REPS1;REEP3;SNAP23;LDLRAP1;MITD1;GRB2;TF;GAK;EPS15;AGFG1;PIP5K1C;DNM2;USO1;GAPVD1;SH3KBP1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.6941795591980464,1.0846637766949139,0.3116883116883117,0.9891373813108284,1.0,2/6,15.15%,TGFB1;TP53BP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6277413757593657,1.0845182991299571,0.4418604651162791,0.9889760090522813,1.0,9/17,27.42%,CRY1;PIAS2;CLOCK;ZBTB7A;PER1;SMARCA4;CNOT1;STRN3;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7107945308562278,1.0844688871352808,0.3684210526315789,0.9882971902193924,1.0,2/6,15.15%,NECTIN2;TP53BP1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.7140595081881855,1.0843193715315498,0.37333333333333335,0.9880209053782893,1.0,2/5,18.53%,WASHC5;ARF1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.718128289640401,1.0841737786484824,0.40789473684210525,0.9876649128589827,1.0,1/6,3.80%,ADGRB3
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5350466818762488,1.0840824916521647,0.3793103448275862,0.9871403959009766,1.0,12/38,20.05%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SMURF2;SNX25;ZBTB7A;FBN1;SMAD2;SMAD7
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.6476394386021445,-1.083749149859115,0.4375,0.9870737354026861,1.0,1/6,2.33%,ATM
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.5659829670601144,1.0832113147351101,0.3695652173913043,0.9899524029811366,1.0,14/54,19.70%,CSF1;MPZL1;PTPRD;CSF1R;FLT1;EGFR;EPHA7;SHC2;FGFR2;INSR;ACVR1B;ACVR2A;LIFR;KDR
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.5136740239841826,1.0831363479048275,0.29591836734693877,0.9894801174340552,1.0,42/165,22.29%,NEDD4L;PSMB1;AMFR;ZNRF1;PSMB2;RC3H2;UBE2J1;PELI1;BTRC;PSMA7;RNF168;BLMH;MARCHF6;RNF34;RPS27A;RNF152;SMURF2;PSMA4;SIAH1;MDM2;FBXL13;RNF19A;TRIM5;HECTD1;PSMD14;RBX1;WWP1;TNKS;HECW1;HECTD2;ANAPC4;RBBP6;CBFB;FBXO11;AREL1;SKP1;UBR5;MARCHF1;UBE2B;UBE4B;UBE2K;LNPEP
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5582510940056966,1.0829598682157426,0.425531914893617,0.9894437476292348,1.0,7/39,14.89%,LPIN1;PRKCI;SELENOS;IRS1;DENND4C;INSR;RAB12
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.6232196549513442,1.0828933293971188,0.39285714285714285,0.9889372543612877,1.0,6/16,18.19%,CACNA1B;IRS1;GNAI1;STAT3;ERBIN;PRNP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.6819252916592915,1.0827578029227325,0.41025641025641024,0.9887064248682371,1.0,2/6,12.56%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.6520649882899109,1.0822506445919733,0.4125,0.9902737450383272,1.0,1/9,4.85%,OGN
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5806674318177303,1.081990925567464,0.3763440860215054,0.9903960727549387,1.0,4/28,11.04%,MCC;RHOJ;GLUL;HIF1A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6954694110953559,1.081557591487399,0.4533333333333333,0.9913757010127666,1.0,4/6,28.46%,EGFR;KDR;ABL1;PTK2B
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5090682085463669,1.0812440274148947,0.29,0.9917264976624351,1.0,33/156,18.92%,OS9;PLAA;NEDD4L;PSMB1;AMFR;ZNRF1;PSMB2;UBE2J1;PELI1;BTRC;PSMA7;SELENOS;UBR1;MARCHF6;RNF34;CLOCK;RPS27A;TRIM9;SMURF2;PSMA4;HSPA5;SIAH1;MDM2;FBXL13;PSMD14;RBX1;WWP1;ZSWIM8;HECW1;APPBP2;ANAPC4;ECPAS;AREL1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.5638631062175277,1.0808317559169998,0.4146341463414634,0.9927120727005293,1.0,5/15,18.04%,ANK3;ATP1B3;GLRX;TCAF1;STK39
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5098850082854892,1.0807273526694163,0.36363636363636365,0.9923909824084778,1.0,22/89,21.17%,CSNK1G2;PRKACA;CSNK1D;PRKCB;STK4;CSNK1A1;PRKCI;TBK1;PDK3;UHMK1;ROCK2;MAPKAPK2;LRRK2;LATS2;TNKS;MAPK1;STK39;CSNK2A1;NLK;CAMK2D;MAPKAPK5;RPS6KA2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5852291023420753,1.080698488580328,0.38636363636363635,0.9916564075496185,1.0,8/23,26.47%,RC3H2;CNOT8;TUT7;DCP2;DCP1A;DIS3;PATL1;CNOT1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5501515072149898,1.080694221548308,0.3684210526315789,0.9907998896121998,1.0,15/48,19.91%,NEDD4L;FMN2;GFAP;EGFR;SMURF2;RAB7A;NSF;MDM2;MDM4;WWP1;TIPARP;HECW1;CSNK2A1;AREL1;CDKN1B
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5441036720366542,1.0805773511232462,0.44086021505376344,0.9905076886032934,1.0,14/52,22.89%,HDAC2;HCFC2;SMARCA1;ARID1A;HNRNPC;MBD2;EZH1;ZBTB7A;KDM6A;ZBTB1;SMARCA4;JARID2;MYSM1;NUDT5
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5658268500528265,1.0801892347347035,0.4024390243902439,0.9911122151477989,1.0,9/31,22.24%,CASP8AP2;ROBO1;F3;IFT57;SENP1;APAF1;TNFRSF10B;SLC22A2;COL4A3
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6908675055404457,1.0799910353035207,0.35526315789473684,0.9910572787696222,1.0,3/8,23.08%,MBD2;CHD1;MT3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.6217862243084261,1.0799789612677504,0.3764705882352941,0.9902305745316229,1.0,2/12,8.45%,LZTFL1;TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7133276450066535,1.079713665723971,0.4027777777777778,0.9903517706805751,1.0,3/5,16.53%,NLGN1;TSHZ3;NRXN1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6462472016380302,1.079698498671361,0.36363636363636365,0.9895971616914528,1.0,4/15,18.27%,PTPN1;NDFIP2;NDFIP1;DNAJA1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.5635069653927981,1.0796286907356945,0.4065934065934066,0.9890275770688515,1.0,4/37,7.03%,LPIN1;HSPA4L;NAA11;PIAS2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5107254496510136,1.0795572106693978,0.32608695652173914,0.988450238822314,1.0,18/62,26.40%,USP15;TGFB1;RPS27A;SMURF2;HIVEP1;ACVR1B;RNF111;ACVR2A;ZFYVE9;PDCD4;USP9Y;SMAD2;SMAD7;NLK;SMAD6;JUN;ZMIZ1;FOS
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.7208955772181235,1.0792677441460587,0.4383561643835616,0.98879088677456,1.0,3/6,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.5689835346976536,1.079155083481766,0.40229885057471265,0.9883543625306778,1.0,7/27,17.56%,DPP10;PRKCI;EGFR;CNST;PTPN9;ZDHHC5;LGALS3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5952057158083592,1.079136401752864,0.42045454545454547,0.9876134590768736,1.0,3/17,9.20%,ATP6V1G1;ATP6V1H;ATP6V1E1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.6809447655197044,1.0790673218007394,0.40789473684210525,0.9871003103207087,1.0,3/10,13.55%,SYMPK;CPSF2;CSTF3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4058192006920177,-1.0790396728567835,0.3333333333333333,0.998478337161362,1.0,5/62,3.21%,FAT1;TPM2;LMOD1;EVL;BAIAP2L2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7049320920992383,1.0789515595540788,0.40540540540540543,0.9866924838360916,1.0,2/8,4.33%,NFKBIA;SUFU
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.6337223312240136,1.0781750528692768,0.45977011494252873,0.9888766378089967,1.0,6/16,21.23%,ITGA5;CTR9;COL7A1;RTF1;ITGAV;COL11A1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.5760572169597353,1.0778536785661825,0.38095238095238093,0.9894584240461644,1.0,11/24,32.57%,GGA3;RPS27A;CST3;SIAH1;MDM2;SNCAIP;TSPAN5;GGA2;APP;USP9X;HSPG2
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.533951986504693,1.077725259587852,0.3541666666666667,0.9890322599222987,1.0,15/79,12.47%,KCNC2;ATP6V1H;KCNH7;KCND2;KCNQ1;KCNQ3;SLC6A17;ATP1B3;TMEM165;SCN3A;SLC39A11;TMCO1;KCNQ5;ABCC9;NALCN
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.5336737194671521,1.0772863506798465,0.4,0.9901679922355978,1.0,23/62,32.80%,CSF1R;EIF2AK2;TBK1;PTPN9;MAPKAPK2;AKAP6;STAT3;PTPN2;LIFR;IFITM3;LDLRAP1;ALDH1A2;LEF1;IL1RAPL1;SETD2;MCL1;PTPN11;IL6ST;TIMP3;PTPN14;NFAT5;APP;PID1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5881713753492704,-1.076986581908469,0.32142857142857145,0.9994567004959035,1.0,6/6,41.25%,ZCCHC17;NRDE2;TENT2;NAF1;SLIRP;FMR1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.5025085800703859,1.0769606049698508,0.29,0.990790498011597,1.0,41/188,19.88%,OS9;UBA5;NEDD4L;AMFR;HIF3A;NUP153;CTR9;BTRC;PIAS2;SELENOS;NUP88;UBR1;DCUN1D4;KLHL2;RNF168;TRIM23;MARCHF6;RNF34;RPS27A;RNF152;UHRF2;NUP133;HIF1A;SMURF2;WAC;MDM2;TRIM5;RBX1;RNF111;BRAP;WWP1;MGRN1;ZSWIM8;HECW1;DCUN1D1;UBA2;FBXO11;AREL1;UVSSA;RTF1;SKP1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.6418783527139817,1.0764674411014816,0.3793103448275862,0.9920439867326482,1.0,6/12,25.82%,SLC7A2;SLC3A2;SLC36A4;SLC1A2;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6644442710304361,1.0764118877257778,0.4235294117647059,0.99146135242953,1.0,3/10,19.91%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.5216516215013306,1.0758734992288208,0.36,0.992807195505409,1.0,16/90,18.73%,HNRNPL;PRKACA;RBMS2;HNRNPF;ADARB2;ALKBH5;HNRNPC;PPARGC1A;TUT7;TCERG1;CSTF3;RBM39;NOVA1;DHX15;HNRNPUL1;SF3B1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6695991392770865,1.075714302329157,0.41975308641975306,0.992708521588268,1.0,3/9,5.63%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.47752542509460993,-1.075434338820686,0.46153846153846156,1.0,1.0,4/23,7.18%,PPIP5K2;INPP4B;IPPK;PLCH1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.635636891358431,1.0754178877640788,0.35135135135135137,0.9931967623281274,1.0,3/16,13.77%,CD44;GYPC;EPOR
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.5983722984523848,1.0752171529955397,0.3488372093023256,0.993089302880853,1.0,2/20,2.61%,DDX3X;NEDD4L
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.693752654152147,1.0746210085093357,0.40540540540540543,0.9945583666623338,1.0,2/8,6.17%,CD38;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6533345648694859,1.0744613166654653,0.4266666666666667,0.9942605851900356,1.0,2/8,14.00%,FRMD5;CD9
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5996494812423305,1.0743057018587043,0.40229885057471265,0.9941266960766715,1.0,4/26,7.80%,VAPB;DDX3X;EIF2AK2;PPARA
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.6770525294777106,1.0741288606425246,0.4266666666666667,0.9937610546583675,1.0,7/11,30.38%,AGO2;SMURF2;POMZP3;ACVR1B;LHFPL2;TACR1;VEGFA
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6124727567898871,-1.0739394475938069,0.44,1.0,1.0,1/6,0.19%,WDFY4
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7000342056153734,1.0736907542525986,0.42424242424242425,0.9937435494609805,1.0,1/5,10.05%,RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7000342056153734,1.0736907542525986,0.42424242424242425,0.9937435494609805,1.0,1/5,10.05%,RPS27A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5872971418752415,1.0736243553800835,0.3974358974358974,0.9931906262610134,1.0,5/16,20.38%,PTPRD;SYNDIG1;NLGN1;NRXN1;NAP1L1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6969455715585104,1.0734895526584591,0.38666666666666666,0.992818458343746,1.0,2/6,20.19%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.7198783418891475,1.0733967979848607,0.4507042253521127,0.9923870337487528,1.0,2/6,7.99%,MTMR9;MTMR1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.717950536276913,1.0732552555383315,0.43037974683544306,0.992170044857896,1.0,1/6,1.85%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5116264916702944,1.0730717350612315,0.39361702127659576,0.9921071603705947,1.0,10/55,16.39%,NFKBIA;IL18;PRKCB;EIF2AK2;PRKCI;CLOCK;RPS27A;STAT3;TRIM5;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.717219731161431,1.0725697266183045,0.40298507462686567,0.993204967542662,1.0,5/6,25.22%,NFKBIA;PPARA;ABCA1;ITGAV;ABCA5
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.7331206513137991,1.072537090955969,0.45569620253164556,0.9924933004264083,1.0,2/6,18.47%,AMBRA1;MAP1LC3B
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6696272029498235,1.0724963852577636,0.43209876543209874,0.9918424705509534,1.0,3/8,5.63%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6723167434334152,1.071726191230896,0.44285714285714284,0.9940442962319631,1.0,4/6,29.44%,ASPA;ASS1;MSRA;MTHFR
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7433008387395312,1.0715328928284853,0.3380281690140845,0.9939715916095815,1.0,2/5,10.00%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6561509375117407,1.0713215038876893,0.4605263157894737,0.9940519693225515,1.0,7/13,25.84%,BTRC;DCUN1D4;DCUN1D1;GOLGA2;SKP1;DCUN1D2;UBE2L3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5309215741986296,1.0712269064874944,0.43157894736842106,0.9935548498624363,1.0,22/75,26.38%,RHOB;RIPOR1;CDC42EP4;RRAS2;WASF1;DNMT1;RAP1B;SHC2;GNB1;ROCK2;CFL1;BRAP;GPSM2;MAPKAPK5;NF1;GRB2;CYFIP1;JUN;KRAS;ARHGAP5;USP8;RASSF1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6741194923728537,1.0709126057548388,0.44285714285714284,0.9939238810063742,1.0,6/8,31.20%,INTS2;INTS8;INTS6L;INTS6;INTS7;SSB
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5745158941776115,1.0706182793652548,0.40860215053763443,0.9942668628930931,1.0,6/39,9.46%,OS9;AMFR;RHBDD1;UBE2J1;SELENOS;MARCHF6
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.4741891408322493,-1.0705811752805554,0.38461538461538464,1.0,1.0,4/24,7.18%,PPIP5K2;INPP4B;IPPK;PLCH1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5229168265814803,1.0705804246779698,0.34375,0.9935336767909256,1.0,22/89,18.13%,WWC1;EPM2A;DDX3X;TSC2;DDIT4;WWC2;PPARA;UBR1;DUSP1;RNF34;TNFAIP8L1;TMSB4X;TANK;OTUD7A;RIOK3;MDM2;PDE4D;TWIST1;MGRN1;USP10;PDE10A;PER1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.5709970183941238,1.0705008071240512,0.35555555555555557,0.9930301982025422,1.0,14/37,21.20%,ARRDC2;SLC38A4;SLC7A2;TMEM30A;SCARB2;SLC3A2;RAB7A;ATP11B;SLC22A2;SNX4;SLC6A12;CMTM6;RUFY1;CEP290
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.6377202144638308,1.070490149731636,0.3717948717948718,0.9922823677871808,1.0,3/12,15.56%,ENO1;SCARB2;C9ORF72
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.5088319436335892,1.0703690525733394,0.37777777777777777,0.9919666354249855,1.0,13/48,19.76%,PHYHIPL;EBF4;KCNQ1;ANK3;SLC22A23;MCF2L;SHC2;CP;ARFGEF3;FGFR2;SYBU;MYRIP;MTUS1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5743010187599878,1.0701972934538675,0.41935483870967744,0.99190465787681,1.0,13/29,25.82%,SYT1;LIN7A;SNAP25;SYN3;GLUL;CASK;SLC1A2;NRXN1;SLC22A2;SLC6A16;DNAJC5;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.728371900077025,1.0698354092073314,0.4084507042253521,0.9926271294281216,1.0,4/5,24.95%,TCAF1;PRNP;GOPC;GRM5
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.6458470315665992,1.0697743203341148,0.4342105263157895,0.9920422435111069,1.0,2/10,12.44%,S1PR3;ROCK2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5434812764520965,1.069595101870918,0.4673913043478261,0.991904580372906,1.0,9/59,8.86%,PHYHIPL;CRMP1;PTPRD;LSAMP;ADGRB3;CACNA1B;DCLK1;PCDH17;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5322576763078414,1.0695722320662415,0.4235294117647059,0.9911361928654002,1.0,10/43,19.31%,DDX3X;CASP8AP2;ROBO1;F3;IFT57;SENP1;APAF1;TNFRSF10B;ST18;SLC22A2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.6340981419445851,1.0693288619521084,0.3780487804878049,0.9914282053868424,1.0,4/13,14.00%,TNFRSF1B;TGFB1;EPOR;CD9
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5342322160101968,1.0687183349400087,0.35106382978723405,0.9930299304584167,1.0,20/60,21.31%,PHYHIPL;ELAVL3;CRMP1;PTPRD;LSAMP;ADGRB3;CACNA1B;DCLK1;ATL1;SNAP25;CADM2;ZNF536;LRFN5;NRXN1;NOVA1;NKAIN2;GRIA2;DGKH;PLP1;ERC2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.5333585276801249,1.0686836288475818,0.32989690721649484,0.99239679206299,1.0,19/87,16.67%,SOD1;CADM1;PDE4B;CSF1R;IL18;EIF2AK2;ADAM17;TBK1;TGFB1;MBP;F3;HIF1A;CEBPB;ROCK2;RUNX1;PDE4D;STAT3;TWIST1;POLR1C
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6722635295308742,1.0686315483816338,0.41025641025641024,0.9917563215192039,1.0,1/7,15.63%,ARHGEF4
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.6277367430227931,1.0684459499368633,0.3974358974358974,0.9916949819376722,1.0,3/15,11.04%,CSF1;ADAM17;HIF1A
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.6725978765199876,1.0682555400216698,0.43037974683544306,0.9918011607831247,1.0,2/12,10.58%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.5248416583624493,-1.067989336471455,0.375,1.0,1.0,3/12,4.20%,WNT5B;ATM;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6639512198877404,1.0679687792213701,0.42105263157894735,0.9920828052329963,1.0,3/10,19.43%,ZFPM2;FGFR2;RBPJ
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6534110066660479,1.0676093196470848,0.3835616438356164,0.9926648335741151,1.0,5/11,29.26%,INTS2;INTS8;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5409300366544492,1.0674535403242174,0.41237113402061853,0.9923858439208224,1.0,8/47,14.98%,DDX3X;GGA3;GIGYF2;IGF2BP2;EIF2AK2;CNOT8;EIF4ENIF1;RTN3
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.6436032908877303,1.067410729675916,0.4375,0.991731874674695,1.0,4/15,5.91%,RIPOR1;ARL5A;COG7;CSNK1D
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.6947079619909755,1.0669533843965737,0.373134328358209,0.992787915716467,1.0,3/6,29.76%,STAT3;CANX;IL6ST
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3772309207295778,-1.0668235317788335,0.2727272727272727,1.0,1.0,4/35,8.19%,CAV2;TTL;KLHL13;PIK3R4
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.4963301906063949,1.0666961763501968,0.36363636363636365,0.9931092292655587,1.0,22/175,11.34%,HNRNPL;TAF1B;RBMS2;DARS1;RPS21;NUP153;AGO2;HNRNPF;FARSB;SEC13;ADARB2;NUP88;PWP1;SYMPK;CPSF2;ALKBH5;RPL28;RPS27A;RPL21;NUP133;RPL41;FYTTD1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6636941676223702,1.0666516966747073,0.4155844155844156,0.9924396369335058,1.0,1/9,3.19%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.5032809905021516,1.0661032373717843,0.33,0.9938500544955783,1.0,39/185,20.22%,SOD1;CSF1;TAF1B;GJA1;DDX3X;CADM1;HABP4;ANK3;RAB27A;RIMS2;AGO2;NOS1AP;FUBP1;EIF2AK2;DNMT1;TGFB1;EGFR;ROBO1;DDX21;F3;PPARGC1A;ELAVL1;HIF1A;ROCK2;FUBP3;CAMK2N1;STAT3;METTL14;TTN;TWIST1;MAPK1;POLR1C;MAP2K1;SF3B1;SLC22A2;RBPJ;C1QTNF1;SP1;UBR5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.5501527571505572,-1.0658950920200303,0.37037037037037035,1.0,1.0,3/7,12.50%,HSPA1A;TPR;CHMP4B
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.531598101704347,1.0658238882799347,0.33695652173913043,0.9941780078896791,1.0,13/55,21.34%,TSC2;NRG3;GFAP;PTPN1;SEMA4D;RAP1B;ROCK2;PACSIN2;ABL2;ABL1;RUFY1;CAMK2D;SNCAIP
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5206387406717836,1.0653737560939565,0.3854166666666667,0.9951944820643774,1.0,22/78,22.60%,RHOB;RHOJ;MYDGF;CEMIP2;AGO2;NIBAN2;FLT1;PRKCB;F3;GLUL;HIF1A;ROCK2;RUNX1;PGK1;TWIST1;ANGPTL4;KDR;SP1;NF1;PTPRM;COL4A3;SARS1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.5120690674604351,1.064953529500943,0.40425531914893614,0.996076562679346,1.0,13/58,16.80%,NFKBIA;PSMB1;PSMB2;ZFP36L2;TNFRSF1B;PSMA7;ADAM17;TMSB4X;TANK;PSMA4;PSMD14;ERBIN;MAP3K14
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.6379044999888153,-1.0648904952239795,0.4117647058823529,1.0,1.0,1/5,2.85%,MAPK14
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.6003582447217936,1.0646089563710694,0.4157303370786517,0.9967168332302294,1.0,6/23,19.09%,HDAC2;SMARCA1;ARID1A;HNRNPC;MBD2;SMARCA4
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.6078641177721485,1.064550837981035,0.41025641025641024,0.996105547884138,1.0,2/11,12.38%,DDX52;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6896226248767803,-1.0643453257817204,0.48148148148148145,1.0,1.0,2/5,28.09%,PKM;DHX36
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.6503005153494559,1.0639833064449702,0.43478260869565216,0.9973653461780618,1.0,2/7,19.20%,MDM4;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.6324233267797374,1.0627350627230652,0.4461538461538462,1.0,1.0,3/8,9.86%,ANK3;ATP1B3;GLRX
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.49803032115992385,1.0626685446334594,0.40404040404040403,1.0,1.0,31/123,21.25%,RHOB;PRKACA;TSC2;TGFB1;APBB1;DUSP1;CDC123;SDCBP;UHRF2;SRA1;UHMK1;MADD;MAP2K6;WDR6;TBRG1;ANKRD17;TBX3;MDM2;CAMK2N1;STAT3;FGFR2;NF2;MAP2K1;PDCD4;CRLF3;CSNK2A1;JUNB;CDKN1B;ABL1;RPS6KA2;TP53INP1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7068335602977811,1.0626506247729557,0.4305555555555556,1.0,1.0,3/7,20.81%,GRIK2;GRIA2;NAPB
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3665856392870108,-1.0625749282219548,0.25,1.0,1.0,4/34,7.23%,ZDHHC15;ZDHHC21;ARL6;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6265591385673044,1.0620933437168418,0.3815789473684211,1.0,1.0,1/11,4.26%,NUP153
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6774961270278725,1.0615257876624347,0.36619718309859156,1.0,1.0,1/7,5.46%,SEC11A
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6090171233765915,1.0613577949195412,0.4470588235294118,1.0,1.0,4/18,15.32%,SMOC1;RAB18;SMCHD1;ATF6
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6757650186112598,1.0612633864524519,0.45,1.0,1.0,6/11,30.80%,PLAA;MVB12B;UBAP1;TOM1L1;RNF115;NEDD4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.4978510826958269,-1.0611411074338375,0.4375,1.0,1.0,2/10,8.16%,SNAPC3;GTF3C3
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.620472968622047,-1.060991728853774,0.43333333333333335,1.0,1.0,2/5,2.43%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.647549374442742,1.0607400864601608,0.39473684210526316,1.0,1.0,5/14,22.52%,NR4A3;PPARGC1A;MTFR1;NDUFS1;COX10
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.6353771608928234,1.060685098173607,0.42168674698795183,1.0,1.0,4/11,29.76%,EIF2AK4;RIOK3;CD81;IL6ST
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.5113693474927754,1.0605472766436383,0.36,1.0,1.0,34/150,20.10%,RNMT;TAF7;ELL2;GLIS3;NR4A3;INTS2;TBPL1;CTR9;PKNOX1;ESR2;PPARA;SYMPK;CPSF2;DDX21;NRBP1;PPARGC1A;RARB;CCN2;CCNH;DEAF1;INTS8;CSTF3;CEBPD;TEAD1;ZBTB1;NFIX;CBFB;AFF4;RTF1;RBPJ;MLLT1;CCNK;SP1;SUPT16H
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6729838032303883,1.0604805429782769,0.4305555555555556,1.0,1.0,3/8,17.23%,TGFB1;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6796061317509778,1.0603039922486064,0.4492753623188406,1.0,1.0,3/9,14.53%,PANK2;PPARA;PDK4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3778942713312303,-1.0601787908270044,0.2727272727272727,1.0,1.0,3/45,3.97%,SPRY3;SPRY1;MAPKAP1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.5428747207888224,1.059662879954153,0.34065934065934067,1.0,1.0,10/39,14.42%,IPO9;TSC2;NUP153;IPO5;SEC13;CSE1L;NUP88;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.6278305129488869,1.0594099480510082,0.4878048780487805,1.0,1.0,4/15,21.20%,CSNK1D;TTC8;IFT57;CEP290
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.6193965251768171,1.0592444251194755,0.40229885057471265,1.0,1.0,8/18,25.88%,RBM4B;SAMD8;METAP1;MAPKAPK5;CYFIP1;FOXO3;GRM5;PUM3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6158857382522472,-1.0590743077441038,0.42857142857142855,1.0,1.0,3/7,8.59%,SERPINI1;NFASC;NTF3
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.5839607051428384,-1.0590555518389637,0.4642857142857143,0.9975670909933163,1.0,1/7,0.93%,PLA2G4C
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.5767792343055738,1.0581799656398203,0.4166666666666667,1.0,1.0,4/20,10.62%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.696964570172096,1.0580465245994286,0.42168674698795183,1.0,1.0,2/5,16.63%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4874248904772729,1.0580434153579428,0.37,1.0,1.0,53/230,20.67%,CSNK1G2;PRKACA;PDK1;DCLK1;SIK2;CAMKK2;USP15;CRY1;CSF1R;CSNK1D;FLT1;PRKCB;STK33;STK4;CSNK1A1;EIF2AK2;MAPK6;PRKCI;TBK1;TGFB1;EGFR;OXSR1;NRBP1;EIF2AK4;PDK3;MELK;UHMK1;ROCK2;CCNH;MAP2K6;MAPKAPK2;PDK4;MAK;FGFR2;SLK;INSR;LRRK2;ACVR1B;ACVR2A;LATS2;TNKS;MAPK1;MAP2K1;STK39;CSNK2A1;SMAD2;KDR;SMAD7;ABL2;NLK;ABL1;CAMK2D;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.4921549170688441,1.0579328959407401,0.33,1.0,1.0,57/207,26.40%,KLF2;HDAC2;CD38;CAMKK2;NIBAN2;SMARCA1;RNF10;BTRC;ESR2;YAF2;PPARA;TGFB1;TP63;APBB1;EGFR;MED14;ARID1A;CLOCK;PPARGC1A;HIF1A;ZBTB16;CEBPB;KDM3A;ELF1;DEAF1;FUBP3;RUNX1;WAC;STAT3;TP53BP1;TEAD1;CREB3L2;RNF111;NAA15;MAP2K1;CRLF3;SETD3;SMAD2;SMARCA4;SP1;ELF2;CTCF;CEP290;TP53INP1;KLF6;SP3;MT3;LEF1;DNM2;TCF4;JUN;FOXO3;RFX3;ETS1;ESRRG;ZMIZ1;FOS
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.6062214563385825,1.057793523969793,0.4146341463414634,1.0,1.0,4/14,13.80%,AKIRIN1;TGFB1;SRA1;TBX3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6608059433987297,1.057661687148354,0.47368421052631576,1.0,1.0,3/7,27.54%,DUSP1;PPM1E;PPP2CB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.6912326713300422,1.0573302072728898,0.4027777777777778,1.0,1.0,3/5,30.38%,HIF1A;RBPJ;VEGFA
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.5481879388646614,1.057107572786617,0.40229885057471265,1.0,1.0,6/29,18.01%,ADAMTS9;MARCHF6;SIAH1;RAB12;DENND3;MANBA
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.5769412264744425,-1.0568525286019461,0.4,0.9997263727245415,1.0,2/8,6.85%,RALBP1;SLC25A26
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6290024565770445,1.0567196542815909,0.47560975609756095,1.0,1.0,5/12,14.13%,KCNQ1;ANK3;NOS1AP;GNB1;AKAP6
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.5215988215071379,1.0566727128077174,0.3711340206185567,1.0,1.0,15/78,17.76%,ATP6V1G1;ATP6V1H;PDHX;ACADVL;NDUFV1;COX6C;ATP6V1E1;GLUD1;SLC25A3;SLC25A4;NDUFS2;NDUFB2;PDK4;SUCLG1;COX4I1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.5022874937327133,1.0565942618640114,0.40625,1.0,1.0,16/59,21.63%,AMFR;NUP153;SEC13;NUP88;CORO2B;NUP133;CEBPB;ROCK2;DNAJC7;MAPKAPK2;MAPK1;RPA1;HSPH1;ABL1;CAMK2D;NUP205
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.5433033589943119,1.0561336951250009,0.45263157894736844,1.0,1.0,9/46,14.42%,CD44;CSF1R;IL18;NAIP;TBK1;TGFB1;CEBPB;MAPKAPK2;STAT3
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6324464178394646,1.05611708181645,0.4125,1.0,1.0,7/16,16.47%,PRKACA;NR4A3;KCNQ1;PDE4B;GNB1;LRRK2;MAPK1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.5061849797407887,1.056095084907872,0.37373737373737376,1.0,1.0,32/193,15.62%,TBC1D20;RANBP10;VAPB;WASF3;TOR1AIP2;COG2;FAM174B;ATL1;DPYSL2;COG7;CSNK1D;NECTIN2;DIAPH1;CSNK1A1;PRKCI;ATL2;AGTPBP1;VAPA;WDR73;PPARGC1A;MTFR1;RAB18;RAB7A;ARHGEF7;CAPZB;RANBP9;PLAAT3;REEP5;MICAL3;CFL1;LRRK2;PACSIN2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.7211230408985841,1.0560628609456135,0.42028985507246375,1.0,1.0,1/5,7.80%,PPARA
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5705777728894845,1.0557882743231148,0.43209876543209874,1.0,1.0,11/35,21.57%,EPM2A;TSC2;BNIP3L;TBK1;SESN1;SLC25A4;WAC;C9ORF72;KDR;BNIP3;SPTLC1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7193826500691591,1.0557313531796921,0.3974358974358974,1.0,1.0,1/5,7.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.7150513306573705,1.0554548092292426,0.47368421052631576,1.0,1.0,1/5,24.19%,USP25
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5283282852516384,1.0553989085927151,0.3763440860215054,1.0,1.0,22/55,20.81%,ELAVL3;PCBP3;LSAMP;ADGRB3;CACNA1B;ARHGEF9;NCAM1;LIN7A;CTNNA2;SNAP25;RNF152;CADM2;ZNF536;CDH20;CNTNAP2;SGIP1;SLC1A2;NRXN1;UNC79;NLK;GRIA2;NAPB
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6069348636430139,1.0552593992310388,0.4383561643835616,1.0,1.0,3/13,12.81%,RNF34;RPS27A;MAP2K6
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4131047097395034,-1.0551256733816026,0.3076923076923077,1.0,1.0,5/29,7.23%,ZDHHC15;ZDHHC21;ARL6;RFTN1;ZDHHC3
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6093376390429142,1.0549743661947886,0.4578313253012048,1.0,1.0,3/14,15.32%,SMOC1;RAB18;ATF6
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5325596334742377,1.0549494470243672,0.40816326530612246,1.0,1.0,18/68,18.63%,NR4A3;KCNQ1;IL18;SSH1;DIAPH1;TGFB1;EGFR;RAP1B;GNB1;RIOK3;ROCK2;GNAI1;AKAP6;LRRK2;LCOR;TIPARP;GABRB1;RYR3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.6206654844228543,1.0542274332879986,0.4342105263157895,1.0,1.0,4/11,13.15%,GGA3;SCARB2;SZT2;RAB7A
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.5500327875351998,1.0541465890619803,0.4175824175824176,1.0,1.0,7/41,20.19%,CSF1;EIF2AK2;LPAR6;ELF1;TRIM5;IFIT3;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5678653505516035,1.0541465030308588,0.4,1.0,1.0,1/17,0.42%,SOD1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5669587536700023,1.053850484988139,0.40476190476190477,1.0,1.0,10/20,26.40%,PPARA;TGFB1;HIF1A;STAT3;TEAD1;SMARCA4;JUN;FOXO3;ETS1;FOS
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.5280330882758901,1.0535862656097437,0.40816326530612246,1.0,1.0,19/71,21.68%,PTPN1;TNFRSF1B;PPARA;IRS1;CNOT8;RNF152;GRSF1;HIF1A;TRIM5;INSR;LRRK2;ATF6;TWIST1;ZSWIM8;PRR5L;BNIP3;ABHD5;TP53INP1;IRS2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.4415056888274054,-1.0535766096484707,0.375,1.0,1.0,2/19,2.99%,ZDHHC15;ZDHHC21
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.6620868055569601,1.0535242216665526,0.48,1.0,1.0,2/7,18.08%,TDG;RPA1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6664714475282543,1.0534131133023876,0.4473684210526316,1.0,1.0,2/6,24.02%,SENP1;SENP2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6668158834023588,1.0533377940269535,0.44155844155844154,1.0,1.0,3/8,14.53%,IRS1;PDK3;PDK4
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6524789420938595,1.053304631973871,0.45569620253164556,1.0,1.0,1/9,1.24%,CHST11
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.6479308492944995,1.0531936229925725,0.475,1.0,1.0,4/11,18.53%,DDX3X;HIF1A;RIOK3;ARF1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6088549835951138,1.0529499785101832,0.47058823529411764,1.0,1.0,2/15,2.37%,PARVB;RHOJ
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6695291227798621,1.0529204408164088,0.4383561643835616,1.0,1.0,1/9,2.70%,FMN2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.635615451632279,1.0529100765576496,0.4588235294117647,0.9992977576960604,1.0,7/17,16.35%,SLC23A2;SLC38A4;SLC38A9;SLC16A7;SLC13A3;SLC36A4;SLC38A10
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5210415467774352,1.0528887707521006,0.3958333333333333,0.9985744482885369,1.0,20/81,21.37%,PRKACA;TUBA1A;CCP110;PSMB1;PSMB2;ZFP36L2;CSNK1D;BTRC;PSMA7;RPS27A;CEP57;PSMA4;CEP70;PSMD14;ANAPC4;PAFAH1B1;CNTRL;SKP1;CEP290;YWHAG
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.615914920276638,1.0527330045173269,0.3670886075949367,0.9984078078090619,1.0,3/16,15.56%,DDX3X;CSDE1;C9ORF72
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.5023331429407791,1.052461819823904,0.43617021276595747,0.9985586259236627,1.0,19/74,16.19%,HSPA4L;DDIT4;CCP110;PITPNC1;SLC35D1;TGFB1;TP63;KIF13B;ZBTB16;PTPRE;SLC3A2;SESN1;MXD4;MDM2;APAF1;ELP1;ACVR1B;DRAM1;WWP1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.6589073044371649,1.05235336737983,0.4583333333333333,0.9981703964951146,1.0,1/7,10.13%,PPARGC1A
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.629953695859487,1.0521293376389955,0.47368421052631576,0.9981786498155768,1.0,2/11,3.68%,NR4A3;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6453500688991857,1.0521119038884674,0.4230769230769231,0.9974511433913086,1.0,3/10,11.04%,HDAC2;ADAM17;HIF1A
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5145120387691398,1.0517660978359005,0.42424242424242425,0.9980370165307366,1.0,23/91,19.68%,TSC2;DHRS3;AMFR;PTPN1;SIK2;NCAM1;UGCG;TGFB1;RGS5;GALNT11;ELF1;RUNX1;FGFR2;TRIM5;LRRK2;IGFBP2;BRAP;PTPN2;PRNP;CBFB;LIFR;UBASH3B;GIT2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.6926286942537476,1.051744197595826,0.4857142857142857,0.9973423558787501,1.0,2/6,14.72%,MICAL3;CFL1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.40748624017881385,-1.051269616052731,0.3333333333333333,1.0,1.0,6/26,10.86%,VIT;ATM;FBLN2;CXCL12;ZFHX3;MAGI1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.6085535782262946,1.0510943882619943,0.475,0.9982985879683666,1.0,8/17,22.52%,NDUFB9;NDUFV1;COX6C;NDUFS2;NDUFB2;COX4I1;NDUFS1;COX10
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.6085535782262946,1.0510943882619943,0.475,0.9982985879683666,1.0,8/17,22.52%,NDUFB9;NDUFV1;COX6C;NDUFS2;NDUFB2;COX4I1;NDUFS1;COX10
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.5024381163675955,1.050463522507311,0.37755102040816324,0.9998197301419463,1.0,28/119,17.08%,CSNK1G2;MCC;DDX3X;PSMB1;AMFR;UBAC2;PSMB2;CSNK1D;STK4;BTRC;CSNK1A1;PSMA7;TGFB1;EGFR;CTNND2;SMURF2;PSMA4;BICC1;FGFR2;TMEM64;LRRK2;IGFBP2;PSMD14;RBX1;LATS2;TNKS;LGR4;HECW1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.5568768044640422,1.0497003507603049,0.44086021505376344,1.0,1.0,2/30,6.87%,CCP110;DCDC1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6442666283168967,1.0494830228666612,0.5063291139240507,1.0,1.0,2/8,12.25%,SEMA4D;SEMA3B
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5587530230326774,1.0492420939176872,0.4457831325301205,1.0,1.0,6/21,16.53%,PTPRD;ROBO2;SYNDIG1;NLGN1;LRFN5;NRXN1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6824582796260925,1.0488297565003266,0.3918918918918919,1.0,1.0,4/7,18.50%,GNPAT;NCEH1;PLAAT3;PAFAH1B1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5836069988099434,1.0486440697664898,0.4358974358974359,1.0,1.0,6/15,26.94%,AP2A1;TGFB1;SNX25;AP2B1;AP2M1;CLTC
prerank,MSigDB_Hallmark_2020__Complement,0.5240550418233666,1.0482877258806855,0.3763440860215054,1.0,1.0,19/65,23.12%,USP15;RAF1;CPM;F3;C1R;CTSL;CEBPB;CP;ZFPM2;LIPA;CFH;HSPA5;LGALS3;CA2;DOCK4;DGKH;GRB2;MT3;LAMP2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6458446039209421,1.0482429078203965,0.5,1.0,1.0,2/12,3.71%,GRIN1;ANK3
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5194609116305953,-1.0478018890750733,0.4,1.0,1.0,1/14,1.66%,FGF1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.4990199615902409,1.0477489017113804,0.3958333333333333,1.0,1.0,24/105,16.47%,PLAA;KCNC2;NR4A3;KCNQ1;CAMKK2;PDE4B;SSH1;CTR9;IPO5;SLC38A9;TNFRSF1B;SELENOS;EGFR;IRS1;RAP1B;GNB1;ADNP2;PDK3;ROCK2;AKAP6;PDK4;LCOR;CPEB4;MAPK1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.696667894815251,1.0476876108364743,0.4358974358974359,1.0,1.0,3/5,23.22%,GBE1;PHKB;UGP2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.5599559315710949,1.047467424056396,0.42168674698795183,1.0,1.0,8/25,20.27%,CSF1R;FLT1;EGFR;FGFR2;INSR;KDR;ABL2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.6405221584124938,1.0471200126268128,0.4594594594594595,1.0,1.0,1/8,2.82%,PTPRD
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5416453549610758,1.0469631443355698,0.43333333333333335,1.0,1.0,9/34,20.64%,PRKACA;KCNQ1;ATP1B3;ABCC9;PDE4D;RYR3;SMAD7;CAMK2D;AHCYL1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.6057703996648915,1.046938626263257,0.5058823529411764,1.0,1.0,2/16,9.31%,TBK1;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6802823183337982,1.0469215209043472,0.4625,1.0,1.0,3/9,19.01%,CCT4;CORO2B;CCT3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.5732669015841912,1.0468683524333793,0.425,1.0,1.0,3/23,8.45%,XPO4;IPO5;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7149846979744828,1.0468430825624178,0.463768115942029,1.0,1.0,2/5,13.46%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.5077504921619691,1.0466580034808592,0.3469387755102041,1.0,1.0,8/74,8.51%,RIPOR1;MICALL2;ANK3;XPO4;TMEM30A;IPO5;TGFB1;TP63
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.5462065411251689,1.0464682782865575,0.4827586206896552,1.0,1.0,8/38,13.46%,DDX3X;RAF1;RUBCN;CRACD;TRAF3IP1;WASHC2C;RIOK3;HSPA5
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6474855445324884,1.0463183444742115,0.43373493975903615,1.0,1.0,2/10,20.55%,TMCO1;CAMK2D
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4843361244304127,1.0462085781160482,0.32,1.0,1.0,44/197,20.78%,CSNK1G2;PRKACA;PANK2;PDK1;DCLK1;SIK2;CAMKK2;DGKI;CSNK1D;PRKCB;STK4;CSNK1A1;EIF2AK2;MAPK6;PRKCI;TBK1;TGFB1;OXSR1;AGK;NRBP1;EPHA7;EIF2AK4;PDK3;MELK;ROCK2;GK5;MAPKAPK2;STAT3;PGK1;PDK4;MAK;INSR;LRRK2;ACVR1B;ACVR2A;LATS2;MAPK1;MAP2K1;STK39;CSNK2A1;NLK;ABL1;CAMK2D;DGKH
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.6037854510141158,1.0461906416140343,0.48717948717948717,0.999381343888286,1.0,8/19,26.40%,DDIT4;EFNB2;EPHA7;GRIN2B;PRNP;NF1;FOXO3;FOS
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.4989363117348216,1.045972925299546,0.3979591836734694,0.9992722816869505,1.0,23/104,17.25%,PLAA;NEDD4L;PSMB1;RHBDD1;ZNRF1;PSMB2;PELI1;BTRC;PSMA7;MARCHF6;RNF34;CLOCK;TRIM9;SMURF2;PSMA4;SIAH1;MDM2;PSMD14;RBX1;WWP1;ZSWIM8;HECW1;APPBP2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6093203826063714,1.0459262381968655,0.4367816091954023,0.9986447230078488,1.0,3/17,14.36%,AGO2;CNOT8;MOV10L1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.6183841089540258,1.0458415013648026,0.5,0.9981883037806232,1.0,6/11,21.43%,NEDD4L;FHL1;SLC4A10;AP3D1;CAMK2D;UNC80
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.6634639440940661,1.0458101146643353,0.45569620253164556,0.9976243726152423,1.0,1/9,1.40%,GJA1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7084497301027757,1.0457151198189831,0.4666666666666667,0.9972543917898474,1.0,3/7,20.38%,KDM1A;FZD3;NAP1L1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4488792476162775,-1.045281163735384,0.3333333333333333,1.0,1.0,4/11,21.96%,MRPL1;ZNHIT6;RPL35;RPL10A
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5567486959006023,1.0452716977435235,0.43478260869565216,0.9981275043200308,1.0,8/36,20.27%,DDX3X;CSF1R;CCNH;MTCP1;MAP2K1;CDKN1B;CCNK;ABL1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.5854787737813829,1.0451731079823177,0.49411764705882355,0.9977345695773141,1.0,5/21,20.52%,WIPI1;AMBRA1;WDR45B;MAP1LC3B;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.6118327603945226,1.0449571731950853,0.36046511627906974,0.9978585216981707,1.0,3/17,10.41%,WWC1;WWC2;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7110254023423097,1.0448738891581593,0.4925373134328358,0.9974586922996064,1.0,2/5,17.35%,PPARGC1A;PTPN2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6088625286108681,1.0448194998381817,0.4936708860759494,0.9968825105590448,1.0,4/10,28.07%,LPAR6;PTH1R;GRM5;TACR1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6234476927553846,1.044647585258074,0.4578313253012048,0.9969145709020386,1.0,4/16,20.67%,CCT4;TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.7122647602210738,1.044482742588948,0.43478260869565216,0.9968236657149727,1.0,1/5,3.19%,NR4A3
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6440497886823168,1.0444022267266102,0.44155844155844154,0.9963874587800609,1.0,3/8,15.00%,GRIN1;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5023378912678638,1.0443949356639923,0.41,0.9956604321232475,1.0,27/153,14.87%,CSF1;S1PR3;GJA1;HDAC2;NRG1;KDM1A;NR4A3;EAPP;CSF1R;IL18;FLT1;PRKCI;CCAR1;ADAM17;TGFB1;EGFR;IRS1;EFNB2;CNOT8;CDC123;SDCBP;PRLR;ZFPM2;TBX3;MDM2;FGFR2;INSR
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6177602221311481,1.0443150013347338,0.42857142857142855,0.9951491242269264,1.0,3/12,5.32%,KCNE4;KCNQ1;ATP1B3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5851968365100264,1.0435162086980543,0.4588235294117647,0.9971660498417011,1.0,7/34,16.41%,WWC1;SLC7A2;EFNB2;SHC2;ARFGEF3;TEAD1;CKB
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.6962947101922745,1.0434016221152818,0.4666666666666667,0.9968610105207216,1.0,2/6,12.39%,NDFIP2;NDFIP1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.6208868599826026,1.0430061245799143,0.47435897435897434,0.9976194150244908,1.0,1/11,2.47%,RAD21
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.6456261043344568,1.0428755639987444,0.4444444444444444,0.9975055332755948,1.0,5/11,24.81%,ACADVL;ACADL;PDK4;ELOVL5;WDTC1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6276655501625099,1.042633096734665,0.4358974358974359,0.9975445393305221,1.0,2/10,5.32%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.6542235659921687,1.0425144394138761,0.4533333333333333,0.9972477666654145,1.0,4/11,20.05%,PRKACA;C12ORF57;MYL3;SMAD7
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.6866933632963743,1.0424704363400665,0.42424242424242425,0.9965854797784502,1.0,2/5,20.27%,ZFP36L2;ABL1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.5370361145112018,1.0424357541794282,0.46808510638297873,0.9959699041311987,1.0,10/51,13.21%,GRIN1;ACTR3;AP2A1;ANKS1B;EFNB2;EPHA7;SDCBP;GRIN2B;ROCK2;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6385877366566595,1.0421717777617112,0.4691358024691358,0.9962992346790278,1.0,5/10,22.08%,STMN1;HEG1;SCAI;ABL2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.6043509305666057,1.042120058752167,0.4430379746835443,0.9956543754656553,1.0,3/11,16.11%,CSF1R;ADAM17;TWIST1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.6056754546865601,1.0419968677490297,0.47619047619047616,0.995246126732858,1.0,2/13,8.48%,CSNK1D;NUDCD3
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4851031809210862,-1.0419146164259097,0.38095238095238093,1.0,1.0,2/9,3.57%,MAPK14;HDAC9
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.5733779883188267,-1.0414601256364595,0.4090909090909091,1.0,1.0,1/7,0.48%,FGF13
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6373657246406594,1.0413506148434297,0.45569620253164556,0.9969120699379606,1.0,1/8,4.26%,NUP153
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6093871893971778,1.0412008191974342,0.4166666666666667,0.9966856445561164,1.0,6/18,24.40%,GGA3;ROCK2;RTN3;PRNP;SP1;RTN1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3516641189158461,-1.0411894084597146,0.4166666666666667,1.0,1.0,2/40,1.16%,SPRY3;SPRY1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.49009972670287727,1.0410586546963068,0.33,0.9963382140844089,1.0,75/399,20.27%,NELL1;WWC1;CSF1;HNRNPL;PRDM6;GJA1;PCBP3;DDX3X;ZC3H7B;ANK3;RAB27A;RIMS2;SUFU;AGO2;HCFC2;WWC2;NOS1AP;FUBP1;CTR9;NDFIP2;HNRNPF;IGF2BP2;PRDM10;ESR2;YAF2;DNMT1;CCAR1;TGFB1;APBB1;ROBO1;ZC3H7A;PTBP2;CLOCK;F3;PPARGC1A;NFKBIZ;GRSF1;HIF1A;ADNP2;MTF2;CEBPB;ZNF536;PTRH2;NDFIP1;ROCK2;FUBP3;CREM;BCL6;RUNX1;CAMK2N1;STAT3;TRIM5;SRSF10;INSR;ACVR1B;TTN;TWIST1;MAPK1;TIPARP;MZF1;KDM6A;MAP2K1;TDG;PLAG1;PER1;NOVA1;AFF4;SLC22A2;RBPJ;KDR;C1QTNF1;SP1;UBR5;NLK;ABL1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6860231287719518,1.0409695027466541,0.47435897435897434,0.996014040873968,1.0,2/6,15.65%,SLC23A2;SLC1A2
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5527048144318367,1.040830677586826,0.4659090909090909,0.9949661009962807,1.0,12/31,28.21%,CTR9;CCNH;AFF4;RTF1;MLLT1;CCNK;SUPT16H;ELL;POLR2F;ELOB;SETD2;ELP2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.5527048144318367,1.040830677586826,0.4659090909090909,0.9949661009962807,1.0,12/31,28.21%,CTR9;CCNH;AFF4;RTF1;MLLT1;CCNK;SUPT16H;ELL;POLR2F;ELOB;SETD2;ELP2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.5005862166747612,1.0404521360614913,0.38,0.9954829960942563,1.0,32/198,14.87%,CSF1;S1PR3;HDAC2;GRIN1;DDX3X;NRG1;EAPP;RAB27A;CSF1R;RNF10;FLT1;TNFRSF1B;CCAR1;ADAM17;FRMD5;TGFB1;EGFR;IRS1;EFNB2;CNOT8;CDC123;SDCBP;ADNP2;CCN2;PRLR;ANKRD17;TBX3;MDM2;AKAP6;FGFR2;PPP3CA;INSR
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6341124259837784,1.0399682092546094,0.4603174603174603,0.9963844572030586,1.0,2/9,12.64%,GRIK2;SLC4A10
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.6720759555419576,1.0399523013061862,0.4852941176470588,0.9957066107990209,1.0,2/6,23.08%,SLC39A11;MT3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5518189856916511,1.039764777167689,0.4050632911392405,0.9956106965119738,1.0,8/26,23.08%,DDIT4;EFNB2;GRIN2B;LRRK2;PRNP;CDKN1B;BNIP3;MT3
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.4681479316828068,-1.0394066581287194,0.4,1.0,1.0,1/10,0.56%,IL34
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5022203244145704,1.039270320460286,0.42,0.9965401959775222,1.0,35/199,14.87%,CSF1;COL4A6;ATP6V1G1;GRIN1;TSC2;ATP6V1H;NRG1;MPZL1;DDIT4;NR4A3;ACTR3;AP2A1;CSF1R;FLT1;GIGYF2;HNRNPF;STMN1;ANKS1B;EGFR;IRS1;EFNB2;ATP6V1E1;EPHA7;SHC2;SDCBP;CEP57;GRIN2B;PRLR;ROCK2;ARHGEF7;MAPKAPK2;STAT3;PDK4;FGFR2;INSR
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5234857464003172,1.0387767140949142,0.4731182795698925,0.997460773971675,1.0,7/44,8.45%,CD44;ITGA5;PTPN1;CSF1R;SEMA4D;IL18;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5520482572643599,1.0387741832973492,0.4235294117647059,0.9967164002597559,1.0,6/29,20.84%,DDX3X;RNF34;UNC5B;TNFRSF10B;LGALS3;ITGAV
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.620783766703347,1.0381300062984224,0.47368421052631576,0.9986057973838527,1.0,4/12,20.55%,KCNQ1;MYL3;TTN;CAMK2D
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4948812313907316,1.0380638322828535,0.4020618556701031,0.9980646194306801,1.0,22/90,21.17%,CSNK1G2;PRKACA;NAA11;CSNK1D;PRKCB;STK4;CSNK1A1;PRKCI;TBK1;PDK3;UHMK1;ROCK2;MAPKAPK2;LRRK2;LATS2;TNKS;MAPK1;STK39;CSNK2A1;CAMK2D;MAPKAPK5;RPS6KA2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4919060984918853,1.0377992508883196,0.38,0.998185187767499,1.0,50/244,19.91%,SCML1;TAF7;HDAC2;DDX3X;NRG1;KDM1A;CBFA2T2;CD38;BASP1;ENO1;CRY1;NIBAN2;GIGYF2;SNX6;IGF2BP2;BTRC;EIF2AK2;YAF2;SELENOS;CTBP2;TGFB1;TP63;CNOT8;CLOCK;RCOR1;ZBTB16;EIF4ENIF1;SIN3A;ZFPM2;SMURF2;DEAF1;TSHZ3;BCL6;TBX3;MDM2;EED;MBD2;TWIST1;WWP1;ZBTB7A;PDCD4;LOXL3;PER1;ZHX3;SMAD2;SMARCA4;MBTD1;RBPJ;FOXP2;CDKN1B
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.5928372030717465,-1.0373639456973085,0.55,1.0,1.0,3/11,2.43%,BCL2L11;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6313589570045092,1.0372405271183263,0.4625,0.9993788056538705,1.0,1/13,1.54%,PRKACA
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.6265284283053248,1.0368933834349237,0.47058823529411764,0.9997157036292507,1.0,4/12,22.80%,ENO1;PGK1;HK1;TPI1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.718601206485155,1.0368419854420987,0.5066666666666667,0.9991303456597047,1.0,1/7,1.27%,TPT1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6140579839157627,1.036167832213826,0.47560975609756095,1.0,1.0,7/19,23.91%,AGO2;GNB1;FZD3;PPP3CA;NLK;LEF1;GNAO1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.6106194777296851,1.0357165842905662,0.5057471264367817,1.0,1.0,5/14,21.23%,ITGA5;DUSP1;COL7A1;ITGAV;COL11A1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.5162825653107624,1.0349954371315018,0.42391304347826086,1.0,1.0,15/69,15.00%,PLAA;PANK2;PTPRD;MINPP1;TGFB1;PPA1;AGK;EPHA7;GK5;PLAAT3;STAT3;PGK1;FRA10AC1;PPP3CA;LRRK2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6388257538673283,1.0345996081562812,0.4691358024691358,1.0,1.0,1/10,3.72%,RAB27A
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6329030116792417,1.0343748415764256,0.3974358974358974,1.0,1.0,4/13,25.45%,IRS1;MYO16;NF1;PLEKHA1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.6843670448549493,1.0339970882721636,0.47368421052631576,1.0,1.0,2/6,19.84%,FADS2;ELOVL5
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6010865120959084,1.033954525788452,0.4430379746835443,1.0,1.0,2/13,6.58%,HS3ST5;NECTIN2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6387577905459043,1.033881695888279,0.44871794871794873,1.0,1.0,3/9,15.00%,GRIN1;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.49934709181034453,1.0337691608738107,0.5054945054945055,1.0,1.0,18/69,20.56%,PSMB1;PSMB2;RC3H2;ZFP36L2;IGF2BP2;PSMA7;CNOT8;RPS27A;ELAVL1;DCP2;PSMA4;PABPC1;MAPKAPK2;PSMD14;DCP1A;PRR5L;DIS3;CARHSP1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.5809863760953394,1.033369865676344,0.4230769230769231,1.0,1.0,5/12,22.30%,DNAJC7;ST13;HSPA5;DNAJC18;GAK
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.45329247666083605,-1.0331382129496454,0.5,1.0,1.0,4/18,8.45%,MRPL3;MRPL33;FASTKD2;MRPL1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6314318770290767,1.0330686662805055,0.5176470588235295,1.0,1.0,4/12,19.84%,PPARA;SREBF1;SCARB1;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.540760029972906,1.032893811989283,0.42857142857142855,1.0,1.0,9/35,21.20%,RIPOR1;TGFB1;APBB1;CNST;SYTL4;EXOC1;TTN;PRR5L;CEP290
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5374008968910111,1.0324675399458474,0.42045454545454547,1.0,1.0,7/28,23.70%,TGFB1;HIF1A;ROCK2;FGFR2;LOXL3;RBPJ;LEF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.6894307181939342,1.0323696979798804,0.4666666666666667,1.0,1.0,4/8,21.68%,IRS1;STAT3;SMARCA4;IRS2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.6894307181939342,1.0323696979798804,0.4666666666666667,1.0,1.0,4/8,21.68%,IRS1;STAT3;SMARCA4;IRS2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6114715612343913,1.0323110070821564,0.4189189189189189,1.0,1.0,4/13,16.00%,TGFB1;EGFR;STAT3;LCOR
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.5828848790251533,1.0322123333164954,0.5,1.0,1.0,5/17,16.78%,IL18;TGFB1;STAT3;LRRK2;TIPARP
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.6595164883772542,1.0316302714528538,0.5,1.0,1.0,2/7,18.19%,EIF2AK4;PRNP
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6621195018998677,1.031024857216885,0.4583333333333333,1.0,1.0,1/6,1.40%,GJA1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.47986973155090495,1.0305199565683687,0.45,1.0,1.0,67/297,21.25%,SOD1;CD44;TPT1;RHOB;HDAC2;DDX3X;NFKBIA;FMN2;MYDGF;CD38;RHBDD1;MTCH2;RAF1;NIBAN2;SEMA4D;STK4;ARHGEF9;APIP;NAIP;PRKCI;CCAR1;BNIP3L;MCF2L;TP63;APBB1;EGFR;WDR73;RPS27A;TMBIM6;SRA1;PRLR;MELK;MADD;NAA38;ARHGEF7;BCL6;HSPA5;IFT57;TBX3;SIAH1;APAF1;CFL1;SLK;PAWR;NF2;ATF6;TNFRSF10B;ARHGEF4;ANKRD13C;LATS2;ZBTB7A;NAA15;ARF4;IFIT3;DNAJA1;GLO1;FBXO11;AREL1;ANGPTL4;VAV3;KDR;ABL1;BNIP3;LANCL1;NF1;RPS6KA2;TP53INP1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3666301129858057,-1.0304823006194619,0.3333333333333333,1.0,1.0,19/81,10.86%,FAT1;FAM13C;SLIT2;DKK3;LMOD1;PDZRN3;GPC6;DZIP1;EML1;PTPN21;NFASC;SEMA6D;EDNRA;CSRNP3;ZNF423;EDIL3;ADCY6;GLI2;MAGI1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5003315301574158,1.0304195752960525,0.4725274725274725,1.0,1.0,15/64,16.95%,CSNK1G2;DDX3X;PSMB1;PSMB2;CSNK1D;PSMA7;TGFB1;EGFR;SMURF2;PSMA4;FGFR2;LRRK2;PSMD14;TNKS;LGR4
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5809072081650009,1.030134830250791,0.4457831325301205,1.0,1.0,4/15,11.91%,GRIN1;LRRC7;GRIN2B;NLGN1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6478274637985744,1.0300164622130175,0.4155844155844156,1.0,1.0,6/10,25.84%,DCUN1D4;DCUN1D1;SMAD7;ABL1;DCUN1D2;UBE2L3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6530196641580563,1.0300127282874396,0.47297297297297297,1.0,1.0,3/7,20.60%,NAA11;NAA15;METAP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.6821257322641506,1.0299965077963376,0.5138888888888888,1.0,1.0,3/6,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6721007715103369,1.0298240638020966,0.4492753623188406,1.0,1.0,1/6,1.61%,NAXD
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.5177134212603501,1.029652924859224,0.4431818181818182,1.0,1.0,13/52,27.47%,DNAJC6;AP2A1;EXOC1;SORCS1;ARF1;SNAP23;GOPC;STXBP6;EPS15;DNM2;CLTC;OSBPL5;RAB14
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.609682721121282,1.0292811843224996,0.44871794871794873,1.0,1.0,3/15,14.13%,KCNQ1;RAP1B;AKAP6
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.5219669996950884,1.0291893459553003,0.5157894736842106,1.0,1.0,13/40,20.84%,CSF1R;SEMA4D;SLC2A1;EFNB2;HIF1A;CST3;LRRK2;CEBPD;ZBTB7A;ABCA1;PTH1R;CA2;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5806206485254963,1.0290631969277,0.47619047619047616,1.0,1.0,3/18,15.00%,CCP110;NBDY;LRRK2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.6168390822031372,1.0288048529284022,0.4125,1.0,1.0,3/14,16.02%,KCNQ1;MYL3;TTN
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6075656994142523,1.028657927006958,0.4823529411764706,1.0,1.0,1/16,0.39%,HS3ST5
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.4550708588615906,-1.028526605574145,0.3333333333333333,1.0,1.0,2/17,2.43%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.6840019120465789,1.0284802637132746,0.44155844155844154,1.0,1.0,3/5,27.85%,SMCHD1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6564565715191624,1.028172709089835,0.5263157894736842,1.0,1.0,2/8,20.84%,HIF1A;ITGAV
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.6087549680579215,-1.0278842797482477,0.5217391304347826,1.0,1.0,2/7,12.70%,COL5A2;SKI
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4180833671573007,-1.0277958113383725,0.5555555555555556,1.0,1.0,5/40,5.24%,SPRY3;SPRY1;SLIT2;ATP2B4;NBL1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.5903151307396077,1.0277701420540104,0.524390243902439,1.0,1.0,5/19,20.52%,WIPI1;AMBRA1;WDR45B;MAP1LC3B;BNIP3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.5674631619548104,1.0273626259805901,0.4943820224719101,1.0,1.0,6/25,5.85%,DPP10;NEDD4L;KCNQ1;DPP6;NOS1AP;FHL1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5564001582569446,1.0271921688118293,0.4090909090909091,1.0,1.0,7/22,20.11%,OLFM2;RIMS2;ARFGAP3;RAB12;CANX;ABCA1;RAB8B
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6384573013676722,1.026812401042568,0.5058823529411764,1.0,1.0,2/10,7.91%,OS9;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6841004938872401,1.0266231763075127,0.4782608695652174,1.0,1.0,1/5,8.82%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6841004938872401,1.0266231763075127,0.4782608695652174,1.0,1.0,1/5,8.82%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.49036129259734534,1.0265016178804967,0.47474747474747475,1.0,1.0,14/86,16.39%,NFKBIA;KDM1A;IL18;PRKCB;ESR2;EIF2AK2;PRKCI;CLOCK;RPS27A;PPARGC1A;STAT3;TRIM5;TP53BP1;ZBTB7A
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5826497321488314,1.0257269731904437,0.42168674698795183,1.0,1.0,2/14,14.42%,CTR9;STAT3
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.6563407899407856,1.0256550637767756,0.525,1.0,1.0,3/7,23.08%,ACADL;PLAAT3;MT3
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6823597059581242,1.025648720949992,0.5138888888888888,1.0,1.0,2/5,19.18%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6823597059581242,1.025648720949992,0.5138888888888888,1.0,1.0,2/5,19.18%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6296944858155653,1.0252380630157913,0.4935064935064935,1.0,1.0,4/10,23.22%,GBE1;PHKB;MT3;UGP2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.44462323394203684,-1.0251153387176581,0.38095238095238093,1.0,1.0,1/16,0.33%,CAV2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5882272092074768,1.0251142794551715,0.4935064935064935,1.0,1.0,3/15,5.85%,NEDD4L;ATP1B3;FHL1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6924744744874696,1.0249731152838166,0.5072463768115942,1.0,1.0,3/5,22.52%,COX6C;COX4I1;COX10
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5455053185286372,1.0247160415136298,0.4782608695652174,1.0,1.0,10/41,16.28%,NELL1;PRKACA;SUFU;SMOC1;SEMA4D;TP63;FGFR2;TMEM64;TWIST1;ACVR2A
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7000512694496969,1.0247081850409294,0.5,1.0,1.0,3/5,20.75%,GRIN1;CPEB4;GRIA2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5400917400612174,1.024574920061418,0.4673913043478261,1.0,1.0,7/39,13.34%,MUCL1;DPM1;TET3;C1GALT1;GALNT15;GALNT11;GALNT7
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.611406016511329,1.024534747394004,0.4927536231884058,1.0,1.0,6/10,33.86%,PEX3;RAB8B;SLC25A17;ATAD1;ALDH3A2;ABCD3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.5101011465415343,1.0245103532394808,0.4791666666666667,1.0,1.0,20/69,23.14%,ANKH;ETV5;TOR1AIP2;EMP1;TNFRSF1B;ADAM17;SNAP25;PTBP2;GLRX;GYPC;SEMA3B;CFH;CA2;ANGPTL4;MAP7;DCBLD2;TFPI;ALDH1A2;BTBD3;RABGAP1L
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.5821617160598815,1.0243840029607432,0.43333333333333335,1.0,1.0,4/18,21.68%,DDX3X;ABCA1;ABHD5;IRS2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.5739484394263996,-1.0243732697631887,0.4166666666666667,1.0,1.0,1/7,1.10%,CD4
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.5739484394263996,-1.0243732697631887,0.4166666666666667,1.0,1.0,1/7,1.10%,CD4
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.6615241286793103,1.024370058291255,0.48717948717948717,1.0,1.0,2/5,25.57%,ERC2;KIF1B
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4884820165078152,1.0238692761956292,0.45,1.0,1.0,43/200,19.91%,SCML1;TAF7;HDAC2;NRG1;KDM1A;CBFA2T2;CD38;BASP1;ENO1;CRY1;NIBAN2;SNX6;BTRC;YAF2;CTBP2;TGFB1;TP63;CLOCK;RCOR1;ZBTB16;SIN3A;ZFPM2;SMURF2;DEAF1;TSHZ3;BCL6;TBX3;MDM2;EED;MBD2;TWIST1;WWP1;ZBTB7A;PDCD4;LOXL3;PER1;ZHX3;SMAD2;SMARCA4;MBTD1;RBPJ;FOXP2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.6027346751698315,1.023710581231392,0.5176470588235295,1.0,1.0,5/13,14.13%,KCNQ1;NOS1AP;FHL1;GNB1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.671344734320127,1.0229659394980464,0.5333333333333333,1.0,1.0,4/7,30.30%,CAMKK2;SLC25A4;VPS13D;VDAC1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.5388269868593933,1.0229638204576355,0.4942528735632184,1.0,1.0,6/30,18.08%,RAD21;MORF4L1;FAN1;PSMD14;ZSWIM7;RPA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.5667089376794441,1.022587082663339,0.42528735632183906,1.0,1.0,4/24,14.35%,CCP110;YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.6328104980530378,1.0224664690838325,0.5,1.0,1.0,8/9,36.79%,CDKN1B;SMAD7;ABL1;IRS2;HNRNPU;POT1;TERF1;GSK3B
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5288451834073853,1.0223000147865078,0.46808510638297873,1.0,1.0,12/37,18.19%,VAPB;TOR1AIP2;ATL1;ATL2;VAPA;RAB18;REEP5;RTN3;LRRK2;LPCAT3;REEP3;PRNP
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.5318571815671903,1.0218661954215553,0.5056179775280899,1.0,1.0,8/27,15.77%,PANK2;PSMB1;PSMB2;PSMA7;PPARA;PSMA4;PDK4;PSMD14
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.7147101499081454,1.0218466798823864,0.5362318840579711,1.0,1.0,1/5,19.12%,GLRX3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6694033726269852,1.0216195152656522,0.5,1.0,1.0,3/6,22.61%,FGFR2;TWIST1;MTHFD1L
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.6238971137431196,1.0212319247483346,0.5866666666666667,1.0,1.0,2/11,12.56%,LPIN1;ACADL
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.5592689405203792,1.021134529454216,0.47191011235955055,1.0,1.0,6/32,13.46%,OS9;AMFR;UBE2J1;SELENOS;MARCHF6;HSPA5
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4813403215174233,1.0208810995490862,0.4166666666666667,1.0,1.0,17/86,15.51%,RHOB;TSC2;NFKBIA;DDIT4;RAF1;STK4;TP63;RNF152;ZBTB16;MELK;IFT57;SIAH1;MDM2;APAF1;YARS1;PAWR;TNFRSF10B
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6755979410817353,1.0203874445205021,0.525,1.0,1.0,3/8,10.13%,NR4A3;PPARA;PPARGC1A
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.6611354346788132,1.0202246429793242,0.52,1.0,1.0,3/8,18.98%,IL18;SCARB1;ANGPTL4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.6410201072950876,1.0201962476336774,0.4864864864864865,1.0,1.0,2/6,10.75%,WNT2B;CSDE1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.688900014895464,1.0197526978437321,0.515625,1.0,1.0,2/5,17.56%,FLT1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.6759838431966982,-1.019727064542582,0.40540540540540543,1.0,1.0,1/5,0.33%,CAV2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.6166307882848459,1.0194727811665265,0.44,1.0,1.0,1/7,7.75%,ADAM17
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.4228694330096674,-1.0190713298116023,0.3333333333333333,1.0,1.0,6/30,5.47%,NRP1;LMOD1;SYNPO2;EVL;BAIAP2L2;NCK1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5452588755381058,1.0189531517826038,0.47674418604651164,1.0,1.0,6/27,13.15%,STX6;MICALL2;VPS50;EHD2;WASHC2C;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6164701298722459,1.0187548141614624,0.5301204819277109,1.0,1.0,2/15,7.80%,TSC2;PPARA
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.630960772827261,1.018549746077747,0.524390243902439,1.0,1.0,3/10,5.63%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5886095775256533,1.0185375510423416,0.5061728395061729,1.0,1.0,3/11,15.29%,USP15;BRCC3;USP3
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5598674803854429,-1.018526119572565,0.3870967741935484,1.0,1.0,3/6,13.18%,ANO6;CXCL12;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.6388456881847762,1.0184126863137517,0.5454545454545454,1.0,1.0,2/5,8.45%,CSF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5993506163693474,1.0183019352373304,0.42857142857142855,1.0,1.0,2/10,14.87%,HIF1A;INSR
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5993506163693474,1.0183019352373304,0.42857142857142855,1.0,1.0,2/10,14.87%,HIF1A;INSR
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5040605420194333,1.018062074146111,0.5102040816326531,1.0,1.0,17/64,22.72%,CSNK1G2;LPIN1;VAPB;MGST1;SGPL1;VAPA;SAMD8;LPCAT3;TYW1B;CHKA;CSNK2A1;ACER3;ELOVL5;CERS6;SPTLC1;SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5017755509018174,-1.0180440000299935,0.38095238095238093,1.0,1.0,4/13,11.88%,SYNPO2;SLC9A1;CDC42;ACTG1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5723648446960096,1.0179711230163453,0.5189873417721519,1.0,1.0,4/17,13.52%,UBA5;KDM1A;UFSP2;RUNX1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5262546256748328,1.0179141302661283,0.5106382978723404,1.0,1.0,8/43,16.75%,DDIT4;WIPI1;SEC11A;CEBPB;DCP2;HSPA5;ATF6;DCP1A
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6147353731151203,1.0176604893388737,0.4857142857142857,1.0,1.0,6/9,33.86%,PEX3;RAB8B;SLC25A17;ATAD1;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6084229389336735,1.0176446048586054,0.5060240963855421,1.0,1.0,1/13,1.54%,PRKACA
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6569171655468026,1.017562283336807,0.5194805194805194,1.0,1.0,3/7,23.62%,GLUL;GLUD1;GCLC
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.5546801730823789,-1.0174230669179463,0.5,1.0,1.0,2/7,5.24%,SLIT2;NBL1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.6337121031951666,1.0172516118309352,0.48717948717948717,1.0,1.0,5/12,21.20%,TENM3;C12ORF57;FBN1;NF1;CEP290
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.5871948310285432,-1.0169906155804658,0.41935483870967744,1.0,1.0,1/5,2.11%,ERCC6
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5690423701791354,1.0168578509168729,0.5121951219512195,1.0,1.0,4/17,13.15%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6148959345524823,1.0168088975191338,0.46835443037974683,1.0,1.0,3/10,10.79%,TGFB1;PTBP2;TMBIM6
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.5142813290697154,1.0166352050250522,0.46153846153846156,1.0,1.0,11/66,13.97%,PPME1;AKAP8;PRKACA;TUBA1A;CCP110;CSNK1D;BTRC;CEP57;MELK;CCNH;CEP70
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.4919490222733242,1.016478143077431,0.5168539325842697,1.0,1.0,18/78,16.75%,PSMB1;PSMB2;RC3H2;ZFP36L2;GIGYF2;IGF2BP2;PSMA7;RPS27A;ELAVL1;EIF4ENIF1;ROCK2;DCP2;PSMA4;PABPC1;MAPKAPK2;METTL14;PSMD14;DCP1A
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5843908516797293,1.0162623308650434,0.475,1.0,1.0,3/17,14.13%,KCNQ1;RAP1B;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.6848825920661596,1.0159989276996326,0.5131578947368421,1.0,1.0,3/5,20.72%,SREBF1;SCARB1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5464432672377474,1.015845098017946,0.5113636363636364,1.0,1.0,8/28,20.53%,DPP10;PRKCI;EGFR;PTPN9;GNAI1;ZDHHC5;LGALS3;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5674726541156845,1.0154975759946687,0.5357142857142857,1.0,1.0,2/20,7.46%,SOD1;XRCC4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.621947566652669,1.0154279349482227,0.5121951219512195,1.0,1.0,3/12,16.33%,SUFU;SIN3A;LATS2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7032419933346863,1.0153206292287946,0.5256410256410257,1.0,1.0,3/5,20.05%,RC3H2;NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.6501587104254398,1.0146774220684183,0.5324675324675324,1.0,1.0,2/7,13.40%,MORF4L1;EP400
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.5463998930457478,1.0144525065923973,0.45348837209302323,1.0,1.0,4/24,11.80%,ATP6V1G1;ATP6V1H;ATP6V1E1;CP
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.5945471985842026,1.0139104707511835,0.47191011235955055,1.0,1.0,9/20,27.85%,KDM1A;FMN2;SPIRE1;TWIST1;UBR5;TRIP12;SPIDR;SETD2;SHLD2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.4166752354768388,-1.0138380616122755,0.391304347826087,1.0,1.0,2/15,2.31%,CTNNA3;CACNA1D
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.49412615636172547,1.013606903799194,0.5154639175257731,1.0,1.0,24/120,15.90%,CSF1;PLAA;RIPOR1;AGO2;CSF1R;SEMA4D;FLT1;CCAR1;ADAM17;SOD2;TGFB1;EGFR;F3;SDCBP;HIF1A;SEMA3B;SMURF2;ROCK2;ARHGEF7;HSPA5;STAT3;PPP3CA;INSR;ACVR1B
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5912872489443332,1.0133594671900963,0.5526315789473685,1.0,1.0,5/15,16.24%,IPO5;SLC38A9;UBR1;SESN1;CPEB4
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5341406099175927,1.013329246385465,0.5060240963855421,1.0,1.0,15/42,20.13%,SLC22A6;ATP5MK;ACOT11;ALDH1L1;PPARA;SLC16A7;PPARGC1A;LARP1B;CYP3A5;INSR;ABO;CPEB4;SLC22A2;ADGRF5;MAP7
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.6474125834769697,1.0130282638014998,0.5526315789473685,1.0,1.0,3/9,18.98%,IL18;SCARB1;ANGPTL4
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.6457206514764262,1.0128258699324775,0.5526315789473685,1.0,1.0,1/7,7.80%,PPARA
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.57780093681841,1.012708891941836,0.4375,1.0,1.0,2/16,14.42%,CTR9;STAT3
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.6166089225893346,1.0126949627357889,0.5294117647058824,1.0,1.0,4/11,11.23%,SOD1;GRIN1;TGFB1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6217322823254045,1.012564884457478,0.5128205128205128,1.0,1.0,4/13,20.55%,NR4A3;ROCK2;AKAP6;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6589386977584291,1.012312340932746,0.5142857142857142,1.0,1.0,4/7,30.20%,PRKAR2A;PRKAR1A;PRKAR1B;PKIG
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5164375195560622,1.01210109316027,0.4574468085106383,1.0,1.0,13/43,23.09%,SOD1;CAMKK2;CSF1R;FLT1;EGFR;EPHA7;FGFR2;INSR;TTN;KDR;CDKN1B;IRS2;AXL
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5801345837701344,1.012042374631812,0.4657534246575342,1.0,1.0,6/15,22.47%,NEDD4L;FHL1;TCAF1;STK39;AHCYL1;FGF12
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6239326765649765,1.0117445247154684,0.550561797752809,1.0,1.0,4/10,21.45%,TAPT1;HSPA5;SKP1;HK1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5883543540234735,1.011710603414006,0.46987951807228917,1.0,1.0,4/19,15.63%,PARVB;WASF1;ARHGEF7;ARHGEF4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6083765844409247,1.011591697069727,0.5063291139240507,1.0,1.0,4/13,15.04%,SELENOS;TMBIM6;LRRK2;LPCAT3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.473214326449177,1.0114129127295433,0.41,1.0,1.0,100/484,21.25%,TAF7;KLF2;KLF15;ETV5;LPIN1;HDAC2;GRIN1;DDX3X;NFKBIA;KDM1A;MYDGF;GLIS3;CD38;NR4A3;ACTR3;TET3;CAMKK2;AGO2;AKIRIN1;KANSL3;NIBAN2;SMARCA1;IL18;RNF10;CDC5L;PRDM10;BTRC;ESR2;YAF2;PPARA;CTBP2;TBK1;TGFB1;TP63;APBB1;EGFR;MED14;ARID1A;CLOCK;RPS27A;PPARGC1A;WDR43;RARB;HIF1A;ZBTB16;MTF2;CEBPB;KDM3A;SIN3A;ZFPM2;PTOV1;ELF1;DEAF1;FUBP3;SREBF1;TCERG1;RUNX1;TBX3;SENP1;WAC;STAT3;FGFR2;PPP3CA;GLYR1;TP53BP1;BCLAF3;ATF6;HIVEP1;TEAD1;CREB3L2;TWIST1;RNF111;ACVR2A;TNKS;NAA15;MZF1;MAP2K1;ARF4;CRLF3;SETD3;PLAG1;PER1;NFIX;HMGN1;ST18;SMAD2;SMARCA4;ZFPM1;RBPJ;JUNB;CCNK;SP1;SMAD7;SUPT16H;ABL1;PAXBP1;ELF2;CTCF;CEP290;TP53INP1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5931927275949231,1.0113735242149737,0.5342465753424658,1.0,1.0,7/12,36.74%,RAP1B;PDE4D;TJP1;RAP1A;RDX;RAPGEF2;RAB1A
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6700327393001313,1.0113026881725247,0.5063291139240507,1.0,1.0,1/5,15.00%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6173290211650883,1.0112133730347261,0.4594594594594595,1.0,1.0,2/8,8.76%,ADAM17;EGFR
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5367829223954215,1.01117170502002,0.46511627906976744,1.0,1.0,8/35,21.68%,CSF1R;IRS1;MYO16;EXOC1;PLCL1;NF1;GAB2;IRS2
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6475849824457467,1.0110243418307152,0.49295774647887325,1.0,1.0,1/6,22.35%,KDM2A
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.4908817502396119,-1.0109069674586133,0.42857142857142855,1.0,1.0,1/13,3.19%,CD58
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.5716242790772118,1.0108415019531933,0.5,1.0,1.0,6/18,24.67%,TGFB1;FGFR2;MYL3;RBPJ;SMAD7;PKP2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4282990794165515,-1.0108355891858558,0.4117647058823529,1.0,1.0,4/14,11.85%,GPC6;ACTB;GPC3;STX8
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.645604795703735,1.010827782623227,0.475,1.0,1.0,2/7,21.34%,MCTP2;SNCAIP
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6710811186010515,1.0104820974392879,0.589041095890411,1.0,1.0,2/6,20.55%,NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6284971400741517,1.010456056306073,0.4875,1.0,1.0,3/10,20.04%,ROCK2;RANBP9;SP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5258109834942957,1.009936743783171,0.45977011494252873,1.0,1.0,10/30,21.17%,RHOB;IPO5;TGFB1;DUSP1;CAMK2N1;HECA;LATS2;PDCD4;CDKN1B;RPS6KA2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.6802188617433425,1.0098606100366478,0.5507246376811594,1.0,1.0,2/5,19.00%,MAPKAPK2;PTGR1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.6213616065189262,1.009312067894151,0.5432098765432098,1.0,1.0,1/11,2.61%,NEDD4L
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5898851812174675,1.0091505204901414,0.5070422535211268,1.0,1.0,1/8,5.63%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.669577053463826,1.0090712351743163,0.47297297297297297,1.0,1.0,2/6,6.58%,PRKCB;NECTIN2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6680805859509732,1.0090590424201988,0.47761194029850745,1.0,1.0,3/5,15.34%,TMEM30A;SCARB2;ATP11B
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.597700609602565,1.0089770553436401,0.5172413793103449,1.0,1.0,2/21,3.68%,KDM1A;PTPN1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.5040938226964163,1.008878466213854,0.5106382978723404,0.9995946762304068,1.0,11/71,12.52%,TAF7;TAF1B;NR4A3;TBPL1;ESR2;PPARA;NRBP1;PPARGC1A;RARB;CCN2;CCNH
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.4984894313207057,1.0080315321456492,0.5053763440860215,1.0,1.0,6/81,6.62%,GPR161;ADAMTS9;GJA1;TENM3;PAPPA;TACC2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.5772515324862747,1.0078024538472687,0.4567901234567901,1.0,1.0,4/15,23.23%,RPS27A;CTSL;MAPKAPK2;TAB2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.6189224807431831,1.0075614775404127,0.5324675324675324,1.0,1.0,3/12,21.84%,PTPN1;PTPN2;UBE2K
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.644184797052393,1.0074776892129562,0.5074626865671642,1.0,1.0,2/9,10.78%,AGO2;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.5070950377299751,1.0073023464438844,0.4791666666666667,1.0,1.0,13/56,23.00%,PRKACA;KDM1A;AMFR;STK4;PSME3IP1;SYMPK;TMBIM6;LRRK2;GOLGA2;ZFPM1;LDLRAP1;MITD1;MARK3
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.6607971562328631,1.0072305831950374,0.5070422535211268,1.0,1.0,4/5,33.14%,GLUD1;IREB2;ASS1;ACO1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6560309247812942,1.0072060067303228,0.5753424657534246,0.9997054517633435,1.0,1/5,8.84%,RNF168
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6374133291923265,1.0071409421829796,0.5131578947368421,0.9992431280335544,1.0,1/8,10.13%,PPARGC1A
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5229290966783413,-1.0071332735513379,0.4074074074074074,1.0,1.0,2/9,8.19%,ATM;PIK3R4
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5715219675570448,1.0070001683278564,0.5,0.999018843605599,1.0,7/13,37.36%,PEX3;RAB8B;SLC25A17;ATAD1;ALDH3A2;ABCD3;ZFAND6
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5587647980926436,1.0064381200317196,0.4888888888888889,1.0,1.0,6/27,15.00%,NRCAM;ZC4H2;EIF2AK4;SIN3A;NLGN1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.6963244871632541,1.0064090481884684,0.49295774647887325,0.9994992501225792,1.0,1/5,11.06%,ZBTB16
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.48401493133834034,1.0058470464749683,0.5052631578947369,1.0,1.0,15/59,17.60%,PLAA;MGST1;PDE4B;CTR9;TNFRSF1B;SELENOS;EGFR;IRS1;ADNP2;PDK3;ROCK2;GNAI1;PDK4;LCOR;PDCD4
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.5582062527358843,1.0056083019961164,0.5617977528089888,1.0,1.0,8/32,18.63%,TPT1;CACNA1B;NDFIP2;SLC3A2;NDFIP1;TRPC4;MAGT1;RYR3
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.6523996077288782,1.005409257027299,0.5217391304347826,1.0,1.0,3/7,20.67%,TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6672413482253282,1.0050062420988093,0.5428571428571428,1.0,1.0,2/5,16.00%,EGFR;LCOR
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.3932242765103558,-1.0046846013822324,0.3333333333333333,1.0,1.0,2/14,4.28%,GLB1;ARSB
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6334439620330807,1.0046640338128725,0.5625,1.0,1.0,4/8,30.27%,GNAI1;GPSM2;CLTC;MAP9
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5186540895910077,1.0046315293932122,0.5108695652173914,1.0,1.0,17/37,30.09%,KDM1A;CRY1;NDFIP2;DCUN1D4;NDFIP1;LRRK2;RBX1;DCUN1D1;SMAD7;RCHY1;SENP2;MARCHF7;DCUN1D2;UBE2L3;UBQLN1;UBE3A;MALT1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5508055271607134,1.0044130020377608,0.49382716049382713,1.0,1.0,2/20,3.26%,SOD1;SGCZ
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6789928654653702,1.003867966763193,0.5217391304347826,1.0,1.0,1/5,6.17%,PRKCB
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6697530293094075,1.0037740977430534,0.515625,1.0,1.0,1/5,3.50%,KCNQ1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.5433048034469218,1.003747388485537,0.5287356321839081,1.0,1.0,8/30,21.90%,WIPI1;ATG16L2;RAB7A;AMBRA1;WDR45B;MAP1LC3B;TP53INP1;STX12
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.4742146063291358,1.0036288661249566,0.5,1.0,1.0,29/161,18.01%,SLC2A3;CD44;DDX3X;PSMB1;RAB27A;MGST1;LRRC7;DIAPH1;TMEM30A;CRISPLD2;TNFRSF1B;ADAM17;ATP11A;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;MAPK1;MAGT1;LGALS3;MANBA
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5298235179714206,-1.0034196688836348,0.4,1.0,1.0,3/11,7.12%,NRP1;NR4A1;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.5503982223281487,1.0032891919546707,0.5294117647058824,1.0,1.0,6/23,17.35%,PPARA;SELENOS;TRAF3IP1;LPCAT3;LRFN5;PTPN2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5913237307129489,1.003264214959179,0.5584415584415584,1.0,1.0,4/10,20.13%,KCNQ1;EGFR;FGFR2;MAP7
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5425497241139999,1.0030848772010097,0.5316455696202531,1.0,1.0,4/20,10.00%,KCNC2;SLC2A1;SNAP25;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5800566691840383,1.0030493721204992,0.5185185185185185,1.0,1.0,3/13,16.11%,MBP;STAT3;TWIST1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.5616351180618846,1.0030186212453693,0.5238095238095238,0.9995164805618149,1.0,4/12,19.88%,CTR9;RNF168;WAC;SKP1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5186863334290701,1.0029840853593877,0.4945054945054945,0.9989666531985932,1.0,11/29,33.25%,CLIP4;WDR73;SLK;DST;CAMSAP1;SLAIN2;CCDC88A;RAB11A;CLIP1;KATNAL1;DLG1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5354654229586303,1.002957367913002,0.5060240963855421,0.9983707022095274,1.0,3/21,12.44%,GFAP;RAP1B;ROCK2
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6535237503880781,1.002893361105442,0.5675675675675675,0.9979026305812461,1.0,6/6,34.71%,DCUN1D4;RBX1;DCUN1D1;DCUN1D2;UBA3;NAE1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6552013301879526,1.0026140555501921,0.5063291139240507,0.9982038923121663,1.0,5/6,34.31%,AGTPBP1;STAT3;CEP290;VEGFA;NKD1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.5670135218298038,-1.0023699382936677,0.47619047619047616,1.0,1.0,1/5,4.42%,SNAPC3
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6298368643915041,1.002341366885312,0.5263157894736842,0.9983577942739809,1.0,1/10,0.59%,STX6
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.277994228434229,-1.002294284420417,0.0,1.0,1.0,13/90,8.22%,NTN4;LMCD1;LMOD1;COL14A1;MYL9;COL5A2;IGFBP7;LAMB2;FKBP9;PTPN21;CXCL12;COL1A2;EDNRA
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.4785767600498259,1.002213943168937,0.4175824175824176,0.9981309825851141,1.0,23/91,23.19%,HDAC2;DUT;ETF1;PSMB2;CCT4;PSMA7;PWP1;DDX21;HNRNPC;PSMA4;SLC25A3;PABPC1;PGK1;PSMD14;CANX;UBA2;DHX15;GLO1;CCT3;NAP1L1;RPL18;EIF3B;TRA2B
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.6468204266301634,1.002114677641583,0.4861111111111111,0.9976776501821458,1.0,3/5,30.44%,BNIP3L;BNIP3;PISD
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6203288771796167,1.0017330233270336,0.5121951219512195,0.9981782678096324,1.0,4/11,26.49%,CCP110;TAPT1;SEPTIN7;CCDC88A
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.530205331362466,1.001482570691933,0.5232558139534884,0.998185207610791,1.0,6/38,12.89%,PANK2;OPA3;SCD;PPARA;SIN3A;SREBF1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6334465149278162,1.0014693258816982,0.5375,0.9975796033880387,1.0,3/10,5.63%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5268032740488828,1.0010484056641957,0.5,0.998112563001178,1.0,7/23,20.75%,GRIN1;LRRC7;GRIN2B;NLGN1;CNIH3;DLGAP1;GRIA2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5356840226826298,1.0008559677678752,0.4588235294117647,0.9981261816004071,1.0,6/30,21.68%,CSF1R;IRS1;EXOC1;PLCL1;GAB2;IRS2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.6000484004358598,1.0007381157902064,0.5783132530120482,0.9978540545858633,1.0,5/14,17.20%,XKR4;CREM;MYT1L;MCF2L2;PDE10A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5255161879687218,1.0005677235883967,0.5227272727272727,0.9976486904197103,1.0,4/28,16.11%,SELENOS;MAPKAPK2;STAT3;TWIST1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6715262821349167,1.000477325744804,0.589041095890411,0.9972577860514773,1.0,1/5,8.45%,TGFB1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5942629159783435,1.000466681083706,0.5308641975308642,0.9966419170978642,1.0,5/12,29.61%,TUBA1A;TUBA1B;KIF1B;CCDC88A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5902496533043324,1.0003562457693744,0.5066666666666667,0.9956311649460902,1.0,2/12,8.45%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5902496533043324,1.0003562457693744,0.5066666666666667,0.9956311649460902,1.0,2/12,8.45%,IPO5;TGFB1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5294080544460903,1.0001730453525122,0.5517241379310345,0.9956662052130772,1.0,14/36,26.23%,PHYHIPL;ELAVL3;CACNA1B;CTNND2;CADM2;ZNF536;PTPRZ1;PURG;GRIA2;ERC2;MAPK4;MAP1B;PCDH19;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.43165957510566244,-1.0000825153304282,0.5,1.0,1.0,4/26,3.06%,NRP1;SYNPO2;ARHGEF10L;EVL
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.4348960478664401,-1.0,1.0,1.0,1.0,28/123,8.47%,TAGLN;TWIST2;IL34;EDN3;PRRX1;DKK3;ACTA2;LAMC1;SLIT3;LMOD1;SYNPO2;COL14A1;SERPINH1;MYL9;TNXB;COL5A2;FBLN2;NOX4;IGFBP7;COL15A1;PAMR1;COL13A1;NR4A1;VIM;CXCL12;COL1A2;EDNRA;SPARC
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.5880295712980333,0.999178067539777,0.5384615384615384,0.9972630566521777,1.0,4/14,11.27%,CD44;ADAMTS4;MMP16;CTSL
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5880295712980333,0.999178067539777,0.5384615384615384,0.9972630566521777,1.0,4/14,11.27%,CD44;ADAMTS4;MMP16;CTSL
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.532403661473711,0.9989691184564968,0.5172413793103449,0.9971978744034334,1.0,4/26,10.62%,NUP153;PIAS2;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.4960253314708705,0.9989438727319988,0.5280898876404494,0.9965980687331047,1.0,9/51,17.59%,HNRNPL;HABP4;HNRNPF;PTBP2;TMBIM6;GRSF1;SRSF10;RBM39;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.6695054119178337,0.9988793162881285,0.5066666666666667,0.9960980030106865,1.0,4/7,25.51%,MTMR9;MTMR1;MTMR2;SMG7
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6778628789981374,0.9988088598747493,0.5352112676056338,0.9957040743809005,1.0,2/5,28.46%,PRLR;PTK2B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6191600749725209,0.9987441381407492,0.5540540540540541,0.9952315994689772,1.0,2/10,29.53%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6486976008406977,0.9986039684075664,0.5588235294117647,0.9949901850950377,1.0,3/7,16.56%,CRY1;STMN1;MGRN1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6390753285994898,0.9985890509813414,0.5384615384615384,0.9944003556601477,1.0,4/8,25.45%,CSF1R;CYFIP1;PIP5K1A;PLEKHA1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.5014109311950368,0.9985183269518941,0.4725274725274725,0.9939362301580836,1.0,13/45,25.74%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;RNF180;ELOB;ARIH2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5399394379449369,-0.9984711795515928,0.40625,1.0,1.0,1/5,2.54%,IGFBP4
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6182747104602866,0.9983989298265671,0.5285714285714286,0.993663275299515,1.0,2/7,8.76%,ADAM17;EGFR
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.49368713447453527,0.9982764378528166,0.5425531914893617,0.9934235106532221,1.0,15/70,18.56%,CNTN3;PHYHIPL;PTPRD;PCDH17;SNAP25;PPARGC1A;SHC2;PDZRN4;THSD7A;ABCC9;FGF14;NRXN1;SYBU;NOVA1;LIFR
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5478494182661369,0.9981260684236595,0.5,0.9931709326216055,1.0,8/27,21.08%,NRG1;RAF1;SYTL4;PPP3CA;SCARB1;DST;DCBLD2;NF1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5707770698254576,0.9979389870560069,0.5432098765432098,0.9932597209241761,1.0,1/14,2.96%,DDIT4
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.644594805435474,0.9977550340404382,0.5441176470588235,0.9931845398581336,1.0,2/6,17.68%,NLGN1;CNIH3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.6416919262444295,0.9977350928835274,0.5476190476190477,0.9925789142527751,1.0,1/8,10.90%,SRA1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.5756858605219477,-0.9975157759978863,0.5517241379310345,1.0,1.0,2/5,24.41%,CLU;HSP90AA1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.39528286598949486,-0.9974582176407667,0.4,1.0,1.0,3/27,4.65%,CDK6;CUL2;CACUL1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5931144391836,0.9973444556410167,0.52,0.993086835673185,1.0,3/12,19.84%,SCD;ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5072482212557403,0.9970604203127209,0.5434782608695652,0.9932408622743386,1.0,14/47,22.72%,CSNK1G2;VAPB;UGCG;SGPL1;AGK;VAPA;SAMD8;ACER3;ELOVL5;CERS6;SPTLC1;SERINC1;SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.609078107060997,0.9966149053576726,0.49333333333333335,0.9940484060975022,1.0,1/9,3.50%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5287233503836838,0.9966057409660359,0.49411764705882355,0.993443789971536,1.0,5/30,20.84%,DDX3X;TMBIM6;LGALS3;CSNK2A1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6146351307472809,0.996544941745252,0.5492957746478874,0.9929835880592527,1.0,3/12,16.42%,HNRNPC;DCP2;TNKS
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.49925359016427584,0.996321064484244,0.4943820224719101,0.9928502056600396,1.0,9/45,18.08%,TEFM;PSMB1;PSMB2;PSMA7;DDX21;RPS27A;PSMA4;PSMD14;RPA1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6427431829034693,0.9962021002757071,0.5657894736842105,0.9926126714473269,1.0,1/6,12.22%,ABCC9
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5049118885162465,0.9957906621051997,0.5730337078651685,0.9930400816129894,1.0,10/40,14.44%,TAF7;GRIN1;NEDD4L;SLC6A17;SCN3A;NDFIP2;SLC3A2;ABCC9;NDFIP1;SLC36A4
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5971597735310733,0.9957534833278109,0.47560975609756095,0.992496674697174,1.0,4/13,17.35%,TGFB1;EFNB2;ZSWIM8;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4923519940549292,0.9956440274575229,0.5268817204301075,0.9921231677470295,1.0,13/65,16.80%,GJA1;PELI1;PRKCB;NDFIP2;TBK1;DDX21;VAPA;CXXC5;NDFIP1;ANKRD17;TRIM5;TNFRSF10B;MAP3K14
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.701961141080913,0.9955909747929159,0.547945205479452,0.9916655975779429,1.0,1/5,13.35%,CST3
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5579607905607031,0.9955105814822056,0.5647058823529412,0.991254111879998,1.0,4/22,8.51%,ERRFI1;STMN1;UGCG;TP63
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6987304843333089,0.995506691000172,0.5846153846153846,0.9906353137099548,1.0,2/5,21.68%,PRKCB;IRS2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4748072214472177,0.995284820356641,0.5454545454545454,0.9906339469857068,1.0,27/114,21.25%,ATP6V1G1;PRKACA;ATP6V1H;GFAP;RHEB;MTMR9;SNX6;RUBCN;SLC38A9;WDR41;ATP6V1E1;RNF152;SREBF1;WDR6;EXOC1;STAT3;TRIM5;LRRK2;ATF6;C9ORF72;DRAM1;USP10;GOLGA2;ABL2;ABL1;BNIP3;TP53INP1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.662351715376508,0.995273116109624,0.5405405405405406,0.9900617505649292,1.0,2/5,24.78%,EIF2AK4;CNTN4
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.6021430141913233,0.9951767707774548,0.5443037974683544,0.9896782836297574,1.0,2/10,15.59%,MTMR9;PPP6R2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.5069326800873171,-0.9947610117009275,0.42857142857142855,1.0,1.0,1/9,1.35%,NRP1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6283354215082545,0.9947392686069864,0.5697674418604651,0.990351286630678,1.0,4/12,25.00%,STMN1;ABL1;CAMSAP1;MAP1B
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5545617886186173,0.9946890167548234,0.5316455696202531,0.9898969095760332,1.0,5/15,20.52%,HABP4;CASP8AP2;TNFRSF10B;MAP3K14;BNIP3
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.494112121409248,0.9946836254832613,0.5473684210526316,0.9892878335628802,1.0,15/66,22.89%,HDAC2;HCFC2;SMARCA1;ARID1A;MTF2;EZH1;ZBTB7A;KDM6A;ZBTB1;HMGN1;CHD1;SMARCA4;JARID2;MYSM1;NUDT5
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.42672983604933057,-0.9942550075758783,0.35714285714285715,1.0,1.0,4/19,12.14%,PER2;HEYL;HOOK3;SNW1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6131222283862204,0.9942116549201022,0.43902439024390244,0.9900761793611608,1.0,2/10,19.84%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.49714027535948174,0.9939561842996416,0.4835164835164835,0.9901785655656129,1.0,6/34,16.47%,CD44;ZFP36L2;HNRNPF;CEP57;FGFR2;MAPK1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5798994424752848,0.993869268555034,0.5316455696202531,0.9898546156906327,1.0,2/11,16.98%,WIPI1;WDR45B
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6052362815969605,0.9936599755791092,0.569620253164557,0.9898473028034096,1.0,4/11,24.40%,GGA3;RTN3;PRNP;RTN1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4834761816675484,0.9935483297255578,0.5959595959595959,0.9895368777782041,1.0,28/177,15.11%,STC1;CSF1;RHOB;RIPOR1;CSF1R;SEMA4D;FLT1;CCAR1;ADAM17;FRMD5;SOD2;TGFB1;CTNNA2;EGFR;ROBO1;F3;TMSB4X;SDCBP;ULK4;SEMA3B;ROCK2;TCAF1;HSPA5;STAT3;SLK;PPP3CA;INSR;NF2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.626067454651472,0.9934452820538807,0.5138888888888888,0.989201068372794,1.0,1/5,9.96%,RAP1B
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.5884772041169123,0.9932380486828972,0.5789473684210527,0.9892585983965899,1.0,5/13,27.05%,MTF2;FGFR2;JARID2;GPM6A;SETD2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.594451267463566,-0.9927523193744192,0.45714285714285713,1.0,1.0,2/5,6.39%,SACS;HSPA1A
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5418191632999102,0.9927390728106277,0.5568181818181818,0.9901593080349443,1.0,9/27,26.71%,IPO5;ADAM17;EGFR;CCNH;LATS2;CDKN1B;CCNK;CCND3;RGCC
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.4633179830332225,0.9923862194764709,0.58,0.9904927700133316,1.0,54/246,20.89%,OS9;NEDD4L;PSMB1;AMFR;HIF3A;ZNRF1;PSMB2;RC3H2;UBE2J1;PELI1;RNF10;CTR9;BTRC;PSMA7;SELENOS;UBR1;KLHL2;RNF168;BLMH;TRIM23;MARCHF6;RNF34;RPS27A;RNF152;UHRF2;HIF1A;SMURF2;PSMA4;WAC;SIAH1;MDM2;FBXL13;RNF19A;TRIM5;PSMD14;RBX1;RNF111;BRAP;WWP1;TNKS;MGRN1;ZSWIM8;HECW1;HECTD2;RBBP6;CBFB;FBXO11;AREL1;UVSSA;RTF1;SKP1;UBR5;MARCHF1;UBE2B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.46625760056655907,0.9923629751811648,0.55,0.9899386268936365,1.0,154/774,20.36%,WWC1;TAF7;KLF2;PURB;KLF15;ETV5;PRDM6;LPIN1;HDAC2;GRIN1;DDX3X;NFKBIA;EBF4;RAD21;NEDD4L;KDM1A;TENM2;MYDGF;GLIS3;NR4A3;HIF3A;ACTR3;TET3;SUFU;ENO1;ZNF608;HDX;AGO2;HCFC2;WWC2;CRY1;AKIRIN1;KANSL3;ARID3A;CSF1R;SMARCA1;SEMA4D;IL18;RNF10;PRKCB;CDC5L;CTR9;SAP130;PRDM10;PKNOX1;ESR2;PIAS2;CHD2;HIVEP2;PPARA;SOD2;CTBP2;KLF9;PHF20L1;TBK1;TGFB1;TP63;APBB1;EGFR;MED14;ARID1A;CXXC5;CLOCK;RPS27A;PPARGC1A;SDCBP;RARB;SRA1;TSHZ2;RCOR1;HIF1A;ZBTB16;MTF2;ZBTB40;CEBPB;ZNF536;KDM3A;SIN3A;ZFPM2;PTOV1;ELF1;SMURF2;CCNH;DEAF1;ZFY;TSHZ3;FUBP3;SREBF1;CREM;MYT1L;TCERG1;MXD4;BCL6;RUNX1;TBX3;SENP1;PHF21A;MDM2;MDM4;EED;STAT3;FGFR2;PPP3CA;GLYR1;MBD2;TP53BP1;BCLAF3;CEBPD;ATF6;HIVEP1;TEAD1;EZH1;ZNF397;CREB3L2;LCOR;ZNF213;TWIST1;RNF111;ACVR2A;ZNF208;ZBTB7A;TNKS;TSHZ1;MZF1;PURG;ARF4;ZNF595;ZBTB1;CRLF3;SETD3;PHF20;PLAG1;PER1;NFIX;CHD1;ZNF780B;CBFB;ZHX3;ZMYM5;HES4;ST18;SMAD2;SMARCA4;ZFPM1;RTF1;RBPJ;FOXP2;JUNB;CCNK;SP1;SMAD7;ABL1;KLF3;PAXBP1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.4760558434651346,0.9922505626903824,0.5555555555555556,0.9896486042759876,1.0,49/222,21.25%,TP53TG5;RHOB;GJA1;DDX3X;TSC2;ENO1;RAF1;NIBAN2;SEMA4D;FHL1;ESR2;EIF2AK2;TNFRSF1B;SOD2;CTBP2;BNIP3L;TGFB1;APBB1;DUSP1;MYO16;TMBIM6;ADNP2;CCN2;PDE8A;WDR6;TBRG1;BCL6;CASK;CD9;MDM4;CAMK2N1;LPCAT3;NF2;PIP4P2;ACVR1B;MAP2K1;PTPN2;PDCD4;CRLF3;IFIT3;ST18;SMARCA4;CDKN1B;BNIP3;DCBLD2;CTCF;COL18A1;RPS6KA2;TP53INP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.5960136854695124,-0.9920013870282444,0.5,1.0,1.0,2/5,16.16%,ANXA1;PIK3CD
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5595273446562383,-0.9917922171590623,0.42857142857142855,1.0,1.0,1/7,0.47%,DNAI4
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.631185872357928,0.9917287958328355,0.5866666666666667,0.9906559234796616,1.0,3/9,26.36%,PPARGC1A;GLYR1;RPS6KA5
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5140680191320465,0.9917133134355698,0.5,0.9900834843816522,1.0,13/40,25.74%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;RNF180;ELOB;ARIH2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4719847818452837,0.9914879112854813,0.5306122448979592,0.9900440100219834,1.0,18/89,18.13%,GJA1;PELI1;PRKCB;NDFIP2;TBK1;DDX21;VAPA;CXXC5;TANK;OTUD7A;RIOK3;NDFIP1;ANKRD17;TRIM5;TNFRSF10B;USP10;MAP3K14;PER1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5885675363098909,0.9914453229169297,0.5529411764705883,0.9895624049197811,1.0,6/13,21.08%,TENM3;AGTPBP1;STAT3;C12ORF57;FBN1;NF1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.598116969488947,0.9912695679415163,0.5294117647058824,0.9894528636802631,1.0,3/13,12.25%,SEMA4D;DIP2B;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6214681907887204,0.9911634647827299,0.5443037974683544,0.9891834542940369,1.0,2/8,13.31%,ZBTB16;TAPT1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.5111847632762043,0.9910262913948334,0.5,0.9890039337705369,1.0,12/46,18.30%,PRKACA;TNFRSF1B;ADAM17;PPARA;SELENOS;GNB1;LPCAT3;LRFN5;PRKAR2A;ADORA2B;PTPN2;PTH1R
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6345484728752815,0.9909641472729305,0.6282051282051282,0.988588130321907,1.0,2/8,13.46%,EIF2AK4;HSPA5
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5514537319055283,0.9909060086942582,0.4942528735632184,0.9881345247828976,1.0,4/18,14.87%,PRKCI;SELENOS;IRS1;INSR
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.4833279456278325,0.9908147669708687,0.5510204081632653,0.9878027910066498,1.0,6/86,5.78%,SOD1;TBC1D20;MMUT;RGS7;ARHGAP15;SEMA4D
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6044366216081577,0.9907844575439843,0.55,0.9872545553483354,1.0,1/11,2.14%,DPM1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5441172676593264,-0.990620857673835,0.47368421052631576,1.0,1.0,2/7,5.13%,IQGAP2;ARPC5
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.6149582020912733,0.9905744128209537,0.5507246376811594,0.987293605902372,1.0,4/7,28.80%,TTC23;EVC;ARMC9;DCDC2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.3380135775284249,-0.9904586713649577,0.3,1.0,1.0,7/36,7.40%,BCL2L11;TRABD2B;SYNPO2;RPS3;VCP;MPP7;TPR
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.6656967252514884,0.9903696301010413,0.547945205479452,0.9871350756033419,1.0,4/5,33.45%,LANCL1;P4HB;UBQLN1;FYN
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.47949491455429494,0.9903376710769478,0.5268817204301075,0.9866010357309578,1.0,14/54,20.05%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SDCBP;SMURF2;SNX25;RNF111;LATS2;ZBTB7A;SMAD2;SMAD7
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.616669397428659,0.9899728235755765,0.5526315789473685,0.9870222613285363,1.0,3/10,19.43%,TGFB1;GALNT11;RBPJ
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.4681516626465845,0.9897800211927524,0.53,0.9869977605453266,1.0,28/159,18.01%,SLC2A3;CD44;DDX3X;PSMB1;RAB27A;MGST1;LRRC7;DIAPH1;TMEM30A;CRISPLD2;TNFRSF1B;ATP11A;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;MAPK1;MAGT1;LGALS3;MANBA
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.49475510355489477,0.9897387647566886,0.5108695652173914,0.9864838844968103,1.0,17/56,27.62%,CSNK1D;CSNK1A1;SDCBP;WAC;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;RNF180;ELOB;ARIH2;EIF3H;RAD23B
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.6082767771965164,0.989527051106813,0.5189873417721519,0.9863835305418038,1.0,4/9,22.97%,ACER3;SPTLC1;SPTLC3;CYB5R3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6868067953192527,0.9894143108931257,0.5,0.9860547776329112,1.0,3/5,30.38%,NEXMIF;RGCC;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5077364791221765,-0.9892786278500385,0.5,1.0,1.0,3/13,14.47%,ATM;UBB;DDX5
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.4925377386247339,0.9891725494373586,0.5531914893617021,0.9860880423517375,1.0,17/62,27.75%,STX6;AP2A1;SNX6;VPS50;WASHC2C;RAB7A;CCDC91;PREPL;EEA1;TBC1D5;DENND2A;GAK;EPS15;CLTC;RAB14;RHOBTB3;VPS29
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.48015444948616587,0.9890094791317429,0.5052631578947369,0.9857979280987931,1.0,5/56,5.99%,TBC1D20;MMUT;RGS7;SEMA4D;MTMR9
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.6668616334221171,0.9886416219978669,0.56,0.986154446419847,1.0,3/7,27.93%,FADS2;ELOVL5;HSD17B4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.5120706672424808,0.9886139006120794,0.5393258426966292,0.985636703277262,1.0,11/39,20.52%,DDIT4;EIF2AK2;BNIP3L;SERINC3;ABCC9;TRIM5;MAP3K14;NCBP3;IFIT3;IFITM3;BNIP3
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6440078894038543,0.9885292667936937,0.5555555555555556,0.9834458921580805,1.0,1/7,3.72%,RAB27A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6440078894038543,0.9885292667936937,0.5555555555555556,0.9834458921580805,1.0,1/7,3.72%,RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6440078894038543,0.9885292667936937,0.5555555555555556,0.9834458921580805,1.0,1/7,3.72%,RAB27A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6440078894038543,0.9885292667936937,0.5555555555555556,0.9834458921580805,1.0,1/7,3.72%,RAB27A
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.46790722275007013,0.9884514154805719,0.54,0.9830072100199929,1.0,28/160,18.01%,SLC2A3;CD44;DDX3X;PSMB1;RAB27A;MGST1;LRRC7;DIAPH1;TMEM30A;CRISPLD2;TNFRSF1B;ATP11A;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;MAPK1;MAGT1;LGALS3;MANBA
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.4839376256196489,0.9883282623366356,0.5319148936170213,0.9826952410711665,1.0,17/82,15.00%,WWC1;CD44;MID1;MYDGF;CSF1R;FLT1;EIF2AK2;TGFB1;EGFR;ROBO1;CCN2;ROCK2;PDE8A;FGFR2;TRIM5;INSR;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.5247620330907928,0.9881288730023293,0.550561797752809,0.9826925719035976,1.0,8/33,17.35%,PPARA;SELENOS;CTNNA2;TRAF3IP1;CASK;LPCAT3;LRFN5;PTPN2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6607162814309094,0.987892930184825,0.5915492957746479,0.9828285136455998,1.0,3/5,23.62%,GLUL;GLUD1;GCLC
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.5062946066548125,0.9878362848771242,0.5617977528089888,0.9823409409313094,1.0,10/39,20.27%,PSMB1;PSMB2;ZFP36L2;EIF2AK2;PSMA7;PSMA4;RUNX1;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6432532987332981,0.9874987928047074,0.6081081081081081,0.9827286317676309,1.0,2/7,16.02%,CDH2;TTN
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.5679401606241778,0.9871462806809557,0.5189873417721519,0.9830718192744349,1.0,4/18,23.05%,UBA5;GFM2;GOLGA2;MCTS1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6853498807941348,0.986775771373622,0.5915492957746479,0.9836031184092858,1.0,1/5,5.77%,ZFP36L2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.5308696237793515,0.9867212725985268,0.5287356321839081,0.9831853657759657,1.0,6/21,29.34%,ACOT11;AK3;LRRK2;BPNT2;ACBD6;ACSF2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6149007049545359,0.9865126055454447,0.5774647887323944,0.983220064167248,1.0,1/8,4.62%,DGKI
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.5986007123642053,0.9864810574179543,0.5454545454545454,0.9826650651605573,1.0,5/12,29.30%,HEG1;NLGN1;JAM3;PCLO;TJP1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.4914355670786756,0.9861474179152246,0.5483870967741935,0.9829884186557205,1.0,13/67,21.25%,TAF7;HDAC2;TP63;RNF34;MAP2K6;MDM2;MDM4;PHF20;RPA1;CSNK2A1;SUPT16H;MAPKAPK5;TP53INP1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.6058287217743755,0.9860693188992385,0.5263157894736842,0.9820122612144583,1.0,2/9,15.00%,AK3;LRRK2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6058287217743755,0.9860693188992385,0.5263157894736842,0.9820122612144583,1.0,2/9,15.00%,AK3;LRRK2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5862515263324459,-0.9859679724214068,0.5263157894736842,1.0,1.0,3/7,19.23%,EXT2;CSGALNACT2;B3GNT2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.5083963415803056,0.9857504186511784,0.5543478260869565,0.982429278178899,1.0,11/53,15.97%,OS9;UBA5;RHBDD1;TMCO1;SELENOS;MARCHF6;CEBPB;HSPA5;ATF6;TNFRSF10B;CREB3L2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.4768148735003644,0.9856691946663799,0.5510204081632653,0.9820578405285526,1.0,38/151,24.24%,STX6;GJA1;ARL5A;WIPI1;GGA3;RAB28;AP2A1;COG7;SNX6;SEC13;SYNDIG1;EGFR;TRIM23;RAB18;ARFGAP3;NSF;CNTNAP2;NAPG;LRRK2;AP3D1;TBC1D15;WDR45B;CNTLN;ARF4;ARF1;TBC1D8;NAPB;STX2;TBC1D5;SEPTIN7;STX12;JAM3;RABGAP1L;USP6NL;TM9SF2;TBC1D4;USO1;SH3PXD2B
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6757109538144748,0.9856517093386855,0.5362318840579711,0.9815181240003094,1.0,2/5,20.84%,PPARA;ITGAV
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6952104798544901,0.9854754172147332,0.5714285714285714,0.9814787341187956,1.0,2/5,28.29%,HIF1A;MCL1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5475697920901401,0.9853566689332498,0.5595238095238095,0.9812084440410317,1.0,4/17,11.12%,SRGN;CSF1R;TNFRSF1B;PTPRE
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.6056149924997883,0.9851616964531429,0.5131578947368421,0.9812316744269257,1.0,3/11,20.55%,NR4A3;ROCK2;CAMK2D
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.5976872925639917,0.9848864188562685,0.547945205479452,0.9807110920562363,1.0,3/11,13.73%,BCKDHB;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.5976872925639917,0.9848864188562685,0.547945205479452,0.9807110920562363,1.0,3/11,13.73%,BCKDHB;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.5065615866134543,0.9846508805035351,0.4883720930232558,0.980709680624696,1.0,7/27,23.87%,SUFU;BTRC;TTC23;FGFR2;MGRN1;EVC;ARMC9
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6341170044739247,0.984070658756729,0.5641025641025641,0.9818034503442771,1.0,1/6,9.26%,DUSP1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5440001198669309,0.9839005767820201,0.5,0.9817143043546775,1.0,5/14,22.30%,DNAJC7;ST13;HSPA5;DNAJC18;GAK
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.5245916271847558,0.9838239291477532,0.5454545454545454,0.9813393808750398,1.0,8/33,21.90%,WIPI1;ATG16L2;RAB7A;AMBRA1;WDR45B;MAP1LC3B;TP53INP1;STX12
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5915927126092259,0.9834180530167113,0.524390243902439,0.9818282641522746,1.0,3/10,21.84%,TGFB1;MAPK1;UBE2K
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6028525618870967,0.9831620149308452,0.5857142857142857,0.9819751446071867,1.0,5/10,20.55%,NEDD4L;HECW1;STK39;GOPC;CAMK2D
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.4651150125223355,-0.9831009196207119,0.5161290322580645,1.0,1.0,4/9,4.31%,JPH2;GRIN2A;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.5238232305825236,0.9825915039319286,0.5111111111111111,0.9829034823184412,1.0,9/35,25.78%,ELL2;INTS2;INTS8;CCNK;SP1;ELL;POLR2F;INTS4;INTS6
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.4824605385843254,0.981971485688993,0.5368421052631579,0.984202658628734,1.0,19/88,16.11%,CSF1;RIPOR1;CSF1R;SEMA4D;FLT1;CCAR1;ADAM17;SOD2;TGFB1;EGFR;F3;SDCBP;SEMA3B;ROCK2;HSPA5;STAT3;PPP3CA;INSR;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.6091964556528209,0.9819057946759407,0.5316455696202531,0.9837963788879085,1.0,4/7,30.26%,INSR;BNIP3;FYCO1;SETX
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6458788770609869,0.9817935447605107,0.589041095890411,0.9835887435915553,1.0,1/5,15.04%,LPCAT3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4814758668362293,0.9816478143966401,0.5319148936170213,0.9833566100531913,1.0,13/60,26.40%,USP15;ZFP36L2;TGFB1;RPS27A;ZFYVE9;USP9Y;SMAD2;SMAD7;NLK;SMAD6;JUN;ZMIZ1;FOS
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.482734863312912,0.9815333548998958,0.4791666666666667,0.983031994294142,1.0,11/64,13.59%,MICALL2;TENM2;TENM3;STMN1;UGCG;VAPA;UHMK1;NLGN1;MYT1L;RUNX1;CNTNAP2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5163339530881876,0.9814554869809468,0.5172413793103449,0.9826397889931652,1.0,6/24,12.84%,NRCAM;DNER;CDH2;KIRREL3;NLGN1;FARP1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.37681562084462455,-0.9812950496171866,0.5384615384615384,1.0,1.0,3/20,4.50%,CD4;HDAC9;GPR89B
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.5249171762426476,0.9811382363296961,0.5168539325842697,0.9829028137258511,1.0,9/34,25.78%,ELL2;INTS2;INTS8;CCNK;SP1;ELL;POLR2F;INTS4;INTS6
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.521239555260183,0.9804907340169884,0.5463917525773195,0.9835759618346651,1.0,10/38,15.65%,SLC2A3;SLC6A17;SLC7A2;SLC2A1;SLC16A7;SLC16A12;SLC13A3;ABCC9;INSR;SLC1A2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.521239555260183,0.9804907340169884,0.5463917525773195,0.9835759618346651,1.0,10/38,15.65%,SLC2A3;SLC6A17;SLC7A2;SLC2A1;SLC16A7;SLC16A12;SLC13A3;ABCC9;INSR;SLC1A2
prerank,PanglaoDB_Augmented_2021__T Cells,-0.45767919248080247,-0.9804829704561631,0.47058823529411764,1.0,1.0,5/19,8.27%,CD4;DKK3;CLEC2D;SEMA6D;NOTCH3
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6578716150947147,0.9799707571807034,0.573170731707317,0.9844113288172599,1.0,1/5,17.35%,PTPN2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5723338033148893,-0.979704090902895,0.4482758620689655,1.0,1.0,3/8,11.62%,OSBPL6;ABCA8;NUS1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4663184555226223,0.9796874227511103,0.4782608695652174,0.9846849522449859,1.0,16/55,26.02%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SMURF2;SNX25;ACVR2A;ZBTB7A;SMAD2;SMAD7;SMAD6;SPART;UBE2D3;SPRED1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.5276560471152406,0.9796848512575175,0.5113636363636364,0.9840961175382035,1.0,6/21,23.19%,PRKACA;SELENOS;PDK3;SELENOT;IRS2;TRA2B
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.5124577347378593,0.979136536912474,0.5531914893617021,0.9851388833532866,1.0,13/44,26.60%,HNRNPL;NUP153;DDX21;ZDHHC5;DHX15;ABCB10;NUP205;EIF3B;DCAF1;YBX1;NUP160;CNOT1;CCT8
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6588838316885556,0.9790607586789352,0.578125,0.9847227044841865,1.0,1/5,11.17%,MTF2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6064899007840754,0.9785755347321186,0.5641025641025641,0.9854564790244628,1.0,4/10,24.40%,GGA3;RTN3;PRNP;RTN1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5771230698657033,0.9781109595951681,0.5263157894736842,0.9862016458628236,1.0,4/13,21.68%,PRKCI;IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4956040177158526,0.9779597111148743,0.5979381443298969,0.9860127337441802,1.0,25/81,27.90%,ADGRV1;MICALL2;DCLK1;STMN1;MYO16;VAPA;OMG;CTNND2;UHMK1;NLGN1;GRM7;CNTNAP2;LRRK2;PLP1;PTPRM;DNM2;TAOK3;CNTN4;GPM6B;CAMSAP1;ATXN10;GPM6A;ZFYVE27;PAK1;RAB11A
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.665992022171766,0.9776005679702855,0.581081081081081,0.9864437424298369,1.0,1/6,1.54%,PRKACA
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.665881947479791,0.97757238040685,0.5277777777777778,0.9859299261230386,1.0,2/7,20.10%,UBN1;SUPT16H
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.5022632905440616,0.9775103482464337,0.5393258426966292,0.9854412465341532,1.0,9/29,19.88%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;TNFRSF10B;PSMD14;MAP3K14;SKP1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.6580978565871135,0.9774984428108767,0.5833333333333334,0.9848857922004186,1.0,3/7,30.38%,TGFB1;TJP1;VEGFA
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4998405172763543,0.9773831435450684,0.5568181818181818,0.9845758384488279,1.0,3/38,3.68%,PARVB;MICALL2;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5265508542222556,0.9773543062810904,0.4827586206896552,0.9840521673613586,1.0,3/16,14.42%,CSF1R;IL18;STAT3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6181347710272315,0.9772848171326716,0.5405405405405406,0.9836086031882249,1.0,4/7,36.76%,SIN3A;MIER1;POT1;TERF1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5136335679238839,-0.9772759916099202,0.5909090909090909,1.0,1.0,2/8,2.78%,DDI2;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.602674609986632,0.9770617636990909,0.6172839506172839,0.9837032159017651,1.0,3/11,15.12%,PPARGC1A;DIP2B;GLYR1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.4923514759525642,0.9770314773397106,0.5684210526315789,0.9832115532235861,1.0,9/53,13.46%,DDX3X;NRG1;GFAP;RAF1;EIF2AK2;TGFB1;TRAF3IP1;RIOK3;HSPA5
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.46509284675420653,0.9770001663480549,0.5050505050505051,0.9827143832702037,1.0,32/128,17.23%,PPP1CC;GRIN1;NRG1;SPTBN4;PSMB1;CAMKK2;RAF1;PSMB2;ZFP36L2;IL18;LRRC7;BTRC;NCAM1;PSMA7;TGFB1;EGFR;IRS1;MBP;RPS27A;SHC2;GRIN2B;PSMA4;RANBP9;MAPKAPK2;FGFR2;LRRK2;RGL3;PSMD14;RBX1;BRAP;MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5984313057629113,0.9767498146404546,0.6235294117647059,0.982833758853664,1.0,2/11,15.00%,SUFU;LRRK2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.49680548120071544,0.9765937889523636,0.5529411764705883,0.9826299671450691,1.0,9/38,15.79%,PSMB1;HIF3A;PSMB2;PSMA7;RPS27A;HIF1A;PSMA4;PSMD14;RBX1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6281567444136923,0.9765344365666964,0.625,0.9822436887489063,1.0,8/15,19.63%,SLC38A4;SLC6A17;SLC7A2;SLC38A9;SLC3A2;SLC36A4;SLC38A10;SLC6A12
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6190083060757512,0.9764800819097885,0.5783132530120482,0.9817787401598124,1.0,2/8,19.84%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6379154556134919,0.976230713146015,0.5540540540540541,0.9818923083183688,1.0,2/5,17.35%,FRMD5;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5328210355325963,0.9761950119481246,0.5862068965517241,0.981355171099014,1.0,7/23,20.07%,NEDD4L;LZTFL1;SIN3A;ROCK2;LATS2;DNAJA1;GOPC
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.5144363740161797,0.9761394329002966,0.5632183908045977,0.9809584386107402,1.0,11/38,20.52%,DDIT4;EIF2AK2;BNIP3L;SERINC3;ABCC9;TRIM5;MAP3K14;NCBP3;IFIT3;IFITM3;BNIP3
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5967784575638573,-0.9761263481889788,0.5294117647058824,1.0,1.0,1/5,2.19%,FOXQ1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.6674376251568714,0.9760827858848676,0.5735294117647058,0.9805318200349517,1.0,3/5,24.95%,GABRE;PRNP;GRM5
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.517374887894121,-0.9759417259647841,0.5185185185185185,1.0,1.0,3/6,1.10%,IL34;CDK6;CD4
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4589941875086001,-0.9754852832893207,0.5217391304347826,1.0,1.0,3/12,8.45%,MRPL3;MRPL33;MRPL1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5597649012089119,0.9751805353421372,0.5194805194805194,0.9824119744548642,1.0,6/14,27.19%,ENO1;PGK1;MANBA;HK1;TPI1;MAN2C1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5889027365181426,0.975022244369532,0.5633802816901409,0.9810659346142454,1.0,6/10,32.44%,C1R;CFH;PROS1;CD81;CD55;C1S
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.5889027365181426,0.975022244369532,0.5633802816901409,0.9810659346142454,1.0,6/10,32.44%,C1R;CFH;PROS1;CD81;CD55;C1S
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5889027365181426,0.975022244369532,0.5633802816901409,0.9810659346142454,1.0,6/10,32.44%,C1R;CFH;PROS1;CD81;CD55;C1S
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5170360899443123,0.9747911605269004,0.5977011494252874,0.9811612216842508,1.0,5/31,15.00%,DCLK1;WASF1;MYO16;CNTNAP2;LRRK2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.600380381157297,0.974617584147726,0.5753424657534246,0.9809417476024522,1.0,5/10,24.53%,CHD1;SMARCA4;SP1;LEF1;JUN
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.550611488533303,0.9746022820814748,0.618421052631579,0.9804262203048557,1.0,4/21,12.90%,ZFP36L2;NBDY;TUT7;DCP2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5863810051647543,0.9745776456218553,0.6097560975609756,0.9798871361765372,1.0,1/14,1.54%,PRKACA
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5175519733633247,0.9741659238118704,0.6067415730337079,0.9803271826312211,1.0,6/34,13.42%,DDX3X;FHL1;ADAM17;EGFR;MYO16;ANKRD17
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5903545999770399,0.9737559295699637,0.5588235294117647,0.9808995035532769,1.0,5/8,38.76%,CDK17;CDK14;BRD4;BACH1;TFDP2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.5248702629456763,-0.9735322914842388,0.4583333333333333,1.0,1.0,1/6,5.49%,SNAP29
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5972238879411913,0.9735254040751247,0.5679012345679012,0.9809161217489772,1.0,1/10,7.09%,PPP2R1B
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.6185733401125905,0.973378579792733,0.5555555555555556,0.9807036104858837,1.0,3/8,15.18%,FKBP5;CWC27;PPIB
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.6134189569031535,0.9731309594386944,0.5365853658536586,0.980750453838701,1.0,3/12,18.19%,ANK3;TCAF1;PRNP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.573942141217115,0.9728584491465436,0.575,0.9809779012818607,1.0,4/11,22.24%,FLT1;ADAM17;SP1;COL4A3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5159988164693275,0.9726912619760056,0.5888888888888889,0.9808981385164669,1.0,14/36,31.34%,NIBAN2;PRKCI;TP63;EGFR;GALNT11;STAT3;ZBTB7A;RBPJ;TSPAN5;ZMIZ1;PRAG1;IL6ST;KAT2B;BMP2K
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5599504499292238,-0.9726216875079363,0.4230769230769231,1.0,1.0,1/5,1.35%,NRP1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.45624210441155283,-0.9724465639211658,0.5217391304347826,1.0,1.0,1/10,1.46%,ZNF568
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.44802386206039446,-0.9722613272169041,0.5454545454545454,1.0,1.0,3/16,4.87%,ATP10A;ABCA4;ATP8A1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6185021931341986,0.9722525445836636,0.5492957746478874,0.9814560416782645,1.0,1/6,6.02%,IL18
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.6152500617870208,0.9722198766780744,0.5316455696202531,0.9809673250981715,1.0,3/11,18.19%,ANK3;TCAF1;PRNP
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5737610968909661,-0.9721685271181884,0.5384615384615384,1.0,1.0,1/8,1.04%,PRPSAP1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.6600678137577447,0.9721644835823687,0.5652173913043478,0.979979629198072,1.0,3/5,28.24%,SLC25A4;SLC25A17;SLC19A1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.6600678137577447,0.9721644835823687,0.5652173913043478,0.979979629198072,1.0,3/5,28.24%,SLC25A4;SLC25A17;SLC19A1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5188253732066563,0.97197649781807,0.5842696629213483,0.979888696523919,1.0,13/41,24.30%,TAF1B;DNMT1;DDX21;MTF2;EED;POLR1C;TDG;SF3B1;CTCF;CREBZF;JARID2;POLR2F;RBBP7
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.6495024404159762,0.9717810312409448,0.5949367088607594,0.9798458474856097,1.0,4/8,22.18%,PRLR;CYP3A5;ITIH2;SPTLC3
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.49485269346617766,-0.9711422453561516,0.6,1.0,1.0,1/11,0.42%,A2M
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.6316326748319908,0.9709986667854836,0.5606060606060606,0.9814272541761216,1.0,1/5,0.51%,CSF1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.651775685552874,0.9709734885258248,0.5846153846153846,0.9809283163278858,1.0,2/5,29.53%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5339711824276557,0.9708842619292134,0.5802469135802469,0.9806275173327826,1.0,10/24,24.86%,EPN1;SNX6;ERRFI1;EGFR;RAB7A;ARHGEF7;PTPN2;GRB2;EPS15;SH3KBP1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.6176481090733152,0.9708318105695957,0.6052631578947368,0.9801715246633209,1.0,2/9,11.65%,ARID1A;KDM3A
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5115974856837304,0.9704966649812797,0.5568181818181818,0.9804814057031638,1.0,8/29,34.04%,RAD21;TTN;CSNK2A1;RAB11A;PDS5B;ZNF207;SMC1A;KLHL22
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.5461441490479597,0.9699389725697878,0.5783132530120482,0.9814064087326317,1.0,1/21,1.10%,TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.5922921588237995,0.9698734420892339,0.5542168674698795,0.9809328485870336,1.0,8/10,39.92%,EPHA7;PRNP;NF1;FOXO3;MCL1;SRPK2;BACE1;TGFB2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.6187572345553127,0.9697479327850542,0.5833333333333334,0.9806985909094809,1.0,3/7,15.18%,FKBP5;CWC27;PPIB
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.5833288692911542,0.9696597139181943,0.5194805194805194,0.9802617995667926,1.0,2/10,18.58%,TTN;CSNK2A1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5378431849459459,0.9696348237265476,0.5730337078651685,0.9797301405895907,1.0,9/33,17.66%,CRY1;IRS1;PPARGC1A;HIF1A;STAT3;PDK4;INSR;PTPN2;SELENOT
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5070894714604213,-0.9693196683567638,0.4375,1.0,1.0,2/14,3.47%,SMARCAL1;THOC1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.6686810241794874,0.9693006683884637,0.6166666666666667,0.9800451420955306,1.0,2/5,23.42%,SZT2;CD81
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6533721100433142,0.9692569177491842,0.589041095890411,0.9795678288307457,1.0,1/5,0.84%,SYT1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4772817836530416,-0.9689520846642918,0.46153846153846156,1.0,1.0,3/9,8.20%,WNT5B;TIAM1;GPC3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.6194352356127644,0.9688597004965073,0.5,0.9793285832160964,1.0,2/6,34.17%,ELOVL5;ELOVL6
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6194352356127644,0.9688597004965073,0.5,0.9793285832160964,1.0,2/6,34.17%,ELOVL5;ELOVL6
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.5681920907624514,0.9687297452719504,0.5432098765432098,0.979072461463142,1.0,2/11,8.76%,NOS1AP;EGFR
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5034603790999629,0.968541461299294,0.5833333333333334,0.9789948543047311,1.0,10/26,27.25%,ADAM17;EGFR;ANKRD17;TBX3;MDM2;FGFR2;CDKN1B;CCND3;RGCC;USP22
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5234327116307457,0.9684450436041898,0.5842696629213483,0.9786442395277245,1.0,10/30,21.25%,SCD;ERRFI1;FADS2;PDK3;SEMA3B;GNAI1;CD9;LGALS3;CHKA;TP53INP1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.5570417863905293,0.9683743423111413,0.5316455696202531,0.9782643700290801,1.0,3/13,8.98%,ROBO2;TNFRSF1B;ROBO1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.45561659373125707,-0.9683552832579008,0.55,1.0,1.0,3/13,8.45%,MRPL3;MRPL33;MRPL1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5570586052676485,0.9678494656172283,0.5238095238095238,0.9791420973603807,1.0,2/11,14.87%,HIF1A;INSR
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.4497476178315853,0.9675230867309115,0.66,0.9794083669154009,1.0,161/738,23.11%,WWC1;SCML1;TAF7;KLF2;PURB;KLF15;ETV5;HDAC2;NRG1;EBF4;RAD21;KDM1A;CBFA2T2;GLIS3;CD38;NR4A3;HIF3A;BASP1;SUFU;ENO1;ZNF608;HDX;CAMKK2;HCFC2;WWC2;CRY1;ARID3A;NIBAN2;SMARCA1;RNF10;PRKCB;CDC5L;CTR9;SNX6;BTRC;PKNOX1;ESR2;PIAS2;CHD2;YAF2;CCAR1;HIVEP2;PPARA;SOD2;CTBP2;KLF9;PHF20L1;TGFB1;TP63;APBB1;EGFR;MED14;ARID1A;CLOCK;PPARGC1A;SRA1;TSHZ2;RCOR1;HIF1A;ZBTB16;MTF2;ZBTB40;CEBPB;ZNF536;KDM3A;SIN3A;ZFPM2;ELF1;SMURF2;CCNH;DEAF1;ZFY;TSHZ3;FUBP3;SREBF1;CREM;MYT1L;MXD4;BCL6;RUNX1;TBX3;WAC;MDM2;MDM4;EED;STAT3;SRSF10;INSR;MBD2;TP53BP1;CEBPD;ATF6;HIVEP1;TEAD1;ACVR1B;ZNF397;CREB3L2;LCOR;ZNF213;TWIST1;RNF111;WWP1;ZNF208;ZBTB7A;NAA15;TSHZ1;MZF1;MAP2K1;PURG;ZNF595;PDCD4;ZBTB1;CRLF3;SETD3;PHF20;PLAG1;LOXL3;PER1;NFIX;CHD1;ZNF780B;CBFB;ZHX3;HES4;ST18;SMAD2;SMARCA4;MBTD1;RBPJ;FOXP2;JUNB;CDKN1B;CCNK;SP1;SMAD7;NLK;ABL1;KLF3;CAMK2D;ELF2;CTCF;CREBZF;CEP290;ZNF83;TP53INP1;ZNF814;MXI1;JARID2;KLF6;NCOA2;CDK17;KDM2A;SP3;JDP2;NSD2;SMAD6;ZNF483;KLF13;YEATS2;MT3;TRPS1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6459007870680653,0.9674887199100192,0.5901639344262295,0.9789280270759216,1.0,2/6,22.75%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5817212943629095,0.9674116838889031,0.5822784810126582,0.9785725608023457,1.0,4/11,30.80%,CTNNA2;ABL1;IL1RAPL1;NEDD4
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.543386553501416,0.9673039133012169,0.5584415584415584,0.9782530077488009,1.0,2/15,8.92%,DPM1;PIGL
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.6363001533193384,0.9671194552138611,0.5866666666666667,0.9776091157407468,1.0,1/6,6.16%,ACOT11
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.6363001533193384,0.9671194552138611,0.5866666666666667,0.9776091157407468,1.0,1/6,6.16%,ACOT11
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6268902442573043,0.967064584200802,0.5972222222222222,0.9771961976309608,1.0,5/7,35.05%,ROCK2;DLGAP1;APP;AKAP9;TMEM108
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6105452587961675,0.9668007041485926,0.5802469135802469,0.9772087207894543,1.0,4/10,26.99%,PITPNC1;SCARB1;PITPNA;OSBPL5
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.5146573814601033,0.9667151061426944,0.5555555555555556,0.97683781097794,1.0,7/20,27.33%,RNF168;RPS27A;FAN1;WDR48;RPA1;ERCC6L2;FANCC
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5519921875381547,0.9663834708860544,0.5584415584415584,0.9771688749364266,1.0,3/14,13.91%,TGFB1;SNX25;SIAH1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4885526497495632,0.9660451361313341,0.5172413793103449,0.9775290113998323,1.0,6/43,14.87%,CSF1;NFKBIA;PPARA;TGFB1;NSF;INSR
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5938109218603156,0.9657144012999925,0.5949367088607594,0.9778357316727327,1.0,1/8,7.58%,SLC2A1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.5479746843855794,0.9656052859291102,0.5747126436781609,0.9775712512376361,1.0,4/18,13.42%,NAIP;ADAM17;CEBPB;ANKRD17
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5162725187550041,0.9652048608591433,0.5681818181818182,0.9780834432971158,1.0,7/28,20.60%,CAMKMT;CRY1;RGS5;ROCK2;MGRN1;GIT2;METAP1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.4831621351403815,0.9649058025340205,0.6063829787234043,0.9783540355395257,1.0,18/79,17.08%,MCC;TSC2;PSMB1;AMFR;UBAC2;PSMB2;STK4;CSNK1A1;PSMA7;NXN;PSMA4;BICC1;TMEM64;IGFBP2;PSMD14;RBX1;LATS2;HECW1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5580010687852645,0.9648237878416904,0.5813953488372093,0.9779663467531292,1.0,6/18,19.31%,SLC38A4;SLC38A9;SLC3A2;SLC36A4;SLC38A10;SLC22A2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5295385293536075,0.9645978116898221,0.5432098765432098,0.9781016528098018,1.0,2/13,14.53%,PPARA;PDK4
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5800830337651538,0.9644732036801122,0.5972222222222222,0.9778553905450611,1.0,3/10,30.21%,IPO5;KPNA4;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5319887596563774,0.9642765805100574,0.5348837209302325,0.9777677547388991,1.0,6/20,23.88%,NEXMIF;CORO2B;CASK;NF2;KANK1;SPOCK1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4995380855161651,0.9642736856889086,0.6,0.9771996154276039,1.0,10/33,20.27%,PSMB1;PSMB2;EIF2AK2;PSMA7;PSMA4;RUNX1;METTL14;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.3983662791200231,-0.9641049217220495,0.6,1.0,1.0,4/22,9.83%,MRPL3;MRPL33;MRPL1;EEF2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5177293687235249,0.9640824116389378,0.5517241379310345,0.9771124622269761,1.0,6/18,16.11%,ROBO2;TNFRSF1B;TGFB1;ROBO1;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5925939144859992,0.9639443389854583,0.5,0.9769493051029133,1.0,3/10,21.82%,MAPK1;MAP2K1;MTMR2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.46852981988064285,0.9639359681424613,0.61,0.976400181697287,1.0,27/143,21.37%,PRKACA;IFT52;TUBA1A;CCP110;ACTR3;LZTFL1;IFT140;CSNK1D;NUDCD3;TRAF3IP1;CEP57;EHD2;GALNT11;TTC8;EXOC1;IFT57;CEP70;MAK;ARF4;PAFAH1B1;WDR19;CNTRL;RAB8B;ASAP1;SEPTIN7;CEP290;YWHAG
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6706245299283953,0.9636747004467926,0.6323529411764706,0.9764949144576033,1.0,2/5,20.29%,TNFRSF1B;RALY
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.41996942794111247,-0.9635024264951167,0.52,1.0,1.0,3/15,7.27%,SCN1A;CACNA1D;HCN2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5430347513199849,0.9634146961691504,0.6162790697674418,0.9764960324521013,1.0,4/17,20.78%,DGKI;GK5;PLAAT3;DGKH
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.6492799853084531,0.9633722679527259,0.5352112676056338,0.9760474169297507,1.0,2/5,19.88%,RBX1;SKP1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.4835918640512592,0.9631201546364477,0.5543478260869565,0.9762180742461818,1.0,13/72,11.91%,PHYHIPL;GJA1;FAT3;CRMP1;PTPRD;GFAP;ADGRB3;DCLK1;PCDH17;SYNDIG1;CORO2B;ZNF536;NLGN1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.5144067748978156,0.963119512420183,0.5465116279069767,0.9756592938974378,1.0,6/25,12.89%,GNPAT;SCD;PDSS2;PRLR;AGPAT4;SREBF1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.6606240347898777,0.9630797238339306,0.5428571428571428,0.9745902874993335,1.0,2/5,11.27%,KLF9;CTSL
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6606240347898777,0.9630797238339306,0.5428571428571428,0.9745902874993335,1.0,2/5,11.27%,KLF9;CTSL
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.5048092915390854,0.962798847775991,0.5760869565217391,0.9747613919867603,1.0,6/44,15.96%,STX6;SNX6;VPS50;WASHC2C;RAB7A;PREPL
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.47859669928637727,0.9619977985198931,0.632183908045977,0.9760789289558661,1.0,10/45,20.27%,HDAC2;RPS27A;NUP133;MTF2;RBX1;EZH1;ZBTB7A;HMGN1;SMARCA4;ABL1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5954540690160857,0.9619271514146394,0.5897435897435898,0.9757196214964725,1.0,4/12,29.19%,RAB27A;VTA1;RAB11A;STAM2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5863130912581176,-0.9619219927331921,0.5806451612903226,1.0,1.0,2/5,11.10%,ZDHHC21;TRAF6
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5711333674935193,0.9616835108102784,0.5921052631578947,0.975866524224516,1.0,1/11,7.75%,ADAM17
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.4782387418970451,-0.9614747391196198,0.5,1.0,1.0,1/6,14.02%,PTEN
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4782387418970451,-0.9614747391196198,0.5,1.0,1.0,1/6,14.02%,PTEN
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.4782387418970451,-0.9614747391196198,0.5,1.0,1.0,1/6,14.02%,PTEN
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.513294291629806,-0.961462494999532,0.47368421052631576,1.0,1.0,1/5,12.13%,FLOT1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.5421499943426791,0.9614344236714298,0.6282051282051282,0.9758505665603072,1.0,5/15,17.35%,CD44;KIF13B;EIF2AK4;PPP3CA;PTPN2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.6030436180801266,0.9613380775973427,0.547945205479452,0.9755210464014962,1.0,2/9,22.21%,CTR9;VIRMA
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4877549345833419,-0.9612433794257114,0.4166666666666667,1.0,1.0,1/10,1.33%,JPH2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.6584723178439353,0.9601466822399812,0.6338028169014085,0.9778790240431654,1.0,1/5,7.46%,XRCC4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.48407768778240856,0.9599190351604658,0.5425531914893617,0.9778561362592938,1.0,19/54,28.19%,RRAS2;RHEB;ARHGAP31;DNMT1;SHC2;GNB1;RAB18;BRAP;MAPKAPK5;NF1;GRB2;JUN;KRAS;ARHGAP32;USP8;RASSF1;CCDC88A;TIAM2;ABR
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5818215406040579,-0.9597765041910624,0.45454545454545453,1.0,1.0,3/6,8.42%,SLC9A1;HCN2;SLC6A1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.555450394458208,-0.9596186298417442,0.5789473684210527,1.0,1.0,2/10,1.81%,EDN3;SLIT2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5983066592515207,0.9595971304461851,0.6,0.9780825475444315,1.0,2/7,23.70%,SMAD2;LEF1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.5345252723794822,-0.9595882708209996,0.5,1.0,1.0,3/9,5.13%,IQGAP2;LMOD1;ARPC5
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.5662048018237604,-0.959564568097425,0.6129032258064516,1.0,1.0,4/6,12.90%,VIT;GLI2;PKD2;PKD1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6196629445696026,0.9595228235395671,0.6296296296296297,0.9777409150347391,1.0,3/6,21.82%,INSR;PRNP;MTMR2
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.48116944962419783,0.9594986545578467,0.5494505494505495,0.9772201728096179,1.0,9/47,16.02%,KCNC2;SLC2A1;TGFB1;APBB1;SNAP25;CLOCK;SYTL4;EXOC1;TTN
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6189099290262035,0.9594645258448709,0.5822784810126582,0.9767405375514064,1.0,1/8,2.14%,DPM1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5610779011827092,0.959341725126038,0.6219512195121951,0.9764580996633876,1.0,6/13,31.73%,PHF20L1;MORF4L1;PHF20;KAT6A;KAT2B;MORF4L2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5708487498574966,0.9588567810705368,0.6219512195121951,0.977152878245287,1.0,3/13,5.63%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6341560784226381,0.9586276630514056,0.5526315789473685,0.9771767150721976,1.0,4/5,27.06%,HOMER2;GRM7;GRM5;GRM8
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.4711785996721663,0.9586111836162833,0.5876288659793815,0.976657786190573,1.0,30/139,22.75%,NELL1;MCC;TSC2;OGN;RAF1;NIBAN2;EIF2AK2;SOD2;CTBP2;TGFB1;MYO16;WDR6;TBRG1;TBX3;MDM4;CAMK2N1;NF2;MAP2K1;PTPN2;IFIT3;ST18;CDKN1B;CTCF;NF1;COL18A1;RPS6KA2;TP53INP1;ALDH1A2;COL4A3;SMAD6
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.632293164617673,0.958086130647421,0.5555555555555556,0.9774782093409019,1.0,4/5,20.94%,SNAP25;AP3D1;SNAP23;STX2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.5306294423835342,0.9580275357478689,0.6091954022988506,0.9771096489535326,1.0,3/17,13.45%,ACTR3;AKIRIN1;CAPZB
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.5012654788918425,0.9579150423744455,0.5955056179775281,0.9768337324181959,1.0,10/31,32.43%,NEDD4L;HIF1A;PPP3CA;TTN;AHCYL1;MT3;PPP2CB;NEDD4;HVCN1;MTF1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.44892468721970324,-0.9578763850662929,0.6111111111111112,1.0,1.0,2/16,2.40%,GLB1;ST6GALNAC3
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6168276856191316,0.9578465911889128,0.625,0.9764256367017713,1.0,3/9,21.08%,TENM3;C12ORF57;NF1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5925957887354214,0.9576048537342972,0.6103896103896104,0.9764152629767278,1.0,5/11,20.61%,NDUFB9;NDUFV1;NDUFS2;NDUFB2;NDUFS1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.49306728095809693,0.9571204313544267,0.5824175824175825,0.9770320926376643,1.0,3/34,5.74%,TBC1D20;CCP110;IFT140
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5031108393410454,-0.9567124348122003,0.4090909090909091,1.0,1.0,2/8,8.68%,ERCC6;FUS
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5298020897729541,0.9565014406622572,0.5476190476190477,0.9778609974625577,1.0,5/21,22.12%,SMAP1;SGIP1;ARF1;LDLRAP1;TF
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.48277941225664217,0.9564812830986368,0.5729166666666666,0.9773612866450158,1.0,11/74,14.87%,TSC2;NRG1;MYDGF;IL18;PPARA;TGFB1;EGFR;IRS1;F3;FGFR2;INSR
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5488392423137788,0.9563406587751069,0.547945205479452,0.9771723328833323,1.0,4/13,13.20%,SYT1;RIMS2;GRIK2;NSF
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5289168143389099,0.9562093746823579,0.5617977528089888,0.9769204437452003,1.0,7/25,17.66%,CRY1;IRS1;STAT3;PDK4;INSR;PTPN2;SELENOT
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5100675268253254,0.9560699814788931,0.6,0.9766286773712334,1.0,11/25,31.23%,TGFB1;RARB;FGFR2;TEAD1;ZFPM1;RBPJ;KDR;PCSK5;SH2B3;KITLG;KMT2A
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.48652290545313887,0.9559201228063506,0.6129032258064516,0.9765150098727893,1.0,10/59,17.94%,CDC42EP4;FKBP5;SMARCA1;SLC7A2;ERRFI1;EGFR;PRLR;TEAD1;LGR4;CHKA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.5848094222937484,0.955863450029462,0.5432098765432098,0.9760518704468856,1.0,2/9,7.75%,CSF1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.4588422414737632,0.955344005238545,0.5806451612903226,0.9768780369914931,1.0,19/74,20.89%,CSNK1G2;DDX3X;PSMB1;PSMB2;CSNK1D;PSMA7;TGFB1;EGFR;SMURF2;PSMA4;FGFR2;LRRK2;PSMD14;TNKS;LGR4;CSNK2A1;SMARCA4;UBR5;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6024944726160417,0.9553401518470287,0.5909090909090909,0.9763407966491614,1.0,5/7,33.79%,IL18;ZBTB1;AXL;LAMP1;AP1G1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6120579767754831,0.9549143295007673,0.6024096385542169,0.9768912342543826,1.0,7/10,35.16%,CORO2B;DNAJA1;CEP290;GAPVD1;SPIDR;KIAA0586;CEP120
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4867150877863714,0.9548044654013447,0.6263736263736264,0.9765318588058822,1.0,16/68,17.08%,MCC;PSMB1;AMFR;UBAC2;PSMB2;STK4;CSNK1A1;PSMA7;PSMA4;BICC1;TMEM64;IGFBP2;PSMD14;RBX1;LATS2;HECW1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5984051647197881,0.9546616532352591,0.5394736842105263,0.9757971938085916,1.0,3/5,22.18%,ACER3;SPTLC1;SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5984051647197881,0.9546616532352591,0.5394736842105263,0.9757971938085916,1.0,3/5,22.18%,ACER3;SPTLC1;SPTLC3
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.5586623471330061,0.9545150472870232,0.5595238095238095,0.9750242543209818,1.0,3/17,14.35%,YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.5586623471330061,0.9545150472870232,0.5595238095238095,0.9750242543209818,1.0,3/17,14.35%,YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6219202873182037,0.9542005261039065,0.6197183098591549,0.9752257467534338,1.0,6/9,36.76%,HNRNPC;DCP2;XRN1;HNRNPU;POT1;TERF1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5546894225059575,0.9541888609408634,0.5977011494252874,0.9747032656854026,1.0,3/19,5.91%,FSIP2;IFT140;CSNK1D
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.49303683880079946,0.954132396153836,0.6195652173913043,0.974283894885555,1.0,18/50,25.98%,CSF1R;IL18;ROBO2;TBK1;TGFB1;PTPN9;AKAP6;STAT3;LRRK2;ACVR1B;ACVR2A;TIPARP;PTPN2;LDLRAP1;NCOA2;LEF1;SLC1A1;IL1RAPL1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.46716638937558763,0.9540083744257073,0.5729166666666666,0.9740414603898254,1.0,28/97,31.20%,INTS2;DDX52;AGO2;RPL28;NOP58;RPL21;WDR43;TUT7;RPL41;INTS8;RPLP2;SMAD2;TEX10;DIS3;RPL9;SARS1;RPL18;INTS4;INTS6;RPS14;NOL8;RPL27A;INTS7;RPL13A;RCL1;RPL31;RPL32;SSB
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.45825974908817746,-0.9537004647352714,0.5,1.0,1.0,1/11,1.10%,CD4
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.637399955985342,0.9537000651277889,0.647887323943662,0.9742544308407413,1.0,3/6,31.98%,PRNP;ARF1;APP
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5137505002738179,0.9536357392499161,0.6463414634146342,0.9738417081798519,1.0,3/27,10.78%,KDM1A;RHBDD1;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.49977716306413045,0.9535846053067039,0.5730337078651685,0.9734124023592552,1.0,11/31,33.87%,DDX3X;TBK1;RIOK3;POLR1C;POLR2F;SETD2;PTPN11;IRF1;PRKDC;STAT6;XRCC5
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5889518565812819,0.9534510109027163,0.5915492957746479,0.9732277999261302,1.0,2/9,20.08%,PLAAT3;PEX3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5788725596039329,0.9533483465738958,0.5945945945945946,0.9729298785169291,1.0,3/9,19.91%,SOD2;PDCD4;CDKN1B
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.5498214481146159,0.9530055718525782,0.5609756097560976,0.9731996066969196,1.0,3/13,18.97%,BASP1;HES4;SMAD2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.4298700645246634,-0.9525912090338858,0.5217391304347826,1.0,1.0,3/18,1.50%,PPIP5K2;AGPAT5;TPK1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.591134252645627,0.9519261616772612,0.6075949367088608,0.9751643484084807,1.0,3/8,21.82%,INSR;PRNP;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6513326299818498,0.9518854081813999,0.6029411764705882,0.9747241719060519,1.0,2/6,13.21%,STMN1;ARHGEF7
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6390869115418571,0.9516904259738758,0.6197183098591549,0.9747149224386288,1.0,2/5,16.53%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5445358350578511,0.9516376452239839,0.5952380952380952,0.9743377566785787,1.0,7/17,24.95%,TTC8;C12ORF57;MAGT1;DGCR2;NF1;CYFIP1;GRM5
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.5029799343322505,-0.9516203041191725,0.4642857142857143,1.0,1.0,2/7,3.41%,EDN3;CYB5R4
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4994561603049855,0.9514876414187362,0.5581395348837209,0.9741194165870724,1.0,7/27,15.79%,PSMB1;PSMB2;FHL1;PSMA7;PSMA4;PSMD14;RBX1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5540671474858087,0.9514287304904857,0.5802469135802469,0.9737147371392607,1.0,2/12,3.50%,NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.5328127989532842,0.9514147255646004,0.5411764705882353,0.9731974931724255,1.0,6/19,22.80%,ENO1;CRY1;PPARGC1A;PGK1;IRS2;TPI1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.4956538516146384,-0.9512469462994423,0.47058823529411764,1.0,1.0,2/12,2.43%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.5635078882074074,0.9510116508365658,0.5795454545454546,0.9735449315862633,1.0,7/15,22.07%,SLC16A6;SLC16A7;SLC16A12;SLCO1A2;SLC16A4;SLC6A12;NCOA2
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.6204104140341732,0.9506560908536793,0.5833333333333334,0.9739597160204616,1.0,1/5,11.58%,SAMD8
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5153136245138777,0.9503441016681782,0.6086956521739131,0.9742217182661282,1.0,7/29,18.30%,PRKACA;ADAM17;SELENOS;GNB1;PRKAR2A;ADORA2B;PTH1R
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.46394402049113304,0.9502579299178927,0.6354166666666666,0.9739139631151918,1.0,23/78,20.84%,ADGRV1;NFKBIA;SUFU;ZFP36L2;SEMA4D;CTR9;PPARA;TGFB1;EGFR;ANKRD26;EIF2AK4;SRA1;ZBTB16;ZFPM2;TBX3;TMEM64;METTL14;TWIST1;PDCD4;ABCA1;ZFPM1;SMAD7;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.4673550798970161,0.9501636712833362,0.5555555555555556,0.9736459976118392,1.0,7/47,15.01%,DDX3X;HABP4;AGO2;ELAVL1;CDC123;UHMK1;METTL14
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.5238201152855274,0.9495573362455924,0.5869565217391305,0.9746286278161489,1.0,11/21,28.46%,GRIN1;HOMER2;GRIK2;GRIN2B;GRM7;CPEB4;GRIA2;GRIA3;GRM5;GRM8;PTK2B
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6074597640910178,0.9494887248786366,0.6056338028169014,0.9742479861079709,1.0,3/7,26.27%,SLC35D1;UGP2;PGM3
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.46673701397072026,0.949121812629286,0.6195652173913043,0.9745484767404516,1.0,13/64,15.77%,PSMB1;CD38;PDE4B;PSMB2;RC3H2;PRKCB;BTRC;PSMA7;NFKBIZ;PAG1;PSMA4;PDE4D;PSMD14
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6348511729858566,0.9490961808937182,0.6438356164383562,0.9740670981937426,1.0,1/5,1.19%,TEFM
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4806711504340928,0.9486932444833795,0.6170212765957447,0.9745527955106139,1.0,12/55,17.40%,PSMB1;AGO2;AP2A1;PSMB2;PSMA7;GNB1;SMURF2;FZD3;PSMA4;PPP3CA;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5931736795917302,0.948538300622373,0.6547619047619048,0.9744033115424758,1.0,3/11,28.46%,PRLR;CRLF3;PTK2B
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.39073029043484836,-0.9484834064452561,0.6428571428571429,1.0,1.0,3/33,2.05%,CAV2;NRP1;PGF
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.4996878033550405,0.9483089537540872,0.6,0.9743774834985583,1.0,3/26,15.77%,PRKACA;PSME3IP1;PSMD14
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5469446231356057,0.9481733905578287,0.5897435897435898,0.9741497227574512,1.0,4/14,13.46%,PTPN1;RHBDD1;TMBIM6;HSPA5
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.46911946368140384,0.9477211761504005,0.5777777777777777,0.9746399011401572,1.0,12/49,26.40%,USP15;TGFB1;RPS27A;ZFYVE9;USP9Y;SMAD2;SMAD7;NLK;SMAD6;JUN;ZMIZ1;FOS
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6385260552948594,0.9469897759848083,0.6176470588235294,0.9757347459562741,1.0,1/5,10.78%,EIF2AK4
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.4696054575999483,0.9469637540119303,0.5773195876288659,0.9752545797252844,1.0,16/61,18.38%,CD44;HSPA4L;AMFR;FKBP5;HOMER2;COX6C;PRLR;SEMA3B;FARP1;PAPSS2;PLAAT3;CD9;CKB;SCARB1;PDCD4;CA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.6296200673875965,0.9469218299718505,0.6351351351351351,0.9747973367670654,1.0,2/6,5.63%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.49372285416181166,0.946919428272363,0.6451612903225806,0.9742678727436423,1.0,8/40,21.08%,SOD1;ARHGAP15;SCARB2;TBC1D15;TDG;PAFAH1B1;VAV3;NF1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5957062769712204,0.946842231012757,0.5853658536585366,0.9739123285191904,1.0,4/8,30.68%,TNFRSF1B;SMAD7;MALT1;CD55
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4752242484735505,0.9468413935272633,0.5913978494623656,0.9733727649022822,1.0,16/84,15.00%,HDAC2;CSMD3;CRMP1;CBFA2T2;TENM3;CDH2;LRRC7;PRKCI;SCARB2;CTNNA2;EFNB2;KIF13B;PTPN9;ULK4;CFL1;LRRK2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.49469137954865827,0.9462799045429161,0.6179775280898876,0.9742859479392056,1.0,9/31,20.27%,PSMB1;PSMB2;EIF2AK2;PSMA7;PSMA4;RUNX1;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.558489844547383,0.9462476113237427,0.6309523809523809,0.9738305062242502,1.0,1/9,1.57%,KCNC2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.5659181893334131,0.9461221036606324,0.6296296296296297,0.9736266237960611,1.0,2/16,3.26%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.6282139544422185,0.9458627366330856,0.6582278481012658,0.9738857686868715,1.0,1/6,12.38%,RIOK3
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.45760888160327046,0.945612402274826,0.5888888888888889,0.9739495776195888,1.0,8/51,11.34%,NUP153;SEC13;NUP88;SYMPK;CPSF2;ALKBH5;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.610696600910496,0.945526324288367,0.5526315789473685,0.9730415789345942,1.0,2/5,26.72%,PHKB;PYGB
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.610696600910496,0.945526324288367,0.5526315789473685,0.9730415789345942,1.0,2/5,26.72%,PHKB;PYGB
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5552235436685508,0.9451954664554867,0.56,0.973278220273407,1.0,1/15,5.49%,SMOC1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.5620102272110881,0.9451927554364935,0.5974025974025974,0.9722057373860533,1.0,5/10,26.40%,EGFR;MAPK1;MT3;JUN;FOS
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.5620102272110881,0.9451927554364935,0.5974025974025974,0.9722057373860533,1.0,5/10,26.40%,EGFR;MAPK1;MT3;JUN;FOS
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6022727345197426,0.94503186990953,0.5921052631578947,0.9720147566818724,1.0,1/7,10.39%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.5816200646828189,0.9445211944459593,0.6219512195121951,0.9728954018753595,1.0,5/10,18.13%,PPARA;HIF1A;STAT3;PDCD4;PER1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.49318292371532485,-0.9443765761943894,0.42857142857142855,1.0,1.0,2/8,3.41%,CA5B;CYB5R4
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.5794451200543844,0.9439934262583336,0.5769230769230769,0.9734865654647188,1.0,4/12,14.44%,SLC7A2;SLC3A2;ABCC9;SLC36A4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.5026145131388849,0.9439185969307456,0.627906976744186,0.9731676543234177,1.0,10/24,31.98%,NFKBIA;IL18;NFKBIZ;PDCD4;SNX4;CD81;ETS1;IL6ST;CCN4;APP
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.47815282776664064,0.9435321748190476,0.6022727272727273,0.9736250052698925,1.0,13/39,20.55%,TBK1;OXSR1;GALNT11;ROCK2;LRRK2;ACVR1B;TNKS;MAPK1;MAP2K1;STK39;CSNK2A1;NLK;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4600248755077816,0.9434996426127977,0.6326530612244898,0.9731678888022796,1.0,11/65,14.89%,LPIN1;ATP6V1G1;ATP6V1H;PRKCI;SELENOS;IRS1;ATP6V1E1;DENND4C;PDK4;INSR;RAB12
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5100353703286724,0.9424897565521297,0.632183908045977,0.974986628593687,1.0,7/29,20.27%,S1PR3;GRIN1;LPAR6;SELENOT;C1QTNF1;ABL2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.502100365335897,0.942253166827747,0.5851063829787234,0.9750770441530121,1.0,8/40,18.30%,PRKACA;ADAM17;TRAF3IP1;GNB1;PRKAR2A;ADORA2B;LGALS3;PTH1R
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5024621728568963,0.9420873487176316,0.5824175824175825,0.974500373289732,1.0,7/23,31.62%,SEC13;NUP133;REEP3;NUP205;NUP160;PPP2R2A;RANGAP1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5024621728568963,0.9420873487176316,0.5824175824175825,0.974500373289732,1.0,7/23,31.62%,SEC13;NUP133;REEP3;NUP205;NUP160;PPP2R2A;RANGAP1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6118324697970902,0.9418871506222019,0.59375,0.9744583302390913,1.0,1/5,1.86%,TSC2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.3537284430962848,-0.941880716450667,0.3333333333333333,1.0,1.0,6/48,6.90%,NRP1;PHLDB2;ARHGEF10L;EVL;SLC9A1;WASF2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.46558597084588477,0.941745186416258,0.5977011494252874,0.973701189654031,1.0,8/48,11.34%,NUP153;SEC13;NUP88;SYMPK;CPSF2;ALKBH5;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.46558597084588477,0.941745186416258,0.5977011494252874,0.973701189654031,1.0,8/48,11.34%,NUP153;SEC13;NUP88;SYMPK;CPSF2;ALKBH5;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5851841435059169,0.9416542741560985,0.5972222222222222,0.973411479575366,1.0,3/12,18.80%,CSNK1D;RANBP9;GOLGA2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.4991405315286317,0.9414432018981739,0.6235294117647059,0.9733205159807409,1.0,3/29,6.61%,CHST11;COG7;MGAT1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5139261319263336,0.9414241951156667,0.5760869565217391,0.9728274998381371,1.0,6/33,15.11%,SEMA4D;TGFB1;DUSP1;NEXMIF;CORO2B;NF2
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4332373626744303,0.941177522442861,0.77,0.972863590548142,1.0,89/455,20.60%,HS3ST5;CSF1;CSNK1G2;PPP1CC;PRKACA;PDK1;PTPRD;PSMB1;HIF3A;PTPN1;DCLK1;WIPI1;SIK2;RHBDD1;CAMKK2;PSMB2;COG7;CDH2;CSNK1D;MGAT4A;SSH1;PRKCB;STK4;MGAT1;BTRC;CSNK1A1;EIF2AK2;PPP2R1B;MAPK6;PSMA7;PRKCI;TRIOBP;UGCG;TBK1;KLHL2;TGFB1;DUSP1;OXSR1;GLRX;NRBP1;EIF2AK4;HIF1A;ZBTB16;PTPRE;PDK3;PTAR1;MELK;CP;PTPN9;ROCK2;PSMA4;CST3;MAPKAPK2;FBXL13;PTPRZ1;PDK4;MAK;PPP3CA;INSR;LRRK2;PSMD14;RBX1;ACVR1B;ACVR2A;LATS2;TNKS;MAPK1;TIPARP;WDR45B;DCAF5;DCUN1D1;MAP2K1;ARF4;TULP4;SETD3;MANBA;STK39;FBN1;CSNK2A1;FBXO11;GOLGA2;ATG4B;PPM1E;SKP1;ABL2;NLK;ABL1;CAMK2D;METAP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.592056625892932,0.9410374120496723,0.6071428571428571,0.972585975473272,1.0,5/10,29.76%,TGFB1;HIF1A;SARS1;EIF2AK3;IL6ST
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.6042192150111441,0.9408539432621571,0.5540540540540541,0.9725231599783297,1.0,2/5,8.76%,NOS1AP;EGFR
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.49071838322603045,-0.940562401657502,0.5,1.0,1.0,2/11,3.19%,CTNNA3;CD58
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6282525013214726,0.9405157799566101,0.6052631578947368,0.9727297621090574,1.0,2/5,24.12%,CORO2B;SLC38A2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.4575912143542421,0.940386064808693,0.64,0.9724801431834259,1.0,26/151,17.23%,SRGN;DDX3X;AGO2;ZFP36L2;NDFIP2;GIGYF2;IGF2BP2;EIF2AK2;DNMT1;TGFB1;ROBO1;CNOT8;PTBP2;TMBIM6;HIF1A;MTF2;EIF4ENIF1;PTRH2;NDFIP1;ROCK2;DCP2;RUNX1;EED;TIPARP;LGR4;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6013999469502399,0.9403690716574131,0.6309523809523809,0.9719782129238477,1.0,2/9,11.04%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.594085452116393,0.9400402375499602,0.631578947368421,0.9721463586790523,1.0,4/8,20.55%,NEDD4L;HECW1;STK39;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4518271140642994,0.9399256685535607,0.6666666666666666,0.971875524340227,1.0,23/144,16.72%,CSF1;CD44;DDX3X;MYDGF;ITGA5;CAMKK2;RAF1;CSF1R;SEMA4D;CSNK1D;STK4;ADAM17;TBK1;TGFB1;EGFR;SDCBP;ROCK2;PDE8A;INSR;LRRK2;ACVR2A;MAPK1;MTCP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.5095150902297975,0.9398988705624358,0.5813953488372093,0.9714460068393993,1.0,5/26,17.71%,DDX3X;ADAM17;EGFR;ANKRD17;ANAPC4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.49042396507324637,-0.9395838024903884,0.5,1.0,1.0,1/10,2.33%,ATM
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5993473087786247,0.939420651986272,0.6708860759493671,0.9719922191379425,1.0,2/8,20.04%,ROCK2;SP1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.4572621048277191,-0.9392905332003397,0.5714285714285714,1.0,1.0,4/13,11.54%,MAPKAP1;LARP1;TIPRL;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5252040180022328,0.9391688282598071,0.6144578313253012,0.9720011872188821,1.0,11/26,31.34%,ROBO2;PRKCI;TP63;ROBO1;STAT3;RBPJ;TSPAN5;ZMIZ1;IL6ST;KAT2B;BMP2K
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.49654906055557757,0.9390799502388805,0.6222222222222222,0.97169818109558,1.0,8/35,19.70%,PRKACA;CAMKK2;EGFR;MCTP2;PPP3CA;LRRK2;PRNP;KDR
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5574627692931292,0.9389610306415782,0.6219512195121951,0.9714228540767166,1.0,1/11,1.55%,HDAC2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.6083990940483774,0.9387087440944929,0.6176470588235294,0.971453984686593,1.0,2/7,11.68%,TGFB1;UHMK1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5282730461300289,0.9386405531791027,0.5813953488372093,0.9710807332514942,1.0,2/17,5.63%,RHOB;CSF1R
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5676473900205169,0.9384035967243888,0.6086956521739131,0.9711557050469402,1.0,2/8,14.62%,RARB;FGFR2
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.46964091712854805,0.9383505854297537,0.6382978723404256,0.9708266849931458,1.0,23/68,27.47%,SOD1;ATP6V1H;COG2;EGFR;ARFGAP3;SEC24D;NAPG;MAPK1;AP2B1;ABCA1;ARF1;DST;SNAP23;BNIP3;STX12;LAMP2;USO1;KIF1B;AP2M1;TOM1L1;CLTC;GOLGA4;RAB14
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.5694601167819647,0.938297554902126,0.6463414634146342,0.9704216466172101,1.0,5/9,23.42%,NECTIN2;PTPN2;LGALS3;PRNP;CD81
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.6201009425758731,0.9380626416472997,0.6338028169014085,0.9704804960437075,1.0,3/7,17.56%,PAG1;CEBPB;LGALS3
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.4945178901891189,0.9379689085708325,0.6436781609195402,0.970212317498886,1.0,13/29,34.13%,TGFB1;SNX25;CD9;LDLRAP1;GRB2;CD81;DNM2;AP2M1;ADM;CLTC;NEDD4;RAB31;SMURF1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.45782254901309666,0.9376630009916663,0.6428571428571429,0.970423717392856,1.0,23/120,16.53%,DOK6;NRCAM;NRXN3;SPTBN4;ANK3;ATL1;NIBAN2;SEMA4D;ROBO2;NCAM1;APBB1;CTNNA2;ROBO1;EFNB2;EPHA7;SEMA3B;RANBP9;SIAH1;FGFR2;UNC5B;C9ORF72;MAPK1;NRXN1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.5998071554344058,0.9376580091103469,0.6533333333333333,0.9699272309055086,1.0,4/7,34.55%,CTR9;JARID2;MTHFR;CHTOP
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.537327403022476,0.9376043438562551,0.6025641025641025,0.9695346511857232,1.0,4/14,28.29%,CRY1;ABL1;WRNIP1;MCL1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5798332349316823,0.9371861340651777,0.5822784810126582,0.9698820159035866,1.0,4/6,38.73%,PHKB;PYGB;RB1CC1;AGL
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5581460917588676,0.9370563417425911,0.6233766233766234,0.9696692295384745,1.0,5/11,33.06%,OTUD7A;MINDY2;USP25;USP8;USP37
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5445949186051208,0.9366813174399479,0.627906976744186,0.9700704656644626,1.0,3/18,5.38%,NRCAM;CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.4891262449249118,0.9365112029204284,0.651685393258427,0.9699718133141996,1.0,6/27,14.52%,FMN2;EGFR;RNF168;SPIRE1;SMCHD1;BRCC3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.5136116622456015,0.9364954516891507,0.5697674418604651,0.9694880242585563,1.0,5/18,21.88%,APIP;SOD2;RYR3;GOLGA2;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5289191052009982,-0.9364029544415611,0.4857142857142857,1.0,1.0,1/5,2.99%,ZDHHC21
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5717011841828082,-0.9359425100619588,0.625,1.0,1.0,1/7,0.42%,A2M
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.31885456440804105,-0.9357341068001427,0.625,1.0,1.0,14/61,9.18%,TAGLN;FAM13C;FGF1;RCAN2;LAMC1;LMOD1;PDZRN3;TMEM132C;SCN7A;NFASC;SLCO1C1;NDRG1;SLC6A1;ITGA7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.4781850690236481,0.9356401173214288,0.5913978494623656,0.9710546638896222,1.0,10/49,18.19%,DPP10;ANK3;PRKCI;TP63;EGFR;PTPN9;TCAF1;ZDHHC5;LGALS3;PRNP
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5314791833002358,0.935614083108755,0.6329113924050633,0.9705708128928378,1.0,6/15,32.94%,TGFB1;KDR;ADM;SPRED1;VEGFA;CCM2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5266177189075498,-0.9354616180329146,0.56,1.0,1.0,1/6,0.93%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5715182698290959,0.9351409552270474,0.6923076923076923,0.9710950832912058,1.0,2/13,15.04%,NFKBIA;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4942324856383415,0.9350115919331519,0.5862068965517241,0.9708986882255951,1.0,7/26,15.79%,PSMB1;PSMB2;FHL1;PSMA7;PSMA4;PSMD14;RBX1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.49380655557221426,0.9341990614597631,0.6329113924050633,0.972223107535702,1.0,6/26,15.77%,PSMB1;PSMB2;PSMA7;RPS27A;PSMA4;PSMD14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5441391902227958,0.9341685819672795,0.5764705882352941,0.9717829357724199,1.0,2/15,5.07%,STC1;PDE4B
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5922154416018208,0.9338791483694706,0.6111111111111112,0.9718351454715609,1.0,3/6,31.23%,SETD3;SETD2;KMT2A
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6216718783206402,0.9337598217846629,0.6410256410256411,0.9715901504363054,1.0,2/5,35.42%,DGKH;PLPP1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.47151857626590665,0.9336262554324757,0.6195652173913043,0.971367016961618,1.0,9/62,12.52%,TAF7;NR4A3;ESR2;PPARA;NRBP1;PPARGC1A;RARB;CCN2;CCNH
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5672504533859916,0.9334341425954893,0.5866666666666667,0.9703270579401367,1.0,1/10,7.57%,DNMT1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5672504533859916,0.9334341425954893,0.5866666666666667,0.9703270579401367,1.0,1/10,7.57%,DNMT1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5672504533859916,0.9334341425954893,0.5866666666666667,0.9703270579401367,1.0,1/10,7.57%,DNMT1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5649711189849042,0.933104075609064,0.620253164556962,0.9705900207477582,1.0,5/10,37.92%,SIAH1;BNIP3;APP;NAE1;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.48769208715573603,0.9330649850667534,0.6352941176470588,0.9701633717626018,1.0,13/41,25.74%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;RNF180;ELOB;ARIH2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4574365551871087,0.9328403677167766,0.5730337078651685,0.9701570150383025,1.0,8/50,11.34%,NUP153;SEC13;NUP88;SYMPK;CPSF2;ALKBH5;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.5410736413958646,0.9327223095307564,0.5641025641025641,0.9700000347822457,1.0,2/10,13.96%,KDM1A;MDM2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.5526988757633455,0.9325933250648833,0.6,0.9697518165139086,1.0,5/15,26.07%,CP;TRPC4;TF;MT3;IREB2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4938782472190161,0.931903801985384,0.5862068965517241,0.9707774822024001,1.0,8/35,15.00%,CSF1;TNFRSF1B;BNIP3L;PPARGC1A;ADNP2;CCN2;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.5154810200597713,0.9313762945848697,0.5882352941176471,0.9715872131826474,1.0,1/21,0.36%,SRGN
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4547676318257804,0.9297883600219031,0.6236559139784946,0.9747205136876033,1.0,11/44,21.63%,NUP153;SEC13;NUP88;NUP133;DNAJC7;MAPKAPK2;MAPK1;RPA1;HSPH1;CAMK2D;NUP205
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.5985438279841693,0.9295072994066103,0.5970149253731343,0.9748136948210199,1.0,8/10,34.63%,EGFR;VAPA;PRNP;TRAM1;ALDH3A2;TRAM2;APP;SERP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6248294534284953,0.9294056493262716,0.7,0.9744938648380754,1.0,1/6,6.48%,RUBCN
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.5973683018197418,0.9292646198772405,0.6,0.9743244447889566,1.0,4/5,40.28%,BNIP3;ZDHHC6;PID1;HUWE1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.36400197781678734,-0.9289829903962276,0.6,1.0,1.0,2/32,1.81%,FGF13;SLIT2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.4381349586730412,0.9289436076398467,0.7346938775510204,0.9744605421919642,1.0,31/217,16.73%,WWC1;TAF7;RHOB;HDAC2;NFKBIA;RHOJ;DDIT4;WWC2;ARHGAP31;ARHGAP15;STK4;ARHGEF9;FAM13A;MCF2L;TP63;EGFR;RNF34;TMSB4X;NLGN1;ULK4;MAP2K6;ARHGEF7;GNAI1;MDM2;MDM4;AKAP6;LRRK2;NF2;ARHGEF4;MAPK1;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.6328747343714288,0.9289168259156299,0.6811594202898551,0.9740182679751673,1.0,3/6,30.38%,F3;KDR;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5757304483360192,0.9278763171364118,0.6666666666666666,0.975727611136633,1.0,4/9,25.71%,ROCK2;LGALS3;BOD1L1;MGAT5
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5003539755636783,0.9275227578234023,0.6436781609195402,0.9760018032768629,1.0,8/43,20.64%,SYT1;ADGRV1;NLGN1;PPP3CA;TTN;RYR3;CAMK2D;AHCYL1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.4658891562717375,0.9275158158025113,0.6847826086956522,0.9754845792157729,1.0,10/65,13.97%,PPME1;PRKACA;TUBA1A;CCP110;CSNK1D;BTRC;CEP57;MELK;CCNH;CEP70
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.629023628737277,0.9274968178966957,0.6268656716417911,0.9750213291805297,1.0,1/5,11.85%,ZFPM2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4851012038003065,0.9274852591995598,0.5897435897435898,0.9745265309147224,1.0,8/26,23.70%,KANSL3;APBB1;MORF4L1;EP400;PHF20;PER1;JADE2;LEF1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5133360913878189,0.9273616916071987,0.5977011494252874,0.974315115037125,1.0,4/21,15.71%,TRMT9B;WDR6;TRMT13;TYW1B
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.553348459272397,0.9272875040915739,0.6022727272727273,0.9739599010884163,1.0,4/13,28.46%,RAP1B;ROCK2;KANK1;PTK2B
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6071016271211733,0.9272489308105628,0.6410256410256411,0.9735410868292879,1.0,4/6,26.23%,PTPRD;LRFN5;GPC4;LRRC4C
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5899605652751512,0.926979822961638,0.6133333333333333,0.9735436665895265,1.0,2/7,22.12%,HIF1A;TF
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.5358538667038729,-0.9269038758392413,0.6060606060606061,1.0,1.0,2/5,3.77%,BCL2L11;RHOT1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.45339334077678245,0.9267415017691035,0.7010309278350515,0.9735249408774361,1.0,22/119,16.28%,SOD1;AKAP8;SPTBN4;MYDGF;CAMKK2;CSF1R;SEMA4D;CSNK1D;STK4;ADAM17;TGFB1;EGFR;TRAF3IP1;EPHA7;CEBPB;ROCK2;PDE8A;INSR;LRRK2;C9ORF72;TTN;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5901656291265345,0.9266773174890335,0.6338028169014085,0.9731070191792516,1.0,3/10,20.05%,DDIT4;PDE4D;SMAD7
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.406552598667776,-0.9263782618844189,0.6111111111111112,1.0,1.0,6/19,8.42%,ATP2B4;KCNJ8;ATP1B2;SLC9A1;HCN2;SLC6A1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5872675946285175,0.9262235108046081,0.6164383561643836,0.9736365106503896,1.0,1/8,6.00%,SCD
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.441442914582266,0.9261957483102308,0.7575757575757576,0.9732030189573817,1.0,62/266,23.70%,CSF1;S1PR3;HDAC2;TSC2;NRG1;NR4A3;EAPP;RAF1;NIBAN2;CSF1R;FLT1;EIF2AK2;CCAR1;ADAM17;SOD2;CTBP2;TGFB1;EGFR;IRS1;EFNB2;CNOT8;MYO16;CDC123;SDCBP;PRLR;WDR6;TBRG1;BCL6;RUNX1;TBX3;MDM2;MDM4;CAMK2N1;STAT3;FGFR2;INSR;NF2;MAP2K1;PTPN2;IFIT3;LIFR;CSNK2A1;ST18;ACER3;KDR;JUNB;CDKN1B;NAP1L1;TBC1D8;ITGAV;CTCF;COL18A1;RPS6KA2;TP53INP1;GAB2;IRS2;ALDH1A2;COL4A3;SMAD6;MCTS1;CD81;LEF1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.46628075177423056,0.9260633429747992,0.64,0.9729294179500513,1.0,9/59,14.87%,NRG1;MYDGF;IL18;TGFB1;EGFR;IRS1;F3;FGFR2;INSR
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.6337207911768878,0.9260438522380263,0.7301587301587301,0.9724489501720922,1.0,3/5,30.18%,PDCD4;DNAJA1;AIDA
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5469510277010243,0.9257634711448673,0.5866666666666667,0.9725688903566589,1.0,3/9,18.04%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.49245150377270736,-0.9257241972038113,0.6842105263157895,1.0,1.0,2/11,8.62%,PLA2G4C;MGLL
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.5231970426908426,-0.925548971732313,0.5,1.0,1.0,1/5,0.56%,IL34
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4616375986259335,0.9248748464667893,0.6521739130434783,0.9739356323126757,1.0,8/55,8.98%,CBFA2T2;PTPRD;TENM3;LRRC7;ROBO2;PRKCI;SCARB2;ROBO1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5266257014702114,-0.9247878699964275,0.5454545454545454,1.0,1.0,2/5,12.13%,RFTN1;FLOT1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.49293994654117534,0.9243531313987283,0.6559139784946236,0.9745637802570655,1.0,17/35,41.95%,COG7;ARFGAP3;NSF;ARF4;ATP9B;SURF4;GOLPH3;RAB6A;COG3;GOLPH3L;RAB1A;COPA;ARCN1;PLPP3;UVRAG;COPB1;ERGIC2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5123949392452081,0.9242489698038838,0.6444444444444445,0.9743007840559734,1.0,5/21,9.34%,CSMD3;NEDD4L;ADGRB3;SEMA4D;LZTS1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4691969965750263,0.9236923660318122,0.5934065934065934,0.9750870118797738,1.0,14/30,31.73%,PHF20L1;APBB1;MORF4L1;EP400;BRD1;PHF20;PER1;YEATS2;JADE2;LEF1;KAT6A;KAT2B;SUPT3H;MORF4L2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.47476842727092355,0.9234072416226189,0.625,0.9751470081658762,1.0,5/50,2.84%,CNTN3;PHYHIPL;RHOJ;PTPRD;LSAMP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.5884492909380489,0.9230181817674653,0.6133333333333333,0.9755085944465659,1.0,5/6,40.85%,ABCA1;LDLRAP1;NPC1;RELCH;LRP6
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6003654315845047,0.9226100025438737,0.6710526315789473,0.975933274089946,1.0,1/7,1.33%,MMUT
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5513357297335478,0.9225722234290173,0.6190476190476191,0.97550107780846,1.0,5/15,17.35%,SEMA4D;ROBO2;ROBO1;SEMA3B;PTPN2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.6115911193689467,0.9219438859899153,0.6973684210526315,0.9764325651412292,1.0,1/6,3.55%,GFAP
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5102607883019131,0.9216895361152142,0.6190476190476191,0.9764441702251849,1.0,4/24,11.77%,HDAC2;RCOR1;MORF4L1;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6137940848957748,0.9215829284395904,0.6438356164383562,0.9761865693306906,1.0,2/6,33.28%,MTMR2;RDX
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.48919946780388907,0.9213938030270371,0.6022727272727273,0.9760611266388531,1.0,9/34,17.40%,PSMB1;AP2A1;PSMB2;PSMA7;SMURF2;FZD3;PSMA4;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5300078934787213,0.9213927601177322,0.6282051282051282,0.9755561740641687,1.0,7/16,33.25%,DUSP1;ULK4;PER1;CYLD;VEGFA;PHLPP1;DLG1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.44318068267287297,0.9211306958691937,0.648936170212766,0.975473352109422,1.0,15/67,17.23%,WWC1;MYDGF;FLT1;STK4;APIP;EGFR;DUSP1;EPHA7;ULK4;ROCK2;FGFR2;TRIM5;INSR;MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5214587150946248,0.9208519406748893,0.5921052631578947,0.9755381006400032,1.0,4/13,29.85%,RPS27A;MAP2K6;TAB2;CYLD
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.5816422310173428,-0.9207585563595415,0.5588235294117647,1.0,1.0,2/5,6.39%,NCK1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5963285298379521,0.9204157369865232,0.6666666666666666,0.9760134154032645,1.0,1/7,28.71%,UBQLN1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.5476825624705346,-0.9203911881199263,0.5185185185185185,1.0,1.0,1/5,10.25%,EXT2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.424861568847217,0.9202414891206468,0.66,0.9758199869529022,1.0,24/125,20.05%,NFKBIA;CCP110;PSMB1;USP15;PSMB2;PSMA7;DESI2;RPS27A;HIF1A;OTUD7A;SMURF2;PSMA4;SENP1;MDM2;MDM4;BRCC3;USP3;PSMD14;WDR48;USP10;USP9Y;SMAD2;JOSD1;SMAD7
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5014041726851599,0.9199033010125383,0.6463414634146342,0.9760106705981799,1.0,5/25,19.20%,NR4A3;SIN3A;RUNX1;CBFB;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6140980356707992,0.9195997424432952,0.6,0.9761591050629308,1.0,2/5,33.28%,MTMR2;RDX
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.4514172216578753,0.9190676119956162,0.6701030927835051,0.9768169810401978,1.0,11/73,20.05%,CD44;ZFP36L2;FLT1;TGFB1;EGFR;PDE8A;MAPKAPK2;ACVR1B;ACVR2A;KDR;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5869037625426863,0.9190248906316336,0.6666666666666666,0.9763767478728054,1.0,3/8,25.03%,NIBAN2;NAP1L1;RFX3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.47145618980536813,0.9186025283098512,0.6292134831460674,0.9767504285518326,1.0,11/41,20.52%,RRAS2;TNFRSF1B;BNIP3L;TBK1;ADNP2;CCN2;PDE8A;LRRK2;ACER3;CDKN1B;BNIP3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.4254650185601163,0.9181850127847692,0.6666666666666666,0.9771079844699858,1.0,24/121,20.05%,NFKBIA;CCP110;PSMB1;USP15;PSMB2;PSMA7;DESI2;RPS27A;HIF1A;OTUD7A;SMURF2;PSMA4;MDM2;MDM4;BRCC3;USP3;PSMD14;WDR48;USP10;USP9Y;MINDY2;SMAD2;JOSD1;SMAD7
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.5266839558060159,0.9181693463494996,0.6352941176470588,0.9766525585490952,1.0,7/16,26.99%,SOAT1;SCARB1;ABCA1;LDLRAP1;STX12;ABCA5;OSBPL5
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.521295487059627,-0.9179372525672043,0.5555555555555556,1.0,1.0,1/6,0.92%,CSRP2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.5246194880575228,0.9178853633954255,0.6153846153846154,0.9767897170672097,1.0,2/12,11.68%,XPO4;UHMK1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5628000955141935,0.9176196509055161,0.6438356164383562,0.976900547146397,1.0,2/7,10.75%,WNT2B;CSDE1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5160555672938525,0.9176011253624283,0.5769230769230769,0.9764354689227304,1.0,2/12,13.96%,KDM1A;MDM2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4884893677394343,0.9172545763114003,0.632183908045977,0.976692857312851,1.0,9/36,17.40%,PSMB1;AP2A1;PSMB2;PSMA7;SMURF2;FZD3;PSMA4;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4116075913797289,-0.9168690248080521,0.5,1.0,1.0,2/11,4.11%,HECW2;CDC27
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.5615322672813097,0.9168119179851332,0.618421052631579,0.9770650180985693,1.0,3/7,39.92%,TGFBR1;BMPR1A;TGFB2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5614273661879876,0.916653168631128,0.6056338028169014,0.9769193847925426,1.0,1/6,14.42%,STAT3
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.3549099879649227,-0.9163899037819668,0.75,1.0,1.0,3/43,3.37%,TNFRSF19;SH3RF3;MECOM
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5433318274433697,0.9163675290522982,0.6385542168674698,0.9770350843865646,1.0,1/13,1.54%,PRKACA
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.5237449091329538,0.9160866801737234,0.5842696629213483,0.977067129208604,1.0,3/15,18.83%,TGFB1;ARHGEF7;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4688021965983964,-0.9159406299933525,0.55,1.0,1.0,1/6,2.12%,PARP9
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.5009573763952673,0.9157746295825533,0.6404494382022472,0.9771095773482281,1.0,11/25,25.85%,CDH2;FLT1;TGFB1;EFNB2;RBPJ;KDR;SMAD7;NF1;COL4A1;SLC1A1;ADM
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.49095685010902995,0.915678114736534,0.5888888888888889,0.9768286182102551,1.0,5/31,10.22%,CDH2;ROBO2;ROBO1;KIF13B;OMG
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5353237806131125,0.9155705230450079,0.654320987654321,0.9764645439808062,1.0,7/16,29.76%,CD38;IL18;VAV3;IRS2;CD81;NCK2;IL6ST
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5268797561651124,0.9153975298967101,0.6385542168674698,0.9763561432330581,1.0,2/15,10.84%,CNOT8;TUT7
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.5326645256613729,-0.91534374818497,0.5384615384615384,1.0,1.0,2/6,13.24%,RYR2;DAB2IP
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.4452366162812751,0.915170221831384,0.6770833333333334,0.9763467961639783,1.0,24/64,24.78%,FMN2;PTPRD;LSAMP;RAB27A;ADGRB3;SCN3A;ROBO2;CADM2;PDZRN4;ZNF536;FGF14;TBRG1;SGIP1;CPEB4;NRXN1;INTS6L;NOVA1;GRIA2;KCNT2;COL11A1;JAM3;TRPM3;GRIA3;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.4931738913353608,0.9149943542323772,0.6086956521739131,0.9762229537214466,1.0,7/28,26.49%,CCP110;SDCBP;TAPT1;ASAP1;GPSM2;CNOT1;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5889813094612842,0.9147720324266398,0.6410256410256411,0.9761720682684106,1.0,6/9,25.85%,PPARA;IRS1;PPM1K;LDLRAP1;IRS2;ADM
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5400140951716952,0.9145976297083209,0.654320987654321,0.9759964494857265,1.0,6/16,20.55%,PRKACA;DIAPH1;AKAP6;PDE4D;UBASH3B;CAMK2D
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6377926390426457,0.9142570298517586,0.6865671641791045,0.9761795859709623,1.0,1/5,11.04%,HIF1A
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.555076338654194,0.9138528828067509,0.6206896551724138,0.9765235494985907,1.0,4/12,28.46%,RAP1B;ROCK2;KANK1;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.46782618754155053,0.913249485185724,0.6506024096385542,0.9772357469495062,1.0,5/25,10.86%,HABP4;TGFB1;EGFR;WDR43;GRSF1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.45772749393515444,0.9129171732721328,0.6067415730337079,0.9773245665470172,1.0,5/33,11.04%,RHOJ;ADAM17;TGFB1;TMSB4X;HIF1A
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.41298776757106903,-0.9121554031887831,0.4117647058823529,1.0,1.0,1/23,0.12%,TAGLN
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.49612338839556086,-0.9119276736340326,0.5517241379310345,1.0,1.0,2/6,11.24%,TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.49612338839556086,-0.9119276736340326,0.5517241379310345,1.0,1.0,2/6,11.24%,TPR;IWS1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5162933202420013,0.9115692994039963,0.6626506024096386,0.9794980836100274,1.0,3/23,2.90%,ADGRV1;DHRS3;OPA3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.584563493167436,0.9115613182880108,0.6571428571428571,0.9790051111634319,1.0,3/6,33.68%,AHCYL1;VMP1;PDZD8
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.418473940101979,-0.9114285517394961,0.55,1.0,1.0,1/21,0.67%,TNFRSF19
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.6155814398569047,0.9112870777561806,0.6470588235294118,0.9790928851404979,1.0,3/6,36.76%,TDG;POT1;TERF1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5405353730567353,0.911240342902118,0.6216216216216216,0.9786886537693196,1.0,4/12,30.26%,MED14;TWIST1;JUN;SETX
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.615758806857922,0.9109158929262952,0.7058823529411765,0.9788334294259052,1.0,3/5,36.76%,TDG;POT1;TERF1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.44305800516272464,0.910573191689769,0.7368421052631579,0.9790659932467147,1.0,11/104,10.95%,DARS1;RPS21;AGO2;ETF1;RARS1;FARSB;PPA1;RPL28;RPS27A;RPL21;RPL41
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.47100353928776334,0.9103413925483765,0.6521739130434783,0.9789570925307198,1.0,6/37,13.96%,RHBDD1;MARCHF6;RPS27A;CTSL;OTUD7A;MDM2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.5132560062413954,-0.910321314175901,0.6206896551724138,1.0,1.0,1/7,0.93%,PLA2G4C
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5523126522418558,0.9103108870435859,0.6296296296296297,0.9785640939569953,1.0,2/10,23.77%,MTFR1;DNM2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.368838804880162,-0.9102217196872552,0.5,1.0,1.0,4/22,9.06%,VIT;FBLN2;TBCD;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.36030667147867246,-0.9101591379418662,0.7,1.0,1.0,6/36,5.47%,LMOD1;SYNPO2;EVL;BAIAP2L2;RPS3;NCK1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5825633831053019,0.9101309514345846,0.7236842105263158,0.9783884193722048,1.0,3/7,20.05%,ACVR1B;ACVR2A;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.6471588117395443,0.910032661131762,0.647887323943662,0.9780683842519364,1.0,2/5,11.77%,CRY1;SIN3A
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.4598311789975162,0.9098955616816766,0.6276595744680851,0.9777589955627551,1.0,5/48,14.73%,DDX3X;TBK1;SERINC3;ANKRD17;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.5518438031129862,-0.909800831732055,0.56,1.0,1.0,1/5,0.73%,CDK6
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4580990377245291,0.9096573360438487,0.7157894736842105,0.977718080822089,1.0,7/48,14.87%,CSF1;CSF1R;FLT1;EGFR;EPHA7;FGFR2;INSR
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5410485212879282,0.9093064013315842,0.64,0.9779761539214865,1.0,4/12,30.38%,HIF1A;RBPJ;MT3;VEGFA
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.4757618629277483,-0.9092822674291658,0.625,1.0,1.0,1/10,1.66%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.5939836900702022,0.9090775058942416,0.6901408450704225,0.9778578959234699,1.0,1/6,9.96%,RAP1B
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.5509273210423288,0.9090006390076883,0.654320987654321,0.9775698423277832,1.0,3/11,13.15%,GGA3;SCARB2;RAB7A
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.5339025077806862,0.9088554723978456,0.64,0.9774158878342138,1.0,4/10,31.93%,CSNK2A1;IHO1;RAD18;ZNF207
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.46061447771742087,0.9087721833267903,0.6847826086956522,0.9771334971485467,1.0,12/61,14.84%,PPP1CC;PTPRD;PTPN1;SSH1;BTRC;PPP2R1B;DUSP1;PTPRE;PTPN9;PTPRZ1;FRA10AC1;PPP3CA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5859291871091952,0.9080021121866713,0.68,0.9782651986545063,1.0,4/8,20.55%,NEDD4L;HECW1;STK39;CAMK2D
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.6053823988867391,0.9077318626241649,0.696969696969697,0.9782704183313143,1.0,4/6,33.79%,CCDC91;GAK;LAMP1;AP1G1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.5578804826181418,0.9076909937993769,0.6395348837209303,0.977859627116049,1.0,2/8,23.42%,ANKRD17;CD81
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.442162204027746,0.9071570285965781,0.7111111111111111,0.9784759055374036,1.0,18/57,27.95%,PSMB1;NR4A3;PSMB2;BTRC;PSMA7;PSMA4;PPP3CA;PSMD14;MAPK1;VAV3;SKP1;GAB2;GRB2;TAB2;JUN;FOS;PAK1;PLCG1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.5911275781375918,0.9063959679911004,0.6470588235294118,0.9791066020502488,1.0,3/7,36.76%,POLR2F;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.5911275781375918,0.9063959679911004,0.6470588235294118,0.9791066020502488,1.0,3/7,36.76%,POLR2F;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5384566545304749,0.9063502872316757,0.65,0.9787013463189312,1.0,5/14,23.64%,CCNH;CAMK2N1;CDKN1B;CCNK;CCND3
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6105652270388616,0.9061663805148061,0.7142857142857143,0.9784450642789414,1.0,2/6,11.77%,TMSB4X;SIN3A
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.5851044741221234,0.9060641016713975,0.6582278481012658,0.9782248840272529,1.0,1/6,13.66%,SLC25A4
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.48682029457810694,-0.9057048334968647,0.6923076923076923,1.0,1.0,5/15,14.25%,GLB1;ST6GALNAC3;GALC;LARGE1;ST3GAL5
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5184557833423575,0.9052761585033777,0.7045454545454546,0.9793457465927256,1.0,4/22,12.25%,PDLIM1;SEMA4D;SGPL1;SEMA3B
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5840285001237279,0.9051797849013691,0.6756756756756757,0.9790486073700305,1.0,2/9,15.48%,ENO1;MYL3
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.4141993913415553,-0.9042667067235856,0.6086956521739131,1.0,1.0,5/19,13.26%,ATM;TOPBP1;FOXN3;BABAM2;MRE11
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.49543848802536106,0.9038726365931588,0.7142857142857143,0.981037031652191,1.0,2/25,5.63%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.47531197384086604,0.9029898998479278,0.6235294117647059,0.9825891037528348,1.0,7/27,20.27%,PTPRD;SYNDIG1;NLGN1;CNTNAP2;NRXN1;KDR;ABL1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.48550706685732914,0.9029813797907188,0.6666666666666666,0.9821069120819742,1.0,10/24,32.46%,CD9;LDLRAP1;GRB2;CD81;DNM2;AP2M1;ADM;CLTC;NEDD4;RAB31
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5624881145149614,0.9027179745827606,0.5555555555555556,0.9821254672772927,1.0,4/8,26.35%,BCL6;ZBTB1;LEF1;ZMIZ1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.5516406481121203,0.9025463983082644,0.6666666666666666,0.9819144092113901,1.0,2/9,15.07%,MDM4;HECTD1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.5724303801363613,0.9023841358572887,0.6619718309859155,0.9817596592749495,1.0,3/7,38.37%,AHCYL1;PAPOLA;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.3984465743986336,-0.9019197668371185,0.5555555555555556,1.0,1.0,1/10,0.56%,IL34
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5568440272872064,0.9018816930373784,0.6621621621621622,0.9822778622779736,1.0,4/10,27.95%,FLT1;ABL2;ABL1;PLCG1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.517558679123599,-0.9013340874523348,0.56,1.0,1.0,2/6,11.54%,LARP1;RPTOR
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5789053810339629,0.9010022117773802,0.6621621621621622,0.983149761237792,1.0,2/5,23.26%,ABO;FUT8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.5789053810339629,0.9010022117773802,0.6621621621621622,0.983149761237792,1.0,2/5,23.26%,ABO;FUT8
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.48956286410819144,0.9007019016501662,0.6043956043956044,0.9832695186758076,1.0,10/25,35.98%,ARID1A;SMARCA4;SUPT16H;NAP1L1;CTCF;SETD2;ARID2;MCM3AP;ANP32B;MACROH2A1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5905361213005994,0.9006159538640134,0.5675675675675675,0.9829567890373603,1.0,3/5,33.16%,TCF4;SETD2;MCM3AP
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.504920640147241,-0.90030710527137,0.6923076923076923,1.0,1.0,3/8,17.35%,NBL1;GLI2;BMPR1B
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4835127574721234,0.9002397302335321,0.6413043478260869,0.9832392141658438,1.0,12/29,29.89%,PRKACA;ADAM17;GNB1;PRKAR2A;ADORA2B;PTH1R;CD81;ADM;PRKAR1A;PLCG1;ADCY5;PRKAR1B
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.4088519636304607,-0.9000641372070228,0.7,1.0,1.0,3/24,4.31%,EDN3;RCAN2;RYR2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.46889113063834925,0.9000378564716774,0.6847826086956522,0.9831758102079514,1.0,6/29,14.62%,MCC;NR4A3;TGFB1;EGFR;DEAF1;FGFR2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.5520081920742569,0.8994001608272731,0.6710526315789473,0.9839809754216007,1.0,4/7,39.53%,TNKS;XRCC5;POT1;ATR
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.5908920960556637,0.8993503612360504,0.6933333333333334,0.983577141675952,1.0,5/8,25.22%,SOAT1;SCARB1;ABCA1;STX12;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5924696698450956,0.8993492937686981,0.6515151515151515,0.9830823845624329,1.0,1/5,5.32%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4594165098395087,0.8991999072907768,0.6292134831460674,0.9828366195184669,1.0,7/29,28.30%,MICALL2;TP63;YWHAG;UBE2D3;ARIH2;UBE2L3;PPP3CC
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.627332465551249,0.8991655410112963,0.7285714285714285,0.9823883506952962,1.0,1/5,12.44%,ROCK2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5610611378390009,0.8991207984439392,0.6875,0.981996260627319,1.0,2/8,26.35%,UBA2;ZMIZ1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.41982874012901117,0.8988542946812664,0.7010309278350515,0.9819894039310672,1.0,13/132,13.12%,TAF1B;DUT;DARS1;RPS21;AGO2;FARSB;PWP1;RPL28;RPS27A;RPL21;RPL41;FUBP3;TBRG1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.42484201706127656,0.8987560839026851,0.7575757575757576,0.9817041914363567,1.0,23/139,18.69%,CSF1;PSMB1;HIF3A;RHBDD1;PSMB2;CDH2;MGAT4A;BTRC;PSMA7;KLHL2;HIF1A;ZBTB16;CP;PSMA4;CST3;FBXL13;PSMD14;RBX1;DCAF5;DCUN1D1;TULP4;FBN1;FBXO11
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5221420718701343,0.8987111138706669,0.5882352941176471,0.9812725655706471,1.0,4/12,38.28%,NCKAP5;CLIP1;ZNF207;SPAG16
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.4514023111785314,-0.8987083920609783,0.6956521739130435,1.0,1.0,2/8,8.06%,EPHA5;CRTC1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.45585547921652336,0.8980921236436712,0.7222222222222222,0.9819739311513951,1.0,11/44,26.01%,NUP153;PIAS2;NUP88;NUP133;SENP1;METTL21A;UBA2;LOXL3;NUP205;SENP2;NUP160
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5838642855765535,0.8979347065610633,0.7037037037037037,0.9818205469348522,1.0,1/9,1.54%,PRKACA
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5322121762517746,-0.8974100300841744,0.5862068965517241,1.0,1.0,1/8,2.33%,ATM
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.47931269091055084,0.8970997109503288,0.6470588235294118,0.9829805768885743,1.0,2/31,1.75%,GLRB;GRIN1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5667241297955292,0.8970335036028008,0.6486486486486487,0.9826249034187733,1.0,3/7,26.99%,PLAAT3;LPCAT3;OSBPL5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3553254878250162,-0.896994575363996,0.6666666666666666,1.0,1.0,5/37,6.54%,SPRY1;PHLDB2;EPHA3;TIAM1;DAG1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4757809167468067,0.8969367660006846,0.6813186813186813,0.9822645398517599,1.0,12/33,29.31%,EPN1;ERRFI1;EGFR;ARHGEF7;MVB12B;PTPN2;GRB2;EPS15;SH3KBP1;CCDC88A;STAM2;RNF115
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.630241058092566,0.8968439164379213,0.6571428571428571,0.9819701011815528,1.0,2/5,22.19%,RAP1B;JAM3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5112239852967653,0.8964291377344402,0.6575342465753424,0.9822859063297992,1.0,4/13,29.85%,RPS27A;MAP2K6;TAB2;CYLD
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4742012625166149,-0.8962563457111051,0.5294117647058824,1.0,1.0,3/10,20.75%,ACTN4;MYO1D;MYO1E
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5655053540441659,0.8961805006705251,0.6486486486486487,0.9822638240428664,1.0,5/8,37.93%,DHX29;MCTS1;EIF4B;EIF2S2;EIF2S3
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4916006906355076,0.8960819588345575,0.6666666666666666,0.9819748625983645,1.0,11/27,25.88%,ZC3H7B;ZC3H7A;RBM4B;PER1;METAP1;MAPKAPK5;METTL16;CYFIP1;FOXO3;GRM5;PUM3
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.4335527762044526,0.8956308553575777,0.6914893617021277,0.982400926504608,1.0,7/60,9.31%,NRG1;SPTBN4;DNER;HOMER2;IFT140;SGPL1;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5901857553571733,0.8955986147129741,0.676056338028169,0.9819612594652921,1.0,3/7,25.98%,RAB7A;STXBP6;IL1RAPL1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4532983314471185,0.8955567411138294,0.7157894736842105,0.9815773425246914,1.0,15/55,24.67%,TSC2;PDLIM1;TGFB1;NXN;HEG1;ZFPM2;KDM6A;FBN1;ZFPM1;CDKN1B;NF1;FGF12;TAB2;SH3PXD2B;PKP2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.48258181552075224,-0.895201100987771,0.7222222222222222,1.0,1.0,4/9,12.86%,RYR2;SLC8B1;ITPR1;PKD2
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3249931877927402,-0.8951509916053386,0.8181818181818182,1.0,1.0,4/37,3.02%,NET1;NRP1;ARHGEF3;RALBP1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.44769449590171867,-0.8950168814990048,0.5666666666666667,1.0,1.0,4/11,12.22%,TNIP1;MAP3K1;TRAF6;UBB
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6233664283142719,0.89425229966724,0.7333333333333333,0.983802216636301,1.0,1/5,13.46%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.48103513712814716,-0.8936024799920579,0.53125,1.0,1.0,2/7,4.31%,EDN3;RYR2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.46354947931924256,0.8928638841196483,0.6629213483146067,0.9859294314240518,1.0,5/27,13.96%,RHOB;KDM1A;CLOCK;TANK;MDM2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.44280382978430893,0.8919849652137898,0.7578947368421053,0.9871106121312193,1.0,16/67,24.67%,TSC2;PDLIM1;SGCZ;TGFB1;HEG1;ZFPM2;INSR;KDM6A;FBN1;ZFPM1;CDKN1B;NF1;FGF12;TAB2;SH3PXD2B;PKP2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4719982305874411,-0.8919589450865743,0.5652173913043478,1.0,1.0,1/7,4.11%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4719982305874411,-0.8919589450865743,0.5652173913043478,1.0,1.0,1/7,4.11%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4719982305874411,-0.8919589450865743,0.5652173913043478,1.0,1.0,1/7,4.11%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.37425474595414787,-0.8916929181979862,0.6,1.0,1.0,2/28,1.58%,NET1;ARHGEF3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5779618021782383,0.8911352814052015,0.7397260273972602,0.9881902508549207,1.0,1/6,2.61%,NEDD4L
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.47070102172225337,-0.8910358393485455,0.6,1.0,1.0,3/9,12.03%,SLC8B1;AFG3L2;MCU
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.4282325691852421,-0.8909394824411768,0.6875,1.0,1.0,4/26,3.99%,IL34;EDN3;FGF1;RPS3
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5792982390571293,0.89089029697094,0.6142857142857143,0.9882606323025195,1.0,3/6,27.05%,METTL21A;SETD3;SETD2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5992409473444232,0.889308114456047,0.7012987012987013,0.9906671628196131,1.0,3/5,25.22%,SCARB1;ABCA1;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5455200837110622,0.8892126754533176,0.64,0.9903604297515969,1.0,5/7,44.00%,WAPL;TERF1;ATR;TSPYL2;PDS5A
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5448316772411645,0.888260050701112,0.6533333333333333,0.9916116034414612,1.0,1/9,1.97%,ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4204118493607978,0.8880456815907946,0.7142857142857143,0.9915349766681473,1.0,22/97,19.14%,TSC2;DDIT4;PTPN1;SUFU;CRY1;NIBAN2;PRKCB;BTRC;EGFR;IRS1;NXN;TMBIM6;PTPRE;SIAH1;LRRK2;BRAP;ZBTB7A;MGRN1;LGR4;PTPN2;CSNK2A1;UBASH3B
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5732801211935601,0.8873665304866708,0.7205882352941176,0.9922839866570888,1.0,1/7,6.75%,TMEM30A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5831054397457119,0.8873391475055553,0.6883116883116883,0.99183703458706,1.0,2/6,11.91%,SYN3;NLGN1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.4671637556964554,0.8870680994895824,0.6989247311827957,0.9918203912946112,1.0,10/45,18.63%,KCNQ1;SSH1;DIAPH1;IPO5;SLC38A9;RAP1B;AKAP6;CPEB4;GABRB1;RYR3
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.6022296385366216,0.887023397955063,0.676056338028169,0.9914040873707479,1.0,3/7,18.53%,INSR;PRNP;ARF1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5029024357386268,0.8869323577924901,0.6888888888888889,0.991083071952792,1.0,5/19,16.24%,SIK2;SZT2;SESN1;HSPA5;CPEB4
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.42195380062322646,0.8868210231252832,0.82,0.990792320334164,1.0,34/161,22.02%,CSF1;PRKACA;CSF1R;ZFP36L2;IL18;TNFRSF1B;TBK1;TGFB1;DUSP1;OXSR1;RPS27A;F3;HIF1A;TANK;PRLR;PTPN9;BCL6;AKAP6;PTPRZ1;STAT3;CEBPD;ERBIN;TWIST1;USP10;PTPN2;STK39;LIFR;JUNB;CDKN1B;ABL2;LDLRAP1;GAB2;UBE2K;GRB2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4500067971930292,0.8863858287001856,0.7052631578947368,0.9910855168369758,1.0,20/56,29.05%,MICALL2;CSF1R;STMN1;VAPA;UHMK1;NLGN1;CNTNAP2;PLP1;PTPRM;CYFIP1;CNTN4;GPM6B;CAMSAP1;ARMC2;ATXN10;PLEKHA1;GPM6A;ZFYVE27;RAB11A;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.4217489960725144,0.8861908515323101,0.7244897959183674,0.9909147175113662,1.0,30/112,23.93%,KLF2;GRIN1;ITGA5;RIMS2;PRKCB;PRKCI;CTBP2;TP63;IRS1;ROBO1;F3;HIF1A;NLGN1;TTC23;STAT3;FGFR2;LRRK2;ZDHHC5;NRXN1;LOXL3;CSNK2A1;SMARCA4;RBPJ;ITGAV;KANK1;MT3;AXL;EVC;ARMC9;TSPAN5
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.34016525032527895,-0.8860916756665635,0.6666666666666666,1.0,1.0,3/34,4.65%,CDK6;CUL2;CACUL1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.4490798109242756,0.8860331100992527,0.7684210526315789,0.9907291360932904,1.0,5/67,6.54%,CSF1;DDX3X;PTPN1;CSF1R;STK4
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.4265459004831217,-0.8858905429648615,0.6086956521739131,1.0,1.0,2/11,6.81%,TARBP1;TRMT44
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5222157370980272,0.8858708564366863,0.6707317073170732,0.9906084930600617,1.0,3/16,15.63%,PARVB;ARHGEF7;ARHGEF4
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.4173912017003655,-0.8855763039505499,0.52,1.0,1.0,4/16,10.13%,PPARD;HEYL;NOTCH3;TCF7L2
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.47494306275123843,-0.8851092886455257,0.7857142857142857,1.0,1.0,3/11,5.72%,LMCD1;ATP2B4;SLC9A1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.5042572557544575,0.8850554250784138,0.6493506493506493,0.9916181345894295,1.0,1/12,6.00%,SCD
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.43820184477684343,-0.8850019364811086,0.47368421052631576,1.0,1.0,2/13,2.25%,PGR;SYTL2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4804305124714575,0.8847603632612951,0.6629213483146067,0.9917211030976977,1.0,6/23,24.24%,SMOC1;RAB18;ATF6;FBN1;CEP290;SH3PXD2B
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.4542865641827027,0.8847192832896403,0.7252747252747253,0.991306695635132,1.0,7/39,17.56%,DPP10;PRKCI;TGFB1;EGFR;PTPN9;ZDHHC5;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5740966758024404,0.8843551456672151,0.6533333333333333,0.9915489136936376,1.0,2/7,23.57%,GPR137C;SIK3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5504745912234418,0.8842817597627058,0.7236842105263158,0.9912641905351547,1.0,4/12,17.35%,SEMA4D;NF2;SH3BP5;PTPN2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5068932172815689,0.8841013965241865,0.7261904761904762,0.9910890095599337,1.0,5/17,26.33%,RAB27A;WASHC5;EEA1;WASHC4;USP8
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.4861795308761434,-0.8837090711852819,0.6521739130434783,1.0,1.0,3/9,11.51%,ANO6;ANO10;SLC4A11
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.46670906321310734,0.8836739781894711,0.7303370786516854,0.9914302571741738,1.0,7/33,24.53%,CSF1R;MED14;CEBPB;TWIST1;CBFB;LEF1;JUN
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.4592569237518588,-0.8834968954740076,0.4722222222222222,1.0,1.0,1/5,2.76%,ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.4592569237518588,-0.8834968954740076,0.4722222222222222,1.0,1.0,1/5,2.76%,ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5412310196044783,0.8834088173255014,0.6911764705882353,0.9914486676867783,1.0,2/9,9.86%,ANK3;GLRX
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4541220866783719,0.8831362720799858,0.6808510638297872,0.9915513651465434,1.0,13/47,31.62%,PPP1CC;SEC13;STMN1;NUP133;TNKS;PAFAH1B1;GPSM2;NUP160;CENPP;SETD2;RANBP2;CLIP1;RANGAP1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4399320887434696,0.8830892170260727,0.7789473684210526,0.9911186398388271,1.0,19/70,25.20%,DPP10;SPTBN4;DPP6;ANK3;ATP1B3;LIN7A;DENND4C;EHD2;ROCK2;RAB12;WDR19;RAB8B;MAP7;GAK;CD81;TSPAN5;PKP2;KCNIP4;PIP5K1A
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.4403330869641472,-0.8829420826974083,0.6086956521739131,1.0,1.0,3/11,6.51%,NRP1;SLIT2;NR4A1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4644609735995901,0.8827705631543968,0.7294117647058823,0.9912213985131936,1.0,19/40,21.51%,KCNC2;KCNQ1;DPP6;PRKCB;CTNNA2;MOBP;XKR4;ASPA;OTUD7A;SLC4A10;MYT1L;MCF2L2;SLC1A2;NRXN1;ST18;GRIA2;NAPB;UNC80;CCK
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.4348266528272235,0.882492847126738,0.648936170212766,0.991299297210296,1.0,11/58,23.12%,PLAA;WIPI1;LIX1L;AMBRA1;VTA1;MAP1LC3B;CSNK2A1;ATG4B;TBC1D5;VPS39;LAMP2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5554737825405421,0.8822035433741668,0.6447368421052632,0.9913721700739039,1.0,1/7,6.14%,XPO4
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.5639022544655314,0.882179699050266,0.7121212121212122,0.9909304876272805,1.0,3/5,35.98%,SMCHD1;HNRNPU;MACROH2A1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5013639859318757,0.88135781992585,0.7215189873417721,0.9914816337395678,1.0,7/20,25.22%,IL18;SOAT1;SCARB1;ABCA1;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5013639859318757,0.88135781992585,0.7215189873417721,0.9914816337395678,1.0,7/20,25.22%,IL18;SOAT1;SCARB1;ABCA1;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.46275456481775656,0.8813433526396335,0.7065217391304348,0.9910257275073769,1.0,10/32,19.91%,NEDD4L;SMURF2;RAB7A;NSF;WWP1;TIPARP;HECW1;CSNK2A1;AREL1;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5423319445657446,0.8805620872125486,0.6708860759493671,0.9919230807268734,1.0,1/9,9.03%,MED14
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5838092607579161,0.8804963872279828,0.7424242424242424,0.9915562320721262,1.0,1/6,6.75%,TMEM30A
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5184136186100811,-0.8802305329133389,0.5641025641025641,1.0,1.0,1/5,0.19%,WDFY4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5040557266518917,0.8801673765865223,0.7241379310344828,0.991682986754334,1.0,7/20,30.83%,CTNNA2;CTNND2;FARP1;BTBD3;TMEM106B;DCDC2;DIP2A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5470549003666108,0.8801611755361745,0.6176470588235294,0.9912180133517515,1.0,4/6,42.18%,TRIM5;CD55;PRKCA;SASH1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.49853853519651914,0.8800433532514682,0.6923076923076923,0.9909555269295198,1.0,7/16,36.76%,SMCHD1;TP53BP1;POLR2F;SHLD2;ZRANB3;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4902287372420485,-0.8797772593894952,0.5555555555555556,1.0,1.0,1/6,1.38%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4467646028046121,0.8796791274940798,0.723404255319149,0.9911808936558923,1.0,18/59,25.84%,CSF1R;CCT4;FLT1;DCUN1D4;TGFB1;EGFR;EPHA7;FGFR2;INSR;TNKS;MAPK1;DCUN1D1;KDR;MAPKAPK5;SERINC1;AXL;DCUN1D2;UBE2L3
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.47665559422534853,-0.8796348947627022,0.5925925925925926,1.0,1.0,3/8,20.24%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.5812866600410185,0.8789729320770066,0.6904761904761905,0.9919820099502789,1.0,3/8,19.09%,PIAS2;ZBTB7A;SMARCA4
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.578236695566319,0.8789120401978768,0.6944444444444444,0.991601445007191,1.0,2/6,12.13%,DNAH11;GALNT11
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4991207275905939,0.8789057241821313,0.7012987012987013,0.9911228908415453,1.0,2/14,8.76%,FLT1;EGFR
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.43279315237034177,0.8788180532804036,0.7553191489361702,0.9907578623520628,1.0,21/68,27.90%,DPP10;SPTBN4;DPP6;ANK3;ATP1B3;DENND4C;EHD2;ROCK2;RAB12;RAB8B;MAP7;GAK;CD81;TSPAN5;PKP2;NECTIN3;KCNIP4;PIP5K1A;CCDC88A;ZFYVE27;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.5266134396075683,0.878720304084718,0.6705882352941176,0.9904226688185395,1.0,6/9,36.45%,CNOT8;PRR5L;CNOT1;ZC3HAV1;PNPT1;RC3H1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.461489778769408,0.8785587449761032,0.7222222222222222,0.9902105724947331,1.0,12/36,21.20%,ARRDC2;SLC22A6;SLCO1A2;RAB7A;CHKA;ABCA1;SLC22A2;SNX4;CMTM6;PEX3;RUFY1;CEP290
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.4817313271542656,0.8782212014008677,0.6630434782608695,0.9902980976405001,1.0,7/26,30.38%,SGIP1;INSR;TBC1D5;LDLRAP1;TF;ATAD1;VEGFA
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4591875493026954,0.8781175098789401,0.7241379310344828,0.9899685228796326,1.0,6/37,16.47%,NRG1;ADAM17;TGFB1;EGFR;ERBIN;MAPK1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.46074092314446624,0.8778631237885017,0.7127659574468085,0.9898991631244562,1.0,6/37,15.11%,CSF1;NEXMIF;ROCK2;CASK;SLK;NF2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.43569375119848286,-0.8776981649807907,0.7142857142857143,1.0,1.0,5/15,13.26%,ATM;TOPBP1;FOXN3;BABAM2;MRE11
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.42589565314115024,0.876539453335897,0.6739130434782609,0.9918639054079487,1.0,8/39,21.70%,KDM1A;RHBDD1;EGFR;EIF2AK4;ZBTB1;UVSSA;UBE2B;UBE4B
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5177062886439531,0.8764864461626404,0.6585365853658537,0.9914654656634814,1.0,5/16,21.09%,MBP;SBF2;ACER3;NF1;PLP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.537524493419097,0.8764774601363992,0.7285714285714285,0.9909890682778524,1.0,1/9,2.61%,NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.4587737209553271,-0.8760818931524328,0.631578947368421,1.0,1.0,4/10,18.22%,VPS35;PTTG1IP;APOE;VGLL4
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.41843689813468876,0.8758814494022068,0.8181818181818182,0.9916387885954393,1.0,14/99,14.53%,ADAMTS9;LSAMP;NCEH1;DGKI;NIBAN2;SMARCA1;ATL2;GRIK2;DUSP1;C1R;CFH;PAPSS2;GNAI1;PDK4
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.3611370784840598,-0.8757717543093193,0.8,1.0,1.0,5/28,9.74%,A2M;SORBS2;C2ORF72;ABCA8;FAXDC2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4527028161595399,0.8756138734307842,0.7142857142857143,0.9916177048081272,1.0,3/33,2.96%,NRCAM;DNER;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5813717856502504,0.8755440624843613,0.6790123456790124,0.9912886086784561,1.0,2/5,21.84%,ADAM17;UBE2K
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5327967513916643,0.8750279002337427,0.6818181818181818,0.9917319838145537,1.0,4/8,34.49%,RPS27A;RPA1;POLK;RPA3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.45239296864855477,-0.8748367048377741,0.4782608695652174,1.0,1.0,3/9,6.51%,NRP1;SLIT2;NR4A1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5102973076252884,0.8747175359303145,0.7051282051282052,0.9918330023700184,1.0,4/13,18.38%,TMEM165;SLC4A10;LRRK2;CA2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.5425675802457488,0.8745910255620479,0.7352941176470589,0.9916361022592501,1.0,3/10,28.55%,NEXMIF;JAM3;PTPN11
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5330590485721469,0.8745877660111512,0.7391304347826086,0.991166115612069,1.0,4/13,13.46%,PTPN1;RHBDD1;TMBIM6;HSPA5
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.5146806362334536,-0.8744149368096339,0.6153846153846154,1.0,1.0,1/6,1.15%,GALNT16
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5582144560300955,0.8742631266268905,0.7,0.9908515347208675,1.0,3/6,29.48%,ROCK2;GCLC;SCPEP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5582144560300955,0.8742631266268905,0.7,0.9908515347208675,1.0,3/6,29.48%,ROCK2;GCLC;SCPEP1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.4194350884294638,0.8739181570746951,0.7653061224489796,0.990962480357903,1.0,15/109,16.97%,RPS21;ETF1;RC3H2;RPL28;CNOT8;RPS27A;NBDY;RPL21;CSDE1;TUT7;RPL41;DCP2;PABPC1;DCP1A;RPLP2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5065810349268474,-0.8734605547762871,0.4857142857142857,1.0,1.0,1/5,3.13%,SMARCAL1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4890684578762595,0.8731234459227559,0.7333333333333333,0.9919013076097257,1.0,5/18,18.13%,TANK;OTUD7A;RIOK3;USP10;PER1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5578300744642907,0.8730049040480324,0.6419753086419753,0.991588108592105,1.0,4/8,28.23%,CYP3A5;ABO;TFPI;SLC40A1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.4836295174898123,0.8728764070287146,0.6341463414634146,0.9913336016213955,1.0,4/18,14.45%,EGFR;CREM;MOV10L1;CCDC91
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4705910046282733,0.8727266927567056,0.7411764705882353,0.9910452957379898,1.0,7/25,18.95%,HSPA4L;PTPN1;RHBDD1;TMBIM6;HSPA5;DNAJA1;HSPH1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5438695956260414,0.8723488101773809,0.6875,0.9913649093824018,1.0,2/10,19.70%,PPARA;KDR
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.4270242293260243,0.8712221491580132,0.6774193548387096,0.9929426421265389,1.0,11/58,15.77%,PSMB1;PDE4B;PSMB2;RC3H2;BTRC;PSMA7;NFKBIZ;PAG1;PSMA4;PDE4D;PSMD14
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5705065906719542,0.8708257604460498,0.7162162162162162,0.9931396231973505,1.0,2/6,27.85%,TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5377745428969019,0.8705316196134554,0.6578947368421053,0.9931568124206911,1.0,4/8,30.47%,ZBTB1;AXL;ZMIZ1;PRKDC
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.5834710364042837,0.8700891886952432,0.76,0.9934408330251157,1.0,1/7,10.67%,XKR4
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.47018684237049585,0.869922517632434,0.6829268292682927,0.9932444852080474,1.0,6/17,23.79%,ROBO2;ROBO1;ZFPM2;FGFR2;SMAD6;NRP2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4599560818174222,0.8699145700844841,0.7176470588235294,0.992781734640337,1.0,3/19,13.49%,HDAC2;ADAM17;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.46527412471773844,0.8695605009557953,0.7073170731707317,0.9929201824675944,1.0,5/31,12.87%,KDM1A;PTPRD;ROBO2;ROBO1;FZD3
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.49350391308607683,0.8694200855977193,0.6941176470588235,0.9926662578280571,1.0,1/21,0.51%,CSF1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.44101617753535144,0.8691842336435196,0.6907216494845361,0.9925674613506328,1.0,20/57,30.38%,PRKACA;NRG1;IL18;STK4;PRLR;INSR;TNFRSF10B;PRKAR2A;ABL1;MT3;TAOK3;CCDC88A;TOM1L1;PAK1;PRKAR1A;PTK2B;ADCY5;PRKAR1B;MALT1;VEGFA
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.525546597462008,0.8691012743459444,0.6133333333333333,0.9921881661774924,1.0,2/9,5.61%,CACNA1B;SCN3A
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5684859999513778,0.8690085997305323,0.7352941176470589,0.9918334121580836,1.0,4/6,40.18%,AP3D1;DNM2;SNAP91;DNM3
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5388180612595915,0.8688260607477444,0.7466666666666667,0.9916771585747134,1.0,3/9,23.11%,ZBTB16;TAPT1;TRPS1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.5175567931899674,0.8686482215374621,0.6933333333333334,0.9915838559365757,1.0,4/11,30.97%,ACOT11;ACBD6;ACSF2;DLST
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.4939017871876573,0.8678499172181808,0.7058823529411765,0.992393582399599,1.0,4/18,13.49%,KLF9;GNB1;ROCK2;GNAI1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.49999113888518926,0.8677402892114324,0.7307692307692307,0.9921745438994961,1.0,6/18,23.56%,PRKCB;ADAM17;ZBTB7A;PTPN2;KLF6;DCAF1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4389165788500905,0.8675483150839183,0.7865168539325843,0.991994306397548,1.0,9/43,15.79%,PSMB1;PSMB2;ZFP36L2;FHL1;PSMA7;MYO16;PSMA4;PSMD14;RBX1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.4329908373351105,0.8670984165159831,0.8085106382978723,0.9924073017736703,1.0,16/93,20.69%,MID1;COL4A6;GJA1;TENM3;WWC2;SMARCA1;NXN;CD9;STAT3;PAWR;TEAD1;LGR4;LIFR;SMAD2;BNIP3;DCBLD2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.4975586790357746,0.8670848900152951,0.7088607594936709,0.9919524236577109,1.0,6/19,23.98%,VAPA;NSF;NAPG;SNAP23;DNM2;USO1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.466747735888546,0.8664304542842335,0.7126436781609196,0.9926107128765445,1.0,5/22,17.35%,CSF1R;IL18;STAT3;NF2;PTPN2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.47879715156360614,0.8662378171043106,0.7228915662650602,0.9924835732958256,1.0,4/23,21.84%,ADAM17;MADD;PTPN2;UBE2K
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3859140564945236,-0.8661633689613618,0.5714285714285714,1.0,1.0,6/18,8.20%,CYP4V2;ABCA4;GPC6;ALDH1A1;AKR1C3;GPC3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5577992211077566,0.8661382612805323,0.6857142857142857,0.9922073697312631,1.0,1/5,17.35%,PTPN2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.495561390753914,0.8661141204691936,0.6829268292682927,0.9917967458384391,1.0,2/13,3.63%,DPP10;DPP6
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5680760076248942,0.8658699765478481,0.75,0.9919009524191246,1.0,1/5,6.48%,RUBCN
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5276465834100412,0.8657767933093131,0.7386363636363636,0.991553337926766,1.0,4/13,28.18%,NF2;CRLF3;NLK;SH2B3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.43058378934489794,0.8649944765737007,0.78125,0.9923444277103195,1.0,23/64,27.39%,DNAJC6;WASF1;AP2A1;SCARB2;CTSL;SGIP1;CD9;INSR;CANX;SCARB1;AP2B1;HSPH1;LDLRAP1;GRB2;GAK;EPS15;CD81;PIP5K1C;DNM2;AP2M1;ADM;CLTC;GPR107
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.44974672572971336,0.8648251709035074,0.7764705882352941,0.9921505642861466,1.0,7/33,17.71%,PSMB1;PSMB2;PSMA7;RPS27A;PSMA4;PSMD14;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4774764216068855,0.8647127523509435,0.7215189873417721,0.9918561127793037,1.0,2/24,5.32%,TOR1AIP2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.44258516482371896,0.8642959411004176,0.7441860465116279,0.9921614926141009,1.0,10/55,12.95%,OPA3;PSMB1;PSMB2;SCD;PSMA7;PPARA;SIN3A;ROCK2;SREBF1;PSMA4
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5364091783402447,0.8642807944134817,0.7012987012987013,0.9917186977543061,1.0,4/8,22.72%,ACER3;SPTLC1;SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.4805871554765522,0.8642111453856999,0.6923076923076923,0.9913577851088912,1.0,7/18,37.11%,SCD;ELOVL5;SCD5;ABHD3;ABCD3;ELOVL6;GPX4
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.4554865756651544,0.8641663275871204,0.7608695652173914,0.9909397402745299,1.0,7/37,20.60%,CAMKMT;EFNB2;TMSB4X;BCL6;TRIM5;AREL1;METAP1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4786816262078134,0.8639404816050543,0.7126436781609196,0.9908524162883583,1.0,3/24,11.04%,ADAMTS9;MGAT4A;HIF1A
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5363540110376556,0.8637745313318271,0.7283950617283951,0.9905785588337496,1.0,5/13,29.50%,C9ORF72;ABL1;CAMSAP1;MAP1B;AKAP13
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5575482410571713,0.8636458428785935,0.676056338028169,0.9902858300229714,1.0,4/7,29.59%,IMMP1L;SPG7;MIPEP;PMPCB
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.5801070181140734,0.8632789261649974,0.7333333333333333,0.9904236235210602,1.0,3/6,32.96%,NBDY;CNOT1;CNOT2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.40986581765546415,-0.8625566612813672,0.6956521739130435,1.0,1.0,3/15,6.39%,RPS3;CKAP5;HSPA1A
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5651433107891861,0.8625536672838557,0.725,0.9912350174178891,1.0,2/6,26.12%,HSPA5;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.45085322233848557,0.8621500410042667,0.7241379310344828,0.9915107341699412,1.0,8/35,14.39%,PRKACA;GRIN1;ANK3;LRRC7;GRIN2B;NLGN1;FGF14;PDE4D
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.42486582387332256,0.861989705363599,0.7978723404255319,0.9913183662756454,1.0,8/78,10.95%,DARS1;RPS21;AGO2;FARSB;RPL28;RPS27A;RPL21;RPL41
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.55480407428666,0.8618062975051843,0.7012987012987013,0.9911834378094483,1.0,4/6,38.65%,SH3KBP1;PRKDC;HSPD1;CYRIB
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.43702104500965355,0.8617893014703885,0.7052631578947368,0.9907195623548187,1.0,11/46,19.91%,NEDD4L;TNFRSF1B;SMURF2;RAB7A;NSF;WWP1;TIPARP;HECW1;CSNK2A1;AREL1;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5617363727847458,0.8616472502826535,0.6805555555555556,0.9905183072076696,1.0,1/5,0.51%,CSF1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5014848848039792,-0.861445609670994,0.7,1.0,1.0,2/6,5.32%,FGF13;CKAP5
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5302945034727385,0.8613250836158638,0.7375,0.9906507705768313,1.0,3/10,19.01%,CCT4;DCP2;CCT3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.32472718686275526,-0.8613105577725798,0.8,1.0,1.0,4/31,4.13%,DAPK2;ATM;FBXL2;PIP4K2B
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4671781207565182,0.8610946606810505,0.6923076923076923,0.9905545116666796,1.0,12/22,29.87%,ANK3;GGA3;RAB7A;NSF;PREPL;BLZF1;NECTIN3;GGA2;GOLGA4;RILPL1;VAMP5;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.4132475303945957,0.8608110514048739,0.7473684210526316,0.9906059096263332,1.0,12/57,21.68%,DDX3X;EGFR;IRS1;ELAVL1;ATAD5;INSR;METTL14;HSPH1;ABCB10;KDR;SLC25A37;IRS2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.5366363205334388,0.8606302469948485,0.6582278481012658,0.9904764570463219,1.0,1/8,7.57%,DNMT1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5199600498170949,-0.8605994699026175,0.64,1.0,1.0,1/5,4.00%,PPARD
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.5765043098410898,0.8603723371889863,0.7272727272727273,0.990446996348338,1.0,1/6,14.62%,FGFR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5543059186850248,0.8601879306918128,0.7123287671232876,0.9903034802738099,1.0,1/7,3.19%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.43742356588454234,-0.8597887612114856,0.5,1.0,1.0,4/10,19.62%,MDFIC;GTF2F2;NELFA;SUPT5H
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.4953841760783377,-0.8595146582260609,0.6071428571428571,1.0,1.0,2/6,13.17%,ACACA;ACAT1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.554552319251143,0.8590542616642398,0.7540983606557377,0.99168524271509,1.0,2/6,5.61%,ANK3;SCN3A
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5148268369906894,0.8587963699980502,0.75,0.9916552545201315,1.0,1/13,3.72%,RAB27A
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.3543700559504839,-0.858545239391923,0.85,1.0,1.0,2/21,1.01%,WDFY4;PPP1R14A
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.48875957799955266,0.8585231199555388,0.725,0.9916158010422808,1.0,10/22,29.31%,EPN1;ERRFI1;EGFR;ARHGEF7;PTPN2;GRB2;EPS15;SH3KBP1;STAM2;RNF115
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.43663031897685606,0.8583462826591511,0.7391304347826086,0.9914672607007424,1.0,8/48,17.23%,CD44;CSF1R;TGFB1;EGFR;CCN2;PDE8A;FGFR2;MAP2K1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5165499217636919,0.8582015255454681,0.7073170731707317,0.9912619525479542,1.0,6/11,17.45%,DUT;GUK1;GLRX;GSR;AK9;CMPK1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4218002559176833,0.8581020267698406,0.8333333333333334,0.9909667761819236,1.0,26/93,25.20%,ARL5A;DPP10;SPTBN4;DPP6;ANK3;ATP1B3;LRRC7;LIN7A;DENND4C;NLGN1;EHD2;ROCK2;RAB12;AP3D1;NRXN1;WDR19;RAB8B;MAP7;GAK;CD81;TM9SF2;TSPAN5;SH3PXD2B;PKP2;KCNIP4;PIP5K1A
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4668631083827919,0.8578534628853371,0.6744186046511628,0.9908092743295115,1.0,5/23,20.64%,PRKACA;ATP1B3;ABCC9;RYR3;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5029302827015926,0.8573824022025418,0.7183098591549296,0.9911965156223966,1.0,4/10,15.18%,TBC1D20;VAPA;CFL1;PPIB
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3067262644655534,-0.8571930283527814,0.8888888888888888,1.0,1.0,2/27,5.78%,PARP9;RIC3
prerank,PanglaoDB_Augmented_2021__Basophils,0.4728337004308553,0.8571339183430638,0.7222222222222222,0.9912473228830959,1.0,4/31,11.38%,CD44;CSF1R;FADS2;PDK3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5270194003309124,0.8570414865131144,0.7790697674418605,0.9909385136752858,1.0,5/14,21.82%,CTNND2;INSR;PRNP;ARF1;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5678875867451383,0.8569799931989429,0.7761194029850746,0.9905685176657584,1.0,3/5,32.96%,CNOT1;STRN3;CNOT2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.5719125240121627,0.856977477006603,0.7714285714285715,0.9901090604650095,1.0,1/6,6.17%,PRKCB
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.44189476487215396,-0.856962501707758,0.5833333333333334,1.0,1.0,1/16,0.48%,FGF13
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.43440730675563094,0.8563827076471239,0.7159090909090909,0.9907319488636473,1.0,5/37,18.47%,UBA5;RPS27A;RAB7A;AMBRA1;MAP1LC3B
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.4693380981987987,0.8556404033577351,0.6753246753246753,0.991481756366887,1.0,5/15,17.54%,CDC5L;STK33;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.41604625405699647,0.8556076315118264,0.85,0.99105555751512,1.0,29/110,28.94%,IFT52;CCP110;ACTR3;LZTFL1;IFT140;NUDCD3;TRAF3IP1;EHD2;GALNT11;TTC8;EXOC1;MAK;ARF4;WDR19;RAB8B;ASAP1;RTTN;SEPTIN7;CEP290;ARMC9;ARMC2;RFX3;ATP6V1D;RAB3IP;RILPL1;RAB11A;PTPDC1;DCDC2;ARL13B
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4831139215999166,0.8555628054527505,0.6626506024096386,0.990653346808368,1.0,4/16,11.79%,GNPAT;AGK;SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5209020417943545,0.8549049161516559,0.7088607594936709,0.9911144826202656,1.0,1/9,8.98%,ROBO1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.4964525394172705,0.8548763623911422,0.6842105263157895,0.9907079067943736,1.0,1/12,2.37%,RHOJ
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4489477412856635,0.8545201308334333,0.8333333333333334,0.9908293741696155,1.0,10/56,11.60%,PHYHIPL;DHRS3;PTPRD;GFAP;DCLK1;CHL1;PCDH17;SYNDIG1;SHC2;ZNF536
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4462780900205273,0.8545146121767087,0.8,0.9903856384230707,1.0,6/43,12.47%,TPT1;CACNA1B;TMEM165;TMCO1;SLC3A2;NALCN
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5401011313595302,0.8543847583120128,0.7012987012987013,0.990074109539329,1.0,4/9,41.67%,ELOVL5;ABCD3;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5247356509309031,0.85367500497693,0.7361111111111112,0.9903500996811327,1.0,1/8,9.96%,RAP1B
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5247356509309031,0.85367500497693,0.7361111111111112,0.9903500996811327,1.0,1/8,9.96%,RAP1B
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5360344956829398,0.8534899515836375,0.6666666666666666,0.9901894325709033,1.0,1/9,7.57%,DNMT1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5955784510173768,0.8533663156575554,0.7534246575342466,0.9899208584998285,1.0,2/6,27.12%,PRLR;FDFT1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.45272944403575993,0.8532691460774257,0.7619047619047619,0.9896384467166212,1.0,4/25,6.87%,SLC22A6;TACC2;ALDH1L1;DCDC1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5591591875874415,0.8531239062056055,0.8194444444444444,0.9893750727317556,1.0,3/6,28.94%,TGFB1;ALDH1A2;ARL13B
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5663238339533225,0.8527732433839932,0.7333333333333333,0.9894122035046105,1.0,3/7,23.42%,CD9;ABCA1;CD81
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.36746383599149235,-0.8525746745316264,0.75,1.0,1.0,3/25,3.06%,NRP1;ARHGEF10L;EVL
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4254594312912512,-0.8525228950439345,0.5666666666666667,1.0,1.0,1/6,1.10%,CD4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.4586833178652393,-0.8519139150602794,0.5769230769230769,1.0,1.0,1/8,2.99%,ZDHHC21
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5655140825715158,0.8518419045963801,0.7368421052631579,0.990495030963257,1.0,4/6,35.64%,KDR;RAP1A;RAPGEF2;EMP2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5237819255861127,0.8518295376042597,0.7297297297297297,0.9900863229395492,1.0,2/11,15.26%,PPP2R1B;UNC5B
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5429261195290752,0.851658065212496,0.7631578947368421,0.9898279152672635,1.0,2/6,33.25%,RAB11A;DLG1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.31399849855483,-0.8515025082595142,1.0,1.0,1.0,6/37,4.87%,ABCA10;ABCA9;SLCO3A1;PPARD;ABCA4;ATP8A1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5563926245549243,0.8513809086540474,0.7222222222222222,0.9894990463248914,1.0,4/6,33.89%,PPP3CA;PPP3CC;NFAT5;PPP3CB
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5563926245549243,0.8513809086540474,0.7222222222222222,0.9894990463248914,1.0,4/6,33.89%,PPP3CA;PPP3CC;NFAT5;PPP3CB
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5977609171316034,0.8512362850879956,0.7391304347826086,0.9892599846195361,1.0,2/5,18.19%,INSR;PRNP
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5547595792871913,0.8511664392383498,0.7375,0.9889416469066987,1.0,3/5,30.80%,UBR5;UBE3A;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5166633647553578,-0.850887910615881,0.6666666666666666,1.0,1.0,3/5,12.13%,MAPK14;RIPOR2;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4394259202357828,0.8505744552826133,0.717391304347826,0.9894929991897863,1.0,17/39,30.09%,CRY1;NDFIP2;DCUN1D4;TANK;NDFIP1;LRRK2;WDR48;DCUN1D1;UBA2;SMAD7;RCHY1;SENP2;DCUN1D2;UBE2L3;UBQLN1;UBE3A;MALT1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5671550845668543,0.8504118213847075,0.7258064516129032,0.9893056644859112,1.0,4/5,37.83%,STK39;KMT2A;NR1H3;SGK1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.47376291744805743,0.8502155126681241,0.7303370786516854,0.9891605317870436,1.0,6/24,12.07%,HDAC2;CRMP1;CBFA2T2;EFNB2;GRIN2B;PTPN9
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.39520612652875714,0.8495421771920869,0.8282828282828283,0.9897390234342573,1.0,31/140,21.17%,SOD1;RHOB;DDX3X;MTCH2;STK4;ARHGEF9;CCAR1;BNIP3L;MCF2L;TP63;APBB1;RPS27A;EPHA7;MELK;PTRH2;ARHGEF7;BCL6;SIAH1;APAF1;PAWR;ATF6;TNFRSF10B;ARHGEF4;LATS2;PRNP;DNAJA1;VAV3;ABL1;BNIP3;NF1;RPS6KA2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.53382782332317,0.8493631234487976,0.7721518987341772,0.9895611659192822,1.0,3/9,14.13%,ANK3;TMSB4X;AKAP6
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.5361793722421734,-0.8488172361197154,0.6388888888888888,1.0,1.0,1/5,1.77%,AK5
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.49246484501026083,0.8488016347864706,0.6666666666666666,0.990013026682699,1.0,1/13,0.67%,KLF2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5845836899411553,0.8486436842273891,0.7777777777777778,0.9898445293406984,1.0,1/5,17.35%,PTPN2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5080875259372721,0.8481466082160389,0.6625,0.9902119788303203,1.0,1/10,1.54%,PRKACA
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5351100064771724,0.8478903597545718,0.7402597402597403,0.990118055663213,1.0,1/9,2.19%,NRG1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5386823595911439,0.847631401758048,0.7402597402597403,0.9900335286884774,1.0,2/8,23.26%,UGP2;FUT8
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.548330296304727,-0.8474120690829219,0.625,1.0,1.0,1/6,2.12%,PARP9
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.4971530887143612,0.8468027243124905,0.6941176470588235,0.9910377896521997,1.0,2/15,9.60%,GJA1;MBP
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.48962565720573215,-0.8466782884489128,0.5925925925925926,1.0,1.0,1/6,2.87%,MYH11
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5497055285314167,-0.8466400126184858,0.7142857142857143,1.0,1.0,1/5,12.50%,CHMP4B
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.4679816415830251,-0.8464385526145047,0.6296296296296297,1.0,1.0,1/5,1.35%,NRP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.441619429634368,0.8462811462876585,0.7777777777777778,0.9913993608986046,1.0,13/33,29.87%,ANK3;GGA3;NSF;EXOC1;PREPL;GOPC;STXBP6;BLZF1;GGA2;OSBPL5;GOLGA4;VAMP5;GOLPH3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5029983026656957,0.8460931987252318,0.675,0.9912585804955175,1.0,5/13,28.71%,HIF1A;DCUN1D1;DCUN1D2;ZMIZ1;UBQLN1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.46664868255157776,0.8458611135727155,0.7,0.9911504530264146,1.0,8/16,31.08%,AGK;SAMD8;CERS6;SPTLC1;SPTLC3;ASS1;PCSK5;SGMS1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.44721611802723293,0.8449909768284266,0.7777777777777778,0.9920548254796336,1.0,7/26,31.62%,SEC13;NUP133;REEP3;NUP205;NUP160;PPP2R2A;RANGAP1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.3986833542982421,0.8447452141241241,0.89,0.9920439110278221,1.0,34/181,22.95%,CSF1;PCMT1;DARS1;RPS21;PAPPA;AGO2;SEC11A;CDH2;MGAT4A;FARSB;ADAM17;RPL28;RPS27A;RPL21;RPL41;CP;GALNT11;CST3;RAB12;DENND3;IGFBP2;SPG7;ADORA2B;RPLP2;MANBA;FBN1;FBXO11;ABL2;ABL1;RPL9;ITIH2;TF;SARS1;RPL18
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.522717099113126,0.844681212155034,0.7162162162162162,0.991703583231439,1.0,3/11,12.90%,CPSF2;TUT7;DCP2
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.48629769959749214,0.8441902225916716,0.7590361445783133,0.9920313874985652,1.0,5/20,13.66%,SLC22A6;MGST1;SLCO1A2;SLC4A10;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.418757765645317,0.8441164260058106,0.8297872340425532,0.9916821072557606,1.0,17/77,16.53%,GJA1;BASP1;AGO2;NIBAN2;ZBTB16;CEBPB;CCN2;NLGN1;SPIRE1;SMURF2;ARHGEF7;TAPT1;CFL1;INSR;TP53BP1;ACVR1B;NRXN1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.520050014089908,0.8438274602496665,0.7530864197530864,0.9916899175541107,1.0,4/8,14.42%,RARRES1;PRLR;KDM3A;STAT3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.46723882105170933,0.843607429177139,0.7444444444444445,0.9916050957836134,1.0,7/28,20.67%,CCT4;HNRNPC;DCP2;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.41104272449332263,-0.8434823680065549,0.7,1.0,1.0,2/10,7.85%,SLIT3;HEYL
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.4299671649566068,0.8434542210322814,0.7582417582417582,0.9914092530003202,1.0,9/49,14.24%,CNTN3;PHYHIPL;PTPRD;PCDH17;SMARCA1;SNAP25;SHC2;FGF14;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.4436443866981815,-0.8433029390294862,0.6341463414634146,1.0,1.0,2/6,3.74%,WNK2;ATP1B2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5036925869369282,0.8431070340597411,0.7294117647058823,0.9915883765648461,1.0,1/11,5.91%,CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.38303433679273635,-0.8424312100693138,0.6153846153846154,1.0,1.0,2/21,1.35%,EDN3;NRP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.34908659141115517,-0.8421446406250794,0.7333333333333333,1.0,1.0,2/19,1.38%,DAPK2;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.5484833462871663,0.8415994700757133,0.7662337662337663,0.9934276658138989,1.0,1/8,5.78%,SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4159643424121079,0.8414672712789323,0.8387096774193549,0.9931711612028515,1.0,17/89,16.28%,DDX3X;MYDGF;CAMKK2;NOS1AP;CSF1R;SEMA4D;CSNK1D;STK4;ADAM17;SYMPK;TGFB1;EGFR;ROCK2;PDE8A;INSR;LRRK2;ACVR2A
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5150003796717024,0.8408589743580606,0.7317073170731707,0.9937327443992223,1.0,1/13,4.11%,WASF1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.48843488244094907,0.840628241326277,0.7733333333333333,0.993633364730362,1.0,1/11,0.51%,CSF1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5299603440721266,0.8403012293664666,0.7051282051282052,0.9936771846718607,1.0,4/6,31.13%,ACER3;SPTLC1;SPTLC3;QDPR
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5653841387299562,0.8403012144008112,0.7972972972972973,0.9932226205434654,1.0,3/5,41.41%,SARS1;SSB;AARS1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.47291634331833,-0.8402425007821527,0.6176470588235294,1.0,1.0,5/5,52.76%,PIK3CD;PIK3CA;PIK3C2A;PIK3C3;PIK3CB
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.3765995453732741,-0.8400086716200827,0.9090909090909091,1.0,1.0,1/14,0.45%,ZBTB7C
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5252720925716012,0.8397305169944875,0.7307692307692307,0.9936586240524324,1.0,3/12,16.95%,RAF1;ADORA2B;LGR4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.49061376272710483,0.8395279263912827,0.7349397590361446,0.9935317994710567,1.0,5/11,35.38%,TGFB1;AP2M1;CLTC;PID1;TMEM59
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.46655430725238833,0.8389684882331448,0.6956521739130435,0.9938244162393922,1.0,2/11,14.62%,RARB;FGFR2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.49203872927738074,0.8386755864171258,0.7764705882352941,0.9938772606335481,1.0,8/18,27.85%,KDM1A;SMCHD1;TP53BP1;WDR48;SPIDR;SETD2;ARID2;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3244868242890872,-0.8385611193322747,0.7272727272727273,1.0,1.0,5/41,5.89%,SLIT2;NIBAN1;ATP2B4;YWHAB;DNAJC10
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.4191996499287558,0.8383596755591843,0.7849462365591398,0.9938610003002719,1.0,18/45,24.95%,GFAP;CHL1;CSF1R;GALNT15;GLUL;CDH20;EPOR;PDK4;LRRK2;SLC1A2;MAPK1;NRXN1;GRIA2;PLP1;MT3;GRIA3;RTN1;GRM5
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4356531901788679,0.8379882807885078,0.7790697674418605,0.9939459914490006,1.0,10/25,36.76%,EGFR;ANKRD17;ATAD5;RBBP6;CCDC88A;WAPL;USP37;SMC3;ZBTB38;TERF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.5274704850825991,0.8379201194740918,0.7468354430379747,0.993603145319942,1.0,2/5,23.09%,SELENOS;AXL
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.39495437994769395,-0.8379171547703157,0.6666666666666666,1.0,1.0,1/10,1.86%,PRMT3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5215115892502037,0.8378790265232694,0.7804878048780488,0.9932054420701205,1.0,4/12,23.17%,PDE4DIP;MAPK1;MAP2K1;USP6NL
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4198090826148082,0.8376007696634047,0.8064516129032258,0.9932216850711361,1.0,14/71,19.28%,PPP1CC;PTPRD;PTPN1;SSH1;BTRC;PPP2R1B;DUSP1;PTPRE;PTPN9;PTPRZ1;PPP3CA;PTPN2;UBASH3B;PPM1E
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.43717541137165283,0.8374408361995815,0.7032967032967034,0.9929898759526367,1.0,9/30,21.68%,TGFB1;APBB1;ACSL4;GLUD1;SYTL4;EXOC1;TTN;MYRIP;IRS2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.47800415991275513,-0.8372936289465752,0.7407407407407407,1.0,1.0,3/5,16.49%,VPS35;ERBB4;MFF
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.4664985667584433,0.8372201228124179,0.7023809523809523,0.9928776488783776,1.0,5/15,16.11%,ROBO2;TGFB1;ROBO1;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.42060233350301146,-0.8371947237697649,0.5357142857142857,1.0,1.0,3/9,8.59%,PGF;CXCL12;NTF3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5559975013631423,0.8365856619594931,0.8194444444444444,0.993421765837522,1.0,1/5,14.42%,STAT3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.5005232154636137,-0.8357737323194279,0.6666666666666666,1.0,1.0,1/5,1.38%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.5344452122903877,0.8355537440713516,0.8170731707317073,0.9946580275476874,1.0,5/10,38.00%,TMSB4X;KDR;VEGFA;FGFR1;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.4605496694704459,0.835033952329379,0.7613636363636364,0.9950862172821596,1.0,7/25,26.60%,CCT4;IPO5;TGFB1;CCT3;UBR5;EIF2AK3;CCT8
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.29865477484128367,-0.8347947515932131,0.875,1.0,1.0,9/57,8.61%,FAT1;TNFRSF19;FOXQ1;CDC42BPB;PPARD;DZIP1;PTPN21;C2ORF72;ARHGEF17
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5201283645636449,0.8347347688811383,0.7391304347826086,0.9951244757412033,1.0,2/5,37.95%,PPP3CB;HSPD1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.5396375918908074,-0.8346205751966042,0.7083333333333334,1.0,1.0,1/6,1.35%,NRP1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.48319891551881033,0.8343433170016858,0.7380952380952381,0.9951901840597783,1.0,5/22,18.58%,LPIN1;PLAAT3;LPCAT3;CHKA;CSNK2A1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.34736969222681535,-0.8343253923390311,0.72,1.0,1.0,1/20,2.33%,ATM
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.38960642402805934,0.834045303873675,0.7959183673469388,0.9951963097714006,1.0,22/126,16.33%,SOD1;RHOB;DDX3X;MTCH2;STK4;ARHGEF9;CCAR1;BNIP3L;MCF2L;APBB1;RPS27A;MELK;ARHGEF7;BCL6;SIAH1;APAF1;PAWR;LRRK2;ATF6;TNFRSF10B;ARHGEF4;LATS2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.407264472197244,0.8340303675145069,0.8089887640449438,0.994758498629854,1.0,17/56,27.95%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;PPP3CA;PSMD14;MAPK1;VAV3;SKP1;GAB2;GRB2;TAB2;JUN;FOS;PAK1;PLCG1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.4819568654885769,0.8337919226475465,0.7590361445783133,0.9946504511679235,1.0,5/19,8.95%,NR4A3;NCEH1;CSF1R;TNFRSF1B;CPM
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.41029461271555817,-0.8336153093722241,0.5714285714285714,1.0,1.0,1/13,0.06%,PPP1CB
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4322440886008913,0.8329485777521476,0.7727272727272727,0.995360972369561,1.0,8/41,15.79%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;FBXL13;PSMD14;RBX1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.4230079267195137,0.8323347839029617,0.7444444444444445,0.9959611603256949,1.0,7/37,15.17%,RHOB;XRCC4;RNF168;CLOCK;TANK;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5414882667304575,0.8317751849883882,0.7761194029850746,0.9963917767814597,1.0,5/7,37.92%,CEBPB;PRNP;PRKAR1A;RC3H1;TNFRSF21
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4347753622043068,-0.8316049101630124,0.5925925925925926,1.0,1.0,4/8,14.27%,ST6GAL1;ST3GAL1;PARN;ST3GAL4
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.4670693139553676,0.8311984238474981,0.6941176470588235,0.9968630996331037,1.0,7/18,22.18%,SGPL1;AGK;SAMD8;ACER3;CERS6;SPTLC1;SPTLC3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.5663062986959848,0.8298606721683695,0.7671232876712328,0.9984202722385915,1.0,2/5,11.37%,F3;CEBPB
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.48983200886204464,0.8298285065971701,0.7701149425287356,0.9980416966384303,1.0,1/15,2.62%,KDM1A
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.4553086485870479,0.8294220482106667,0.6896551724137931,0.9982015503333784,1.0,1/19,1.10%,TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.45023326157725985,-0.8293243785594883,0.65,1.0,1.0,2/8,6.54%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4659579242006904,0.8293167521540552,0.7710843373493976,0.997891785687632,1.0,4/18,7.75%,CSF1;AKIRIN1;CSF1R;ADAM17
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.4484843453571572,0.8285707695660874,0.7558139534883721,0.9986164992564501,1.0,7/22,20.05%,ROBO2;ROBO1;ZFPM2;MDM4;HECTD1;ZFPM1;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.45605520935706256,0.8284445119522774,0.7857142857142857,0.9983705813367153,1.0,7/25,26.71%,TGFB1;SDCBP;TWIST1;SMAD2;LEF1;OLFM1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5448915186009924,0.8282843432274027,0.7692307692307693,0.9981430926773188,1.0,2/8,25.71%,CRLF3;MGAT5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4122842321233614,0.8280880699035055,0.8105263157894737,0.9979977051907399,1.0,7/63,11.04%,NUP153;SEC13;NUP88;EGFR;SDCBP;NUP133;HIF1A
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.5537915287900512,0.8274015315950222,0.7012987012987013,0.998534607363818,1.0,1/5,14.00%,CD9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.3530343638829846,-0.8271673158333913,0.7857142857142857,1.0,1.0,2/22,4.08%,SHQ1;SDAD1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.521082228481185,0.8271198747561206,0.7714285714285715,0.9984937249873977,1.0,3/8,18.10%,PPARA;SCARB1;ABCA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.4711919957087828,-0.826516882041697,0.6296296296296297,1.0,1.0,1/7,2.99%,ZDHHC21
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5008255218006517,0.8261485856500305,0.7375,0.9994615645687114,1.0,3/12,23.77%,MTFR1;WASHC5;DNM2
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5507435482558811,0.8260372515780384,0.7857142857142857,0.9992159305040894,1.0,1/5,10.78%,EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5144096525546697,0.8259361333604789,0.7402597402597403,0.9988615686436557,1.0,1/8,14.42%,STAT3
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5703979522289166,0.8255473473160295,0.7564102564102564,0.9989885000617154,1.0,4/5,42.31%,GRAMD1A;INSIG2;LRP6;RORA
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4746345714870658,0.8251999693303489,0.735632183908046,0.9991289236969363,1.0,4/13,18.11%,BASP1;SMCHD1;FGFR2;LOXL3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.42845705849641036,0.8251773570270393,0.7954545454545454,0.9987025440711571,1.0,7/34,11.69%,KCNC2;SLC2A1;IRS1;SNAP25;ACSL4;CLOCK;GLUD1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5374204222629444,0.8251651112888034,0.7323943661971831,0.9982629533966128,1.0,2/7,17.23%,MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.43983354293936633,0.8249949915528807,0.7752808988764045,0.9980456954088502,1.0,4/27,11.77%,HDAC2;RCOR1;MORF4L1;SIN3A
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.5307432548454589,-0.8245380885555835,0.6428571428571429,1.0,1.0,1/5,1.38%,BCL2L11
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.39730679574120736,0.8243658316684835,0.92,0.9984579288224241,1.0,35/191,21.90%,DDX3X;IFT52;ACTR3;WIPI1;LZTFL1;IFT140;CSNK1D;ATG16L2;DHX29;NUDCD3;TRAF3IP1;CSDE1;EIF4ENIF1;EHD2;GALNT11;TTC8;RAB7A;EXOC1;MAK;AMBRA1;C9ORF72;TNKS;WDR45B;ARF4;VTA1;MAP1LC3B;GOLGA8B;GOLGA2;WDR19;RAB8B;ASAP1;SEPTIN7;CEP290;TP53INP1;STX12
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.32852709131987734,-0.8240255259262097,0.7777777777777778,1.0,1.0,3/18,6.59%,CYP4V2;CYP27A1;AKR1C3
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5399918950229131,0.8236532272616882,0.7887323943661971,0.9990372277497152,1.0,2/7,19.43%,GALNT11;RBPJ
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5314069524136186,0.8235987229372126,0.8108108108108109,0.9986389847614614,1.0,1/6,7.96%,NUP88
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.4813160108753217,0.8231004732328169,0.7721518987341772,0.9989283248653896,1.0,1/14,1.54%,PRKACA
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.5262133068313287,0.8224523731005765,0.7361111111111112,0.9995066344141749,1.0,4/7,28.46%,OXSR1;STK39;SH2B3;PTK2B
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.4687508625351849,0.8211115829867229,0.7228915662650602,1.0,1.0,10/19,35.25%,ACADVL;ECHDC1;ACADL;SLC25A17;HSD17B4;HADHB;AUH;ABCD3;HADHA;ACOX3
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4115816398321347,0.8209819374873039,0.8163265306122449,1.0,1.0,13/72,17.08%,NEDD4L;ADGRB3;CDH2;SEMA4D;TGFB1;LZTS1;KIF13B;BCL6;CAPZB;FGFR2;CFL1;LRRK2;HECW1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.42951821603656853,0.8205945628983143,0.7526881720430108,1.0,1.0,9/41,19.22%,ARPP21;TENM2;VPS50;SLC16A7;ZBTB16;EFHD1;IGFBP2;PLAG1;SIDT1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.4257055015392213,0.8201932920065452,0.8404255319148937,1.0,1.0,12/52,16.11%,RHOB;NRG1;RAF1;CSF1R;DIAPH1;FRMD5;TGFB1;EGFR;TMSB4X;ROCK2;SLK;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.4965558821555799,0.819883962862591,0.7605633802816901,1.0,1.0,4/11,25.98%,TNFRSF1B;GRM7;STXBP6;IL1RAPL1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.5277328818353039,0.8187700899785819,0.7428571428571429,1.0,1.0,2/6,19.20%,TTN;ZFPM1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.29005990397667675,-0.8178675798574583,1.0,1.0,1.0,14/80,10.45%,TAGLN;ACTA2;LMOD1;COL14A1;CYP27A1;MYL9;IGFBP7;COL15A1;CXCL12;ACADSB;COL1A2;ABCA8;ZNF423;TNS2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.45470161402586357,0.8178434480160104,0.7191011235955056,1.0,1.0,3/22,9.13%,TAF1B;DDX21;ARID1A
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.546419565059945,0.8177578968533935,0.8260869565217391,1.0,1.0,1/5,8.64%,ALKBH5
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.546419565059945,0.8177578968533935,0.8260869565217391,1.0,1.0,1/5,8.64%,ALKBH5
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.5496770656273128,0.8175886068906961,0.7466666666666667,1.0,1.0,1/5,8.45%,TGFB1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.3883521473334263,-0.8172875688676219,0.8095238095238095,1.0,1.0,2/16,5.32%,FGF13;CKAP5
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.543415590373725,-0.8166797095692133,0.7333333333333333,1.0,1.0,2/5,1.81%,NRP1;SLIT2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5510517365616632,0.8162198340797934,0.8,1.0,1.0,2/6,31.13%,MTHFD1L;QDPR
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.527191412733472,0.8160231585255466,0.7647058823529411,1.0,1.0,5/6,46.18%,CFH;CD55;TGFB2;RAC1;MAPK8
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.5183872088595414,0.815540824966936,0.7746478873239436,1.0,1.0,2/8,13.55%,ZC3H12B;CSTF3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.4498375896043702,-0.815176533746895,0.7407407407407407,1.0,1.0,4/9,8.22%,ACTA2;MYH11;MYLK;EDNRA
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.5438813579478967,0.8146548523418797,0.8133333333333334,1.0,1.0,1/7,1.86%,TSC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.40216582896136244,0.8143697915008246,0.8125,1.0,1.0,23/76,33.72%,RPS21;ETF1;RPL28;RPS27A;RPL21;RPL41;PABPC1;DCP1A;RPLP2;RPL9;RPL18;UPF3A;SMG7;RPS14;RPL27A;RPL13A;UPF2;RPL31;RPL32;PPP2R2A;RPS2;RPS4X;RPL34
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5458269801375621,0.8143539650798377,0.7714285714285715,1.0,1.0,2/5,20.72%,PPARA;ABHD5
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.2881859700778174,-0.8139483716279353,1.0,1.0,1.0,6/41,8.00%,NRP1;PGF;MAPK14;NCK1;WASF2;ELMO1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.5228720249109621,0.8134587457656722,0.7564102564102564,1.0,1.0,3/7,44.28%,PRKDC;NSA2;LAS1L
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.5298404003939803,0.8131810065345977,0.7702702702702703,1.0,1.0,2/7,27.85%,TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.506994730742363,0.8131247236503988,0.6944444444444444,1.0,1.0,3/7,18.19%,IL18;IGFBP2;PRNP
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.407437046716398,0.8130632370022371,0.8279569892473119,1.0,1.0,17/55,32.03%,HDAC2;PHF20L1;RCOR1;MORF4L1;SIN3A;USP3;PHF20;UBE2B;MT3;RPS6KA5;USP22;KAT6A;NEK11;SUPT3H;MORF4L2;HDAC5;MIER1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5007452391682304,0.8128564947853419,0.7333333333333333,1.0,1.0,5/8,39.05%,EIF4ENIF1;PATL1;LSM14A;RC3H1;ATXN2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.4215557672437962,0.8123626713949246,0.7872340425531915,1.0,1.0,4/36,11.40%,MID1;EIF2AK2;SDCBP;CCN2
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.44536701381231414,0.8122514516416365,0.8048780487804879,1.0,1.0,3/19,16.70%,HIF1A;TANK;USP10
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.44734449651606506,0.8120751981893628,0.7906976744186046,1.0,1.0,6/31,14.42%,NR4A3;ROBO2;KLF9;SRA1;CTSL;STAT3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.42050045400415104,0.8118763079857751,0.7386363636363636,1.0,1.0,7/36,23.17%,TBC1D20;IFT140;CAPZB;TBC1D15;TBC1D8;TBC1D5;USP6NL
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.46563332672843805,0.8114890187949305,0.8048780487804879,1.0,1.0,4/16,12.56%,CRY1;ACADVL;ROCK2;ACADL
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.4954419767608196,0.8111605734553559,0.7777777777777778,1.0,1.0,4/11,26.72%,GBE1;PHKB;UGP2;PYGB
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4589785368278502,0.8109361399572008,0.7,1.0,1.0,5/14,15.56%,SZT2;GPR137C;RNF152;SESN1;C9ORF72
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5018353918914136,0.8106190384707869,0.7402597402597403,1.0,1.0,3/12,21.82%,RUBCN;LGALS3;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.4666237155403377,-0.8102748855467938,0.5277777777777778,1.0,1.0,2/5,3.74%,WNK2;ATP1B2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.46582763519904974,0.8101576080196782,0.7647058823529411,1.0,1.0,4/15,28.57%,CHCHD3;SPG7;DNAJC11;IMMT
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4316599471733683,0.8099579908242087,0.797752808988764,1.0,1.0,4/33,18.41%,CSF1R;MED14;CEBPB;CBFB
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4078004037462851,0.8098747704720105,0.7391304347826086,1.0,1.0,7/42,23.17%,TBC1D20;IFT140;C9ORF72;TBC1D15;TBC1D8;TBC1D5;USP6NL
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.4377405907444355,0.8089570023201217,0.7073170731707317,1.0,1.0,2/15,16.70%,MDM4;USP10
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.43290284535674256,0.808893038718578,0.8152173913043478,1.0,1.0,11/40,28.58%,NR4A3;ACTR3;WIPF1;MAPK1;VAV3;ABL1;GRB2;CYFIP1;PAK1;PLCG1;CRK
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.40239621206111853,-0.8085089633213346,0.875,1.0,1.0,3/15,12.86%,RYR2;SETDB2;PKD2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.42850231493566343,0.8081601812709046,0.7727272727272727,1.0,1.0,8/28,30.13%,MORF4L1;FAN1;PSMD14;ZSWIM7;RPA1;SFPQ;SPIDR;REV3L
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.46499604704473996,0.8081471236398585,0.75,1.0,1.0,2/15,16.28%,ACVR1B;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.5187153123392874,0.808133353988985,0.7857142857142857,1.0,1.0,2/5,33.30%,IQSEC1;MTOR
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.41865990255744767,0.8077583282504659,0.7529411764705882,1.0,1.0,2/35,1.54%,S1PR3;PRKACA
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.4566906299156435,0.8075808460705113,0.8333333333333334,1.0,1.0,6/17,29.85%,OTUD7A;BRCC3;PSMD14;USP25;USP8;CYLD
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.5325742293520963,0.8071717370979083,0.782608695652174,1.0,1.0,1/5,12.19%,SPIRE1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.40124346909617153,0.8070713733022465,0.7938144329896907,1.0,1.0,7/42,17.35%,ATP6V1G1;ATP6V1H;IRS1;ATP6V1E1;PDK4;INSR;PTPN2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5416430880806656,0.8068362165200768,0.7763157894736842,1.0,1.0,3/8,14.39%,PRKACA;AKAP6;PDE4D
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4556653258110003,0.8064209826184856,0.8043478260869565,1.0,1.0,6/23,21.09%,BASP1;MBP;GLUD1;HSPA5;CKB;PLP1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.4919675073878105,0.8061429248637635,0.7402597402597403,1.0,1.0,1/7,5.32%,ATP1B3
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5286120075879035,0.8057229444609103,0.7721518987341772,1.0,1.0,2/7,33.25%,PRKX;DLG1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5207384337923715,0.8054719271605242,0.7564102564102564,1.0,1.0,2/7,23.06%,CCT3;EIF3B
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.48596460261415203,0.8049406363745231,0.7662337662337663,1.0,1.0,4/12,26.99%,PLAAT3;LPCAT3;SERINC1;OSBPL5
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.5355413423308519,0.8048151421745857,0.782608695652174,1.0,1.0,3/5,40.18%,DNM2;SNAP91;DNM3
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.4003969397177475,-0.8027496011045099,0.6923076923076923,1.0,1.0,4/10,12.84%,PRDM5;SETDB2;SETDB1;SMYD3
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5046623879396342,0.8025141378842526,0.7534246575342466,1.0,1.0,2/8,21.28%,ADAM17;LDLRAP1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.46041065595558506,0.8019858454588106,0.7875,1.0,1.0,2/11,22.46%,PDE4D;ENTPD4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.4091546505378782,0.8013632061675448,0.8089887640449438,1.0,1.0,9/37,19.91%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;PSMD14;ANAPC4;SKP1;CDKN1B
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.47342337318794553,0.8013627549960223,0.8095238095238095,1.0,1.0,2/15,14.31%,TNFRSF1B;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.39710211209972174,0.8013290543504596,0.8191489361702128,1.0,1.0,19/72,21.25%,TPT1;RAF1;BNIP3L;TP63;SRA1;MADD;BCL6;IFT57;APAF1;SLK;LRRK2;NF2;TNFRSF10B;ZBTB7A;FBXO11;ACER3;ABL1;BNIP3;TP53INP1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5263270871450442,0.8011472454653782,0.7631578947368421,1.0,1.0,3/5,46.45%,GNAL;ADCY3;GNAS
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.49224676907588727,0.8010291333453153,0.7721518987341772,1.0,1.0,1/9,3.52%,ITGA5
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.44936884242735214,-0.8009769804777599,0.6785714285714286,1.0,1.0,2/8,11.54%,KCNB1;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.4331759354339288,-0.8009715264273972,0.7222222222222222,1.0,1.0,2/7,4.31%,EDN3;RYR2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4421629362074899,0.8006646383206855,0.7674418604651163,1.0,1.0,2/18,2.11%,PLAA;GNPAT
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5321994465158658,0.8003327979872193,0.8235294117647058,1.0,1.0,3/7,14.08%,HNRNPC;ELAVL1;MAPKAPK2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5274860212891944,-0.8002758025909777,0.75,1.0,1.0,2/6,16.27%,CHMP4B;PPP2R2D
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4728524293735138,0.8002174442078653,0.7831325301204819,1.0,1.0,3/13,17.56%,TNFRSF1B;CEBPB;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.44620306617627514,0.8001710493823134,0.7586206896551724,1.0,1.0,6/18,27.17%,PSME3IP1;SDCBP;WAC;USP25;MARCHF7;EIF3H
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4428629561626824,0.7998630013209501,0.7619047619047619,1.0,1.0,3/21,13.45%,TENM2;NLGN1;CAPZB
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.4886030717256993,0.7997003567071146,0.7564102564102564,1.0,1.0,2/10,20.27%,EIF2AK4;ABL1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.5345343883608236,0.7988420052379243,0.8028169014084507,1.0,1.0,2/5,19.09%,PWP1;SMARCA4
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.40287504905061733,-0.798363354169561,0.5714285714285714,1.0,1.0,4/8,19.18%,ADCY6;ADCY2;ADCY9;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.4452414830999923,0.7980754854942856,0.8192771084337349,1.0,1.0,3/21,15.59%,SYMPK;TGFB1;PPP6R2
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.4075256714229332,0.7980649629871536,0.8297872340425532,1.0,1.0,13/59,16.53%,PHYHIPL;GJA1;GFAP;ADGRB3;ALDH1L1;SYNDIG1;SNAP25;CADM2;CDH20;PTPRZ1;SLC1A2;TEAD1;NRXN1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5181905631388306,0.7979769613535035,0.7866666666666666,1.0,1.0,2/7,21.08%,CEBPB;NF1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.46959560013730806,-0.797894137995309,0.6206896551724138,1.0,1.0,3/5,17.32%,APOE;CLU;PSEN1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.44785733185062937,0.7978810868367044,0.863013698630137,1.0,1.0,4/17,18.08%,RPS27A;FAN1;RBX1;RPA1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5116253735037309,0.7976027327667656,0.7530864197530864,1.0,1.0,5/6,47.81%,SOX13;HNRNPU;NAPEPLD;SIRT1;RREB1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.46651736064507154,-0.7974989022042992,0.75,1.0,1.0,1/5,9.94%,HOOK3
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3653742230044627,-0.7974237807477548,0.875,1.0,1.0,1/17,2.33%,ATM
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.502296620631214,0.797390579045168,0.7857142857142857,1.0,1.0,3/8,39.98%,PAFAH1B1;MTOR;SUN2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.46509246057805326,0.7973494827042598,0.7560975609756098,1.0,1.0,5/14,20.05%,TGFB1;SMURF2;LATS2;SMAD2;SMAD7
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.49640167470973445,-0.7969642804052498,0.75,1.0,1.0,3/6,13.52%,ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.44493234501571377,0.7969429417240049,0.7647058823529411,1.0,1.0,4/15,15.97%,TGFB1;WNT2B;RUNX1;CREB3L2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4303942083885108,0.7969082255894236,0.8275862068965517,1.0,1.0,7/30,20.84%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;SNAP23;ITGAV
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4415585731309878,0.7966868382637174,0.7888888888888889,1.0,1.0,4/24,6.68%,WASF3;MICALL2;WASF1;DIAPH1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4417861090529923,0.7965047778181088,0.8241758241758241,1.0,1.0,10/26,30.47%,ARID3A;CNOT8;WAC;MDM2;MDM4;CDKN1B;CNOT1;RGCC;PLAGL1;PRKDC
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.40810418544475957,0.7956978517158438,0.7857142857142857,1.0,1.0,5/26,18.08%,RPS27A;FAN1;RBX1;DCP1A;RPA1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5284576153165598,0.7955059522484499,0.7536231884057971,1.0,1.0,3/5,45.22%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5284576153165598,0.7955059522484499,0.7536231884057971,1.0,1.0,3/5,45.22%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5284576153165598,0.7955059522484499,0.7536231884057971,1.0,1.0,3/5,45.22%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.4270120189940542,0.7954335276530493,0.75,1.0,1.0,5/20,15.77%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.46496092776294023,0.7953194507178892,0.8493150684931506,1.0,1.0,8/14,26.13%,HIF1A;BRD1;STAT3;ACVR1B;ACVR2A;ABCB10;FOXO3;ETS1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4781643722090642,0.7950803983044015,0.7894736842105263,1.0,1.0,2/10,13.43%,CD38;BCL6
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.3398514211404188,-0.7949855366413201,0.8333333333333334,1.0,1.0,3/18,4.00%,CYP4V2;CYP27A1;PPARD
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.40237289144247906,0.7947806071611985,0.7415730337078652,1.0,1.0,11/28,30.26%,HNRNPF;CEP57;FGFR2;MAPK1;GRB2;HNRNPM;POLR2F;SPRED1;RAB14;PTPN11;SETX
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.4471469969021062,0.7947365421484793,0.7792207792207793,1.0,1.0,6/15,37.17%,ACVR2A;SMAD2;RBPJ;CCN1;FOXD1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.3644047116460814,-0.7943351337467999,0.6666666666666666,1.0,1.0,2/17,6.90%,PHLDB2;WASF2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.3834033002924517,-0.7943167850799,0.6111111111111112,1.0,1.0,3/9,11.21%,MECOM;SETDB2;SETDB1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.4034683643918423,0.7940377159575472,0.8787878787878788,1.0,1.0,5/79,5.57%,CD44;GJA1;PTPRD;DCLK1;PCDH17
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3910489709059798,0.7940304836414585,0.8536585365853658,1.0,1.0,8/45,20.52%,DDX3X;PDK1;TNFRSF1B;CEBPB;APAF1;TNFRSF10B;ABL1;BNIP3
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3886583830480134,0.793923612977516,0.8068181818181818,1.0,1.0,10/51,20.38%,PSMB1;PSMB2;PSMA7;RPS27A;CCNH;PSMA4;PSMD14;RBX1;RPA1;NAP1L1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.41291960456504906,-0.7938169860336927,0.6666666666666666,1.0,1.0,1/7,2.33%,ATM
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.52165737536036,0.7937782237572019,0.8260869565217391,1.0,1.0,3/5,17.66%,SECISBP2L;TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.52165737536036,0.7937782237572019,0.8260869565217391,1.0,1.0,3/5,17.66%,SECISBP2L;TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5368109197972787,0.7935527383638625,0.821917808219178,1.0,1.0,1/5,4.85%,OGN
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5368809550400538,0.7932362812262046,0.7848101265822784,1.0,1.0,1/5,9.31%,TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.49668540418321006,-0.7916216763334603,0.7931034482758621,1.0,1.0,4/5,15.83%,MAPK14;RIPOR2;FLOT1;CFLAR
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.4650731004658246,0.7903010329393867,0.7808219178082192,1.0,1.0,4/7,34.99%,EGFR;PLCG1;ARHGAP6;GNAQ
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.43471510634994565,-0.790169949943003,0.5714285714285714,1.0,1.0,7/7,56.59%,SMYD3;PRMT2;NSD3;EHMT1;PRMT7;NSD1;CREBBP
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.48601034622774264,-0.790091767237411,0.68,1.0,1.0,1/5,1.35%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4108857736607472,0.7900898102052246,0.7738095238095238,1.0,1.0,2/16,5.85%,ANK3;FHL1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4378559635947567,0.7896392679385678,0.7228915662650602,1.0,1.0,6/16,19.45%,PDE4B;HOMER2;RUNX1;PDE4D;PRNP;NAV3
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3811213673725007,0.7896126855944994,0.84375,1.0,1.0,22/95,23.77%,PPME1;PRKACA;TUBA1A;CCP110;CSNK1D;BTRC;CEP57;MELK;CCNH;CEP70;ACVR1B;LATS2;CRLF3;PAFAH1B1;CNTRL;SKP1;CDKN1B;CEP290;YWHAG;ENSA;CCND3;DNM2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.3668151347913816,-0.7889722425592386,0.76,1.0,1.0,1/12,1.10%,CD4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4197318971349113,0.7886830298301988,0.8021978021978022,1.0,1.0,8/32,22.29%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;SNAP23;ITGAV;LNPEP
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.42977004930934837,-0.7877006405352022,0.7368421052631579,1.0,1.0,3/9,12.86%,RYR2;ITPR1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.4928769958425075,0.7874899043958428,0.7532467532467533,1.0,1.0,2/8,21.84%,RIOK3;UBE2K
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.41270810528650037,0.787393018210366,0.7619047619047619,1.0,1.0,3/27,8.76%,RHOB;CAMKK2;EGFR
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.45905681257155057,0.7868032871380807,0.8295454545454546,1.0,1.0,4/18,16.33%,TGFB1;GLUL;SIN3A;LATS2
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.3974891193064718,-0.786688019425173,0.7272727272727273,1.0,1.0,1/10,1.57%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.4132769557085225,0.7860164842997086,0.8131868131868132,1.0,1.0,11/35,35.96%,TBK1;TRAF3IP1;POLR1C;POLR2F;NPLOC4;CYLD;IRF1;PRKDC;STAT6;XRCC5;NFKB1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5194856600170938,0.7857945911367366,0.7638888888888888,1.0,1.0,2/5,27.36%,PCSK6;PCSK5
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3980166137282301,0.7853954942786932,0.8404255319148937,1.0,1.0,5/37,16.02%,PDLIM1;FRMD5;MYOM2;ROCK2;TTN
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.46264538245783604,0.7848363178970997,0.7564102564102564,1.0,1.0,4/9,28.61%,EIF2AK2;IFITM3;AXL;RO60
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.2918542942724449,-0.7842485846359457,1.0,1.0,1.0,14/51,11.23%,ARHGEF10L;GPRC5C;CDC42BPB;BCAM;LAMB2;FKBP9;PTPN21;DAG1;ARHGEF17;SUN1;NFE2L1;ADCY6;PLXNB2;TMEM50B
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.5031332748366603,0.7837940966219787,0.7164179104477612,1.0,1.0,8/11,34.63%,VAPA;PRNP;TRAM1;ALDH3A2;TRAM2;EMC3;APP;SERP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.430119079720848,0.7837661961451606,0.7283950617283951,1.0,1.0,9/19,29.87%,ANK3;GGA3;NSF;PREPL;BLZF1;GGA2;GOLGA4;VAMP5;GOLPH3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4530951277221816,0.7836990591184194,0.8148148148148148,1.0,1.0,2/16,5.01%,GLRB;GABRE
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.502104674989172,0.7835603893948084,0.7733333333333333,1.0,1.0,1/7,16.95%,LGR4
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.41439666732429975,0.7833474868783324,0.782051282051282,1.0,1.0,9/24,22.02%,CDC5L;STK33;CLOCK;MDM4;TP53BP1;USP10;DONSON;ABL1;GRB2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.3844659906291193,-0.783180472252111,0.7391304347826086,1.0,1.0,2/17,3.99%,DAPK2;RPS3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.37722707323989774,0.7829313109867551,0.8404255319148937,1.0,1.0,11/69,18.08%,RAD21;XRCC4;APBB1;RNF168;MORF4L1;FAN1;BRCC3;TP53BP1;PSMD14;ZSWIM7;RPA1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4551875321077873,0.7829194796835557,0.8395061728395061,1.0,1.0,3/16,15.85%,NRG1;EGFR;ERBIN
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.45047677893014726,0.7828170032552442,0.7790697674418605,1.0,1.0,2/16,6.02%,NRG1;IL18
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.4039112553281635,-0.7818283251097836,0.6666666666666666,1.0,1.0,2/7,13.18%,MTERF1;HMGB1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.4567019553050842,0.7816519533112476,0.7530864197530864,1.0,1.0,7/13,38.37%,ENTPD4;NUDT5;RNASEH2C;PNPT1;XRN2;HNRNPD;NCBP1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4253221473045249,0.781638598779639,0.8222222222222222,1.0,1.0,4/22,12.56%,ACADVL;PPARGC1A;ECHDC1;ACADL
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.4043010770680939,0.7813396522815497,0.8736842105263158,1.0,1.0,12/49,18.30%,STC1;SGPL1;CCN2;MYOM2;ZFPM2;SLC25A4;PDE4D;MYL3;TTN;CKB;CKMT2;PTH1R
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.45052829484017404,0.7811016458070922,0.7012987012987013,1.0,1.0,3/10,28.55%,ZBTB16;TRPS1;PTPN11
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.39366278179579023,0.7809240925456598,0.8709677419354839,1.0,1.0,21/64,35.02%,PPP1CC;SEC13;STMN1;NUP133;TNKS;PAFAH1B1;GOLGA2;GPSM2;NUP160;CENPP;RAB11A;LSM14A;RANBP2;MAP9;CLIP1;RANGAP1;ZNF207;SMC1A;SMC3;TAOK1;NEK9
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5097023620720551,0.7801855110634459,0.8169014084507042,1.0,1.0,2/8,12.13%,DNAH11;GALNT11
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.46423556437563906,0.7798534382274561,0.7948717948717948,1.0,1.0,5/11,36.65%,ARHGEF7;PIP5K1A;CTTN;PEAK1;PTPRK
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.3986943999263985,-0.7797477961901765,0.8518518518518519,1.0,1.0,4/8,16.90%,MTM1;TMEM39A;CHMP4B;SEC22B
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.47065989029007427,0.7796783670864589,0.8311688311688312,1.0,1.0,4/10,30.68%,IL18;CD81;MALT1;CD55
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.309353776146762,-0.779155327233045,0.9,1.0,1.0,6/38,7.40%,POLDIP3;THOC1;CKAP5;CASC3;RFTN1;TPR
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.3894217567978809,-0.7781794936886209,0.7,1.0,1.0,3/7,16.58%,CORO1C;ACTN4;FBLN1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.3894217567978809,-0.7781794936886209,0.7,1.0,1.0,3/7,16.58%,CORO1C;ACTN4;FBLN1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5154391062153504,0.7775342934575572,0.7848101265822784,1.0,1.0,3/6,32.21%,SLC1A2;SLC1A1;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.4523986849554408,0.7771428153467079,0.8433734939759037,1.0,1.0,2/18,8.14%,PTPN1;UGCG
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.5217057688712667,0.7766011815322306,0.8108108108108109,1.0,1.0,1/6,14.62%,FGFR2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.44625185640915166,0.7765541655940027,0.8354430379746836,1.0,1.0,5/17,14.13%,KCNQ1;NOS1AP;ATP1B3;GNB1;AKAP6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.382080678382275,0.7762508810751837,0.8541666666666666,1.0,1.0,7/71,10.47%,GJA1;CRMP1;DCLK1;TENM3;SMARCA1;SYNDIG1;SHC2
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.4856424278697081,0.7762049257860467,0.8055555555555556,1.0,1.0,1/7,5.32%,ATP1B3
prerank,PanglaoDB_Augmented_2021__B Cells,-0.36428498915530877,-0.7757892206364377,0.8,1.0,1.0,1/22,0.19%,WDFY4
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.4711425263657082,0.7757536399831699,0.7567567567567568,1.0,1.0,2/8,8.19%,ZFP36L2;KLF9
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.47364969253875655,0.7755958951682316,0.8289473684210527,1.0,1.0,3/8,14.50%,C1R;CTSL;PGK1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.3915817945462556,0.7752301194633535,0.8695652173913043,1.0,1.0,6/64,10.95%,RPS21;ETF1;RPL28;RPS27A;RPL21;RPL41
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.372464060733133,-0.7747834075286673,0.8214285714285714,1.0,1.0,2/12,7.85%,SPRY1;HEYL
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.45813515615919165,0.7745303767705972,0.8024691358024691,1.0,1.0,4/15,20.78%,GNPAT;AGPAT4;ABHD5;DGKH
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.45813515615919165,0.7745303767705972,0.8024691358024691,1.0,1.0,4/15,20.78%,GNPAT;AGPAT4;ABHD5;DGKH
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.4580789351821565,0.7743067181118856,0.8072289156626506,1.0,1.0,5/13,21.08%,ROBO2;ROBO1;HECTD1;SMAD7;NF1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.3390690009874152,-0.7739708351861401,0.9090909090909091,1.0,1.0,6/20,19.70%,RHOT1;CDC42;UBB;LRPPRC;DYNC1I1;HTT
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.47848661417481064,0.773961801638288,0.8395061728395061,1.0,1.0,2/8,14.84%,DUSP1;PPP3CA
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.4443754758992672,0.7737807879705069,0.8,1.0,1.0,4/17,12.25%,SEMA4D;ROBO1;EPHA7;SEMA3B
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.4333027941422308,0.7737211934304669,0.7931034482758621,1.0,1.0,2/17,10.00%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.37389199909191534,0.7735477503535578,0.8602150537634409,1.0,1.0,11/67,13.52%,NRCAM;DNER;PTPRD;DDIT4;SMARCA1;ACSL4;WNT2B;ADNP2;FZD3;MYT1L;RUNX1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.4365793158898831,-0.7733612785663542,0.7037037037037037,1.0,1.0,1/5,10.08%,ANXA1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4369644341166127,0.7732498451819374,0.8777777777777778,1.0,1.0,8/23,29.14%,ARID3A;CNOT8;MDM2;MDM4;CDKN1B;CNOT1;RGCC;PLAGL1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3325118915482829,-0.772636597487391,0.9375,1.0,1.0,1/24,0.36%,PGR
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.48184500286092485,0.7724169886743685,0.8378378378378378,1.0,1.0,1/8,4.11%,WASF1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.468031763393014,0.7722921114541327,0.75,1.0,1.0,2/10,16.02%,CDH2;TTN
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.44493515041543324,0.7721617919889434,0.7848101265822784,1.0,1.0,4/16,16.63%,NOS1AP;EGFR;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.3792106541536146,-0.7719391555752289,0.7222222222222222,1.0,1.0,3/11,15.26%,TOPBP1;ORC5;NOC3L
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.41928829153016556,0.7715997839609212,0.7931034482758621,1.0,1.0,5/19,14.08%,HNRNPC;ELAVL1;EIF4ENIF1;PABPC1;MAPKAPK2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.48059390545201053,0.7712106794657455,0.825,1.0,1.0,3/11,15.17%,XRCC4;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.4446052767732519,0.7709061610032877,0.7763157894736842,1.0,1.0,1/12,4.26%,NUP153
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.412957366347007,0.7708540396178082,0.7674418604651163,1.0,1.0,6/21,18.86%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;PPM1K
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.43406844985976817,0.7706239904993419,0.8426966292134831,1.0,1.0,4/25,15.00%,CSNK1A1;WNT2B;FZD3;LRRK2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4067157964014911,0.7703944572499498,0.8111111111111111,1.0,1.0,6/32,19.91%,ARID3A;CNOT8;MDM2;MDM4;USP10;CDKN1B
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4671800982501151,-0.7702791905218236,0.7714285714285715,1.0,1.0,4/5,25.95%,DOCK10;DOCK11;PPP2R3C;MEF2C
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.41378224022656546,0.7701174483932419,0.7865168539325843,1.0,1.0,10/27,33.55%,SRSF10;RBM39;KHDRBS3;AHCYL1;METTL16;KHDRBS2;SRSF3;RBM23;PAPOLA;SRPK2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4156390499445509,0.7700210700716695,0.7654320987654321,1.0,1.0,8/17,22.47%,NEDD4L;ANK3;GLRX;FGF14;HECW1;STK39;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.44941455051211704,0.769782254140682,0.8701298701298701,1.0,1.0,1/12,1.35%,RHOB
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.43555458676350745,0.7697490139015354,0.8279569892473119,1.0,1.0,6/23,23.09%,NEDD4L;NLGN1;SGIP1;LDLRAP1;TF;AXL
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3939269695150159,-0.7697341286994742,0.7619047619047619,1.0,1.0,2/9,12.50%,CENATAC;CHMP4B
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.4707267299208833,0.769731292162214,0.7567567567567568,1.0,1.0,4/11,23.03%,TMEM165;LRRK2;ABCA1;TMEM106B
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.5420779630908192,0.7696739825638009,0.7971014492753623,1.0,1.0,2/5,27.54%,ABL1;PPP2CB
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.4684681441546167,-0.7696503912750781,0.7352941176470589,1.0,1.0,2/5,12.03%,AFG3L2;MCU
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3270483130029652,-0.7693348198323093,1.0,1.0,1.0,5/29,5.47%,LMOD1;EVL;BAIAP2L2;RPS3;NCK1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.38969190569077616,0.7692796269214935,0.8924731182795699,1.0,1.0,24/73,35.89%,DDX52;RPL28;NOP58;RPL21;WDR43;RPL41;RPLP2;TEX10;DIS3;RPL9;RPL18;RPS14;NOL8;RPL27A;RPL13A;RCL1;RPL31;RPL32;XRN1;RPS2;RPL34;RPL3;BMS1;XRN2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.44042545706876834,0.7690485448925896,0.7727272727272727,1.0,1.0,1/12,7.35%,ENPEP
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.4965755723038363,0.7689779247428925,0.7611940298507462,1.0,1.0,2/5,18.10%,PPARA;ABCA1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3755867924572007,0.7688781836573002,0.9595959595959596,1.0,1.0,35/142,28.94%,PARVB;IFT52;ACTR3;LZTFL1;EMP1;IFT140;NUDCD3;TRAF3IP1;RAP1B;SDCBP;EHD2;GALNT11;TTC8;ARHGEF7;EXOC1;MAK;ARHGEF4;ARF4;WDR19;RAB8B;ASAP1;SEPTIN7;CEP290;ARMC9;CYFIP1;RFX3;ATP6V1D;PIP5K1A;CCDC88A;RAB3IP;RILPL1;RAB11A;PTPDC1;DCDC2;ARL13B
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.44507498652592686,0.7686588162498945,0.7948717948717948,1.0,1.0,4/17,14.10%,NDUFB9;NDUFV1;NDUFS2;NDUFB2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.44507498652592686,0.7686588162498945,0.7948717948717948,1.0,1.0,4/17,14.10%,NDUFB9;NDUFV1;NDUFS2;NDUFB2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.4932830719783424,0.768314919129239,0.8208955223880597,1.0,1.0,2/9,18.97%,MDM4;SMAD2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.38668083066702386,0.7682579327579644,0.9368421052631579,1.0,1.0,20/81,30.65%,DDX52;DHX29;RPL28;NOP58;GLUL;RPL21;WDR43;RPL41;RPLP2;TEX10;DIS3;RPL9;RPL18;RPS14;NOL8;RPL27A;RPL13A;RCL1;RPL31;RPL32
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.35890431638203735,-0.7681686542720791,0.6923076923076923,1.0,1.0,7/18,18.80%,MYL9;ACTB;ACTG1;FLNA;ILK;ACTN1;STXBP3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4128487336880683,-0.7680718852564242,0.7142857142857143,1.0,1.0,4/7,20.39%,ACTB;STX8;APPL1;ZDHHC2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.3999146367430581,0.7679685445749889,0.7948717948717948,1.0,1.0,8/19,30.13%,RPS27A;USP10;ZBTB1;RPA1;RCHY1;NPLOC4;POLK;REV3L
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.37335936531145947,0.7679183386058949,0.8571428571428571,1.0,1.0,16/100,16.53%,DOK6;NRXN3;SPTBN4;NIBAN2;SEMA4D;ROBO2;NCAM1;ROBO1;EFNB2;EPHA7;SEMA3B;RANBP9;SIAH1;UNC5B;MAPK1;NRXN1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4884995168986583,0.7674032332648902,0.8615384615384616,1.0,1.0,1/6,19.20%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4973159077081214,0.7671457077587541,0.821917808219178,1.0,1.0,2/6,19.09%,PWP1;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.46409794855578274,0.7671434274217713,0.7926829268292683,1.0,1.0,2/12,7.55%,SSH1;STMN1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.5206036295241631,0.7667645042342367,0.8421052631578947,1.0,1.0,2/6,40.73%,LEF1;PML
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.4363691732147975,-0.7662704666818594,0.7,1.0,1.0,3/9,13.24%,RPS3;TRAF6;DAB2IP
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4743331403344704,-0.7661888810659687,0.7916666666666666,1.0,1.0,2/5,2.43%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4506707601693245,0.7660152531883722,0.7215189873417721,1.0,1.0,6/10,35.00%,LRRK2;ARF1;MTMR2;ATAD1;SLC24A2;STXBP1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.4590904825024439,0.765434166201105,0.7972972972972973,1.0,1.0,2/10,8.98%,ROBO2;ROBO1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.4185628570646318,0.7651689283734947,0.8505747126436781,1.0,1.0,4/23,11.06%,ROBO2;C1GALT1;TRAF3IP1;ZBTB16
prerank,MSigDB_Hallmark_2020__Androgen Response,0.4034407894209352,0.7649109145365274,0.8876404494382022,1.0,1.0,18/62,20.84%,ANKH;ELL2;FKBP5;CAMKK2;HOMER2;UBE2J1;SCD;VAPA;GSR;SEC24D;MAK;APPBP2;STK39;LIFR;STEAP4;ELOVL5;MAP7;ITGAV
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4410392156255774,0.7643085966977227,0.8072289156626506,1.0,1.0,6/19,22.92%,TGFB1;SMURF2;LATS2;SMAD2;SMAD7;PCSK6
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.40456193251569983,0.7642530232901569,0.8181818181818182,1.0,1.0,7/40,8.98%,DDX3X;CSF1R;FLT1;ADAM17;TGFB1;EGFR;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.4308371851725465,0.7641344138371747,0.7682926829268293,1.0,1.0,5/16,18.19%,PTPN1;CSF1R;ADAM17;DOCK3;PRNP
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4229285413165029,0.764130196947047,0.8433734939759037,1.0,1.0,1/20,2.37%,RHOJ
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5053279984766953,0.7640560384232017,0.8611111111111112,1.0,1.0,1/8,4.82%,AKIRIN1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.43867113326694157,0.7640182072533397,0.9069767441860465,1.0,1.0,4/20,12.31%,CDC42EP4;CRACD;SPIRE1;WASHC2C
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4699622409653835,0.7635873772766248,0.8181818181818182,1.0,1.0,5/13,19.31%,SLC7A2;SLC3A2;SLC36A4;SLC1A2;SLC22A2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4521205499812963,0.7635453688106609,0.8133333333333334,1.0,1.0,5/13,27.79%,TDG;RPA1;ABL1;SETD2;PMS1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.4768125595827475,0.7628097119087356,0.8181818181818182,1.0,1.0,1/7,19.20%,ZFPM1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.38013036297043445,0.7627637415043503,0.8372093023255814,1.0,1.0,12/42,28.01%,RPS27A;FAN1;CCNH;RBX1;RNF111;RPA1;HMGN1;UVSSA;POLR2F;FANCC;RAD23B;POLK
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.328554698317395,-0.7625006866074228,0.85,1.0,1.0,1/14,1.97%,PRPF6
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.4313954356283213,0.7622350591752699,0.8214285714285714,1.0,1.0,4/21,14.10%,NDUFB9;NDUFV1;NDUFS2;NDUFB2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.480294011737959,0.7616675783918806,0.8888888888888888,1.0,1.0,3/11,15.00%,ANK3;ZC4H2;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.3984626301828176,0.7616604057934298,0.7777777777777778,1.0,1.0,6/29,14.62%,MCC;KLF9;TGFB1;ROBO1;CASK;FGFR2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3618480774478555,0.7615185047117538,0.92,1.0,1.0,8/108,5.52%,CD44;RHOB;GJA1;CADM1;ITGA5;BASP1;WIPF1;CDH2
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.3747499045691809,-0.7613824481478247,0.9473684210526315,1.0,1.0,1/10,1.81%,SLIT2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.46969339227439616,0.761341175437086,0.8181818181818182,1.0,1.0,3/8,36.24%,SMCHD1;HNRNPU;PCGF5
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.46243448092868655,0.7609249622389279,0.8732394366197183,1.0,1.0,1/7,7.80%,PPARA
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.36782038476605283,-0.760724841025542,0.8571428571428571,1.0,1.0,3/12,14.02%,ATP2B4;PKD1;PTEN
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.3254534156231479,-0.760518061810975,0.7,1.0,1.0,6/21,8.20%,CYP4V2;ABCA4;GPC6;ALDH1A1;AKR1C3;GPC3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.4322330617216399,0.760131648781256,0.8275862068965517,1.0,1.0,5/19,20.67%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.38228965080328725,0.7601109557993325,0.8969072164948454,1.0,1.0,6/95,5.49%,ADAMTS9;CD44;COL4A6;ADAMTS4;ITGA5;SMOC1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3920767929738402,0.7598901800121235,0.8333333333333334,1.0,1.0,7/28,24.01%,RPS27A;CCNH;RBX1;RPA1;HMGN1;UVSSA;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.42543686379518975,0.7598799456152291,0.8552631578947368,1.0,1.0,8/17,26.13%,HIF1A;BRD1;STAT3;ACVR1B;ACVR2A;ABCB10;FOXO3;ETS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.48175972276002454,0.7597180473818629,0.803030303030303,0.999807030400229,1.0,2/5,20.52%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.39058083339904553,-0.7594794109645985,0.7272727272727273,1.0,1.0,1/12,2.11%,ERCC6
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5121800466228135,0.7593710785483317,0.7727272727272727,0.9997856991275144,1.0,2/5,28.23%,SLC25A37;SLC40A1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.47906361062029434,0.7593500667020465,0.7692307692307693,0.999389564406599,1.0,1/6,18.46%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4940785858576477,0.7592056895298149,0.7662337662337663,0.9991477861719998,1.0,2/6,13.46%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5234431577751063,0.7590110754461397,0.8309859154929577,0.9989062074243931,1.0,1/5,7.80%,PPARA
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.47440834920185126,0.7586003771952992,0.8243243243243243,0.9989060804421549,1.0,1/9,6.02%,IL18
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.4524709583470356,0.7584856247489903,0.8539325842696629,0.9986232223666621,1.0,2/13,15.00%,CST3;LRRK2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.3812951714513729,0.7583390764070259,0.8865979381443299,0.9983946266655535,1.0,6/96,5.49%,ADAMTS9;CD44;COL4A6;ADAMTS4;ITGA5;SMOC1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.37457174331167425,-0.7582951703799897,0.8571428571428571,1.0,1.0,1/12,0.62%,EDN3
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.37457174331167425,-0.7582951703799897,0.8571428571428571,1.0,1.0,1/12,0.62%,EDN3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.42905305565458274,0.7578533028891915,0.8275862068965517,0.9984902614382003,1.0,5/21,20.67%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5046770448160648,0.7578421393064222,0.8266666666666667,0.9980916489607876,1.0,3/7,26.60%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.523604278741581,0.7577730796366696,0.8648648648648649,0.9965170591640095,1.0,1/6,2.23%,PANK2
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.523604278741581,0.7577730796366696,0.8648648648648649,0.9965170591640095,1.0,1/6,2.23%,PANK2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.523604278741581,0.7577730796366696,0.8648648648648649,0.9965170591640095,1.0,1/6,2.23%,PANK2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.523604278741581,0.7577730796366696,0.8648648648648649,0.9965170591640095,1.0,1/6,2.23%,PANK2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.5357570539445579,0.7577330238486555,0.8933333333333333,0.995739989100087,1.0,1/5,7.15%,GBE1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.5357570539445579,0.7577330238486555,0.8933333333333333,0.995739989100087,1.0,1/5,7.15%,GBE1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3909802017925771,0.757688294761225,0.8571428571428571,0.9953974807385032,1.0,4/39,8.45%,NUP153;XPO4;CSE1L;TGFB1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.39145884742814985,0.7576420657364545,0.8387096774193549,0.9950345582449478,1.0,12/54,22.08%,TSC2;BTRC;NXN;CTNND2;RUNX1;FGFR2;LRRK2;CBFB;CSNK2A1;SMARCA4;NLK;KANK1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.4705114585116236,-0.7575844230178728,0.64,1.0,1.0,1/6,3.95%,YWHAB
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4425682258940632,-0.7572858230273525,0.6538461538461539,1.0,1.0,1/5,6.50%,VCP
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.450661703751869,0.7572075303192353,0.8148148148148148,0.9952056511978702,1.0,3/11,20.61%,SOD2;BNIP3;NDUFS1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.470332395545361,0.7570971543105672,0.7916666666666666,0.9949630388155445,1.0,1/10,12.19%,SPIRE1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3902568061425181,0.7569959712260287,0.9120879120879121,0.9946751517860142,1.0,7/56,12.08%,MID1;TENM3;SMARCA1;FHL1;EGFR;NXN;EHD2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.46755995172317094,0.7569345060291457,0.8214285714285714,0.9943255167044742,1.0,3/8,27.95%,ADAM17;SP1;PLCG1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.32843505863988176,-0.7568125573599639,0.7857142857142857,1.0,1.0,7/21,17.88%,PIP4K2B;MTM1;TMEM39A;CHMP4B;SEC22B;PIKFYVE;TBC1D12
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4381182741511836,0.7562681570553823,0.8604651162790697,0.9946494508394732,1.0,4/20,13.06%,PANK2;PAPSS1;GMPS;PAPSS2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4155819063212905,0.7560400997765224,0.8,0.9944652676702602,1.0,4/18,18.08%,RPS27A;CCNH;RBX1;RPA1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.36813481595805037,0.7555547139624649,0.9183673469387755,0.9944999762700834,1.0,19/104,16.28%,MYDGF;CAMKK2;CSF1R;SEMA4D;CSNK1D;FLT1;STK4;ADAM17;TGFB1;EGFR;EPHA7;SDCBP;HIF1A;ROCK2;PDE8A;FGFR2;INSR;LRRK2;ACVR2A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4530023877317012,0.7548901859286138,0.810126582278481,0.9948234415862804,1.0,4/11,23.42%,CD38;VAV3;IRS2;CD81
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.38284648850217523,-0.7547463065129109,0.7894736842105263,1.0,1.0,12/12,61.80%,ACTN4;MYO1D;MYO1E;MYO1B;SYNE2;WASL;MYO5A;FNBP1L;MYO6;MYO19;SUN2;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.5024790465574652,0.7540190191918595,0.8823529411764706,0.9955095381293457,1.0,3/5,45.52%,TGFBR1;TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.4678915317585832,0.7532880764196486,0.8076923076923077,0.9960796542765877,1.0,4/9,15.01%,CDH2;NDUFS2;CD9;METTL14
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.39993182501906904,0.7532217779597097,0.8522727272727273,0.9957675292459012,1.0,7/28,16.98%,DPM1;WIPI1;UGCG;PIGL;GLUL;ZDHHC5;WDR45B
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.4358014571229969,0.7531550518599774,0.7790697674418605,0.9954350652988091,1.0,1/11,4.85%,OGN
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.3643773646386179,-0.752830547481582,0.8235294117647058,1.0,1.0,2/18,6.90%,PHLDB2;WASF2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.4828327158982847,0.7527636885187737,0.8732394366197183,0.9954528247336123,1.0,1/9,3.13%,CD38
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.3573058680595536,0.7524869685313204,0.875,0.9954006078361352,1.0,11/62,16.89%,PITRM1;WASF1;MIGA1;BNIP3L;AGTPBP1;PPARGC1A;MTFR1;SLC25A4;CHCHD3;LRRK2;SPG7
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.44598411264664745,0.7521212512107492,0.8260869565217391,0.9953484335299282,1.0,2/11,11.77%,EIF2AK4;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.43248612474637504,0.7519429745699848,0.8764044943820225,0.9951194837423126,1.0,3/21,8.98%,SEMA4D;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4755098021457913,0.7511797962578736,0.8133333333333334,0.9956634703597055,1.0,4/10,30.38%,NEXMIF;RGCC;TJP1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.3896802226496429,0.7506435468298054,0.9090909090909091,0.9958783180464892,1.0,10/47,20.27%,RHOB;ADAM17;TGFB1;TMSB4X;HIF1A;ROCK2;SCARB1;KDR;SP1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.44538767317969996,0.7504457939653553,0.7901234567901234,0.9957028234833544,1.0,4/13,30.38%,INSR;TBC1D5;ATAD1;VEGFA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.4781155413256164,0.7503053262700328,0.8133333333333334,0.9950650049749223,1.0,4/8,25.98%,PTPRD;LRFN5;GPC4;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.4781155413256164,0.7503053262700328,0.8133333333333334,0.9950650049749223,1.0,4/8,25.98%,PTPRD;LRFN5;GPC4;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3698349951961113,-0.7501199217866523,0.75,1.0,1.0,1/10,2.78%,ATP2B4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.4079095593470676,0.7491947585296899,0.8313253012048193,0.9959483747565668,1.0,2/20,5.01%,GLRB;GABRE
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.4590015047588644,0.7487730564667805,0.8591549295774648,0.9959371509138583,1.0,3/9,25.25%,SLC4A10;CA2;SLC9A9
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.40975733948378673,0.7486593779095453,0.8426966292134831,0.9956349299186438,1.0,3/27,14.62%,CCP110;TP63;FGFR2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.44005128751400807,0.7484478826642108,0.8641975308641975,0.995480446976892,1.0,3/16,11.41%,RHOB;CLOCK;TANK
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.42646407621891447,0.7481517157803895,0.8857142857142857,0.9953711383468852,1.0,1/14,5.30%,NIBAN2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.35959969349350296,-0.7479305132980917,0.8846153846153846,1.0,1.0,1/11,10.75%,CDC42
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.4977806557644908,0.747514663103157,0.8289473684210527,0.995564851474616,1.0,3/5,44.96%,WRNIP1;WRN;SIRT1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3284327374772708,-0.7473968726513597,0.8,1.0,1.0,8/21,18.80%,MYL9;ACTB;ACTG1;FLNA;MEGF10;ILK;ACTN1;STXBP3
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.36716540791994123,0.7471574170243327,0.9489795918367347,0.9955783581593317,1.0,11/101,11.57%,DDX3X;ETF1;GIGYF2;IGF2BP2;EIF2AK2;CNOT8;ELAVL1;CSDE1;EIF2AK4;RBM4B;EIF4ENIF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.46529812155823735,0.7459756986655465,0.8529411764705882,0.996520367773644,1.0,2/10,15.51%,CEBPB;TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5062726020211971,0.7456306766475879,0.7972972972972973,0.9964966777858518,1.0,4/5,33.28%,CD9;C1QTNF1;SH2B3;RDX
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.3226766393656721,-0.7449375519266689,0.8636363636363636,1.0,1.0,3/22,6.59%,MAPK14;AATF;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.43762423969646985,-0.7438584120343635,0.6571428571428571,1.0,1.0,2/5,6.50%,TNIP1;VCP
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4201273148272729,0.7437856269882305,0.7857142857142857,0.9979811302201562,1.0,8/14,36.83%,CHD1;SMARCA4;SP1;LEF1;JUN;CCNT1;TARDBP;NAPEPLD
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.48861373750711307,0.7434158399935598,0.8714285714285714,0.9979772947782803,1.0,4/7,47.18%,CDKN1B;ANKLE2;SIRT1;DYNLL1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3915743419655308,0.7433733179080906,0.8478260869565217,0.9976263440785642,1.0,4/28,5.61%,NEDD4L;SLC6A17;ATP1B3;SCN3A
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.4113027487061905,0.7422971587680095,0.8125,0.9983247752797717,1.0,2/19,12.38%,PTPN1;RIOK3
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.37996000119363854,0.7418044486895412,0.8979591836734694,0.9983493685677258,1.0,8/74,11.40%,GJA1;WASF3;CRMP1;PTPRD;DCLK1;SYNDIG1;SHC2;CCN2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.48250107032417544,0.7410757481616281,0.8051948051948052,0.9987328756142629,1.0,1/7,2.11%,GNPAT
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.4993872390010241,0.7410609315748126,0.8378378378378378,0.9983414155003538,1.0,2/5,30.47%,LGALS3;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.4031984575908709,0.7403871457963201,0.9213483146067416,0.9986716344145659,1.0,7/27,26.71%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5;CCT8;RGCC
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.4400712563996834,0.7403173933322686,0.8681318681318682,0.9983497706790805,1.0,4/21,15.38%,KLF9;GNB1;GNAI1;GRAMD1A
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.35783095090118083,-0.7393132099736132,0.8,1.0,1.0,12/12,64.30%,CXCL12;WDR1;PLEKHG2;LATS1;GBA2;PAK3;FCHSD2;ARHGAP28;RASA1;ESAM;ARHGAP35;CTTN
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.42770548154754107,0.7393105025538186,0.7922077922077922,0.9989810627466224,1.0,2/15,11.91%,TENM2;NLGN1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4488140534311251,0.7391516612536159,0.8421052631578947,0.9987041100938984,1.0,1/9,5.32%,ATP1B3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.43082780589527425,0.7388743773126293,0.8023255813953488,0.9986064133351161,1.0,3/14,20.84%,XKR4;SCARB1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.42608400134742785,0.7383825370726796,0.8414634146341463,0.9988423122204727,1.0,4/15,22.08%,SSH1;IQCJ-SCHIP1;PLEKHH2;KANK1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.38626241217419705,0.7379377446988156,0.9032258064516129,0.9989357235636535,1.0,7/26,24.02%,NR4A3;CTBP2;PPARGC1A;ZBTB7A;STEAP4;SMAD6;SENP2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.4799264769767331,-0.7378278148838374,0.8,1.0,1.0,1/5,0.19%,WDFY4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4843704937525032,0.7375999046960071,0.7875,0.9989233956015785,1.0,4/7,36.79%,ITGAV;MCL1;DCC;GSK3B
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4763254186056077,0.7375427353448245,0.875,0.9985657765795658,1.0,1/8,14.42%,STAT3
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.39994655707560495,0.737262331286979,0.8536585365853658,0.9984642714335213,1.0,6/24,23.84%,TBX3;MDM4;INSR;TTN;ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.39695656645164923,0.7362499376406788,0.8735632183908046,0.9992030806628064,1.0,3/18,14.69%,ZBTB16;CEBPB;TMEM64
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.47560578753138405,0.7359866097282275,0.8607594936708861,0.9990729985848775,1.0,5/8,25.82%,SLC6A17;SLC3A2;SLC36A4;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.4827580801575376,0.7353633096128803,0.821917808219178,0.9992472084286329,1.0,1/8,3.97%,RIMS2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.38162601882296243,0.7347893364161405,0.9135802469135802,0.9994374950350021,1.0,10/32,20.27%,NRG1;RAF1;DIAPH1;ADAM17;EGFR;ROCK2;CD9;ZSWIM8;ABL2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3582390340830628,-0.7347688019693305,0.7692307692307693,1.0,1.0,2/13,4.99%,RALBP1;VPS35
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.42326232944384246,0.7342092865711722,0.9397590361445783,0.9996195235956711,1.0,4/17,21.82%,MTMR9;MTMR1;PIP4P2;MTMR2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.4225034841491339,0.7339956922759899,0.8382352941176471,0.9994449228516519,1.0,4/12,25.73%,RPS27A;RPA1;RCHY1;NPLOC4
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.38276377861373484,0.7333940620729241,0.9333333333333333,0.9996268022814747,1.0,9/41,20.84%,GRIN1;TMEM165;TMCO1;GRIN2B;NALCN;TRPC4;SPG7;RYR3;ITGAV
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.40481236011285,0.7331039102030122,0.8518518518518519,0.9996021033912695,1.0,3/15,17.56%,IL18;NFKBIZ;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3209786393704623,-0.7330622330597872,0.9166666666666666,1.0,1.0,3/30,3.99%,ERCC6;ATM;RPS3
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4570786891166929,0.7329400612127753,0.8888888888888888,0.9993832129795778,1.0,1/10,8.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.4248166893067008,-0.7328853323010848,0.896551724137931,1.0,1.0,1/5,1.92%,TNIP1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.3642696979151965,0.7327625089564174,0.9479166666666666,0.9991968536789384,1.0,11/85,14.00%,SRGN;RHOJ;APOLD1;EMP1;FLT1;SLC2A1;C1R;CCN2;RGS5;CFH;CD9
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3857242254987615,0.7325397153919448,0.8695652173913043,0.99908745746154,1.0,6/34,16.02%,RAB27A;TGFB1;APBB1;SYTL4;EXOC1;TTN
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.4123198093901568,0.7322473334013073,0.9069767441860465,0.9989781489013672,1.0,5/20,22.72%,MTMR9;MTMR1;PIP4P2;MTMR2;SGPP1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.37123675234724735,0.7315239196628673,0.946236559139785,0.9993455992785997,1.0,8/64,15.74%,MID1;TENM3;SMARCA1;ERRFI1;EGFR;TTC23;TBX3;TEAD1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.3628715320704522,-0.7298939263746961,0.8095238095238095,1.0,1.0,3/11,13.12%,BAIAP2L2;PLS3;ADD1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.45452437265383105,0.7298811685541253,0.8333333333333334,1.0,1.0,4/11,35.67%,VTA1;RAB11A;STAM2;IST1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.3130443394563146,-0.7296153744564622,0.8571428571428571,1.0,1.0,3/19,6.39%,CDK6;MAPK14;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.48145344815744157,0.7293431348555767,0.868421052631579,1.0,1.0,1/6,10.84%,TUT7
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4483882751264064,0.7289112832640559,0.9066666666666666,1.0,1.0,1/10,3.19%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.4528039108234748,0.7281511790426064,0.8227848101265823,1.0,1.0,1/9,7.57%,DNMT1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.36633820935361816,0.7280873194793693,0.967391304347826,1.0,1.0,18/67,33.72%,RPS21;RPL28;RPS27A;RPL21;RPL41;RPLP2;RPL9;TRAM1;RPL18;RPS14;RPL27A;RPL13A;SSR1;RPL31;RPL32;RPS2;RPS4X;RPL34
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4050565594745631,0.7280356811890194,0.8902439024390244,1.0,1.0,4/19,23.48%,ZFP36L2;DCP2;METTL16;RNASEH2C
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.45729114560912365,0.7276516506111425,0.8088235294117647,1.0,1.0,3/8,32.74%,AKAP6;PLCG1;GPER1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.3994101210804098,-0.7275244082803749,0.7714285714285715,1.0,1.0,6/6,60.11%,SKI;FBXW4;MBNL1;PTCH1;LRP6;TGFB2
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.3868085701131341,0.7271393927511092,0.9102564102564102,1.0,1.0,7/22,28.01%,RPS27A;USP10;ZBTB1;RPA1;UBE2B;RAD18;POLK
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.3866211392208599,-0.7270326762897483,0.72,1.0,1.0,5/5,61.38%,HLA-E;STX7;HLA-B;HLA-A;CYRIB
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.426399138647842,0.7270196614481926,0.8433734939759037,1.0,1.0,2/15,13.90%,SDCBP;WAC
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.4150305448518239,0.7261085400471518,0.8656716417910447,1.0,1.0,6/12,36.51%,RPS27A;RPA1;POLK;REV3L;RPA3;REV1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.4680951978205448,0.7256865515408593,0.8395061728395061,1.0,1.0,1/8,11.55%,SLC3A2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.4217890611562161,0.7255774977981977,0.8536585365853658,1.0,1.0,3/11,20.89%,RNF168;SKP1;UBE2B
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.4681346449256085,0.7253385303835774,0.8,1.0,1.0,3/7,39.89%,SGPP1;PLPP1;PLPP3
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.49900299354250144,0.7249758151781767,0.8452380952380952,1.0,1.0,1/5,10.72%,GNB1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3667558668551757,-0.7240878713282265,0.8571428571428571,1.0,1.0,3/10,13.12%,BAIAP2L2;PLS3;ADD1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.35686000366871257,0.7239204221019027,0.9072164948453608,1.0,1.0,15/87,21.82%,LPIN1;GNPAT;SELENOI;MTMR9;MTMR1;AGK;AGPAT4;LPCAT3;CHKA;ARF1;CSNK2A1;RUFY1;ABHD5;DGKH;MTMR2
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.46304516706444304,0.7238224098669396,0.7972972972972973,1.0,1.0,3/6,28.18%,CD9;C1QTNF1;SH2B3
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.4003635430045613,0.7234551052463781,0.9239130434782609,1.0,1.0,7/26,19.70%,HDAC2;BASP1;ACADVL;PGK1;FGFR2;LGALS3;KDR
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3104798559888704,-0.7229973986799543,0.8461538461538461,1.0,1.0,5/22,9.15%,PRMT3;RPS3;PER2;HSPA1A;N4BP1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.46562837380766187,0.7226675158257702,0.8157894736842105,1.0,1.0,3/6,28.80%,ADORA2B;PTK2B;DCDC2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.37260974958123955,0.7225807213040032,0.9101123595505618,1.0,1.0,7/27,25.70%,EGFR;RNF168;SMCHD1;BRCC3;UBR5;TRIP12;WRNIP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.408893142298234,0.7224327122744173,0.8765432098765432,1.0,1.0,6/18,22.49%,EAPP;TCERG1;HMGN1;CCNK;SUPT16H;ELL
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.46871162982792086,0.722242424766322,0.8235294117647058,1.0,1.0,1/8,15.80%,PIP4P2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3549334669088325,0.7215908746884244,0.9438202247191011,1.0,1.0,14/66,19.91%,PSMB1;PSMB2;BTRC;PSMA7;TGFB1;SDCBP;SRA1;PSMA4;MDM2;HECA;PSMD14;ANAPC4;SKP1;CDKN1B
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.4192948145610687,0.7212779778125981,0.8552631578947368,1.0,1.0,5/12,22.18%,AGK;SAMD8;CERS6;SPTLC1;SPTLC3
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4056442325482357,-0.7212736430241483,0.7307692307692307,1.0,1.0,1/7,3.01%,GPRC5C
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.4368071661042454,0.7205342520562196,0.8589743589743589,1.0,1.0,4/10,7.80%,CD38;CSF1R;TNFRSF1B;PPARA
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4425176815538491,0.7200278286313693,0.8717948717948718,1.0,1.0,2/9,15.00%,NECTIN2;LRRK2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.36007112764881366,0.7193181684335536,0.9361702127659575,1.0,1.0,27/78,35.89%,DDX52;RPL28;NOP58;RPL21;WDR43;RPL41;RIOK3;RPLP2;TEX10;DIS3;RPL9;RPL18;RPS14;NOL8;RPL27A;RPL13A;RCL1;PRKDC;RPL31;RPL32;SRFBP1;RPS2;RPL34;NSA2;RPL3;BMS1;XRN2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.4950696666777279,0.7193134531714226,0.8873239436619719,1.0,1.0,4/6,49.19%,RFX3;BTG1;FGF2;AHI1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4662931491325274,0.7189442044139174,0.8311688311688312,1.0,1.0,2/6,15.32%,PTPN1;ATF6
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.4337954911181062,0.7187281106883248,0.8831168831168831,1.0,1.0,2/9,15.62%,WASF1;PACSIN2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.4166414768012213,0.7186693116681986,0.8554216867469879,1.0,1.0,5/13,23.56%,ADAM17;ZBTB7A;PTPN2;KLF6;DCAF1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.3865120391529664,0.7186438197266032,0.8314606741573034,1.0,1.0,3/19,14.07%,ELAVL1;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.4254255953733743,0.7185327791941806,0.8947368421052632,1.0,1.0,5/18,22.07%,KDM1A;PIAS2;ZBTB7A;SMARCA4;NCOA2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.4485401456405448,0.717357162212453,0.8484848484848485,1.0,1.0,2/9,11.77%,EIF2AK4;SIN3A
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.39172989108053147,-0.7168724231927979,0.6842105263157895,1.0,1.0,1/5,4.31%,RYR2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.4614353096861249,0.7167865819514669,0.8611111111111112,1.0,1.0,3/8,36.97%,WAPL;XRCC5;HNRNPD
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4329760856684509,0.7165075313521707,0.7974683544303798,1.0,1.0,1/10,5.97%,MGAT4A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.44012797504569423,0.7159097620463231,0.8974358974358975,1.0,1.0,7/11,44.18%,FGFR2;ANKRD11;TGFBR1;FGFR1;LRP6;WWOX;DSCAML1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.42512735480270325,-0.7156872692269299,0.8260869565217391,1.0,1.0,1/7,5.04%,MRTFB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.44767054365872666,0.7152163897336362,0.8888888888888888,1.0,1.0,3/9,33.28%,LRRK2;CPEB2;RDX
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3637620047783783,0.7151331188963829,0.8780487804878049,1.0,1.0,8/37,23.37%,SYMPK;CPSF2;GRSF1;CSTF3;PABPC1;THOC2;AHCYL1;SRSF5
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2905364533854589,-0.7151235950082803,1.0,1.0,1.0,10/69,7.40%,DNAI4;VAMP4;SHQ1;TIAM1;ARL6;NCK1;HSPA1A;OTUD6B;TBCD;TPR
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4258125403093589,0.7149252785652762,0.8933333333333333,1.0,1.0,3/12,18.04%,DUSP1;OXSR1;STK39
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.45233855370342385,0.7142302334542834,0.881578947368421,1.0,1.0,4/10,18.56%,ELF1;RUNX1;CBFB;LIFR
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.4591915089084528,-0.7141372220299428,0.7666666666666667,1.0,1.0,1/5,3.26%,AP3M1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.4591915089084528,-0.7141372220299428,0.7666666666666667,1.0,1.0,1/5,3.26%,AP3M1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.490757938713819,0.714129447400305,0.9142857142857143,1.0,1.0,2/6,19.14%,DIAPH1;UBASH3B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.33923853923853925,-0.7140627439296727,0.9130434782608695,1.0,1.0,13/13,66.16%,MRE11;PPP1R10;SMG6;DHX36;YLPM1;SMG1;ATRX;TERF2IP;NBN;PML;USP7;HNRNPD;XRCC5
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.4844701672520213,0.7139694501604978,0.8615384615384616,1.0,1.0,2/5,30.68%,HSPH1;CD55
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.4408804616591878,0.7139481926329407,0.8656716417910447,1.0,1.0,2/8,12.92%,UBR1;SESN1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.4408804616591878,0.7139481926329407,0.8656716417910447,1.0,1.0,2/8,12.92%,UBR1;SESN1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.448739717777515,0.7139335309884081,0.8472222222222222,0.9997728262339508,1.0,3/8,37.95%,LRFN5;NR1H3;HSPD1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3089809870335713,-0.7135675217262698,1.0,1.0,1.0,1/21,3.47%,THOC1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.40615335469000957,0.7131073935984545,0.8414634146341463,1.0,1.0,1/17,4.44%,GGA3
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.37690782667195766,0.7127212561153041,0.9111111111111111,1.0,1.0,21/47,39.21%,HNRNPC;PPARGC1A;TCERG1;SRSF10;NOVA1;DHX15;SF3B1;TRA2B;SFPQ;SNRNP48;SF3B3;SRSF2;SRPK2;TXNL4A;HNRNPH3;RNPC3;TARDBP;PRPF3;NCBP1;CDK12;PPIG
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.4547417755249099,0.7126434954273203,0.8493150684931506,0.9999061972716273,1.0,2/7,12.92%,EIF2AK4;SESN1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.3505681064426821,0.7125597959476271,0.925531914893617,0.9996006216748544,1.0,7/81,8.17%,RHOB;RHOJ;ARHGAP31;ARHGAP15;ARHGEF9;FAM13A;MCF2L
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.4714379625794365,0.712124028675858,0.8875,0.9995923075607148,1.0,1/7,10.33%,CTNND2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.43173499993575803,0.7116379858631114,0.92,0.9997265143546847,1.0,4/11,36.94%,RBPJ;CCDC88A;GPER1;RTN4
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.358278672734224,0.7114921070148373,0.9456521739130435,0.999476769408149,1.0,5/63,10.95%,RPS21;RPL28;RPS27A;RPL21;RPL41
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.36877463452303855,0.7114777681690477,0.9120879120879121,0.9990887733618193,1.0,5/40,7.94%,CBFA2T2;TENM3;LRRC7;PRKCI;SCARB2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.39608826459544966,-0.7105452096742089,0.92,1.0,1.0,2/9,12.50%,NSFL1C;CHMP4B
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4227790233385962,0.7104650214246568,0.8426966292134831,0.9995551622100027,1.0,4/17,20.27%,CDH2;CTNNA2;FGFR2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.44456083190808404,0.7100808311607303,0.8354430379746836,0.9994994518634271,1.0,1/9,7.80%,PPARA
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.37947210239524476,0.7096535988661569,0.8701298701298701,0.999534657693839,1.0,6/19,28.01%,RPS27A;USP10;ZBTB1;RPA1;WRNIP1;POLK
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.4028607087456479,0.7096152946040438,0.8764044943820225,0.9991827915446544,1.0,5/14,20.87%,PARP11;TNKS;TIPARP;ARF4;PARP6
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.4146679484786546,0.7094109998816716,0.8518518518518519,0.9989654289866238,1.0,3/14,14.07%,ELAVL1;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.46422486485330167,0.7089612374314087,0.8823529411764706,0.9989139828911738,1.0,1/6,8.92%,PIGL
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4138979083293496,0.7083477487701031,0.9146341463414634,0.9990637617886223,1.0,3/17,14.42%,F3;TMSB4X;STAT3
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.4421195272979785,0.7081483773261136,0.8205128205128205,0.9988348709130104,1.0,2/10,10.39%,SSH1;TMSB4X
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.4735747293285014,0.7080968815298707,0.9180327868852459,0.9984879074479971,1.0,1/5,19.20%,ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4761823032322058,0.7076767411945346,0.9142857142857143,0.9981453321554596,1.0,2/5,18.19%,HOMER2;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4761823032322058,0.7076767411945346,0.9142857142857143,0.9981453321554596,1.0,2/5,18.19%,HOMER2;PRNP
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.4605446527002175,0.7068861220157335,0.8974358974358975,0.9985313447891715,1.0,2/7,25.54%,LRRK2;RGN
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.3064834921023941,-0.7066774587568387,0.9444444444444444,1.0,1.0,2/33,2.85%,TNFRSF19;MAPK14
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.4335331280162373,-0.70640935013529,0.7619047619047619,1.0,1.0,1/7,4.31%,RYR2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4845049744279094,0.706251598983829,0.9090909090909091,0.9987714403248846,1.0,2/5,40.85%,VEGFA;LRP6
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4647133211963682,-0.7060120186717755,0.8076923076923077,1.0,1.0,1/5,1.35%,NRP1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.34205346764886885,0.7057860584740667,0.8762886597938144,0.9988107130814556,1.0,13/65,21.46%,SLC35D1;ENPEP;MARCHF6;MCCC2;TMBIM6;GSR;PAPSS2;PDK4;CA2;PTGR1;SLC6A12;ELOVL5;PROS1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.4595342832903231,0.7049667375518668,0.8840579710144928,0.9991724198569087,1.0,4/8,40.26%,AP3D1;AP1G1;DTNBP1;AP3B1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.46839640977471375,0.7047845493187342,0.875,0.9989520621736087,1.0,3/6,28.18%,CD9;C1QTNF1;SH2B3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.38256176446085965,0.7042534558149262,0.8902439024390244,0.9990580190094281,1.0,2/20,5.01%,GLRB;GABRE
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.4375372857336165,0.7036416404203375,0.8552631578947368,0.9992149560449393,1.0,3/7,21.60%,AGK;SPTLC1;SERINC1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.3220768996165251,-0.7026244859378619,1.0,1.0,1.0,1/16,1.29%,JADE3
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.33934028946305955,0.7026019268372398,0.9361702127659575,0.999807598264038,1.0,14/77,17.35%,CD44;PTPN1;CSF1R;APIP;TGFB1;EGFR;EPHA7;CCN2;PDE8A;RANBP9;CAMK2N1;FGFR2;MAP2K1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3531508835406974,0.7017579423705248,0.9347826086956522,1.0,1.0,9/47,20.30%,DDX3X;NRG1;TGFB1;RAP1B;RBX1;LGALS3;RPA1;ABCA1;ASAP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.463731972614506,0.7016159910987133,0.8378378378378378,0.9998851238882377,1.0,2/5,31.84%,KMT2A;HDAC5
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.3855252418105817,0.7014599129151853,0.8588235294117647,0.9996218634359345,1.0,5/19,20.05%,ROBO2;ROBO1;ZFPM2;ZFPM1;SMAD7
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.4154237198259566,-0.7009589691002385,0.8857142857142857,1.0,1.0,1/7,1.77%,AK5
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.3586167030545925,0.6996328148062863,0.9,1.0,1.0,9/41,21.68%,PPARA;TGFB1;TRAF3IP1;LRRK2;C9ORF72;PRNP;PRR5L;CDKN1B;IRS2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.425665701420049,0.6996070353148588,0.8974358974358975,1.0,1.0,1/10,8.14%,UGCG
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.4110852162045237,0.6991679840194178,0.8863636363636364,1.0,1.0,7/15,40.74%,EZH1;NAP1L1;CTCF;ANP32B;MACROH2A1;RBBP4;SART3
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.41465735547305477,0.6990287381056461,0.9090909090909091,1.0,1.0,1/13,3.86%,CACNA1B
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.3925812748831433,-0.698888352446456,0.9166666666666666,1.0,1.0,2/9,8.39%,YWHAB;TIPRL
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.4484844860829481,0.6988523228488587,0.8055555555555556,1.0,1.0,3/5,49.24%,NSMCE2;SMC5;RAD52
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.4081627970209095,0.6987105364383196,0.8333333333333334,0.9997877257621061,1.0,3/13,26.18%,UBN1;RBBP7;CENPP
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.47097337676277895,0.6978365295117265,0.8783783783783784,1.0,1.0,4/6,37.25%,SLCO1A2;NCOA2;ATP8B1;NCOA1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.437959730305263,0.6970055994992801,0.9027777777777778,1.0,1.0,3/7,45.52%,TGFBR1;TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.34573654574888474,0.6962393082678741,0.968421052631579,1.0,1.0,5/68,10.95%,RPS21;RPL28;RPS27A;RPL21;RPL41
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.35324145568739806,0.695813038083739,0.8791208791208791,1.0,1.0,10/33,27.95%,ADAM17;TGFB1;TMSB4X;HIF1A;KDR;SP1;NF1;ETS1;RGCC;PLCG1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.38893908779518094,0.6953991341641869,0.8846153846153846,1.0,1.0,4/14,17.54%,CDC5L;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.46655020875734315,0.6934682728271166,0.9014084507042254,1.0,1.0,1/5,5.29%,EMP1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.373232731237064,0.6932752676100726,0.9318181818181818,1.0,1.0,4/23,21.63%,WDR73;NUP133;REEP3;NUP205
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.37001341726633125,0.6928814024724533,0.9456521739130435,1.0,1.0,10/39,28.58%,ACTR3;WIPF1;MAPK1;VAV3;ABL1;GRB2;CYFIP1;PAK1;PLCG1;CRK
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.37001341726633125,0.6928814024724533,0.9456521739130435,1.0,1.0,10/39,28.58%,ACTR3;WIPF1;MAPK1;VAV3;ABL1;GRB2;CYFIP1;PAK1;PLCG1;CRK
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.36144350025960703,-0.6926595969525485,0.9047619047619048,1.0,1.0,3/12,12.50%,HSPA1A;TPR;CHMP4B
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.39342572899539685,0.6924238089994081,0.8795180722891566,1.0,1.0,1/14,7.75%,ADAM17
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3333150353910698,-0.6924191625149614,0.9,1.0,1.0,2/13,8.68%,ERCC6;FUS
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.3863931663712985,0.6922093229124233,0.896551724137931,1.0,1.0,4/21,23.12%,CSNK1A1;LIX1L;MAP1LC3B;LAMP2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.36288216522753347,-0.6921724731377988,0.8333333333333334,1.0,1.0,3/11,6.39%,BCL2L11;NCK1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3713073814446654,0.6921579699083469,0.898876404494382,1.0,1.0,4/27,20.84%,MADD;TNFRSF10B;LGALS3;ITGAV
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.4160377908776249,0.6918946963945115,0.8780487804878049,1.0,1.0,1/9,5.78%,SEMA4D
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4591866303010105,0.6912576348043178,0.8421052631578947,1.0,1.0,1/5,17.46%,MAGT1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.39194631924264517,0.6910273086214238,0.9080459770114943,1.0,1.0,7/20,27.47%,NIBAN2;CFL1;INSR;TDG;SEPTIN7;TRIP12;RAB14
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.44846680261102706,0.6907462587328478,0.8717948717948718,1.0,1.0,1/6,19.70%,KDR
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3986517399225886,0.6905894109524519,0.8953488372093024,1.0,1.0,4/20,20.67%,CCT4;TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.4618539103401442,0.6899917108422996,0.8421052631578947,1.0,1.0,3/7,49.26%,ARHGAP24;PIK3CB;OGT
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.3067343264642384,-0.6896045805018254,0.85,1.0,1.0,2/17,4.76%,ANKRD13A;AATF
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.42307053692289953,0.6893274148358212,0.875,1.0,1.0,1/9,14.04%,MDM4
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3858046598332159,-0.6889699800217353,0.7575757575757576,1.0,1.0,2/6,6.39%,CKAP5;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.4428499964602105,0.6889594902287685,0.8918918918918919,1.0,1.0,3/7,36.45%,LGALS3;CD55;RC3H1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.4495788295086681,0.6882410322660425,0.8375,1.0,1.0,2/6,37.73%,NF1;APPL2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3591858366726288,0.6867080569540152,0.8913043478260869,1.0,1.0,13/41,28.58%,RHOB;CSF1R;CORO2B;ROCK2;C9ORF72;ABL2;ABL1;GPM6B;CCDC88A;RHOBTB3;PAK1;PTK2B;CRK
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.4551282780421132,0.6865191657186753,0.9452054794520548,1.0,1.0,1/5,21.45%,HK1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.4298258723062737,0.6861670059955384,0.8356164383561644,1.0,1.0,4/8,20.27%,TNFRSF1B;PAG1;LGALS3;ABL1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.4702179160601472,0.6859953866641595,0.9285714285714286,1.0,1.0,2/5,40.18%,DNM2;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.4702179160601472,0.6859953866641595,0.9285714285714286,1.0,1.0,2/5,40.18%,DNM2;DNM3
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.35144365104004965,-0.6854488100170834,0.8518518518518519,1.0,1.0,6/6,64.90%,ULK2;ATG7;ATG13;ULK1;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.35144365104004965,-0.6854488100170834,0.8518518518518519,1.0,1.0,6/6,64.90%,ULK2;ATG7;ATG13;ULK1;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3372728377679717,0.6851799606715934,0.9,1.0,1.0,4/40,15.01%,DDX3X;ELAVL1;ROCK2;METTL14
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.4670272744636043,0.6849082685815399,0.9090909090909091,1.0,1.0,1/5,22.29%,LNPEP
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.39575433526078463,0.68475507165705,0.8607594936708861,1.0,1.0,5/15,33.10%,TGFB1;TFPI;UBE2L3;UBE3A;NR1H3
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.3937888198757764,-0.6847301185390348,0.7391304347826086,1.0,1.0,8/8,60.69%,ATP5PF;ATP5MC2;ATP5F1A;ATP5ME;ATP5F1E;DMAC2L;ATP5F1B;ATP5F1C
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3937888198757764,-0.6847301185390348,0.7391304347826086,1.0,1.0,8/8,60.69%,ATP5PF;ATP5MC2;ATP5F1A;ATP5ME;ATP5F1E;DMAC2L;ATP5F1B;ATP5F1C
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.2821713740821531,-0.6838868306656349,0.9565217391304348,1.0,1.0,1/16,2.36%,LAMC1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.4180082374136973,0.683326226136632,0.8333333333333334,1.0,1.0,2/9,18.24%,FGFR2;FBN1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4099224369396954,0.6832130788312304,0.8860759493670886,1.0,1.0,2/11,31.45%,DIS3;XRN1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.3382154540906998,0.6828808078879377,0.9468085106382979,1.0,1.0,19/74,28.02%,RAD21;STMN1;CASP8AP2;TGFB1;HIF1A;MTF2;SRSF10;PAFAH1B1;CDKN1B;ABL1;CTCF;NSD2;TRA2B;SFPQ;RPS6KA5;FANCC;RAD23B;PDS5B;AMD1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.34892815802152705,0.6820840700924934,0.946236559139785,1.0,1.0,6/47,14.13%,PITRM1;PRKCI;KIF13B;SDCBP;NLGN1;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.4577377811461708,0.6810075395406262,0.8888888888888888,1.0,1.0,2/5,31.98%,ABL1;APP
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.33428992591106776,-0.6808102366369903,0.8518518518518519,1.0,1.0,4/8,22.33%,PKD2;THADA;ATP1A2;YWHAE
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.33354248429519756,0.6803104882851806,0.9069767441860465,1.0,1.0,5/35,20.38%,DUT;TBRG1;DONSON;RPA1;NAP1L1
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.47066128961997045,0.6803024625099767,0.8970588235294118,1.0,1.0,2/5,11.27%,NECTIN2;CTSL
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.47066128961997045,0.6803024625099767,0.8970588235294118,1.0,1.0,2/5,11.27%,NECTIN2;CTSL
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.31410160490214994,0.6798537971794731,1.0,1.0,1.0,41/153,28.97%,FMN2;CRY1;STK33;TNFRSF1B;APBB1;RNF168;ZBTB40;FAN1;TANK;MAP2K6;BCL6;SUSD6;WAC;MAPKAPK2;TP53BP1;USP3;WDR48;USP10;ZBTB1;STXBP4;RBBP6;RPA1;VAV3;CCNK;UBR5;ABL1;UBE2B;BOD1L1;GRB2;TAOK3;TRIP12;RAD18;SPIDR;FANCC;PAK1;PDS5B;POLK;MCL1;USP47;APTX;PWWP3A
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.4178104925985,0.6798482611879777,0.8939393939393939,1.0,1.0,2/8,37.07%,CAMK2D;ATP1A1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.4178104925985,0.6798482611879777,0.8939393939393939,1.0,1.0,2/8,37.07%,CAMK2D;ATP1A1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.3801124195750818,-0.6795345354232949,0.7586206896551724,1.0,1.0,3/9,10.08%,BCL2L11;AKR1C3;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.36366114837824876,0.6770078584572039,0.9310344827586207,1.0,1.0,8/35,19.70%,MYDGF;NR4A3;EGFR;F3;HIF1A;FGFR2;STXBP4;KDR
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.40313781105726987,0.6769978017999772,0.8701298701298701,1.0,1.0,6/10,27.85%,SMCHD1;TP53BP1;TWIST1;UBR5;TRIP12;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.42421395979525667,0.6768260215119406,0.8974358974358975,1.0,1.0,6/8,50.43%,VEGFA;MINK1;MAP3K4;SASH1;GADD45B;RELL1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.41661324736989597,0.6767033364424723,0.926829268292683,1.0,1.0,1/11,11.91%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.43612016544999954,0.6764437106113911,0.855072463768116,1.0,1.0,1/5,25.81%,RAD18
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.37326747439196073,0.674877019290033,0.9213483146067416,1.0,1.0,4/19,29.02%,GRM7;GNAI1;GRM8;ADCY5
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.437078400569458,0.6748339232287538,0.8805970149253731,1.0,1.0,3/6,12.92%,SZT2;RNF152;SESN1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3788505593087266,0.6743825214189979,0.9,1.0,1.0,3/16,16.13%,RPS27A;RBX1;RNF111
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.41008593028325513,-0.6739413586966679,0.8148148148148148,1.0,1.0,1/6,2.99%,ZDHHC21
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3501452532543283,-0.6738755189529899,0.8928571428571429,1.0,1.0,3/8,12.50%,VCP;TMEM50B;CHMP4B
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.3389777846823054,-0.6737978763986131,0.8695652173913043,1.0,1.0,11/11,66.18%,ACACA;APOE;SLC27A1;ACACB;RPS6KB1;CPT1A;PRKAG2;ACSL1;ACSL3;PRKAA2;ABCD3
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.4164727487655859,-0.6737610231807274,0.78125,1.0,1.0,1/6,8.72%,NSFL1C
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.3565784750462579,0.6733626952808738,0.9550561797752809,1.0,1.0,8/28,26.71%,NIBAN2;ROCK2;PGK1;PTPRM;COL4A3;SARS1;SPRED1;RGCC
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.40229293342873435,0.6732914665600855,0.88,1.0,1.0,6/13,31.37%,DUSP1;OXSR1;STK39;SH2B3;PTK2B;SLC12A2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.3298502017258022,0.6729408164275417,0.9222222222222223,1.0,1.0,6/48,10.47%,PHYHIPL;PTPRD;PCDH17;SNAP25;PPARGC1A;SHC2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.38258021223740957,0.6729116168648466,0.8809523809523809,1.0,1.0,9/21,33.53%,STMN1;NAV3;ABL1;CAMSAP1;SLAIN2;DRG1;PAK1;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.3650670403382053,0.6719135176110486,0.9186046511627907,1.0,1.0,5/17,21.70%,CRY1;CLOCK;UVSSA;UBE2B;UBE4B
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.36749222293378625,0.6718973999233016,0.9195402298850575,1.0,1.0,8/26,28.40%,SMURF2;ACVR2A;FBN1;SMAD7;SMAD6;SPART;UBE2D3;TRIM33
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.35050392502123573,0.6717698040483472,0.9390243902439024,1.0,1.0,3/30,15.85%,ZFP36L2;TANK;ERBIN
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.34773557463824484,0.6716294822741321,0.9325842696629213,1.0,1.0,15/39,37.17%,SMURF2;ACVR2A;SMAD2;RBPJ;SMAD7;SMAD6;PCSK6;SPART;UBE2D3;TRIM33;CCN1;SMURF1;FOXD1;FSTL1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.3862647573638016,0.670706476644304,0.9036144578313253,1.0,1.0,2/15,12.44%,ROBO2;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3190642134186086,0.6706894991632342,0.9387755102040817,1.0,1.0,16/87,23.82%,TBC1D20;MMUT;RGS7;SEMA4D;ARHGEF7;GARNL3;TBC1D15;SIPA1L2;RALGAPA2;TBC1D8;TBC1D5;NF1;ZC3H15;RABGAP1L;USP6NL;TBC1D4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4747925420576167,0.6705464949297821,0.9428571428571428,1.0,1.0,2/5,35.64%,CAMK2D;EMP2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4550644016767827,0.6704052503682257,0.9104477611940298,1.0,1.0,1/6,5.91%,CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4356305303543274,0.669862328875227,0.9078947368421053,1.0,1.0,4/7,38.23%,KDR;VEGFA;HSPB1;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.3599813722446445,-0.6688962041478893,0.8260869565217391,1.0,1.0,6/6,64.05%,FOXC1;NUMA1;PRKCH;SFRP4;NCOA3;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3688967146687494,0.6682536015597346,0.9545454545454546,1.0,1.0,3/22,18.58%,SDCBP;WAC;CSNK2A1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.2879160341804249,-0.6678330490870936,1.0,1.0,1.0,7/28,13.18%,TNIP1;MAP3K1;RFTN1;PIK3R4;TRAF6;UBB;HMGB1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.38921980081622076,0.6677986368291262,0.8941176470588236,1.0,1.0,1/14,10.67%,XKR4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.36489040985775334,0.6662121301176821,0.9294117647058824,1.0,1.0,4/27,11.04%,MYDGF;ADAM17;F3;HIF1A
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.40980893577500904,-0.6661731908897457,0.8666666666666667,1.0,1.0,1/5,9.00%,COMT
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.3856818330538788,0.6656923609166767,0.9125,1.0,1.0,2/15,11.23%,GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.4470300417823254,0.6655777925099421,0.8450704225352113,1.0,1.0,2/5,22.52%,ABCB10;COX10
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.36065615572677634,0.6646696394686372,0.9294117647058824,1.0,1.0,2/23,7.43%,DDIT4;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.3680352957979125,0.6640789299570115,0.9506172839506173,1.0,1.0,7/19,41.33%,PPARGC1A;FYCO1;SURF4;SORBS3;GSK3B;ATL3;UVRAG
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.38085074387424933,0.6640133323354112,0.9125,1.0,1.0,2/16,9.65%,FHL1;MYO16
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.42514125731002617,0.6638999317201447,0.9024390243902439,1.0,1.0,3/7,19.31%,SNAP25;GLUL;SLC22A2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.40317987693309076,0.6632256469326823,0.8987341772151899,1.0,1.0,3/9,33.25%,ROCK2;FMNL2;DLG1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.38549297026230245,0.6631053866505521,0.8809523809523809,1.0,1.0,2/11,12.56%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.333447260541438,0.6629287286167659,0.9574468085106383,1.0,1.0,6/54,12.44%,RHOB;DIAPH1;TRAF3IP1;CORO2B;IQCJ-SCHIP1;ROCK2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2924438494924073,-0.6627865603546355,0.9,1.0,1.0,2/13,5.65%,YWHAB;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2924438494924073,-0.6627865603546355,0.9,1.0,1.0,2/13,5.65%,YWHAB;YWHAQ
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.44682124278550084,0.662042722406348,0.9041095890410958,1.0,1.0,1/7,8.82%,IRS1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.44930874823968864,0.6617914065651704,0.9014084507042254,1.0,1.0,2/5,18.19%,GRIN2B;PRNP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3890048396099134,0.6611008135329458,0.9651162790697675,1.0,1.0,2/13,14.62%,TRAF3IP1;FGFR2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3389959455873037,0.660510276926372,0.967391304347826,1.0,1.0,11/32,33.37%,CSNK1D;TNKS;GOLGA8B;GOLGA2;RAB11A;LSM14A;MAP9;ZNF207;SMC1A;GOLGA8A;SMC3
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.42740717592211125,0.660066166768688,0.881578947368421,1.0,1.0,3/6,34.97%,UBE2K;IRF1;PNPT1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.4460871514276467,0.6599680398964277,0.8904109589041096,1.0,1.0,1/6,21.63%,NUP205
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.404501576522889,0.6597120179172852,0.9259259259259259,1.0,1.0,3/10,19.09%,PWP1;WDR43;SMARCA4
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3415137517137143,-0.6594383194089289,1.0,1.0,1.0,2/15,3.47%,ERCC6;THOC1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.38083543716413426,0.6589752746742376,0.9375,1.0,1.0,2/17,9.65%,FHL1;MYO16
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3229006064548695,-0.658372417840001,0.7307692307692307,1.0,1.0,1/9,1.92%,TNIP1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.3631044286832703,-0.65778124247244,0.7931034482758621,1.0,1.0,2/8,8.64%,LEMD3;SUN1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.4333274013405915,0.6574866611305495,0.9390243902439024,1.0,1.0,1/8,11.77%,SIN3A
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.4172897417179131,0.6571555499256875,0.9605263157894737,1.0,1.0,2/7,17.97%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.3898804904547571,-0.6557989071787964,0.7777777777777778,1.0,1.0,5/5,61.06%,HLA-E;IDE;B2M;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.32992983546720844,0.6557503649100013,0.9693877551020408,1.0,1.0,13/85,17.23%,AGO2;NDFIP2;DNMT1;TGFB1;ROBO1;SDCBP;HIF1A;PTRH2;NDFIP1;ROCK2;RUNX1;TIPARP;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.4695811675359697,0.6542417606241858,0.9428571428571428,1.0,1.0,1/5,18.11%,LOXL3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3001026954600976,-0.6541966073471426,0.9,1.0,1.0,1/16,2.33%,ATM
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.35342996975697233,-0.6536792355221126,0.8636363636363636,1.0,1.0,1/6,4.16%,INPP5F
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3529041883497147,0.6531612361854334,0.9101123595505618,1.0,1.0,9/26,30.47%,PTPRD;TRIOBP;ARHGEF7;ABL1;IL1RAPL1;P4HB;NEDD9;CRK;PRKDC
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.413476071166598,0.6517232836128134,0.9066666666666666,1.0,1.0,2/6,13.52%,WNT2B;RUNX1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.36187979997570163,0.6516211941691512,0.9186046511627907,1.0,1.0,2/20,9.31%,DIAPH1;TRAF3IP1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3270708041348652,0.6513100842177354,0.9795918367346939,1.0,1.0,17/80,24.69%,EMP1;PPARA;TP63;EGFR;ZC3H7A;EHD2;FILIP1L;SLK;TEAD1;FBN1;DST;ITGAV;STARD13;FAM114A1;NRP2;SH3PXD2B;COL4A1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4126282781409063,0.6510264090943261,0.9130434782608695,1.0,1.0,2/9,12.90%,TUT7;DCP2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.325205777294611,-0.6509814336680948,0.8571428571428571,1.0,1.0,9/9,67.54%,PTEN;MAP2;HSP90AA1;GBA2;HSP90AB1;NTRK2;ARHGAP35;RAPGEF2;B4GALT5
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.4006072561977582,0.6508689286834302,0.9135802469135802,1.0,1.0,4/10,34.97%,IFITM3;UBE2K;IRF1;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.34539564832686775,0.650336257267771,0.946236559139785,1.0,1.0,2/33,7.79%,CSF1;TRIOBP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.35258500232883094,-0.6500345471621454,0.782608695652174,1.0,1.0,7/7,64.80%,ANXA1;PIK3CD;MEF2C;PIK3CB;SIRT1;LYN;RAPGEF2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.3643244667246057,-0.6499121870086177,0.8636363636363636,1.0,1.0,1/7,2.12%,PARP9
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.33057662041100566,-0.6495963943048447,0.9047619047619048,1.0,1.0,5/16,16.75%,MDFIC;TRIM62;GTF2F2;UBP1;NELFA
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.338862368945004,0.6491834307683177,0.9746835443037974,1.0,1.0,4/33,13.55%,SYMPK;CPSF2;TUT7;CSTF3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.27201790018546734,-0.6483619020889163,0.9411764705882353,1.0,1.0,6/17,16.86%,EPHA3;SLC9A1;CORO1C;ACTG1;PTK2;LIMCH1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.32569750700348016,0.6481305129303571,1.0,1.0,1.0,13/83,18.19%,LPIN1;TSC2;FHL1;SCD;SMTN;NCAM1;TGFB1;PDE4DIP;MYOM2;MYL3;CKB;CKMT2;PRNP
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.3514914222196126,0.6478868928174618,0.9036144578313253,1.0,1.0,5/18,39.24%,IFIT3;IFITM3;IRF1;IFNAR1;IP6K2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.3514914222196126,0.6478868928174618,0.9036144578313253,1.0,1.0,5/18,39.24%,IFIT3;IFITM3;IRF1;IFNAR1;IP6K2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.3365152425602008,0.6477319520439706,0.9325842696629213,1.0,1.0,13/46,30.91%,RHOB;HIF1A;ROCK2;SCARB1;KDR;ABL1;NRP2;ETS1;RAB11A;PLCG1;PTK2B;VEGFA;IQSEC1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.385273657673902,0.6472616743205196,0.9078947368421053,1.0,1.0,2/11,12.22%,ATP1B3;ABCC9
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2974814772051875,0.6472349641244041,0.98989898989899,1.0,1.0,29/118,28.97%,RAD21;XRCC4;APBB1;ALKBH5;RNF168;RPS27A;FAN1;BRCC3;TP53BP1;USP3;WDR48;TDG;ZBTB1;RPA1;ABL1;UBE2B;NSD2;ERCC6L2;WRNIP1;RAD18;SETD2;FANCC;RAD23B;PMS1;PDS5B;POLK;USP47;APTX;PWWP3A
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.4138830629245812,0.6471336390016813,0.9342105263157895,1.0,1.0,3/8,21.68%,SELENOS;SELENOT;IRS2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.4034863659645108,0.6468256022124018,0.9130434782608695,1.0,1.0,1/9,14.04%,MDM4
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.4124683133924859,0.6465269405670167,0.9041095890410958,1.0,1.0,2/8,11.06%,CTR9;ZBTB16
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3271754305265167,0.64515133833051,0.968421052631579,1.0,1.0,19/68,23.76%,CDC42EP4;NECTIN2;EGFR;SHC2;C1R;PRLR;SEMA3B;CST3;TBX3;NF2;PTH1R;ANGPTL4;C1QTNF1;GPX3;COL18A1;MATN2;TF;DIAPH2;FAM114A1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.37771629499189185,0.6446706300845857,0.9195402298850575,1.0,1.0,2/16,21.08%,OMG;NF1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.3324486365133438,0.644261359124301,0.9354838709677419,1.0,1.0,3/27,5.61%,SLC6A17;ATP1B3;SCN3A
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.4375772739065702,0.6435986844492245,0.9210526315789473,1.0,1.0,2/5,20.60%,NAA15;METAP1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.3180448736673536,0.6435854803662056,0.98989898989899,1.0,1.0,8/126,8.45%,ADAMTS9;CD44;COL4A6;ADAMTS4;ITGA5;SMOC1;MMP16;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3558343476786482,0.6433938576984146,0.9444444444444444,1.0,1.0,4/20,15.82%,FMN2;SPIRE1;SMCHD1;WDR48
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.32008075788165863,-0.6428706678550461,1.0,1.0,1.0,9/9,68.05%,CDC42;DYNC1I1;SPG11;DYNC1I2;ARHGAP21;APBA1;COPG2;BORCS5;APP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.28065467336031236,-0.6422961001658867,0.9047619047619048,1.0,1.0,2/14,5.65%,YWHAB;YWHAQ
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.4283531251148859,0.642265794135994,0.9523809523809523,1.0,1.0,2/7,12.24%,DGUOK;GMPS
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.3586342682247691,-0.6414437552810703,0.8846153846153846,1.0,1.0,1/7,8.59%,NTF3
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.4142198062466901,0.6407807718651104,0.8888888888888888,1.0,1.0,2/6,14.62%,ROBO2;FGFR2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.36255210024187423,0.6397251868283517,0.927536231884058,1.0,1.0,3/16,18.08%,RPS27A;RBX1;RPA1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.3755836644740823,0.6389836841831773,0.9014084507042254,1.0,1.0,3/9,23.36%,KANSL3;PHF20;JADE2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.3755836644740823,0.6389836841831773,0.9014084507042254,1.0,1.0,3/9,23.36%,KANSL3;PHF20;JADE2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.3640822123537278,0.6378431951343927,0.9195402298850575,1.0,1.0,2/18,9.31%,STMN1;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.3839958191166488,-0.6372407228098373,0.7931034482758621,1.0,1.0,1/6,8.89%,MSH6
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.411091764025615,-0.6370973196231393,0.8857142857142857,1.0,1.0,3/5,19.79%,ADAM19;FLOT1;DENND6A
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.36137845389630546,-0.6369411729425564,0.8387096774193549,1.0,1.0,6/6,63.91%,PSEN1;DYRK1A;IDE;APH1B;BACE1;BACE2
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3080583538965585,-0.636817400027201,1.0,1.0,1.0,1/17,2.65%,TTC7A
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.3674907619415384,0.6354488949339111,0.9222222222222223,1.0,1.0,3/17,15.11%,NEXMIF;CASK;NF2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.33576642335766427,-0.6351054946830568,1.0,1.0,1.0,9/9,66.49%,IWS1;SRPK1;SUPT6H;DHX9;SLTM;SAFB2;SAFB;NCBP1;SRPK2
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.3257087737690332,-0.6350831135543767,0.7916666666666666,1.0,1.0,2/6,13.29%,HOOK3;KIF3A
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.3256011905968698,0.6346817819516244,0.98,1.0,1.0,14/81,18.30%,CD44;GJA1;ITGA5;EMP1;EFNB2;C1R;HIF1A;EHD2;FGFR2;INSR;NF2;SVEP1;FBN1;PTH1R
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.38966697412942136,0.6342760298397953,0.935064935064935,1.0,1.0,4/14,11.10%,PPP1CC;CRY1;CLOCK;RBM4B
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.43323407972751105,0.6340932319251728,0.9264705882352942,1.0,1.0,3/5,31.85%,GOPC;JAM3;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3797040278790946,0.6335511986514168,0.8974358974358975,1.0,1.0,5/11,21.68%,ACSL4;GLUD1;SELENOT;MYRIP;IRS2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.38251952863820404,0.6333724499742504,0.9523809523809523,1.0,1.0,6/15,40.74%,UBN1;NAP1L1;ANP32B;MACROH2A1;RBBP4;SART3
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.3861092501267059,0.6331245914901661,0.9325842696629213,1.0,1.0,5/14,42.87%,ABL1;CAMSAP1;CTTN;ESAM;RASA1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.34431040235513627,0.6318634741556677,0.9340659340659341,1.0,1.0,3/32,9.21%,CDC42EP4;SSH1;CRACD
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.36435926788178746,0.631749609208115,0.9487179487179487,1.0,1.0,9/16,32.60%,SOAT1;ABCA1;LDLRAP1;MT3;ABCA5;OSBPL5;FDFT1;FDPS;INSIG2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.3045621478409555,-0.6315061212235593,0.9090909090909091,1.0,1.0,2/14,7.85%,SLIT3;HEYL
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.31388492238696974,0.6311890413849368,0.9534883720930233,1.0,1.0,16/36,38.93%,TGFB1;SMURF2;JUNB;SMAD7;SMAD6;UBE2D3;NCOR2;TRIM33;TJP1;RAB31;SMURF1;TGFBR1;BMPR1A;SMAD3;HIPK2;APC
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.3201863354037267,-0.6307207544187265,0.7916666666666666,1.0,1.0,8/8,68.04%,HMGB1;EXOG;DNASE1;KPNB1;FBH1;DICER1;KPNA1;CECR2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.34083179678767106,-0.6301451672424967,0.8095238095238095,1.0,1.0,1/9,3.06%,EVL
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.403003626192711,0.6298831050619209,0.8888888888888888,1.0,1.0,2/6,26.85%,VTA1;TMEM50A
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.28705254074054626,-0.6296479260111678,0.9411764705882353,1.0,1.0,2/13,8.64%,SYNE1;SUN1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.39022007556809346,0.6281317916878698,0.8985507246376812,1.0,1.0,1/8,12.00%,ASPA
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.4103816800439111,0.6280466727603592,0.9367088607594937,1.0,1.0,1/8,18.11%,LOXL3
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3270436121218243,0.627774402650199,0.9418604651162791,1.0,1.0,15/36,36.10%,MANBA;FBXO11;ABL2;ABL1;USP25;UBE2D3;UBE2L3;MSRA;PRKDC;UBA3;SERP1;PARP4;UBE2D2;PLOD2;CPE
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.3863041146297216,0.627630963115736,0.9382716049382716,1.0,1.0,1/6,15.00%,LRRK2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.41394349439886446,0.6271341444038314,0.9154929577464789,1.0,1.0,3/6,34.20%,LDLRAP1;OSBPL5;NPC1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.37555282088065145,0.6267986092973535,0.918918918918919,1.0,1.0,2/12,7.75%,ZFP36L2;ADAM17
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.36275778172500583,0.6265084464317253,0.9310344827586207,1.0,1.0,4/16,18.19%,PTPN1;CSF1R;SH3BP5;PRNP
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.320236061500233,-0.6255825033994014,0.8636363636363636,1.0,1.0,9/9,68.04%,HMGB1;EXOG;BLCAP;KPNB1;ACIN1;DICER1;KPNA1;GPER1;CECR2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.42334882804579016,0.6254062781845857,0.9692307692307692,1.0,1.0,3/6,15.62%,TMEM30A;WASHC2C;PACSIN2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.3547850113684522,-0.6242332294322226,0.9,1.0,1.0,1/7,4.16%,INPP5F
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.34625307782406495,0.6239994980031144,0.9230769230769231,1.0,1.0,1/15,4.90%,ETF1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.3627856910417504,-0.6239303518664431,0.8888888888888888,1.0,1.0,3/7,17.91%,HSPA1A;CLU;BCL2L1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.3792759890073283,0.6237087279511846,0.9166666666666666,1.0,1.0,1/10,5.74%,IFT140
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.3568024573532394,0.6232896745773856,0.9493670886075949,1.0,1.0,4/18,18.19%,GGA3;BTRC;MDM2;PRNP
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.3653507645627967,0.6232315375745715,0.9358974358974359,1.0,1.0,2/12,27.36%,TBX3;PCSK5
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.31234413431811225,0.6231113823324733,0.9438202247191011,1.0,1.0,4/36,14.52%,EGFR;RNF168;SMCHD1;BRCC3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.3815626588523105,-0.6228622612807079,0.8787878787878788,1.0,1.0,1/5,10.48%,ACACA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.327075830101777,0.6225519463782244,0.9555555555555556,1.0,1.0,5/22,20.52%,CAMKK2;PPARGC1A;SPIRE1;KDR;BNIP3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3033531339680587,0.622488478146623,0.9896907216494846,1.0,1.0,16/118,21.08%,MID1;CDC42EP4;WASF1;CSNK1D;CEP57;FARP1;ARHGEF7;CAPZB;RANBP9;PAFAH1B1;ATG4B;DOCK4;DST;CNTRL;ABL1;NF1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.4285227412769871,0.6221949669148685,0.8783783783783784,1.0,1.0,1/5,21.74%,MITD1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.29484841969443665,-0.6221392394250569,0.8888888888888888,1.0,1.0,3/11,11.88%,SLC9A1;CDC42;ACTG1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.3123865075413474,-0.6217931598833506,0.9047619047619048,1.0,1.0,1/9,2.40%,ST6GALNAC3
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.39695427065203104,0.6210356450994294,0.9444444444444444,1.0,1.0,1/7,23.08%,MT3
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.36256402297066587,-0.620989567047325,0.8064516129032258,1.0,1.0,5/5,63.79%,PCGF3;MECP2;DNMT3A;PRMT7;PCGF5
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.38068283351992854,0.6201962979049475,0.9459459459459459,1.0,1.0,5/10,38.97%,TRIM5;IRF1;CD55;APPL2;ERAP1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.4056603060437757,0.619844076817874,0.9420289855072463,1.0,1.0,1/5,15.87%,POMP
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.4177521082067614,0.6196812293095039,0.9324324324324325,1.0,1.0,1/5,17.74%,ZBTB1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.2890802780937355,0.6196811373116957,1.0,1.0,1.0,15/108,22.05%,GJA1;ARHGEF9;BCKDHB;MMP16;IRS1;DUSP1;F3;RUNX1;ACVR2A;ADORA2B;CDKN1B;SMAD7;TFPI;COL11A1;PTPRM
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.3225155279503106,-0.6190825267763437,0.9545454545454546,1.0,1.0,8/8,67.80%,APOE;CLU;LRP1;HDAC1;ROCK1;IFNGR1;MYOCD;LRPAP1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.3453213530582444,-0.6185223913211488,0.96,1.0,1.0,2/8,8.25%,RALBP1;SLCO1C1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.31870874978824315,0.6184135330354538,0.9204545454545454,1.0,1.0,8/34,22.57%,XRCC4;RNF168;BRCC3;TP53BP1;PSMD14;ZBTB7A;KDM2A;NSD2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.32758888371370903,-0.6171726397556729,0.8888888888888888,1.0,1.0,7/7,67.29%,ASXL3;PRKAA1;PPP2R5A;CCDC3;APOD;NCOR1;GPER1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.37036441826278843,0.6165557546174809,0.925,1.0,1.0,2/11,12.25%,SEMA4D;SEMA3B
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.3042883815468984,-0.6159866257267338,0.9473684210526315,1.0,1.0,1/10,1.66%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.24268633102826975,-0.6150415802069364,0.9166666666666666,1.0,1.0,5/18,15.80%,ATP2B4;HMGB1;PDCD10;APOE;THBS1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3449352960158895,0.6143560374958419,0.9036144578313253,1.0,1.0,4/19,31.98%,STAT3;TWIST1;PTPN11;APP
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.3449352960158895,0.6143560374958419,0.9036144578313253,1.0,1.0,4/19,31.98%,STAT3;TWIST1;PTPN11;APP
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.325465132293267,-0.6142815862207966,0.7916666666666666,1.0,1.0,2/7,13.29%,HOOK3;KIF3A
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.30351920469099447,-0.6142297279803033,0.8947368421052632,1.0,1.0,1/8,5.32%,CKAP5
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3115487166016773,0.6134019530732752,0.978494623655914,1.0,1.0,8/55,14.84%,CYTH1;SEMA4D;IL18;FRMD5;DUSP1;EPHA7;ROCK2;PPP3CA
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3397051111058578,-0.6129784222729522,0.92,1.0,1.0,3/7,17.73%,FLOT1;DAB2IP;APPL1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.3709008917515988,0.6125415529698751,0.9146341463414634,1.0,1.0,1/12,7.48%,DHX29
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.36096486128844707,-0.6124926630343651,0.8888888888888888,1.0,1.0,1/6,2.03%,ANKRD13A
prerank,PanglaoDB_Augmented_2021__Podocytes,0.2930378234685763,0.6124287077606921,0.98989898989899,1.0,1.0,19/125,22.88%,MID1;GJA1;ETF1;SMARCA1;ENPEP;EGFR;CORO2B;CCN2;THSD7A;TEAD1;LGR4;PTH1R;PLEKHH2;LIFR;DST;PROS1;KANK1;COL4A3;STARD13
prerank,MSigDB_Hallmark_2020__Apical Junction,0.30751910787330794,0.6123642667504007,1.0,1.0,1.0,13/73,22.19%,MPZL1;NECTIN2;SYMPK;EGFR;IRS1;CADM2;GNAI1;NF2;FBN1;NEGR1;NF1;LDLRAP1;JAM3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.36841409035172856,-0.610472824351661,0.9259259259259259,1.0,1.0,2/5,17.56%,DDX5;DDX17
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4044520215879712,0.6099680667584356,0.9558823529411765,1.0,1.0,3/6,31.70%,ATAD5;RAB11A;BRD4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.3587036852787012,0.6096801637759404,0.9390243902439024,1.0,1.0,4/17,20.55%,NR4A3;ROCK2;GLRX3;CAMK2D
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.3966053089200795,-0.6095713813362984,1.0,1.0,1.0,1/5,5.24%,NBL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.34784823830214406,-0.6074180497200716,1.0,1.0,1.0,1/6,3.24%,WDR75
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.37945834525073885,0.6073278710243957,0.9342105263157895,1.0,1.0,5/10,38.37%,NUP205;MALT1;NEMF;BACH2;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3872892043634348,0.6071276709712576,0.9523809523809523,1.0,1.0,2/11,13.45%,CCP110;CAPZB
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.30406489926100444,0.6066624354329089,0.9574468085106383,1.0,1.0,4/65,8.92%,DPM1;MTMR9;MTMR1;PIGL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.3558414090779123,0.6063128411457324,0.9736842105263158,1.0,1.0,3/11,14.39%,PDE4B;RUNX1;PDE4D
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3808399092501269,0.6059757493957123,0.9710144927536232,1.0,1.0,2/10,20.44%,RAB7A;EEA1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.41029555075506613,0.6059109653735576,0.9436619718309859,1.0,1.0,2/5,26.15%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.41029555075506613,0.6059109653735576,0.9436619718309859,1.0,1.0,2/5,26.15%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3312116693339645,0.6054496084189988,0.9545454545454546,1.0,1.0,9/22,32.23%,SDCBP;INSR;ARF1;TBC1D5;MTMR2;ANKRD13D;ATAD1;VEGFA;LRPAP1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.322757843487642,0.6047716177132917,0.9456521739130435,1.0,1.0,3/25,15.00%,PPARGC1A;SREBF1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.29980746716009876,-0.6047482442833279,1.0,1.0,1.0,5/16,15.54%,TNIP1;N4BP1;SETDB1;IFI16;SRPK1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.32566389100238613,-0.6046513941170661,0.8421052631578947,1.0,1.0,2/11,10.67%,EVC2;GLI2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2815157893533772,0.6046026802705844,1.0,1.0,1.0,10/97,18.08%,RAD21;DNMT1;DDX21;RPS27A;UHRF2;FAN1;USP3;TDG;ZBTB1;RPA1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.39716339838038683,0.60457566134836,0.9558823529411765,1.0,1.0,1/6,23.08%,MT3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.34598393584575715,-0.6043361083599144,0.8387096774193549,1.0,1.0,1/7,8.89%,MSH6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3059935883355256,0.6040404390847579,0.9895833333333334,1.0,1.0,11/48,20.83%,NRG1;NEDD4L;TMEM30A;TGFB1;RUNX1;INSR;NRXN1;LGALS3;ASAP1;BNIP3;FRMPD4
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.3246725676515569,0.6040161915465564,0.9534883720930233,1.0,1.0,6/22,31.70%,TMSB4X;BCL6;AREL1;CYLD;IRF1;BRD4
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.31152304516560664,-0.6038964306512423,0.8333333333333334,1.0,1.0,3/11,11.06%,AK5;RNASEH2B;CTPS2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3245598798783192,0.6021863638073964,0.9772727272727273,1.0,1.0,9/27,22.13%,PITPNC1;TMEM30A;SCARB2;ATP11A;ATP11B;SCARB1;ABCA1;ATP9B;PITPNA
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.33515337501768994,0.6017321564742607,0.9879518072289156,1.0,1.0,6/27,21.60%,CSF1R;PIGL;AGK;PAFAH1B1;DGKH;SERINC1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.30776680660053396,0.6006056363417244,0.9893617021276596,1.0,1.0,3/33,10.33%,PRKCI;TGFB1;CTNND2
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.38323670229739826,0.5997893335678645,0.935064935064935,1.0,1.0,1/5,18.58%,CSNK2A1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.4067843483781075,0.5994887793389504,0.9848484848484849,1.0,1.0,4/6,44.90%,MT3;HVCN1;PAM;MT2A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.36342097546285484,0.5991310044324909,0.9529411764705882,1.0,1.0,3/10,18.11%,ERRFI1;FGFR2;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.36396258315092034,0.5985358597456397,0.9518072289156626,1.0,1.0,5/13,38.65%,ZBTB1;MALT1;CD55;HSPD1;CYRIB
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.32430443217392657,-0.5985144002943282,0.967741935483871,1.0,1.0,2/7,16.16%,ANXA1;PIK3CD
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.3195010453352144,0.5981533455566772,0.945054945054945,1.0,1.0,9/31,21.88%,ACADVL;ERRFI1;TGFB1;PGK1;FGFR2;LGALS3;LOXL3;KDR;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.33317807793820836,-0.597723540863425,0.9354838709677419,1.0,1.0,7/7,66.73%,PPP1R12A;PDGFRB;CALM1;HSP90AB1;MAGI2;ITGA1;MTOR
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.34983703243830516,-0.5975389528231695,0.9090909090909091,1.0,1.0,5/5,65.06%,NEK4;NUAK1;MARCHF5;LMNA;PNPT1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3403400049975473,0.5970409485600722,0.9230769230769231,1.0,1.0,6/13,33.82%,GNAI1;GPSM2;CLTC;DRG1;MAP9;HNRNPU
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.3103010824393558,-0.5967379616681532,0.8636363636363636,1.0,1.0,1/8,3.57%,HDAC9
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.3709170776924488,0.5963319514660335,0.9529411764705882,1.0,1.0,3/8,37.73%,LGR4;IRF1;APPL2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.39484300544385814,0.5959365713236233,0.958904109589041,1.0,1.0,2/6,14.62%,ROBO2;FGFR2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.31103611312148405,0.5943997531003737,0.9512195121951219,1.0,1.0,4/23,17.54%,STK33;WAC;BRCC3;DONSON
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.38010191481129485,0.5943621127317911,0.9367088607594937,1.0,1.0,2/6,14.84%,AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.3515230248600003,0.5939611265309661,0.9625,1.0,1.0,2/10,19.88%,RNF168;SKP1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.34651393760924853,0.5928992532172374,0.9761904761904762,1.0,1.0,4/18,19.84%,SCD;FADS2;PTGR1;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.32376350649665486,0.5922721580643429,0.9620253164556962,1.0,1.0,1/21,3.09%,HABP4
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.30832438136544915,0.5915413536503054,1.0,1.0,1.0,1/32,2.47%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.3599255005432252,-0.5899545004999999,0.92,1.0,1.0,5/5,64.05%,FOXC1;NUMA1;PRKCH;NCOA3;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.3885003655149658,0.5896564099366916,0.9846153846153847,1.0,1.0,3/5,50.65%,ATL3;TMEM33;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.353525081863417,0.5894421370910272,0.925,1.0,1.0,2/10,14.42%,F3;STAT3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3550815383200191,0.5892258269859724,0.948051948051948,1.0,1.0,1/9,11.91%,NLGN1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.34496178963118757,0.5889001213508175,0.961038961038961,1.0,1.0,4/16,26.71%,NIBAN2;TNKS;TOM1L1;RGCC
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.34463748758876545,0.5876613903090002,1.0,1.0,1.0,4/14,17.56%,PDE4B;PPIB;ADGRE2;LGALS3
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.38602201709051154,0.5852303441430273,0.9620253164556962,1.0,1.0,2/6,29.02%,GNAI1;ADCY5
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.38602201709051154,0.5852303441430273,0.9620253164556962,1.0,1.0,2/6,29.02%,GNAI1;ADCY5
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.30247663857090656,-0.5851183291401452,0.9310344827586207,1.0,1.0,3/6,15.80%,ST3GAL4;APOE;THBS1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.3878048533957694,0.5846416328553676,0.9253731343283582,1.0,1.0,1/6,13.96%,MDM2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.3143877414981814,0.5838234928644136,0.9560439560439561,1.0,1.0,3/42,7.55%,AMFR;STK4;STMN1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.3287068805273716,0.5828700643911372,0.9540229885057471,1.0,1.0,5/17,28.71%,LIX1L;MAP1LC3B;LAMP2;VMP1;UBQLN1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.37204124976608055,0.5828156969111412,0.9135802469135802,1.0,1.0,3/8,37.73%,FBN1;GSK3B;APPL2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.32499766497309623,0.582726837217701,0.9886363636363636,1.0,1.0,2/32,6.54%,AMFR;STK4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.29880837552956935,0.5826782579936445,0.9895833333333334,1.0,1.0,7/51,15.74%,SMARCA1;TACC2;EGFR;F3;CCN2;SEMA3B;TEAD1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.3799565946789078,0.5823698644637472,0.9508196721311475,1.0,1.0,3/5,40.87%,C1QTNF1;LYN;PRKCA
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.33967904554949147,0.5816809184738403,0.9571428571428572,1.0,1.0,3/12,23.36%,KANSL3;PHF20;JADE2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.3051586999531126,0.5813944159802303,0.967032967032967,1.0,1.0,3/33,12.44%,RHOB;CORO2B;ROCK2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.37820477311353407,0.5812688976825595,0.9565217391304348,1.0,1.0,1/6,21.08%,NF1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3717499922110582,0.5810713766648195,0.9571428571428572,1.0,1.0,1/8,9.04%,AGTPBP1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.3214415533567783,-0.5806253126180142,1.0,1.0,1.0,2/11,14.04%,CHMP4B;RMDN1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.40846727524356463,0.5796816570572844,0.9428571428571428,1.0,1.0,4/5,26.38%,GUK1;EPOR;CCND3;RASSF1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3757730786487712,0.5788901685217982,0.9436619718309859,1.0,1.0,3/8,28.18%,NF2;PTPN2;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3189018742178452,0.5788201860707946,0.9770114942528736,1.0,1.0,7/22,25.29%,CRY1;NXN;DNAJA1;SMAD7;ABL1;SENP2;MARCHF7
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.3689185295063876,0.5782612335512597,0.9452054794520548,1.0,1.0,2/8,12.76%,GRIN2B;TSHZ3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.26652548669868936,-0.578090545916043,1.0,1.0,1.0,5/12,15.73%,MYLK;ANXA1;ITGB1;ACTG1;PTK2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.3920113050186259,0.5777752075367955,0.9696969696969697,1.0,1.0,1/5,30.38%,VEGFA
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.34873782186012214,0.5776373013433322,0.9615384615384616,1.0,1.0,5/11,26.99%,SOAT1;ABCA1;LDLRAP1;ABCA5;OSBPL5
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.3210632161706599,-0.5775586694815676,0.8333333333333334,1.0,1.0,1/11,2.33%,ATM
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.32008692952499224,-0.5774418539832735,0.9666666666666667,1.0,1.0,6/6,68.04%,HMGB1;EXOG;KPNB1;DICER1;KPNA1;CECR2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.3703706708993222,0.5771820585585757,0.9135802469135802,1.0,1.0,3/8,23.43%,SMAD7;JAM3;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.27317872261135545,-0.5766352659056757,0.8888888888888888,1.0,1.0,4/16,13.49%,NCK1;DOCK8;ANXA1;IL7
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.29668034712177416,0.5762290425302579,0.978021978021978,1.0,1.0,4/38,13.96%,AMFR;RNF10;UHRF2;MDM2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.3696978518618288,0.5744304037961612,0.9428571428571428,1.0,1.0,3/6,31.37%,PDK4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3038085733502126,0.5741561609367544,0.9578947368421052,1.0,1.0,5/33,20.84%,ITGA5;ERBIN;DST;ABL1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.379067136041658,0.5740253347103789,1.0,1.0,1.0,3/7,28.18%,NF2;PTPN2;SH2B3
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.31956521739130433,-0.5730646931071259,1.0,1.0,1.0,8/8,68.10%,NSL1;INO80;LATS1;TOP2B;RB1;KLHL22;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.37925870971984527,0.5716268553214635,0.9855072463768116,1.0,1.0,2/7,38.80%,GPER1;LYN
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.3211994942837945,-0.5712449505101318,1.0,1.0,1.0,1/7,2.73%,POLDIP3
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.3079367722745535,0.5705247887092298,0.9772727272727273,1.0,1.0,6/28,19.14%,PTPN1;CASK;LPCAT3;TWIST1;BRAP;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3208109750082788,-0.570316078785974,0.8846153846153846,1.0,1.0,3/5,22.33%,BIN1;ATP1A2;YWHAE
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.3107730518472524,-0.5679031012164897,1.0,1.0,1.0,6/6,68.97%,ESCO1;EP300;KAT7;SIRT1;CREBBP;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2875941421619984,-0.5669683771409281,1.0,1.0,1.0,5/12,20.18%,DAB2IP;PTEN;CLU;PTK2;PSMC2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.35230605847428875,0.566891585757232,0.9726027397260274,1.0,1.0,2/11,15.69%,IL18;IGFBP2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.3434425088892535,0.5654985975505075,0.95,1.0,1.0,3/8,33.87%,RPS14;PRKDC;XRCC5
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.3107730518472524,-0.5637770157406513,0.896551724137931,1.0,1.0,6/6,68.97%,BRCA1;ALMS1;TRIM37;CEP295;CDK5RAP2;KAT2B
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.31282426431319654,0.5631666263922999,0.95,1.0,1.0,2/16,17.71%,RPS27A;ANAPC4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.3126805854412194,0.5629390883684245,0.9662921348314607,1.0,1.0,4/18,20.52%,SPIRE1;LRRK2;KDR;BNIP3
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.3257192617843092,0.5607322495060215,0.9411764705882353,1.0,1.0,2/15,12.25%,SEMA4D;SEMA3B
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.2799034577597568,0.5603739187328424,1.0,1.0,1.0,11/70,20.01%,GJA1;TACC2;EGFR;C1R;PRLR;PDE8A;SVEP1;LIFR;ADGRF5;KDR;C1QTNF1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3037582987395067,0.560276410119803,0.9772727272727273,1.0,1.0,8/27,28.58%,TRIOBP;WASHC2C;ARHGEF7;ABL1;KANK1;P4HB;NEDD9;CRK
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.28301677004357434,0.5601843822445902,1.0,1.0,1.0,14/51,30.09%,CRY1;NDFIP2;NXN;NDFIP1;LRRK2;DCUN1D1;DNAJA1;SMAD7;RCHY1;SENP2;UBE2L3;UBQLN1;UBE3A;MALT1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.3374745039598817,0.5600344879520357,0.9634146341463414,1.0,1.0,3/13,18.30%,EGFR;SDCBP;PTH1R
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.31460077172390977,0.5583796634486138,0.945054945054945,1.0,1.0,2/17,10.31%,SNAP25;GLUL
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.3140281090019527,0.5567837557500399,1.0,1.0,1.0,3/23,12.56%,ACSL4;FADS2;ACADL
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3560612801180211,0.5566944298931019,0.9253731343283582,1.0,1.0,3/5,25.43%,TWIST1;UBR5;TRIP12
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.35141293283269337,0.5563507116746483,0.9571428571428572,1.0,1.0,3/7,36.76%,PRKDC;POT1;TERF1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.3188702737736083,-0.5562233178660348,0.9259259259259259,1.0,1.0,1/5,6.67%,ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.3188702737736083,-0.5562233178660348,0.9259259259259259,1.0,1.0,1/5,6.67%,ATG5
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.32507426285669494,0.5561737102051197,0.9333333333333333,1.0,1.0,4/13,25.84%,ANAPC4;UBE2B;UBE2D3;UBE2L3
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.32674950786654877,-0.5558222528800159,0.8846153846153846,1.0,1.0,2/6,18.10%,CENATAC;BRCA1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.35835518259472576,0.5555369198868062,0.9722222222222222,1.0,1.0,1/6,33.82%,HNRNPU
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.3572858042198094,0.5554809809120101,0.9871794871794872,1.0,1.0,1/6,12.22%,ABCC9
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.19134901138101365,-0.555145827666642,1.0,1.0,1.0,5/28,16.63%,CEP192;NSL1;CHMP4B;PPP2R2D;FLNA
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3445624296800162,-0.5550251574738077,0.8181818181818182,1.0,1.0,1/5,7.13%,RAD51B
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.2987738631072482,-0.5547506015419609,1.0,1.0,1.0,5/5,70.16%,ITGB1;JAM2;ROCK1;VCAM1;GOLPH3
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2987738631072482,-0.5547506015419609,1.0,1.0,1.0,5/5,70.16%,ITGB1;JAM2;ROCK1;VCAM1;GOLPH3
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.3255969089702691,0.5543449000890976,0.96,1.0,1.0,5/14,27.95%,PRKCI;PDCD4;KDR;RGCC;PLCG1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.33003831393240646,0.5513904278892202,0.9625,1.0,1.0,4/13,27.40%,TBX3;MAP2K1;MAPKAPK5;KAT6A
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.3098897686694613,-0.5513129242901381,1.0,1.0,1.0,7/7,69.06%,SLC25A21;PHYKPL;OGDH;AASS;ALDH7A1;DLD;DLST
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.3098897686694613,-0.5513129242901381,1.0,1.0,1.0,7/7,69.06%,SLC25A21;PHYKPL;OGDH;AASS;ALDH7A1;DLD;DLST
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3616437997739421,0.5511419545503045,0.958904109589041,1.0,1.0,1/5,19.31%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.3267914161725187,0.5509288448546213,0.972972972972973,1.0,1.0,4/11,44.96%,YPEL3;TGFB2;MAVS;SIRT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3156200900124515,0.5499830308301803,0.9577464788732394,1.0,1.0,2/14,15.79%,RPS27A;RBX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.28804781000624124,-0.5499028276046282,0.9142857142857143,1.0,1.0,2/10,10.47%,DDB2;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.28804781000624124,-0.5499028276046282,0.9142857142857143,1.0,1.0,2/10,10.47%,DDB2;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.31936771725455404,0.5488068815261898,0.9855072463768116,1.0,1.0,2/14,15.79%,RPS27A;RBX1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.29944213889953897,0.5475482073590731,0.9883720930232558,1.0,1.0,2/20,9.31%,C1GALT1;TRAF3IP1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.31988204252677327,-0.5456808128431747,0.9523809523809523,1.0,1.0,5/5,68.05%,CLU;JAK2;IFNGR1;CRTC3;APP
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.32219432768565126,0.5448170967109419,0.9864864864864865,1.0,1.0,6/14,30.18%,PDCD4;PER1;DNAJA1;TAOK3;CYLD;AIDA
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.3328182357007759,0.5444379757111073,0.9722222222222222,1.0,1.0,5/9,43.46%,SGPP1;ABCD3;PRKAA2;PRKAG2;PLEKHA8
prerank,MSigDB_Hallmark_2020__Coagulation,0.28736329482387807,0.5441897520411407,0.9883720930232558,1.0,1.0,10/35,25.54%,F3;C1R;CFH;CD9;ARF4;FBN1;PROS1;TF;LAMP2;RGN
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.2984008694302127,-0.5440241002625321,1.0,1.0,1.0,7/7,70.21%,STX5;LMAN1;SNX1;TRAPPC10;SNX2;RAB6A;SURF4
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.2740159132817919,-0.5439520530810444,1.0,1.0,1.0,1/15,3.94%,SHQ1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.3506540957268553,0.5419493725383101,0.9859154929577465,1.0,1.0,1/8,14.73%,TRIM5
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.3197878183740913,0.5409589433466501,0.9540229885057471,1.0,1.0,2/16,23.70%,SMARCA4;LEF1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.31291592133295776,0.5404236713128727,0.9605263157894737,1.0,1.0,1/8,12.70%,DEAF1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.31287035937678775,0.5400978319156363,0.9358974358974359,1.0,1.0,6/11,42.00%,STAT3;MALT1;APP;HSPB1;GSTP1;LPL
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.315520605834672,0.5396712904703851,0.974025974025974,1.0,1.0,4/11,27.95%,PRKCI;PDCD4;RGCC;PLCG1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.30407773152150175,0.5396032029570421,0.9666666666666667,1.0,1.0,6/20,25.00%,EIF2AK4;C9ORF72;NRP2;CYFIP1;ALCAM;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.32208155722364173,0.5395053080826926,0.96,1.0,1.0,4/10,21.68%,ACSL4;GLUD1;MYRIP;IRS2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3027709924207421,0.5392041621704673,0.9629629629629629,1.0,1.0,3/16,25.29%,PSME3IP1;CSNK2A1;MARCHF7
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.30835902756066524,-0.5390172702267665,1.0,1.0,1.0,1/5,8.59%,NTF3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3164454744873275,0.5384850915195132,0.9875,1.0,1.0,2/14,12.17%,CTNNA2;ULK4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.3559917981305658,0.5339011796907832,1.0,1.0,1.0,2/6,40.68%,HDAC5;FRS2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.2961813101521267,-0.5336329568297206,0.9565217391304348,1.0,1.0,6/6,70.42%,DLG2;MAP1A;MAPK8IP3;KIF5B;HSPB1;KIF5C
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.2961813101521267,-0.5336329568297206,0.9565217391304348,1.0,1.0,6/6,70.42%,DLG2;MAP1A;MAPK8IP3;KIF5B;HSPB1;KIF5C
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.2961813101521267,-0.5336329568297206,0.9565217391304348,1.0,1.0,6/6,70.42%,DLG2;MAP1A;MAPK8IP3;KIF5B;HSPB1;KIF5C
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.34193548539019103,0.5331433626626371,0.9852941176470589,1.0,1.0,1/6,22.72%,SGPP1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.30104021114733737,-0.5301306567035469,0.8571428571428571,1.0,1.0,7/7,69.94%,TRAF6;HLA-E;B2M;MAP3K7;HLA-A;CD55;MALT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.2891063958663537,0.529768555099749,1.0,1.0,1.0,7/19,33.37%,GOLGA2;RAB11A;LSM14A;MAP9;ZNF207;SMC1A;SMC3
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.3749845433227585,0.5294131864557025,0.9565217391304348,1.0,1.0,1/5,31.13%,QDPR
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2997561464623312,0.5277622144418989,0.9647058823529412,1.0,1.0,6/18,28.58%,TRIOBP;ARHGEF7;ABL1;P4HB;NEDD9;CRK
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.31855860023114146,0.5273022869103902,0.9565217391304348,1.0,1.0,4/8,27.95%,PRKCI;PDCD4;RGCC;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.31841969438633466,0.5251945780584069,0.974025974025974,1.0,1.0,6/12,33.53%,NAV3;SLAIN2;DRG1;PAK1;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.32620585174316985,0.5244089538691636,0.9873417721518988,1.0,1.0,2/8,31.84%,STARD13;HDAC5
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.2841112490846663,-0.5241038208290916,0.9411764705882353,1.0,1.0,3/6,17.80%,SNX27;PIK3CD;PRDX1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3237117272979423,-0.5241004486466325,0.9666666666666667,1.0,1.0,3/5,20.18%,ATF7IP;HMGB1;PSMC2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3108095487060318,0.5235902918603815,0.9880952380952381,1.0,1.0,3/10,21.68%,CHST15;HK1;IRS2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.3550157526042026,0.5226920784010487,0.9841269841269841,1.0,1.0,2/5,30.38%,CAMK2D;VEGFA
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.25361001288497137,-0.5222717035144575,1.0,1.0,1.0,2/8,15.20%,NEXN;PALLD
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.2778007451510358,0.5222699351894056,0.987012987012987,1.0,1.0,3/26,18.08%,RPS27A;RBX1;RPA1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3060999921422939,0.5215755668363978,0.975,1.0,1.0,2/16,12.25%,SEMA4D;SEMA3B
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.27267080745341615,-0.5210321272110608,0.9565217391304348,1.0,1.0,8/8,72.78%,CELF1;BRCA1;UBR3;RICTOR;TGFB2;STOX2;FGFR1;USP22
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.30223774002560955,0.5198308100914758,1.0,1.0,1.0,3/15,36.74%,PAFAH1B1;FYCO1;RAB1A
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.27404068764976247,-0.5184638831446526,1.0,1.0,1.0,1/14,3.94%,SHQ1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.27404068764976247,-0.5184638831446526,1.0,1.0,1.0,1/14,3.94%,SHQ1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.29707202705334956,0.5180134741305583,0.975609756097561,1.0,1.0,9/16,40.04%,DUSP1;PER1;TAOK3;CYLD;AIDA;DLG1;FOXO1;NCOR1;GSTP1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.30669653241178296,0.5136600126898968,0.9876543209876543,1.0,1.0,2/9,25.82%,SLC22A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3059480260731881,0.5133084123293254,0.948051948051948,1.0,1.0,6/11,32.23%,SDCBP;ITGAV;MTMR2;ANKRD13D;APP;LRPAP1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.27054961838978997,0.5113300473151248,0.989010989010989,1.0,1.0,2/29,13.43%,NECTIN2;BCL6
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.28021549687645686,0.5105150983591422,1.0,1.0,1.0,12/43,34.21%,DIAPH1;SCARB2;PDE4DIP;MAPK1;USP6NL;TJP1;SURF4;GOLPH3;PISD;RDX;AKAP9;TAOK1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.342141372777319,0.5053416902470105,1.0,1.0,1.0,2/5,30.38%,CD81;VEGFA
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.2853022737730035,0.5051072733854391,0.9880952380952381,1.0,1.0,2/18,21.42%,PPP6R2;BOD1L1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.29866501086619063,-0.5043248158178257,0.9666666666666667,1.0,1.0,6/6,70.18%,TRPM7;DNM1L;RIPK1;ITPK1;IPMK;CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.29866501086619063,-0.5043248158178257,0.9666666666666667,1.0,1.0,6/6,70.18%,TRPM7;DNM1L;RIPK1;ITPK1;IPMK;CYLD
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.25969370459855134,0.504133455931674,1.0,1.0,1.0,13/60,27.95%,CSF1R;MTMR9;MTMR1;PLAAT3;PIP4P2;ARF1;RUFY1;MTMR2;PIP5K1C;PIP5K1A;PLEKHA1;RAB14;PLCG1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.33642438432866134,0.5040041729325454,0.958904109589041,1.0,1.0,1/5,19.43%,RBPJ
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.2726984550662652,0.5025977661743021,0.9886363636363636,1.0,1.0,8/26,32.82%,PPIB;MT3;GRM5;PUM3;SPRED1;CCDC88A;KAT2B;NDUFS4
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.30588419880968554,-0.501331958277851,0.9166666666666666,1.0,1.0,1/6,4.85%,EPHA5
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.25894269591209174,0.5011661896891476,1.0,1.0,1.0,15/42,31.62%,GARNL3;TBC1D15;SIPA1L2;RALGAPA2;TBC1D8;TBC1D5;RABGAP1L;USP6NL;TBC1D4;PIP5K1A;TIAM2;ABR;RALGAPB;ARHGAP42;RANGAP1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.27398237508596684,0.5009000778250512,1.0,1.0,1.0,5/23,23.26%,TGFB1;DEAF1;FGFR2;ALDH1A2;FUT8
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.2841319579731536,-0.5004613661060645,1.0,1.0,1.0,1/5,7.12%,CXCL12
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.31866059835657917,0.49859242200231646,0.9571428571428572,1.0,1.0,1/5,24.69%,COL4A1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.2996943093540426,0.49791002008583374,0.9866666666666667,1.0,1.0,3/10,31.98%,STAT3;MALT1;APP
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.34402791717292647,0.49759549689672816,0.9846153846153847,1.0,1.0,1/5,15.56%,C9ORF72
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.2739030908481082,0.49701303901560306,1.0,1.0,1.0,3/21,20.19%,EIF2AK2;TRIM5;IFITM3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.2935473579344612,-0.4941151423821362,0.9428571428571428,1.0,1.0,2/5,11.51%,MYLK;SLC4A11
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.2825209562247749,-0.4930088491910386,1.0,1.0,1.0,6/6,71.79%,PLEKHA3;SLC27A1;CERT1;DISP1;PLEKHA8;SLC19A1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.3259876826680431,0.492038483443555,1.0,1.0,1.0,3/6,32.60%,FDFT1;FDPS;INSIG2
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.2821869102534945,0.49175205871200717,0.972972972972973,1.0,1.0,6/13,43.25%,VAV3;RDX;MTOR;PRR16;LARS1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3033200265397809,0.4907262925518192,0.9863013698630136,1.0,1.0,2/9,28.29%,UNC5B;MCL1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.3033200265397809,0.4907262925518192,0.9863013698630136,1.0,1.0,2/9,28.29%,UNC5B;MCL1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.28713332298618655,-0.4905128428572797,1.0,1.0,1.0,5/5,71.32%,PKD2;CALM1;GNB5;FMR1;UBQLN1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.27394207284149236,0.4870744403582426,0.9743589743589743,1.0,1.0,4/16,33.30%,VAV3;AP2M1;RDX;MTOR
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.2982217865569743,0.48546714841639876,0.9879518072289156,1.0,1.0,1/12,13.80%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.2982217865569743,0.48546714841639876,0.9879518072289156,1.0,1.0,1/12,13.80%,TBX3
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.3166881298767357,0.48468007143224234,0.9864864864864865,1.0,1.0,2/5,28.94%,WDR19;ARL13B
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.32747960760455047,0.4834822477066109,1.0,1.0,1.0,2/5,22.72%,SPTLC3;SGPP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3221584772132633,0.48164822853839445,0.9863013698630136,1.0,1.0,2/5,30.38%,JCAD;VEGFA
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.2733837972731935,0.4814586807447837,1.0,1.0,1.0,4/21,28.94%,RPS27A;WDFY3;UBQLN1;ARL13B
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.1952741117576342,-0.48069494439186866,1.0,1.0,1.0,5/26,15.73%,QRICH2;GLMN;PTEN;CLU;PTK2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.3127603900812104,0.4804308879867935,1.0,1.0,1.0,2/6,33.30%,IQSEC1;MTOR
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.28826871417126027,0.47764445530765165,0.9772727272727273,1.0,1.0,3/11,39.98%,PAFAH1B1;CEP120;SUN2
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.28717789506364483,-0.4773562175723906,1.0,1.0,1.0,6/6,71.32%,SVIP;NFE2L2;HERPUD1;CAV1;USP14;UBQLN1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.3152321103910828,0.47683272491205814,1.0,1.0,1.0,2/5,38.83%,AP2M1;RAB5A
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.27245490360231084,0.47314671090714633,0.9861111111111112,1.0,1.0,5/14,30.18%,PDCD4;DNAJA1;TAOK3;PAK1;AIDA
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.2648976405696356,-0.4730577136952664,1.0,1.0,1.0,1/5,7.17%,IPPK
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.28663444085225326,0.47265229394576225,1.0,1.0,1.0,1/8,25.51%,SMG7
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3063795145841902,0.47163393670865844,0.9859154929577465,1.0,1.0,2/8,33.30%,ELL;MTOR
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.2970719863266375,0.4714923328884223,1.0,1.0,1.0,3/10,23.03%,LRRK2;ABCA1;TMEM106B
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.3082878240388209,0.47094790436674233,0.9876543209876543,1.0,1.0,2/7,29.02%,PDE4D;ADCY5
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.3311509760488395,0.469469335420012,0.987012987012987,1.0,1.0,1/5,18.80%,GOLGA2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.3123688825333085,0.4643477271723523,0.9705882352941176,1.0,1.0,1/5,21.34%,SNCAIP
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.3213277155435878,0.4632645589530324,1.0,1.0,1.0,2/5,33.10%,AXL;NR1H3
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.28092503492162035,-0.4601596223762297,1.0,1.0,1.0,5/5,71.94%,MRE11;RAD9A;RAD17;ATF2;NEK11
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.29905667793773205,0.4576330350620235,0.9852941176470589,1.0,1.0,3/5,34.62%,AXL;RO60;IFNAR1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.2346227468546905,-0.457255287307505,1.0,1.0,1.0,3/5,19.77%,CDC42;APPL1;ANKFY1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.1855252918287938,-0.4562027444920955,1.0,1.0,1.0,23/23,81.53%,ACTN4;TANC2;MYO1D;DYNC1I1;HTT;MYO1E;NDE1;MYO1B;WASL;CCDC186;FBXW11;MYO5A;NDEL1;TRAK2;FNBP1L;MYO6;TRAK1;MYO19;KIF5B;MYO1C;RAB1A;PPFIA2;PAFAH1B1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.27732885583268446,0.4536885797980428,1.0,1.0,1.0,3/9,30.63%,SPG7;PMPCB;MICU1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.27743822239651417,0.4510618071317323,1.0,1.0,1.0,1/6,20.19%,IFITM3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.25222902083241244,0.4487238223430333,0.9871794871794872,1.0,1.0,4/14,34.48%,MDM2;USP22;APP;EIF4E
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.27393535814477654,0.44618299969151015,0.9863013698630136,1.0,1.0,1/6,23.09%,AXL
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.303234123901916,0.4445822800760325,0.9857142857142858,1.0,1.0,1/5,26.27%,PGM3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.2699426677085719,0.4383953464233483,1.0,1.0,1.0,2/11,33.30%,ELL;MTOR
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.29116369312493784,0.4369587319192768,0.9855072463768116,1.0,1.0,1/5,16.63%,SCARB1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2103464346745378,-0.4342391652872131,1.0,1.0,1.0,11/11,79.02%,CIRBP;SNW1;NCL;DAZAP1;NUP98;THRAP3;PRDX6;RBMX;NCBP1;TRA2B;TRA2A
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.24247128221049363,-0.42074088979898067,1.0,1.0,1.0,6/6,75.79%,SPTLC2;ARID5B;ZNF516;PGRMC2;NAMPT;SH3PXD2B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.24639795539306591,0.4205907863253677,1.0,1.0,1.0,3/13,31.98%,STAT3;MALT1;APP
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.3017394497684003,0.4194646969860828,1.0,1.0,1.0,2/5,32.49%,PLP1;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.21041181041181042,-0.4154570330638315,1.0,1.0,1.0,13/13,79.02%,CIRBP;SNW1;NCL;DAZAP1;DHX36;CDC73;NUP98;THRAP3;PRDX6;RBMX;NCBP1;TRA2B;TRA2A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.21214068309994916,0.41438675914244827,1.0,1.0,1.0,2/62,7.48%,STRAP;DHX29
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.2585831473140236,0.41072114901391854,1.0,1.0,1.0,2/9,26.18%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.2585831473140236,0.41072114901391854,1.0,1.0,1.0,2/9,26.18%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.2585831473140236,0.41072114901391854,1.0,1.0,1.0,2/9,26.18%,RBBP7;CENPP
prerank,MSigDB_Hallmark_2020__Apical Surface,0.2415097957838673,0.40458446291707234,1.0,1.0,1.0,7/14,42.26%,DCBLD2;ATP8B1;APP;HSPB1;LYN;ADAM10;NCOA6
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.20984777881329605,-0.4001522611682147,1.0,1.0,1.0,10/10,79.06%,AKR1C3;TRERF1;NR3C1;URI1;ATP1A2;ABHD2;ATP1A1;GPER1;UBE2L3;TFPI
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.21083682657972364,-0.3966666388104879,1.0,0.9996718832474999,1.0,7/7,78.95%,SKI;DAB2IP;MORC3;CDC73;GSTP1;FTH1;NF1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.24609264338668374,0.39203998851855687,1.0,1.0,1.0,2/10,26.18%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.24878774944633655,0.39128321118472137,1.0,1.0,1.0,2/10,26.18%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.26519859498445614,0.3828658974895909,1.0,0.9999169773349708,1.0,2/5,31.27%,ETS1;NFAT5
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.22838605449524743,0.37828071169332633,1.0,0.9996521775424952,1.0,4/11,37.97%,NF1;ETS1;EMP2;RNH1
